CN107109488A - The method predicted the method for the reaction to breast cancer treatment agent and treat breast cancer - Google Patents

The method predicted the method for the reaction to breast cancer treatment agent and treat breast cancer Download PDF

Info

Publication number
CN107109488A
CN107109488A CN201580068041.7A CN201580068041A CN107109488A CN 107109488 A CN107109488 A CN 107109488A CN 201580068041 A CN201580068041 A CN 201580068041A CN 107109488 A CN107109488 A CN 107109488A
Authority
CN
China
Prior art keywords
substrate
score
breast cancer
barycenter
grader
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201580068041.7A
Other languages
Chinese (zh)
Inventor
A·C·彼得森
H·乌帕尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mai Diweixun Prostate Treatment Ltd Co
Medivation Prostate Therapeutics LLC
Original Assignee
Mai Diweixun Prostate Treatment Ltd Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mai Diweixun Prostate Treatment Ltd Co filed Critical Mai Diweixun Prostate Treatment Ltd Co
Publication of CN107109488A publication Critical patent/CN107109488A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/41661,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/106Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/112Disease subtyping, staging or classification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers

Abstract

There is provided the method for the method that triple negative breast cancer is treated using androgen receptor inhibitor, and the possibility for the validity of screening this treatment.

Description

The method predicted the method for the reaction to breast cancer treatment agent and treat breast cancer
The cross reference of related application
This application claims the rights and interests of following U.S. Provisional Application, the entire disclosure is incorporated herein by reference:2014 No. 62/091,195 submitted on December 12, in;No. 62/142,504 submitted on April 3rd, 2015;With May 27 in 2015 No. 62/167,110 submitted day.
Sequence table
The application includes the sequence submitted and be incorporated herein by reference in their entirety with ASCII fromat by EFS-Web List.The ASCII is copied to be created in 12/04/2015, is named as 212181_0001_00_WO_SeqListing_ST25, greatly Small is 262,467 bytes.
Invention field
This area is related to breast cancer treatment.
Background of invention
Breast cancer is considered as the disease of genetic heterogeneity and bio-diversity.Have shown that the clinic approved for a long time It is related to the difference of gene expression to phenotypic difference.Tumor of breast research in the past has identified related from different clinical effectivenesses Breast cancer five kinds of different subtypes:Tube chamber A (ERs (ER)+));Tube chamber B (ER+);HER2 is overexpressed;Normal breast Sample;With substrate sample.Referring to Perou et al. .Nature, 406 (6797):747-52(2000);Sorlie et al. .PNAS, 98 (19):10869-74(2001)。
Breast cancer biopsy and the analysis of specimens from pri generally include core and cell surface receptor (ER, PgR and HER2 assessment), HER2 gene magnification (if by the HER2 of immunohistochemistry (IHC) analysis not being to determine property), And other prognosis tests such as capilary invasion and attack and proliferation marker.For the targeting ER signal transduction pathway of ER+ diseases Endocrine therapy and HER2 targeted therapies for HER2+ diseases play a crucial role in the treatment of most of patient with breast cancers. However, lacking the effective of the patient of these acceptors (i.e. so-called " three is negative " breast cancer or " TNBC ") for its disease in identification Almost it is not in progress in terms of targeted therapy, and nonselective cytotoxic chemotherapy is still main therapeutic choice.
Androgen receptor (AR) is the nuclear hormone receptor of most common expression in breast cancer, although its originate or drive it is pernicious Function in tumour is unclear.In the research of 3093 breast cancer, in 77% aggressive tumor of breast and all AR expression (more than 10% IHC nuclear stainings) (Collins et al., Mod Pathol 2011 is observed in molecular phenotype;24 (7):924-931).However, Androgen Receptor Level is not assessed routinely, because they not yet show prediction to making at present The reaction of therapy.
The part for using AR inhibitor as the therapeutic scheme for treating breast cancer is proposed.See, e.g., Garay and Park,Am.J.Cancer Res.2012;2(4):434-445.Generated recently in terms of TNBC treatments emerging Interest.Whole miss predictions of ERs, progesterone receptor and HER2 three's expression will not be to available endocrine (tamoxifen Sweet smell, aromatase inhibitor) and anti-HER2 (Herceptin) targeted therapy react.10 to 35% such TNBC tumours table Up to androgen receptor (Ogawa et al., Int J.Clin, Oncol.2008;13:431435).AR targeted therapies may be proved to be Include the valuable treatment of three negative cancers for most of breast cancer.
Suppress despite the presence of by androgen receptor signal transduction as treating the side that breast cancer particularly treats TNBC The interest of formula, but still need to predict whether individual patient has reaction before treatment.Prediction particular patient is particularly Whether the test of possibility reacted to the treatment that suppresses androgen receptor signal transduction will be plan patient to TNBC patient The valuable instrument for the treatment of.
Summary of the invention
It is used for the method for the treatment of triple negative breast cancer there is provided screening in one embodiment, the treatment includes Using androgen receptor inhibitor, methods described includes determining the biological sample obtained from subject, to determine to obtain from subject Whether the biological sample obtained is classified as substrate sample hypotype or another hypotype.If biological sample is classified as not be substrate sample Hypotype, then when sample is classified as substrate sample hypotype compared with, the breast cancer treatment comprising androgen receptor inhibitor is more likely It is effective.
Additionally provide the screening treatment three comprising androgen receptor inhibitor in the subject for needing this treatment negative The method of the possibility of the validity of breast cancer treatment.This method includes:
The biological sample obtained from subject is determined, to determine whether biological sample is classified as substrate sample hypotype or another Plant hypotype;With
If wherein biological sample is classified as not be substrate sample hypotype, substrate sample hypotype phase is classified as with sample Than the breast cancer treatment comprising androgen receptor inhibitor is it is more likely that effective.
Additionally provide the possibility that the classifying biological samples from subject are treated to validity for triple negative breast cancer patient Property finger calibration method, the treatment includes androgen receptor inhibitor, and methods described includes:
The biological sample obtained from subject is determined, to determine whether biological sample is classified as substrate sample hypotype or another Plant hypotype;With
Wherein it is classified as not be that the biological sample of substrate sample hypotype shows to include the breast cancer of androgen receptor inhibitor Treatment is more likely effective when being classified as substrate sample hypotype than sample.
In some embodiments of screening and sorting technique (being referred to as " above method "), by detecting shown in table 1 The expression of intrinsic gene set carry out the measure biological sample to determine whether biological sample is classified as substrate sample hypotype Or another hypotype.
In some embodiments of the above method, the substrate barycenter grader score of sample is consolidating shown in table 1 There is the expression of gene set to determine.
In an embodiment of the above method, if substrate barycenter grader score is less than or equal to 0.9, it is determined that Compared with substrate barycenter grader score is more than 0.9, the breast cancer treatment comprising androgen receptor inhibitor is in treatment subject When be more likely effective.In another embodiment, if substrate barycenter grader score is less than or equal to 0.6, It is determined that the breast cancer treatment comprising androgen receptor inhibitor may be bigger than substrate barycenter grader score in treatment subject It is more effective when 0.6.In another embodiment, if substrate barycenter grader score is in the range of 0.2 to 0.8, Breast cancer treatment comprising androgen receptor inhibitor is more likely effective when treating subject.In another embodiment party In case, if substrate barycenter grader score is in the range of 0.4 to 0.7, the breast cancer comprising androgen receptor inhibitor Treatment is more likely effective when treating subject.
In some embodiments of the above method, the substrate barycenter grader score and tube chamber A barycenter graders of sample The expression of intrinsic gene set shown in score from table 1 is determined.This method also includes from substrate barycenter being classified according to following equation Device score and tube chamber A barycenter graders score calculate the substrate and tube chamber A grader scores of weighting:
The substrate of weighting and tube chamber A graders score=- 0.25 (substrate barycenter grader score)+0.27 (tube chamber A barycenter Grader score)
If the substrate and tube chamber A graders score of wherein weighting are more than -0.3, classify with the substrate and tube chamber A of weighting Device score is compared less than or equal to -0.3, and the breast cancer treatment comprising androgen receptor inhibitor is more likely in subject Effectively.In another embodiment, if the substrate and tube chamber A graders score of weighting are more than -0.2, with weighting Substrate is compared with tube chamber A graders score less than or equal to -0.2, the breast cancer treatment comprising androgen receptor inhibitor by It is more likely effective in examination person.In another embodiment, if the substrate and tube chamber A grader scores of weighting are big In -0.25, then compared with the substrate and tube chamber A graders score of weighting are less than or equal to -0.25, suppress comprising androgen receptor The breast cancer treatment of agent is more likely effective in subject.
In some embodiments, for determining that the substrate of weighting and the equation of tube chamber A grader scores have following shape Formula:
The substrate of weighting and tube chamber A graders score=- 0.2468275 (substrate barycenter grader score)+0.2667110 (tube chamber A barycenter graders score)
In some embodiments of the above method, breast cancer is characterised by depositing for androgen receptor positive tumor cell .
In some embodiments of the above method, biological sample is selected from cell, tissue and body fluid.In some embodiments In, body fluid is selected from blood, lymph, urine, saliva, emulsion and nipple aspirate from ductal lavage fluid.In some embodiment party In case, tissue is obtained from biopsy.
In any above method, being determined the androgen receptor state of the cell of sample, (i.e. AR is positive relative AR is negative) measure.
The method that triple negative breast cancer is treated in subject is additionally provided, the subject, which has, to be included being classified as It is not the breast cancer of the breast cancer cell of substrate sample hypotype, methods described includes applying subject to be suppressed comprising androgen receptor The breast cancer treatment of agent, so as to treat the triple negative breast cancer in subject.
In an embodiment for the treatment of method, the breast cancer cell of subject is characterised by shown in table 1 The substrate barycenter grader score for being less than or equal to 0.9 that expression of the intrinsic gene set in the cell is determined.In treatment side In another embodiment of method, the breast cancer cell of subject is characterised by that substrate barycenter grader score is less than or equal to 0.6.In another embodiment for the treatment of method, the breast cancer cell of subject is characterised by that substrate barycenter grader is obtained Divide in the range of 0.2 to 0.8.In another embodiment for the treatment of method, the feature of the breast cancer cell of subject exists In substrate barycenter grader score in the range of 0.4 to 0.7.
In another embodiment for the treatment of method, the breast cancer cell of subject be characterised by weighting substrate and Tube chamber A graders score is more than -0.3.In another embodiment for the treatment of method, the feature of the breast cancer cell of subject It is that the substrate and tube chamber A graders score that weight are more than -0.2.In another embodiment for the treatment of method, subject's Breast cancer cell is characterised by that the substrate and tube chamber A graders score of weighting are more than -0.25.
Additionally provide for treat the triple negative breast cancer in subject in need include androgen receptor inhibitor Triple negative breast cancer treatment, wherein the treatment method includes:(a) biological sample from subject is determined to determine biology Whether sample is classified as substrate sample hypotype or another hypotype;If biological sample is classified as not be that substrate sample is sub- (b) Type, then treat to the subject using the triple negative breast cancer.
Additionally provide the therapeutic agent for the treatment treated for triple negative breast cancer or for subject in need, wherein institute It is androgen receptor inhibitor to state therapeutic agent, and the treatment includes:(a) biological sample from subject is determined to determine whether Whether biological sample is classified as substrate sample hypotype or another hypotype;If biological sample is classified as not be substrate (b) Sample hypotype, then apply the therapeutic agent to the subject.
The androgen receptor inhibitor for treating the triple negative breast cancer in subject is additionally provided, wherein from tested The biological sample of person has been measured to determine whether sample is classified as substrate sample hypotype or another hypotype.
The method that triple negative breast cancer is treated in the subject for needing to treat is additionally provided, including:(a) biological sample is determined Product are to determine whether biological sample is classified as substrate sample hypotype or another hypotype;If the biological sample is divided (b) Class applies the breast cancer treatment comprising androgen receptor inhibitor, so as to treat tested to be not substrate sample hypotype to subject The breast cancer of person.
In above-mentioned treatment method, treatment and some embodiments for the androgen receptor inhibitor for the treatment of, determine Biological sample is by shown in detection table 1 to determine whether biological sample is classified as substrate sample hypotype or another hypotype The expression of intrinsic gene is carried out.
In above-mentioned treatment method, treatment and some embodiments for the androgen receptor inhibitor for the treatment of, determine Biological sample includes the substrate barycenter grader score of the expression determination sample of the intrinsic gene set shown in table 1, wherein such as Fruit substrate barycenter grader score is less than or equal to 0.9, then using breast cancer treatment.In one embodiment, if substrate Barycenter grader score is less than or equal to 0.6, then using breast cancer treatment.In one embodiment, if substrate barycenter point Class device score is in the range of 0.2 to 0.8, then using breast cancer treatment.In another embodiment, if substrate barycenter point Class device score is in the range of 0.4 to 0.7, then using breast cancer treatment.
In above-mentioned treatment method, treatment and some embodiments for the androgen receptor inhibitor for the treatment of, determine Biological sample includes the substrate barycenter grader score and pipe of the expression determination sample of the intrinsic gene set shown in table 1 Chamber A barycenter grader scores, and the substrate and tube chamber A grader scores of weighting are calculated, if wherein the substrate and tube chamber A of weighting Grader score is more than -0.3, then applies breast cancer treatment to subject.In one embodiment, if weighting substrate and Tube chamber A graders score is more than -0.2, then using breast cancer treatment.In another embodiment, if weighting substrate and Tube chamber A graders score is more than -0.25, then using breast cancer treatment.
It is tested in above-mentioned treatment method, treatment and some embodiments for the androgen receptor inhibitor for the treatment of The breast cancer of person is further characterized in that the presence of androgen receptor positive tumor cell.
In above-mentioned treatment method, treatment and some embodiments for the androgen receptor inhibitor for the treatment of, hero swashs Plain acceptor inhibitor is selected from:The miscellaneous Shandong amine of grace, Bicalutamide, Flutamide, Nilutamide, ARN509, ketoconazole, acetic acid Ah's bit Dragon, VN/124-1 (TOK-001), orteronel (TAK-700), Finasteride, galeterone, CPA, Andarine, with and combinations thereof.The list of androgen receptor inhibitor is exemplary, is not meant to be restricted.
In certain embodiments, androgen receptor inhibitor is the miscellaneous Shandong amine of grace.In such embodiment, grace Miscellaneous Shandong amine is oral daily once, and dosage is 160mg.In some embodiments, the miscellaneous Shandong amine of grace is as including the miscellaneous Shandong amine of 160mg grace Single capsule apply.In other embodiments, the miscellaneous Shandong amine of grace is applied in the form of four capsules, and each capsule includes 40mg The miscellaneous Shandong amine of grace.
In above-mentioned treatment method, treatment and some embodiments for the androgen receptor inhibitor for the treatment of, comprising The breast cancer treatment of androgen receptor inhibitor is not also other anticancers of androgen receptor inhibitor comprising one or more. The other anticancers for not being androgen receptor inhibitor can be selected from endoxan, fluorouracil, 5 FU 5 fluorouracil, first ammonia butterfly Purine, thiotepa, carboplatin, cis-platinum, taxane, taxol, the taxol that protein is combined, docetaxel, vinorelbine, tamoxifen Sweet smell, Raloxifene, Toremifene, fulvestrant, gemcitabine, Irinotecan, Ipsapirone, Temozolomide, TPT is long Spring new alkali, vinblastine, eribulin, mutamycin, capecitabine, capecitabine, Anastrozole, Exemestane, Letrozole, Leuprorelin, abarelix, Bath woods, Goserelin, megestrol acetate, Risedronate, Pamidronate, ibandronic acid Salt, Alendronate, ground promise monoclonal antibody, zoledronate, Herceptin, Lapatinib or Avastin, with and combinations thereof. The list of other anticancers is exemplary, is not meant to be restricted.
In one embodiment, non-AR inhibitor anticancer is taxol.In another embodiment, AR inhibitor It is the miscellaneous Shandong amine of grace, non-AR inhibitor anticancer is taxol.
In certain embodiments, treatment method includes test subject includes removing substrate to determine whether subject has The step of breast cancer of breast cancer cell outside sample hypotype.
In certain embodiments, treatment method includes test subject to determine the substrate of the breast cancer cell of subject The step of barycenter grader score.
In certain embodiments, treatment method includes test subject to determine the weighting of the breast cancer cell of subject Substrate and tube chamber A grader scores the step of.
It is tested in above-mentioned treatment method, treatment and some embodiments for the androgen receptor inhibitor for the treatment of The wheel prior treatment that person does not receive or received the anticancer in addition to androgen receptor inhibitor is negative to treat three Breast cancer.
In the reality of above-mentioned screening technique, sorting technique, treatment method, treatment and androgen receptor inhibitor for treatment Apply in scheme, biological sample can be selected from cell, tissue and body fluid.In certain embodiments, body fluid be selected from blood, lymph, Urine, saliva, ductal lavage fluid and nipple aspirate fluid.In some embodiments, tissue is obtained from biopsy.
In any of above screening technique, sorting technique, treatment method, treatment and androgen receptor inhibitor for treatment Embodiment in, the survey of the androgen receptor state (i.e. AR positive relative AR negative) of the cell of sample can be determined It is fixed.
As contemplated by the present invention on the composition and method of disclosed material, in one aspect, the present invention Embodiment include component disclosed herein and/or step.On the other hand, embodiment of the present invention is substantially by herein Disclosed component and/or step composition.On the other hand, embodiment of the present invention is by component disclosed herein and/or step Composition.
Definition
One or more than one of article " one " and " one kind " grammar object herein for being used to refer to the article are (i.e. extremely It is few one).As an example, " element " refers to an element or more than one element.
" about " will be understood by those of ordinary skill in the art, and by according to using its context and to a certain extent Change.As used herein, " about " it is intended to include ± 20% or ± 10%, more preferably ± 5%, even more preferably ± 1%, it is also more excellent The change of choosing ± 0.1%.
" androgen receptor inhibitor " refers to the chemical combination for directly or indirectly suppressing androgen receptor (AR) signal transduction pathway Thing or molecule.In one embodiment, the direct inhibitor of AR acceptors includes the miscellaneous Shandong amine of grace, Bicalutamide (Casodex), fluorine His amine, Nilutamide, ARN509 etc..In another embodiment, AR indirect inhibitor includes the inhibitor of Cyp 17, for example Ketoconazole, abiraterone acetate, VN/124-1 (TOK-001), orteronel (TAK-700) etc..In another embodiment In, AR inhibitor includes Finasteride, galeterone, CPA and andarine etc..
" detection expression " is intended to determine the RNA transcript of intrinsic gene or the quantity of its expression product or presence.
" suppression " or the suppression of other forms mean to hinder or suppress special characteristic.It should be understood that this generally with some standards Or desired value is related, in other words it is relative, but this is not always required for standard or relative value.
As it is used herein, " subject " means individual, typically mammal or poultry.Mammal can include Such as performing animal (such as cat or dog), domestic animal (such as ox, horse, pig, sheep, goat etc.), experimental animal (such as mouse, rabbit, Rat, cavy etc.) and primate.Preferably, mammal is people.
" triple negative breast cancer " or " TNBC " refers to not express ERs (ER), PgR (PR) and Her2/neu Gene any breast cancer.The term includes primary epithelial TNBC, and is related to the TNBC of other tumours.Cancer can be with Including triple negative breast cancer, breast ductal cancer, lobular carcinoma of breast, undifferentiated breast cancer, mammary gland capsule granuloma, mammary gland blood vessel Sarcoma and primary breast lymphoma.TNBC can also include any stage of triple negative breast cancer, and can include having The tumor of breast of histology and ultra microstructure heterogeneous (for example, cell mixing type).
" TNBC comprising androgen receptor inhibitor is treated " is to include treating using the TNBC of androgen receptor inhibitor. The treatment can include other anticancers or chemotherapeutant.
" needs " TNBC treatment subject be with TNBC or present TNBC one or more symptoms subject or Relative to the subject for the risk that whole colony has increased development TNBC.Preferably, the subject for " needing " TNBC to treat It is the subject tormented by TNBC.
As used herein, " therapeutically effective amount " or " treatment effective dose " refers to containing being at least enough to produce therapeutic effect Medicament, compound, material or the composition of compound.Effective dose be prevention, healing, improvement, prevent or part prevent disease or The amount of therapeutic agent needed for the symptom of illness.
" treatment " or " therapy " is not meant to complete healing.It means that the symptom of underlying diseases is reduced, and/or cause One or more reductions in the basal cell of symptom, physiology or biochemical reason or mechanism.It should be understood that it is as used herein, subtract Few state meant relative to disease, includes the molecular state of disease, and the not exclusively physiological status of disease.
Brief description of the drawings
Fig. 1 is that the prescreening or screening of the clinical test that the miscellaneous Shandong amine of grace is assessed in the patient that its TNBC also expresses AR are recruited The result figure of some patients raised." diagnosis-" represents there is substrate sample hypotype by what PAM50 gene breast cancer Subtypes were determined Patient." diagnosis+" represents the patient of Her2, LumA, LumB or normal hypotype.According to the standard provided in embodiment 1, it will suffer from Person is chosen as " reactor " or " not reactor " of the miscellaneous Shandong amine treatment of grace.
Fig. 2A and 2B are that patient gene's expression grader score of wherein substrate sample hypotype is identical with patient's reaction correlation The figure of TNBC clinical test results.Using patient's substrate barycenter grader score that threshold cutoff value is 0.2." diagnosis+" represents it Sample, which meets the prognosis characterizations specified, includes the patient for the threshold cutoff value specified." diagnosis-" represents that sample is unsatisfactory for specifying threshold to cut The patient of disconnected value.According to the standard provided in embodiment 1, patient is chosen as " reactor " of the miscellaneous Shandong amine treatment of grace or " not reacted Person ".
Fig. 3 A and 3B are that patient gene's expression grader score of wherein substrate sample hypotype is identical with patient's reaction correlation The figure of TNBC clinical test results.Using patient's substrate barycenter grader score that threshold cutoff value is 0.3." diagnosis+" represents it Sample, which meets the prognosis characterizations specified, includes the patient for the threshold cutoff value specified." diagnosis-" represents that sample is unsatisfactory for specifying threshold to cut The patient of disconnected value.According to the standard provided in embodiment 1, patient is chosen as " reactor " of the miscellaneous Shandong amine treatment of grace or " not reacted Person ".
Fig. 4 A and 4B are that patient gene's expression grader score of wherein substrate sample hypotype is identical with patient's reaction correlation The figure of TNBC clinical test results.Using patient's substrate barycenter grader score that threshold cutoff value is 0.4." diagnosis+" represents it Sample, which meets the prognosis characterizations specified, includes the patient for the threshold cutoff value specified." diagnosis-" represents that sample is unsatisfactory for specifying threshold to cut The patient of disconnected value.According to the standard provided in embodiment 1, patient is chosen as " reactor " of the miscellaneous Shandong amine treatment of grace or " not reacted Person ".
Fig. 5 A and 5B are that patient gene's expression grader score of wherein substrate sample hypotype is identical with patient's reaction correlation The figure of TNBC clinical test results.Using patient's substrate barycenter grader score that threshold cutoff value is 0.5." diagnosis+" represents it Sample, which meets the prognosis characterizations specified, includes the patient for the threshold cutoff value specified." diagnosis-" represents that sample is unsatisfactory for specifying threshold to cut The patient of disconnected value.According to the standard provided in embodiment 1, patient is chosen as " reactor " of the miscellaneous Shandong amine treatment of grace or " not reacted Person ".
Fig. 6 A and 6B are that patient gene's expression grader score of wherein substrate sample hypotype is identical with patient's reaction correlation The figure of TNBC clinical test results.Using patient's substrate barycenter grader score that threshold cutoff value is 0.6." diagnosis+" represents it Sample, which meets the prognosis characterizations specified, includes the patient for the threshold cutoff value specified." diagnosis-" represents that sample is unsatisfactory for specifying threshold to cut The patient of disconnected value.According to the standard provided in embodiment 1, patient is chosen as " reactor " of the miscellaneous Shandong amine treatment of grace or " not reacted Person ".
Fig. 7 A and 7B are that patient gene's expression grader score of wherein substrate sample hypotype is identical with patient's reaction correlation The figure of TNBC clinical test results.Using patient's substrate barycenter grader score that threshold cutoff value is 0.65." diagnosis+" represents it Sample, which meets the prognosis characterizations specified, includes the patient for the threshold cutoff value specified." diagnosis-" represents that sample is unsatisfactory for specifying threshold to cut The patient of disconnected value.According to the standard provided in embodiment 1, patient is chosen as " reactor " of the miscellaneous Shandong amine treatment of grace or " not reacted Person ".
Fig. 8 A and 8B are that patient gene's expression grader score of wherein substrate sample hypotype is identical with patient's reaction correlation The figure of TNBC clinical test results.Using patient's substrate barycenter grader score that threshold cutoff value is 0.7." diagnosis+" represents it Sample, which meets the prognosis characterizations specified, includes the patient for the threshold cutoff value specified." diagnosis-" represents that sample is unsatisfactory for specifying threshold to cut The patient of disconnected value.According to the standard provided in embodiment 1, patient is chosen as " reactor " of the miscellaneous Shandong amine treatment of grace or " not reacted Person ".
Fig. 9 A and 9B are that patient gene's expression grader score of wherein substrate sample hypotype is identical with patient's reaction correlation The figure of TNBC clinical test results.Using patient's substrate barycenter grader score that threshold cutoff value is 0.8." diagnosis+" represents it Sample, which meets the prognosis characterizations specified, includes the patient for the threshold cutoff value specified." diagnosis-" represents that sample is unsatisfactory for specifying threshold to cut The patient of disconnected value.According to the standard provided in embodiment 1, patient is chosen as " reactor " of the miscellaneous Shandong amine treatment of grace or " not reacted Person ".
Figure 10 A and 10B are that the patient gene of wherein substrate sample hypotype expresses the grader score phase related to patient's reaction With the figure of TNBC clinical test results.Using patient's substrate barycenter grader score that threshold cutoff value is 0.9." diagnosis+" is represented Its sample, which meets the prognosis characterizations specified, includes the patient for the threshold cutoff value specified." diagnosis-" represents that sample is unsatisfactory for specifying threshold The patient of cutoff value.According to the standard provided in embodiment 1, patient is chosen as to " reactor " or " not anti-of the miscellaneous Shandong amine treatment of grace The person of answering ".
Figure 11 is included in the table of various patient's subgroups for being treated in clinical test with the miscellaneous Shandong amine of grace to the reaction of the miscellaneous Shandong amine of grace Show.Reaction is represented with the clinical benefit rate (CBR24) of >=24 weeks.Subgroup includes treatment of purpose (ITT) patient;It is appreciable Patient;Breast tumor tissues patient (the IHC AR of AR dyeing >=10%>=10%);By PAM50 Subtypes device by mammary gland Tumor tissues are categorized as the patient (non-substrate PAM50) of non-substrate sample hypotype;Staging is patient's (substrate of substrate sample hypotype PAM50);Pass through application<0.6, >=0.6,<0.7, >=0.7,<0.75 and >=0.75 specified cutoff value is from patient's substrate barycenter Grader score is come the Patient Sample A that is analyzed." DX- " represents that sample is unsatisfactory for specifying the patient of threshold cutoff value." DX+ " table Sample product meet the patient for specifying threshold cutoff value.Combination standard IHC AR are also show in Figure 11>=10% and DX+<0.6 number According to.
Figure 12 is various patient's subgroups for being treated in clinical test with the miscellaneous Shandong amine of grace enters one to the reaction of the miscellaneous Shandong amine of grace Step is represented.Reaction is represented with the clinical benefit rate (CBR24) of >=24 weeks.Subgroup includes treatment of purpose (ITT) patient;It can comment The patient estimated;Breast tumor tissues patient (the IHC AR of AR dyeing >=10%>=10%);Be used as first (First Line) or The patient of the miscellaneous Shandong amine treatment of grace is applied in two (the second lines) treatment.Subgroup further comprises by answering substrate barycenter grader score With<Patient Sample A's subgroup that 0.6 cutoff value is analyzed (" Novel DX+ "), and comprising being controlled from the first and second lines The subgroup of the sample for the treatment of, will<0.6 cutoff value is applied to substrate barycenter grader score.
Figure 13 is to show the middle position progression free survival phase (MPS) that patient is treated as the miscellaneous Shandong amine of grace of the function of time Kaplan-Meier schemes.The curve, which corresponds to, to be accredited as meeting<The new prognosis characterizations of 0.6 substrate barycenter grader score Patient's (" Novel DX Pos ") of condition is relative to the patient's (" Novel DX Neg ") for being unsatisfactory for this definition.
Figure 14 A-14D include the result of the patient's reaction in the clinical test for the miscellaneous Shandong amine of medicine grace for treating TNBC. Gene expression analysis is carried out to patient's Breast Tumor Samples using the PAM50 of table 1 intrinsic gene sets.To each sample evaluating and base The Spearman rank correlations of original pattern gene expression barycenter, and it is assigned as " substrate barycenter grader score ".To each sample The Spearman rank correlations estimated with tube chamber A gene expression barycenter are judged, and are assigned as " tube chamber A graders score ".Suffer from The substrate and tube chamber A grader scores of the weighting of person's sample are determined by following formula:
The substrate of weighting and tube chamber A graders score=- 0.2468275 (substrate barycenter grader score)+0.2667110 (tube chamber A barycenter graders score).
Use the substrate and tube chamber A grader score cutoff values of weighting>- 0.2 (Figure 14 A),>- 0.25 (Figure 14 B),>-0.3 (Figure 14 C) and>- 0.35 (Figure 14 D), to analyze the response data of grace miscellaneous Shandong amine reaction/not.Data are as shown in Figure 14 A-14D.Every In individual figure, " diagnosis+" represents that its sample meets the patient for the specified prognosis characterizations for including specifying threshold cutoff value." diagnosis-" is represented Sample is unsatisfactory for specifying the patient of threshold cutoff value.According to the standard provided in embodiment 1, patient is chosen as to treat the miscellaneous Shandong amine of grace " reactor " or " not reactor ".
Figure 15 is included in the table of various patient's subgroups for being treated in clinical test with the miscellaneous Shandong amine of grace to the reaction of the miscellaneous Shandong amine of grace Show.Reaction is represented with the clinical benefit rate (CBR24) of >=24 weeks.Subgroup includes treatment of purpose (ITT) patient;It is appreciable Patient;Breast tumor tissues are categorized as to the patient (non-substrate PAM50) of non-substrate sample hypotype by PAM50 Subtypes device; Staging is the patient (substrate PAM50) of substrate sample hypotype;Applied with passing through>- 0.2,>- 0.25,>- 0.3 and>- 0.35 Cutoff value is specified in the substrate and tube chamber A graders score of weighting to analyze the patient of breast tumor tissue samples.“PR-AR DX- " represents that sample is unsatisfactory for specifying the patient of threshold cutoff value." PR-AR DX+ " represent that sample meets the trouble for specifying threshold cutoff value Person.It also show and controlled in the previous of medicine for not receiving or receiving the non-androgen receptor inhibitor for being once used for TNBC treatments Treat (" and 0-1 prior treatment ") afterwards or receive for TNBC treatment non-androgen receptor inhibitor medicine twice Or more time prior treatment (" and>=2 prior treatments ") sample of patient that is followed by the research by the treatment of grace miscellaneous Shandong amine Response data (application>The substrate and tube chamber A grader scores cutoff value of -0.25 weighting).
Figure 16 is the Kaplan- for showing the progression free survival phase of the miscellaneous Shandong amine treatment patient of grace as the function of 56 time-of-weeks Meier schemes.The curve, which corresponds to, is accredited as the substrate and tube chamber A grader scores (" PR-AR that meet the weighting more than -0.2 DX+:>- 0.2 ", top curve) relative to grader score (" the PR-AR DX- less than or equal to -0.2:<=-0.2 ", bottom Curve) characteristic condition patient.
Figure 17 is the Kaplan- for showing the progression free survival phase of the miscellaneous Shandong amine treatment patient of grace as the function of 56 time-of-weeks Meier schemes.The curve, which corresponds to, is accredited as the substrate and tube chamber A grader scores (" PR-AR that meet the weighting more than -0.25 DX+:>- 0.25 ", top curve) relative to grader score (" the PR-AR DX- less than or equal to -0.25:<=-0.25 ", Bottom curve) characteristic condition patient.
Figure 18 is the Kaplan- for showing the progression free survival phase of the miscellaneous Shandong amine treatment patient of grace as the function of 56 time-of-weeks Meier schemes.The curve, which corresponds to, is accredited as the substrate and tube chamber A grader scores (" PR-AR that meet the weighting more than -0.3 DX+:>- 0.3 ", top curve) relative to grader score (" the PR-AR DX- less than or equal to -0.30:<=-0.3 ", bottom Portion's curve) characteristic condition patient.
Figure 19 is the Kaplan- for showing the progression free survival phase of the miscellaneous Shandong amine treatment patient of grace as the function of 56 time-of-weeks Meier schemes.The curve, which corresponds to, is accredited as the substrate and tube chamber A grader scores (" PR-AR that meet the weighting more than -0.35 DX+:>- 0.35 ", top curve) relative to grader score (" the PR-AR DX- less than or equal to -0.35:<=-0.35 ", Bottom curve) characteristic condition patient.
Figure 20, which is shown in not receive or receive, is once used for the medicine for the non-androgen receptor inhibitor that TNBC is treated Prior treatment grace miscellaneous Shandong amine treatment patient progression free survival phase Kaplan-Meier figures.The curve corresponds to identified To meet the substrate and tube chamber A graders score (" PR-AR DX+ of the weighting more than -0.25:>- 0.25 ", top curve) it is relative In grader score (" the PR-AR DX- less than or equal to -0.25:<=-0.25 ", bottom curve) characteristic condition patient.
Figure 21 A and 21B including the use of>The substrate and tube chamber A grader score cutoff values of -0.25 weighting be not as connecing By or non-male swashing of receiving once that (0-1 prior treatment) or two or more times (2+ prior treatment) are used for that TNBC to treat The new prognosis of the predictive factor of the reaction of AR inhibitor for treating in the patient of the prior treatment of the medicine of plain acceptor inhibitor The figure of the effect of feature.Figure 21 B 56 patients are accredited as meeting the substrate weighted more than -0.25 and tube chamber A graders are obtained The characteristic condition divided.The 62 research patients identified by the grader score less than or equal to -0.25 are reflected in Figure 21 A It is fixed.Each bar in figure represents a patient.The patient's bar for indicating triangle is active (" active ") under study for action.Indicate Patient's bar of asterisk represents to react (CR) or partial reaction (PR) completely.
Figure 22 A and 22B include showing that the middle position of the miscellaneous Shandong amine treatment patient of grace as the function of time gets nowhere life respectively Deposit the phase Kaplan-Meier figures of (Figure 22 A) (mPFS) and Overall survival (mOS).Curve correspond to be accredited as meet be more than- The substrate and tube chamber A graders score (" PR-AR DX+ ", top curve) of 0.25 weighting are relative to less than or equal to -0.25 Grader score (" PR-AR DX- ", bottom curve) characteristic condition patient.Figure 22 A:Trouble for meeting characteristic condition Person, mPFS=16.1 weeks;Patient for being unsatisfactory for characteristic condition, mPFS=8.1 weeks.Figure 22 B:For meeting characteristic condition Patient, mOS=NYR (not yet the reaching) at 84 weeks;Patient for being unsatisfactory for characteristic condition, mOS=32.1 weeks.
Figure 23, which is shown in not receive or receive, is once used for the medicine for the non-androgen receptor inhibitor that TNBC is treated Prior treatment grace miscellaneous Shandong amine treatment patient progression free survival phase Kaplan-Meier figures.The curve corresponds to identified To meet the substrate and tube chamber A graders score (" PR-AR DX+ of the weighting more than -0.25:>- 0.25 ", top curve) it is relative In grader score (" the PR-AR DX- less than or equal to -0.25:<=-0.25 ", bottom curve) characteristic condition patient. The continuity of the research of tables of data diagram 20,64 weeks into Figure 23 of 56 weekly intervals more than Figure 20.In fig 23, it is special for meeting The patient for levying condition, mPFS=40.4 weeks;Patient for being unsatisfactory for characteristic condition, mPFS=8.9 weeks." NYR " refers in figure " not yet reaching " in the statement for 95% confidential interval (CI) that the data representated by the patient of characteristic condition are met in 23.
Figure 24 A, 24B and 24C are shown when the miscellaneous Shandong amine (Enza) of grace, taxol (PTX) or its group with prescribed concentration respectively When closing processing, TNBC cell lines BT549, MDA-MB-436 and MDA-MB-453 viability.It is presented flat for each cell line Average (n=5).
Figure 25 A and 25B are shown in (i) and feed the miscellaneous Shandong amine (Enza) of (PO) grace with 3mg/kg/ days (n=10) mouths, (ii) with 6mg/kg QMWF (IP) (n=7) taxol (PTX), or after (iii) (i) and (ii) (n=10) combination, transplanting has TNBC thin The growth of the tumour induced in the NOD-SCID mouse of born of the same parents system MDA-MB-453 cell.Measured under the number of days shown in Figure 25 A Gross tumor volume.Data point in Figure 25 A represents every group of mean tumour volume, and error bars reflect the SEM of data.In Figure 25 B Tumor weight was determined at the 35th day.
Detailed description of the invention
The invention provides the method for the TNBC in subject of the treatment with TNBC, wherein the subject influenceed by TNBC Breast cancer cell be characterised by be derived from expression of some intrinsic gene sets more specifically described below in those cells Score.(may be effectively) whether be recommended to be used to apply conduct present invention also offers the TNBC assessed comprising AR inhibitor treatments The method of TNBC patient's treatment course.Therefore, the present invention provides assess including the use of androgen receptor in one embodiment The method of the triple negative breast cancer treatment of body inhibitor, methods described includes determining the biological sample obtained from subject, with true Whether the fixed biological sample obtained from subject is classified as substrate sample hypotype or another hypotype.If biological sample is classified Not to be substrate sample hypotype, then when classifying sample as substrate sample hypotype compared with, the mammary gland comprising androgen receptor inhibitor Cancer is treated it is more likely that effective.Therefore, the present invention provides treatment and suffered from and includes being classified in one embodiment For be not substrate sample hypotype breast cancer cell cancer subject in triple negative breast cancer method.This method include pair Subject applies the breast cancer treatment comprising androgen receptor inhibitor, so as to treat the triple negative breast cancer in subject.
Invention further provides by determining whether TNBC patient should receive to include the treatment of AR inhibitor for treating, It is then based on the method that the determination applies optimal AR inhibitor for treating to treat TNBC to patient.Although the research being mentioned above is Patient Sample A's (including tumor sample) of AR acceptor stained positives is carried out by immunohistochemistry (IHC), but the present invention Scope be not limited to AR (+) TNBC treatment and prognosis.
Tumor of breast research based on intrinsic genetic analysis has identified five kinds of different subtypes of breast cancer:Tube chamber A (LumA), tube chamber B (LumB), HER2 are enriched with (Her-2-E), substrate sample and normal (Perou et al. .Nature, 406 (6797): 747-52(2000);Sorlie et al. .PNAS, 98 (19):10869-74(2001)).HER2 enrichment hypotypes herein can be with It is referred to as " HER2 ", it should be understood that the latter also means that HER2 is enriched with hypotype.Substrate sample hypotype is properly termed as " substrate " herein, should Work as understanding, the latter also means substrate sample hypotype.Therefore, by the way that cell or sample distributed into above-mentioned hypotype, breast cancer sample or Cell is by " classification ".Breast cancer sample or cell may be considered as negativity " classification ", i.e., it is determined that cell or sample are After LumA, LumB, HER2 or normal sample hypotype, cell or sample can be categorized as " non-substrate " or " in addition to substrate ".
We have surprisingly found that the presence of substrate sample hypotype shows the clinical nothing to AR inhibitor for treating in TNBC The possibility of reaction.We have found that the substrate barycenter grader score less than or equal to 0.9 represents to face AR inhibitor The possibility of bed reaction.We have been unexpectedly discovered that, based on the substrate sample and pipe carried out to the biological sample from TNBC patient The empirically determined weight score of chamber A Subtypes shows the possibility of the clinical response to AR inhibitor for treating.Therefore, one In individual embodiment, the biological sample from the patient with TNBC is measured to determine breast cancer hypotype.At another In embodiment, the biological sample from the patient with TNBC is measured to determine substrate barycenter grader score, or Both substrate barycenter grader score and tube chamber A grader scores.
For determine biological sample whether be classified as the hypotype in addition to substrate sample hypotype measure can include be used for Determine the determination method of the presence of substrate sample hypotype;Negative findings represents non-basal subtype.Can use can identify that substrate sample is sub- Any determination method of the presence of type.About 70-90% three negative cancers be shown as substrate sample breast cancer (Bertucci et al., Int.J.Cancer2008,123,236–240;Wang et al. .Eur.J.Clin.Invest.2008,38,438-446), three Negative phenotype has been used as the substitute of substrate sample hypotype.However, research shows, three feminine genders and substrate sample tumor of breast are not same Justice.See, for example, Choo and Nielsen, Cancers 2010,2,1040-1065.Therefore, it is necessary to which carefully choosing is used for Identify the measure of substrate sample hypotype.
Recently, have issued for dependent on have been found to be the feature of substrate sample hypotype following characteristics spectrum substrate sample The measure of hypotype:ER is negative, and HER2 is negative, and CK5/6 and/or the HER1 positives.Therefore one group four is had been proposed Kind of antibody (ER, HER1, HER2 and CK5/6) as the immunohistochemistry spy for being used to identify mammary gland substrate sample tumour Levy (Nielsen et al., Clinical Cancer Research 2014;10:5367-5374).
Substrate sample and tube chamber A Subtypes are carried out by determination of gene expression, and the expression of its by the use of intrinsic gene is used as breast The grader gene of gland cancer classification.Intrinsic gene (such as Perou et al. (2000) Nature 406:Described in 747-752) united It is to have between the biological sample repetition thing of same individual with low change and between the sample of Different Individual to count and learn selection There is the height change of expression.The present invention utilizes PAM50 Gene Expression Assays (Parker et al. .J Clin Oncol., 27 (8):1160-7 (2009) and U.S. Patent Application Publication No. 2011/0145176, are hereby incorporated herein by full). PAM50 determination of gene expression can be used for identification from the standard biological sample such as tumor tissues of formalin fixation FFPE The intrinsic hypotype (tube chamber A, tube chamber B, HER2 enrichment, substrate sample and normal sample) of breast cancer.PAM50 gene expressions classification device is prison The Forecasting Methodology based on barycenter superintended and directed, breast cancer classification is above-mentioned five kinds of molecules using the intrinsic gene expression characteristicses of 50 genes by it One of hypotype.
Such as Parker et al. and U.S. Patent Application Publication No. 2011/0145176 and U.S. Patent Application Publication No. Described in 2013/0004482, PAM50 determination of gene expression method utilizes and supervises algorithm according to the intrinsic hypotype of breast cancer to tested Person's sample is classified.The algorithm is referred to herein as " PAM50 disaggregated models " or " PAM50 graders ", and it is based on having identified The gene expression profile of 50 intrinsic genes for the intrinsic hypotype of breast cancer of classifying stator collection really.In U.S. Patent Application Publication Gene subset, and the specific primer for its detection are provided in number 2013/0004482 table 1, and is reproduced in below In the table 1 of present disclosure.The selection sequence of the intrinsic gene of identical 50 is as shown in table 2 below.Publication number 2013/0004482 Complete disclosure be incorporated herein by reference.
The detection and estimation of the expression of the set of 50 hypotype predicted genes of table 1 are carried out by any suitable means.
PAM50 gene expressions classify device by using the prototype hardware based on the objective selection for " training " algorithm spy The monitoring forecast algorithm for levying spectrum exploitation is operated.According to U.S. Patent Publication No. 2009/0299640, (entire contents pass through Be incorporated herein by reference) disclosed in method, use the intrinsic gene set selection of extension and sub- parting sample.According to hypotype to instruction After white silk sample is layered, using the prediction algorithm based on barycenter, the express spectra based on the intrinsic gene set shown in table 1 builds every The barycenter of individual molecular isoform.Barycenter is average gene expression divided by the gene of each gene in each hypotype (or " classification ") Classification internal standard deviation.Closest to barycenter classify obtain fresh sample gene expression profile, and by its with these class centroids Each is compared.By the way that the Spearman rank correlations of each test case are calculated to five barycenter of PAM50 hypotypes, and Sample is distributed to hypotype based on immediate barycenter, to complete hypotype prediction.
According to an embodiment, it is not necessarily referring to distribute Patient Sample A to PAM50 hypotypes, it is determined that with substrate sample base Because expressing the Spearman rank correlations of barycenter.Spearman rank correlations between sample and substrate sample barycenter are designated as " substrate barycenter grader score ".The Spearman rank correlations with tube chamber A gene expression barycenter are determined.Sample and tube chamber A Spearman rank correlations between barycenter are designated as " tube chamber A barycenter graders score ".Using the feature based on PAM50 with The method for providing substrate barycenter grader score and tube chamber A barycenter grader scores is well known by persons skilled in the art.Referring to Such as U.S. Patent Application Publication No. 2009/0299640;Parker et al., J Clin.Oncol., 27 (8):1160-7 (2009);U.S. Patent Application Publication No. 2011/0145176.Referring also to such as Prat et al., British Journal Of Cancer, (2014) 111,1532-1541, it is incorporated herein by reference.
Clinical test such as the TNBC patient treated by using the miscellaneous Shandong amine of AR inhibitor grace is confirmed, it has been found that be less than Or the substrate barycenter grader score equal to 0.9 represents the possibility for having clinical response to AR inhibitor.In some embodiments In, predicted using the substrate barycenter grader score less than or equal to 0.9,0.2 to 0.8,0.4 to 0.7 to AR inhibitor The possibility of clinical response.In one embodiment, predicted using the substrate barycenter grader score less than or equal to 0.6 To the possibility of the clinical response of AR inhibitor.
We have further found that, substrate barycenter grader score and tube chamber A barycenter grader scores, when true with some experiences There is provided androgen receptor inhibitor is treated available for further prediction individual TNBC patient when fixed weight factor is combined Reactive score (" substrate and tube chamber A graders score of weighting ").The substrate and tube chamber A grader scores of weighting are under The equation in face is determined:
The substrate of weighting and tube chamber A graders score=- 0.25 (substrate barycenter grader score)+0.27 (tube chamber A barycenter Grader score).
In some embodiments, for determining that the substrate of weighting and the equation of tube chamber A grader scores have following shape Formula:
The substrate of weighting and tube chamber A graders score=- 0.2468275 (substrate barycenter grader score)+0.2667110 (tube chamber A barycenter graders score).
Clinical test such as the TNBC patient treated with the miscellaneous Shandong amine of AR inhibitor grace is proved, if the substrate and pipe of weighting Chamber A graders score is more than -0.3, and patient is confirmed as the patient that may have reaction to AR inhibitor for treating.Or, if plus The substrate and tube chamber A graders score of power are more than -0.2, then can also be accredited as patient may have instead to AR inhibitor for treating The patient answered.Selection -0.25 can improve the degree of accuracy as prediction to the reactive cutoff value of AR inhibitor for treating.Therefore, In preferred embodiments, if the substrate and tube chamber A graders score of weighting are more than -0.25, patient is identified as possibility There is the patient of reaction to AR inhibitor for treating.If substrate and tube chamber A grader score quilts that TNBC patient passes through determination weighting The patient that there may be reaction to the AR inhibitor for treating for TNBC is identified as, then can apply appropriate AR inhibitor for treating and come Treat the TNBC illnesss of patient.
The substrate and tube chamber A graders score of weighting are used to predict patient to the effectiveness of the reaction of AR inhibitor for treating as schemed Shown in 14A-14D and Figure 15.Various TNBC patient's subgroups that accompanying drawing is included in clinical test with the miscellaneous Shandong amine treatment of grace are miscellaneous to grace The expression of the reaction of Shandong amine.The reactivity that patient treats to the miscellaneous Shandong amine of grace is related to the substrate and tube chamber A grader scores that weight, Using>- 0.2 (Figure 14 A),>- 0.25 (Figure 14 B),>- 0.3 (Figure 14 C) and>A series of -0.35 (Figure 14 D) cutoff values extremely add The substrate and tube chamber A grader scores of power.In " diagnosis-" and Figure 15 in Figure 14 A-D " PR-AR DX- " represent its sample not Meet substrate and the patient of tube chamber A grader score threshold cutoff values for the weighting specified.In " diagnosis+" and Figure 15 in 14A-D " PR-AR DX+ " represent that its sample meets the patient for specifying threshold cutoff value.From the consideration to data can be seen that more than- The substrate and tube chamber A graders score of 0.25 weighting provide prediction TNBC patient the miscellaneous Shandong amine of grace is treated it is reactive most High accuracy, using the standard more than -0.2 or more than -0.3, also provides acceptable result.
The Kaplan- of correlation between patient's reaction and the substrate and tube chamber A grader scores of weighting in Figure 16-19 Further illustrated in Meier figures, it is shown that use the nothing of the function as 56 time-of-weeks of the TNBC patient of the miscellaneous Shandong amine treatment of grace It is in progress life cycle.Curve in Figure 16 is obtained corresponding to the substrate and tube chamber A graders for being accredited as meeting the weighting more than -0.2 Divide (" PR-AR DX+:>- 0.2 ", top curve) relative to grader score (" the PR-AR DX- less than or equal to -0.2:< =-0.2 ", bottom curve) characteristic condition.Figure 17,18 and 19 are similar to Figure 16, wherein being applied more than -0.25 (Figure 17), greatly In -0.3 (Figure 18) and the characteristic condition more than -0.35 (Figure 19).It is appreciated that hanging down between each each upper curve of individually figure The amplitude directly separated is the precision of the correlation between the substrate and tube chamber A graders score and Progression free survival of patient's weighting Measure.On this basis, can be further understood from Figure 16-19 comparison year, using the weighting more than-0.25 substrate and The standard of tube chamber A graders score (Figure 17) is provided the substrate of weighting and tube chamber A graders score with TNBC patient to grace The associated most accuracy of miscellaneous Shandong amine therapeutic response, using more than -0.2 (Figure 16) or the standard more than -0.3 (Figure 18), There is provided acceptable result.
It has also been found that, it is used as the new weighting substrate and tube chamber of the reactive predictive factor of the AR inhibitor for treating to TNBC The acquisition in the patient treated no more than a previous TNBC of wheel is treated or received without the previous TNBC of receiving of A graders score The accuracy of even more high.From relatively can be seen that in 0 to 1 prior treatment patient's group for Figure 20 and 17, with all experiments Larger group of patient compares (Figure 17), and the substrate of the weighting more than -0.25 and the standard (Figure 20) of tube chamber A grader scores cause Identify the accuracy increase that the patient for having reaction is treated to the miscellaneous Shandong amine of grace, such as perpendicular separation relative to the curve in Figure 17, figure Larger perpendicular separation is proved between 20 curve.The trend, wherein Figure 20 research are further observed that in fig 23 64 weeks more than 56 weeks in Figure 20 into Figure 23 of Progression free survival time showing in object.
The result is also shown in Figure 21 A and 21B, it is shown that be accredited as meet more than -0.25 weighting substrate and 56 patients (Figure 21 B) of the characteristic condition of tube chamber A grader scores obtain with respect to the grader less than or equal to -0.25 Divide the degree (progression free survival phase) without progression of disease treatment time of 62 patients (Figure 21 A) of identification.Each bar is represented One patient.Patient is in the miscellaneous preceding elder generation in the medicine for not receiving or receiving once non-androgen receptor inhibitor of Shandong amine treatment of grace Prior treatment (the 2+ of the medicine of preceding TNBC treatments (0-1 prior treatment) or the non-androgen receptor inhibitor of two or more times Secondary prior treatment).The patient's bar for indicating triangle is active (" active ") under study for action.The patient's bar for indicating asterisk has been represented Full response (CR) or partial reaction (PR).Receive once or not to receive in the reactor of prior treatment without progression of disease Golden hour is obvious (Figure 21 B).
Correlation between patient's reaction and the substrate and tube chamber A grader scores of weighting is in Figure 22 A and 22B Further illustrated in Kaplan-Meier figures, the middle position progression free survival phase (mPFS) (Figure 22 A) and middle position of comparative studies patient The terminal of Overall survival (mOS) (Figure 22 B).Curve in Figure 22 A and 22B, which corresponds to, is accredited as meeting adding more than -0.25 The substrate and tube chamber A graders score (" PR-AR DX+ ", top curve) of power are relative to the grader less than or equal to -0.25 The patient of the characteristic condition of score (" PR-AR DX- ", bottom curve).Therefore, as a result show in addition to progression free survival phase, Substrate and tube chamber A graders more than the weighting of -0.25 score is also related to overall survival phase.It is unsatisfactory for prognosis characterizations condition Patient be characterized in 8.1 weeks middle position progression free survival phase and the middle position Overall survival of 32.1 weeks.By contrast, prognosis is met special The patient for levying condition is characterised by the middle position progression free survival phase of 16.1 weeks, and not yet reach middle position Overall survival within 84 weeks (mOS NYR)。
Gene expression detection
As determining the of the substrate barycenter grader score of TNBC patient or the substrate of weighting and tube chamber A grader scores One step, by any method the gene expression detection to the gene of the intrinsic gene set of Patient Sample A's carry out table 1 be used to determine The intrinsic RNA transcript of gene or the quantity of its expression product or presence.This method description is in U.S. Patent Application Publication No. In 2009/0299640 and 2013/0004482, it is incorporated herein by reference.They include for example based on polynucleotides hybridizing The method of analysis, the method being sequenced based on polynucleotides, immunohistochemical method and the method based on proteomics.It is described Method generally detects the expression product (such as mRNA) of intrinsic gene shown in table 1.
It can be used in one embodiment as the RNA sequencings of the method for determining gene expression.Intrinsic gene The gene expression detection of collection can also be included but is not limited to real by being carried out for assessing gene expression/quantitative other technologies When PCR, microarray, microfluid gene expression and target gene sequencing.These methods include the hybridization analysis of such as polynucleotides, The method being sequenced based on polynucleotides, immunohistochemical method and the method based on proteomics.PCR-based can be used Method, such as reverse transcription PCR (RT-PCR) (Weis et al., TIG 8:263-64,1992) and the method based on array is for example micro- Array (Schena et al., Science 270:467-70,1995).
It is well known in the art for the RNA conventional methods extracted, and it is public in the standard textbook of molecular biology Open, including Ausubel et al., ed., Current Protocols in Molecular Biology, John Wiley& Sons,New York 1987-1999.The method that RNA is extracted from paraffin-embedded tissue is disclosed in such as Rupp and Locker,Lab Invest.56:A67,(1987);With De Andres et al., Biotechniques 18:42-44, (1995).The RNA of separation can be used for hybridization or amplification assay, and it includes but is not limited to PCR analyses and probe array.In sample The measure of intrinsic gene expression product level can also include nucleic acid amplification, for example by RT-PCR (U.S. Patent number 4,683, 202), ligase chain reaction, self training sequence is replicated, transcription amplification, rolling-circle replication and other using nucleic acid amplification method Method, the molecule then expanded using technology for detection well known to those skilled in the art.
Microarray can be used for expression analysis.Each array includes the reproducible mould for being connected to the capture probe of solid support Formula.The RNA or DNA of mark hybridize with the complementary probe on array, then pass through laser scanning inspection.Determine each to visit on array The intensity for hybridization of pin is simultaneously translated into the quantitative values for representing relative gene expression level.See, for example, U.S. Patent number 6,040, 138th, 5,800,992 and 6,020,135,6,033,860 and 6,344,316.High density oligonucleotide array can be used in particular for really A large amount of RNA gene expression profile in random sample product.
Total serum IgE for analyzing intrinsic gene set can be separated from biological sample such as tumour.If RNA source is Primary tumor, can be for example from freezing or the FFPE and the tissue sample of fixation (for example, formalin is fixed) filed RNA (such as mRNA) is extracted in (for example, tissue core sample that virologist instructs)).
Genetic analysis and data processing
For example, Patient Sample A's gene expression data from intrinsic gene set can be by the pretreatment of known technology with reality Existing sequence data is compared, the average centralization of data normalization and data.Method for normalizing includes, for example, (i) is used on array The global normalization of all genes;(ii) normalized using the house-keeping gene for the house keeper/constant gene unchangeably expressed;With (iii) the internal contrast normalization (Quackenbush of the exogenous crt gene for the known quantity added during hybridization is used Nat.Genet.32(Suppl.),496-501(2002)).Gene count estimation can also be normalized to fix quartile, example Such as fixed upper quartile.Then resulting normalization gene expression estimate can be adjusted so that in each gene It is worth the intermediate value that expression value is equal to known subset (such as the gene subset from TNBC patient).
According to an embodiment, the Patient Sample A handled by PAM50 graders expresses data first by comparing sum Pre-processed according to centralization technology.RNA sequence data are first by such as MapSplice (Nucleic Acids Res.2010Oct;38(18):e178.doi:10.1093/nar/gkq622) with people's (homo sapiens) genome sequence hg19 (https://genome.ucsc.edu/cgi-bin/hgGatewayDb=hg19) (http:// Www.ncbi.nlm.nih.gov/assembly/GCF_000001405.25/) compare.Gene and isotype level can be estimated Count, for example, using the RNA-Seq (http by expectation maximization (RSEM)://deweylab.biostat.wisc.edu/ rsem/).Gene count estimate is normalized to fixed upper quartile.Then resulting normalization base can be adjusted Because of expression estimate so that the intermediate value expression value of each gene is equal to " Comprehensive Molecular Portraits of Human Breast Tumors”,The Cancer Genome Atlas Network,Nature 490,61-70 (October 4,2012)(http://www.nature.com/nature/journal/v490/n7418/full/ Nature11412.html the median of the negative subset of the three of the TCGA RNA-seq data of report in).
After pre-processing, handled according to for handling the known technology of intrinsic gene set data from PAM50 genes battle array Patient Sample A's expression data of row.At least it is described in detail in herein below for handling from the intrinsic gene sets of PAM50 The complete explanation of Patient Sample A's gene expression data, and will only summarize and be not described in detail herein:Parker et al. .J Clin Oncol.,27(8):1160-7(2009);U.S. Patent Application Publication No. 2011/0145176;And U.S. Patent application (U.S. Patent Application Publication No. 2013/0004482 describes PAM50 graders to be used to screen breast publication number 2013/0004482 Application of the gland cancer subject to the possibility reactivity of anthracycline therapy, it depends on and especially patient is swollen by PAM50 graders Knurl is categorized as HER2 hypotypes).It is determined that the Spearman rank correlations with substrate sample gene expression barycenter.Sample and substrate sample barycenter Between Spearman rank correlations be designated as substrate barycenter grader score.Determine and tube chamber A gene expression barycenter Spearman rank correlations.Spearman rank correlations between sample and tube chamber A barycenter are designated as tube chamber A barycenter graders Score.Then the substrate barycenter grader score so determined and tube chamber A barycenter graders score are inserted into equation,
The substrate of weighting and tube chamber A graders score=- 0.25 (substrate barycenter grader score)+0.27 (tube chamber A barycenter Grader score)
With the substrate and tube chamber A grader scores of the weighting for providing Patient Sample A.
Sample
Sample for analyzing intrinsic Subtypes can include the biological sample containing cancer cell or tissue, such as mammary gland Tissue sample or primary breast tumor tissue sample.In some embodiments, biological sample includes breast tissue or cell. " biological sample " refers to any sampling for the cell, tissue or body fluid for being able to detect that intrinsic gene expression.Such biological sample The example of product includes but is not limited to biopsy and smear.Body fluid available for present disclosure includes blood, lymph, urine Liquid, saliva, nipple aspirate, the liquid from ductal lavage fluid, gynaecology's fluid or any other body exudates or its derivative Thing.Blood can include whole blood, blood plasma, serum or any blood derivatives.In some embodiments, biological sample includes breast Gland cell, and can especially include the breast tissue from biopsy, such as breast tumor tissue samples.Biological sample Product, for example by scraping or wiped area, can draw cell or body fluid, or pass through removal by various technologies by using pin Tissue sample (i.e. biopsy) is obtained from subject.The method for collecting various biological samples is well known in the art. In some embodiments, obtained for example, by fine needle aspiration biopsy, core needle biopsy or excisional biopsy Sample of breast tissue.In another embodiment, fluid is obtained by ductal lavage.Fine duct is inserted into the natural of ductus lactiferi Opening.Then saline solution is injected with irrigating catheter by conduit, this relaxes cell from conduit lining.Relaxation cell will be contained Solution is taken out by conduit and carries out biopsy.Fixed and staining solution can apply to cell or tissue to preserve sample Be easy to check.In one embodiment, biological sample is the sample of breast tissue for the FFPE that formalin is fixed, special It is not primary breast tumor sample.In various embodiments, tissue sample is the tissue core sample instructed from virologist What product were obtained.
Therapeutic agent
Androgen receptor inhibitor directly or indirectly suppresses androgen receptor (AR) signal path.In an embodiment In, the direct inhibitor of AR acceptors includes the miscellaneous Shandong amine of grace, Bicalutamide (Casodex), Flutamide, Nilutamide, ARN509 etc.. In another embodiment, AR indirect inhibitor includes the inhibitor of Cyp 17, such as ketoconazole, abiraterone acetate, VN/ 124-1 (TOK-001), orteronel (TAK-700) etc..In another embodiment, AR inhibitor includes Finasteride, Galeterone, CPA and andarine etc..Antigen receptor inhibitor may cause the biology of androgen receptor living The complete or partial suppression of property.
In preferred embodiments, AR inhibitor is the miscellaneous Shandong amine of graceIt has system (IUPAC) name Claim 4- (3- (4- cyano group -3- (trifluoromethyl) phenyl) -5,5- dimethyl -4- oxo -2- thiocarbamoyl imidazole quinoline -1- bases) fluoro- N- of -2- Methyl benzamide, directly in conjunction with androgen receptor (AR) and with three avtive spots.It suppresses androgen and AR combination, Suppress AR core transposition, and suppress the DNA combinations of AR mediations.
In certain embodiments, the breast cancer treatment comprising androgen receptor inhibitor is not also comprising one or more Other anticancers of androgen receptor inhibitor.This non-AR inhibitor of patient can also be given together with AR inhibitor for treating Anticancer include such as endoxan, fluorouracil (or 5 FU 5 fluorouracil or 5-FU), methotrexate (MTX), thiotepa, carboplatin is suitable Platinum, taxane, taxol, the taxol that protein is combined, docetaxel, vinorelbine, TAM, Raloxifene, Tuo Rui Meter Fen, fulvestrant, gemcitabine, Irinotecan, Ipsapirone, Temozolomide, TPT, vincristine, vinblastine, Eribulin, mutamycin, capecitabine, capecitabine, Anastrozole, Exemestane, Letrozole, Leuprorelin, A Barui Gram, Bath woods, Goserelin, megestrol acetate, Risedronate, Pamidronate, ibandronate, Alendronate, Ground promise monoclonal antibody, zoledronate, Herceptin, Lapatinib or Avastin, or its combination.
In one embodiment, non-AR inhibitor anticancer is taxol.In one embodiment, AR inhibitor is The miscellaneous Shandong amine of grace, non-AR inhibitor anticancer is taxol.As discussed below, it has also been discovered that, the combination of the miscellaneous Shandong amine of grace and taxol is led Enhanced cytotoxicity in tumour cell is caused, the cell is to the substrate by the weighting more than -0.25 and tube chamber A grader scores The prognostic marker of composition is positive.
One or more AR inhibitor of therapeutically effective amount are applied to subject according to the present invention, with using when in treatment cancer Usually used administration and therapeutic scheme treat TNBC when AR inhibitor is applied in disease.AR inhibitor can be as described herein Applied in breast cancer treatment by generally applying the approach of these medicaments.A kind of representativeness of the miscellaneous Shandong amine of such AR inhibitor grace Scheme is oral 160mg/ days, once a day.Formulation can include such as capsule.Daily dose for example can include 160mg grace The form of the capsule of miscellaneous Shandong amine is applied.In another embodiment, using four capsules, each capsule includes the miscellaneous Shandong of 40mg grace Amine.Lower or higher dosage can be used.Non- AR inhibitor used crowd when treating breast cancer according to such medicament Well known dosage and therapeutic scheme are applied.
The intrinsic gene tables of table 1-PAM50
The intrinsic gene orders of table 2-PAM50
Illustrate the practice of the present invention by following non-limiting example.
Embodiment
Embodiment 1
Clinical Study Protocol
Carry out clinical test miscellaneous Shandong amine of grace in determining its tumour as androgen receptor positive (AR+) and three negative patients The clinical benefit for the treatment of.In our current research, AR+ is defined as any core AR dyeing by immunohistochemistry (IHC), and TNBC is defined as IHC for ERs (ER) and progesterone receptor (PgR)<1% dyeing, IHC gives birth to for people's epidermis 0 or 1+ of growth factor receptor body 2 (HER2), or it is negative for the HER2 amplifications of 2+IHC diseases by situ hybridization (ISH).Pass through IHC carries out single optimization in AR dyeing, each comfortable breast cancer tissue of antibody using two kinds of different antibody.Daily oral one It is secondary to apply the miscellaneous Shandong amine (160mg/ days) of grace in the case where being with or without food with four 40mg Perles.It has recorded basis Reaction evaluation criteria (RECIST1.1) in solid tumor version 1.1 receives patient of the miscellaneous Shandong amine of grace untill progression of disease, Unless because other reason treatments specified in testing program stop.Including prescreening during research, (patient can be in its disease During any time signature agree to submit tissue carry out AR expression test);Screening is (28 days before first dose of quantifier elimination medicine); Treatment (the 1st day to drug withdrawal);Security follow-up (about 30 days or starts new antineoplaston after last time dose study medicine Before, it is defined by first comer);With the long term follow-up (life of every 3 to 6 months after the assessment and treatment drug withdrawal of subsequent breast cancer treatment Deposit state).Objective reaction-reacting (CR) or partial reaction (PR) completely-is determined by researcher according to RECIST 1.1.
The experiment is the research of the stages of Simon 2, wherein research is expanded to it is more extensive before, in predefined patient Minimum benefit is needed in colony.In the 1st stage, 42 patients participate in research can assess patient to obtain predetermined 26. The necessary clinical benefit for proceeding to for the 2nd stage is observed in the 1st stage, other 76 patients are recruited, altogether 118 patients.Connect It is excluded by the patient shifted with central nervous system (CNS) of the prior treatment of androgen receptor signal transduction inhibitor Outside;Quantity to prior treatment is not limited, and the patient with the immeasurablel disease of measurable disease or only bone is that have Qualification.16 weeks clinical benefit rate (CBR16) be defined as complete incidence graph (CR), part and alleviate (PR) or stable type disease (SD) The ratio for assessing patient of the optimum response of >=16 weeks (CBR16).It also have evaluated the clinical benefit rate (CBR16) of >=24 weeks.
In the stage 1,42 patients are recruited to obtain 26 evaluable patients (n=26).Appreciable patient be There is the patient that AR is dyed after >=10% tumour and at least 1 time baseline in tumor evaluation.Treatment of purpose (ITT) crowd's (the 1st rank Section n=42) it is defined as central evaluation AR+TNBC and receives all recruitments of at least 1 dose quantifier elimination medicine Patient.It is appreciable to have 26 (62%) in 42 ITT patients, has 16 can not assess in 42.It is being unsatisfactory for assessing mark In accurate 16,10 AR having less than 10% are expressed;6 AR with >=10% are expressed, but are commented after no progress baseline Estimate and (find that 2 there are CNS transfers soon after research enters, and removed before tumor evaluation after carrying out baseline from treatment Go out).Patient more than 50% receive the miscellaneous Shandong amine of grace as its first or second line treatment, and before the miscellaneous Shandong amine treatment of grace is received,> 30% patient has >=3 previous schemes.
Intrinsic gene expression analysis
Human breast cancer from TNBC patient is obtained from the clinical research of the foregoing miscellaneous Shandong amine of AR antagonist grace.Patient Dyeing is expressed for AR by breast cancer tissue.Patient's dyeing is by virologist according to staining power (3+, 2+ and 1+) and in standard The tumour cell percentage of the dyeing provided in operation sequence is classified.AR dyes are all have evaluated in nucleus and cytoplasm Color.
The RNA-seq data used in this research are carried out as follows pretreatment.By RNA-seq data with coming from human genome People's (homo sapiens) genome sequence hg19 (hg19 created by UC Santa Cruz genome bioinformatics group of browser Assembly (https://genome.ucsc.edu/cgi-bin/hgGatewayDb=hg19) (http:// Www.ncbi.nlm.nih.gov/assembly/GCF_000001405.25/)) using MapSplice (Nucleic Acids Res.2010Oct;38(18):e178.doi:10.1093/nar/gkq622) be compared.Using passing through expectation maximization RNA-Seq(RSEM)(http://deweylab.biostat.wisc.edu/rsem/) estimate gene and isotype leveler Number.Gene count estimate is normalized to fixed upper quartile.Normalization gene expression estimate obtained by adjustment, So that the intermediate value expression value of each gene is equal to " Comprehensive Molecular Portraits of Human Breast Tumors”,The Cancer Genome Atlas Network,Nature 490,61-70(October 4, 2012)(http://www.nature.com/nature/journal/v490/n7418/full/nature11412.html) The median of the negative subset of the three of the TCGA RNA-seq data of middle report.
Use Parker et al. .J Clin Oncol., 27 (8):The PAM50 disaggregated models of 1160-7 (2009) descriptions will Intrinsic Subtypes proceed in LumA, LumB, substrate, HER2 and normal group.To the Fu Er collected from subject's tumor of breast The genomic data that the RNA sequencings for the RNA that the paraffin-embedded tissue that Malin fixes is obtained are obtained carries out intrinsic Subtypes.Data Pre-processed as described above.Subtypes are carried out on " training and test " collection and further " checking " collection.Instruction Practice and test set is made up of 122 Patient Sample As, wherein 42 patients come from prescreening crowd, but have neither part nor lot in research, 80 trouble Recruitment crowd of person's sample in clinical research.Checking collection is made up of 55 Patient Sample As, wherein 15 patients come from and do not joined With the prescreening crowd of research, 40 crowds of the sample from recruitment.
The method point of the intrinsic gene set data of PAM50 is analyzed according to known being used for as described in Parker et al. (ibid) Analyse data.Substantially, carry out the detection of the expression of 50 hypotype predicted gene collection of the table 1 from patient tumor samples and estimate Meter.Analysis provides 50 hypotype predicted gene collection of the methods described of substrate sample, HER2, LumA, LumB and normal Subtypes Express spectra.To each sample and PAM50 centroid calculation Spearman correlations.These values are used as sample and each barycenter The continuous estimation of distance or similarity.The hypotype of each sample is assigned to closest to (maximum positive correlation) barycenter.Using with it is every The fundamental measurement of the correlation of individual hypotype classifies sample as one of 4 kinds of tumors subtypes (substrate sample, HER2, LumA and LumB) Or normal sample.
In addition, have evaluated the Spearman rank correlations with substrate sample gene expression barycenter.Sample and substrate sample barycenter it Between Spearman rank correlations be designated as " substrate barycenter grader score ".It has evaluated and tube chamber A gene expression barycenter Spearman rank correlations.Spearman rank correlations between sample and tube chamber A barycenter are designated as that " tube chamber A graders are obtained Point ".
In patient (treatment of purpose (ITT)) colony of recruitment, nothing of the substrate sample hypotype generally with being treated to the miscellaneous Shandong amine of grace Reaction is related, and the presence of one of other hypotypes is generally related to the reaction treated to the miscellaneous Shandong amine of grace.Referring to Fig. 1, wherein " examining Disconnected-" substrate sample subgroups are represented, " diagnosis+" represents the patient of Her2, LumA, LumB or normal hypotype.Therefore, represent non- The PAM50 gene expressions classification device result of substrate sample tumor type is for predicting the reaction treated to the miscellaneous Shandong amine of grace in TNBC Mark.
Embodiment 2
The clinical study results of embodiment 1 are further analyzed using patient's substrate barycenter grader score.Utilize substrate matter A series of threshold cutoff values of heart grader score have evaluated therapeutic response data.Using 0.2,0.3,0.4,0.5,0.6,0.65, 0.7th, the miscellaneous Shandong amine reaction/reactionless data of 0.8 and 0.9 substrate barycenter grader score cutoff value analysis grace.Data such as Fig. 2A/ Shown in B to 10A/B.In each figure, " diagnosis+" represents that its sample meets the specified prognosis characterizations including specifying threshold cutoff value Patient." diagnosis-" represents that its sample is unsatisfactory for specifying the patient of threshold cutoff value.
As shown in Fig. 2A/B-10A/B, the 0.6 or lower target substrate barycenter grader for defining Dx+ and Dx- patients Score is most related to the reaction treated to the miscellaneous Shandong amine of grace, and is omited based on the predictive value that 0.2 to 0.9 score defines Dx+ and Dx- It is low.Therefore, according in the range of 0.2-0.9 substrate barycenter grader cutoff value score define the group of reactor and non-reactor Body is for predicting the further basis of reactivity treated in TNBC to the miscellaneous Shandong amine of grace, 0.6 or lower substrate matter of sample Heart grader score is the preferred embodiment for predicting the mark of reactivity.As shown in Figure 6A, according to 0.6 relative base Substrate heart grader score define Dx+ and Dx- cause to produce the big diagnosis with most of reactors in diagnosis+colony+ The prediction of high nonresponder in colony and diagnosis-crowd.
Embodiment 3
Further analysis and summary were as shown in figure 11 for the clinical study results of embodiment 1, it is shown that in the clinic of >=24 weeks The reaction that various patient's subgroups are treated to the miscellaneous Shandong amine of grace in terms of earning rate (CBR24).Subgroup is suffered from including institute's intention to treat (ITT) Person;Appreciable patient;Breast tumor tissues patient (the IHC AR of AR dyeing >=10%>=10%);Pass through PAM50 hypotypes point Breast tumor tissues are categorized as the patient (non-substrate PAM50) of non-substrate sample hypotype by class device;Staging is substrate sample hypotype Patient (substrate PAM50);Pass through application<0.6, >=0.6,<0.7, >=0.7,<0.75 and >=0.75 specified cutoff value is from base Substrate heart grader score is come the Patient Sample A that is analyzed." DX- " represents that sample is unsatisfactory for specifying the patient of threshold cutoff value. " DX+ " represents that sample meets the patient for specifying threshold cutoff value.It also show in Figure 11 and meet combination standard IHC AR>=10% He DX+<The data of 0.6 sample, i.e. sample meet the AR dyeing of (i) more than 10% and (ii) 0.6 or lower PAM50 gene tables Up to the standard of substrate barycenter grader score.
Embodiment 4
Further analysis and summary were as shown in figure 12 for the clinical study results of embodiment 1, it is shown that in the clinic of >=24 weeks The reaction that various patient's subgroups are treated to the miscellaneous Shandong amine of grace in terms of earning rate (CBR24).Subgroup is suffered from including institute's intention to treat (ITT) Person;Appreciable patient;Breast tumor tissues patient (the IHC AR of AR dyeing >=10%>=10%);With the treatment of grace miscellaneous Shandong amine It is used as independent (First Line) or the patient of second (the second line) treatment.Subgroup further comprises by application<0.6 substrate barycenter Patient Sample A's subgroup that grader score cutoff value is analyzed (" Novel DX+ "), and comprising from the first and second lines The subgroup of the sample for the treatment of, application<0.6 cutoff value.Use<42% CBR of 0.6 prognosis substrate barycenter grader score (being 60% when being used in the group comprising both the first and second line patients) has exceeded for predicting in TNBC to treatment The typical reference of reactivity, the prediction energy with the model of the reaction for predicting the hormone agents treatment to ER+/PgR+ breast cancer Power is the same.
Embodiment 5
Utilize<0.6 substrate barycenter grader score is used as the new of the predictive factor of the reaction to AR inhibitor for treating Patient of the effect of prognosis characterizations further in fig. 13 on 56 weeks shows the Progression free survival time.As a result show, with >=0.6 compares apart from patient's (" Novel DX Neg ") of score, is accredited as meeting<0.6 substrate barycenter grader score New prognosis characterizations condition patient's (" Novel DX Pos ") in progression free survival phase.
Embodiment 6
The clinical research knot of embodiment 1 is further analyzed using patient's substrate barycenter grader and tube chamber A graders score Really.Analyze grader score and response data.As the result of analysis, substrate and the tube chamber A classification of weighting are empirically devised Device score, it predicts the reactivity treated to androgen receptor inhibitor in clinical test.The substrate of the weighting of Patient Sample A Determined with tube chamber A grader scores by below equation:
The substrate of weighting and tube chamber A graders score=- 0.2468275 (substrate barycenter grader score)+0.2667110 (tube chamber A barycenter graders score).
Then therapeutic response data are assessed using the substrate of weighting and a series of threshold cutoff values of tube chamber A grader scores. Specifically, using more than -0.2, more than -0.25, the substrate and tube chamber A graders of the weighting more than -0.3 and more than -0.35 Score cutoff value analyzes grace miscellaneous Shandong amine reaction/non-response data.Data such as Figure 14 A (>- 0.2), 14B (>- 0.25), 14C (>- 0.3) and 14D (>- 0.35) shown in.In each figure, " diagnosis+" represents that its sample meets the finger for including specifying threshold cutoff value Determine the patient of prognosis characterizations." diagnosis-" represents that its sample is unsatisfactory for specifying the patient of threshold cutoff value.
As shown in Figure 14 A-14D, (wherein x is -0.2 for the substrate of weighting of the selection more than x and the standard of tube chamber A graders In the range of to -0.3) it is most preferably related to the reaction treated to the miscellaneous Shandong amine of grace, wherein the score criteria more than -0.25 is optimal 's.Therefore, substrate and tube chamber A grader scores based on the weighting more than -0.2 or more than -0.3 define reactor and non-reaction The colony of person is to predict the reactive basis treated in TNBC to the miscellaneous Shandong amine of grace, wherein the substrate of weighting more than -0.25 and Tube chamber A grader scores are the preferred embodiments for predicting the standard of reactivity.
Embodiment 7
The result of the clinical research of embodiment 1 was further analyzed and summarized in fig .15, it is shown that in the clinic of >=24 weeks The reaction that various patient's subgroups are treated to the miscellaneous Shandong amine of grace in terms of earning rate (CBR24).Subgroup is suffered from including institute's intention to treat (ITT) Person;Appreciable patient;Pass through application>- 0.2,>- 0.25,>- 0.3 and>- 0.35 specified cutoff value in weighting substrate and Tube chamber A graders score analyzes the patient of breast tumor tissue samples." PR-AR DX- " represent that sample is unsatisfactory for specifying threshold to cut The patient of disconnected value." PR-AR DX+ " represent that sample meets the patient for specifying threshold cutoff value.Thus, for example, " PR-AR DX+>- 0.25 " represents that sample meets the patient of the standard of substrate and tube chamber A graders score more than -0.25 of weighting.
Also illustrate that (i) is not receiving or received once to be used for the non-androgen receptor inhibitor that TNBC is treated in fig .15 Medicine prior treatment (" and 0-1 prior treatment ") afterwards or (ii) receiving for TNBC treat non-androgen receptor The medicine of inhibitor two or more times prior treatment (" and>=2 prior treatments ") it is followed by being ground by the miscellaneous Shandong amine treatment of grace The response data of the sample of patient in studying carefully.These Patient Sample As are applied>The substrate and tube chamber A graders of -0.25 weighting Score cutoff value.
Embodiment 8
Use>The substrate of -0.2 weighting and the new prognosis characterizations of tube chamber A grader score cutoff values press down as to AR The effect of the predictive factor of the reaction of preparation for treating is further illustrated the Progression free survival time on the patient of 56 weeks in figure 16. As a result show and be accredited as the substrate and tube chamber A graders score (" PR-AR DX+ that meet the weighting more than -0.2:>- 0.2 ", top curve) relative to grader score (" the PR-AR DX- less than or equal to -0.2:<=-0.2 ", bottom curve) Prognosis characterizations condition patient in extension progression free survival phase.
Embodiment 9
Use>The substrate of -0.25 weighting and the new prognosis characterizations of tube chamber A grader score cutoff values press down as to AR The effect of the predictive factor of the reaction of preparation for treating is further illustrated the Progression free survival time on the patient of 56 weeks in fig. 17. As a result show and be accredited as the substrate and tube chamber A graders score (" PR-AR DX+ that meet the weighting more than -0.25:>- 0.25 ", top curve) relative to grader score (" the PR-AR DX- less than or equal to -0.25:<=-0.25 ", bottom is bent Line) prognosis characterizations condition patient in extension progression free survival phase.
Embodiment 10
Use>The substrate of -0.3 weighting and the new prognosis characterizations of tube chamber A grader score cutoff values press down as to AR The effect of the predictive factor of the reaction of preparation for treating is further illustrated the Progression free survival time on the patient of 56 weeks in figure 18. As a result show and be accredited as the substrate and tube chamber A graders score (" PR-AR DX+ that meet the weighting more than -0.3:>- 0.3 ", top curve) relative to grader score (" the PR-AR DX- less than or equal to -0.3:<=-0.3 ", bottom curve) Prognosis characterizations condition patient in extension progression free survival phase.
Embodiment 11
Use>The substrate of -0.35 weighting and the new prognosis characterizations of tube chamber A grader score cutoff values press down as to AR The effect of the predictive factor of the reaction of preparation for treating was further illustrated the Progression free survival time in Figure 19 on the patient of 56 weeks. As a result show and be accredited as the substrate and tube chamber A graders score (" PR-AR DX+ that meet the weighting more than -0.35:>- 0.35 ", top curve) relative to grader score (" the PR-AR DX- less than or equal to -0.35:<=-0.35 ", bottom is bent Line) prognosis characterizations condition patient in extension progression free survival phase.
Embodiment 12
Use>The substrate of -0.25 weighting and the new prognosis characterizations of tube chamber A grader score cutoff values press down as to AR The effect of the predictive factor of the reaction of preparation for treating in fig. 20 on patient's Progression free survival time of 56 weeks not receiving or Receiving once is used to further show in the patient of the prior treatment of the medicine for the non-androgen receptor inhibitor that TNBC is treated. As a result show and be accredited as the substrate and tube chamber A graders score (" PR-AR DX+ that meet the weighting more than -0.25:>- 0.25 ", top curve) relative to grader score (" the PR-AR DX- less than or equal to -0.25:<=-0.25 ", bottom is bent Line) characteristic condition patient in extension progression free survival phase.- 0.25 section is relatively appreciated that from Figure 17 and Figure 20 Disconnected value can identification mark be longer Progression free survival duration (Figure 20) of 0 to 1 prior treatment group, relative to spy Levy the shorter Progression free survival duration (Figure 17) for being the colony of all research patients.
Use>The substrate of -0.25 weighting and the new prognosis characterizations of tube chamber A grader score cutoff values press down as to AR The effect of the predictive factor of the reaction of preparation for treating is not receiving or received once to be used for the non-hero that TNBC is treated in fig 23 Further shown in the patient of the prior treatment of the medicine of hormone receptor inhibitor.Figure 23 is similar to Figure 20, except in research The Progression free survival time is confirmed as 64 weeks of 56 weeks more than Figure 20 into Figure 23.
Embodiment 13
Use>The substrate of -0.25 weighting and the new prognosis characterizations of tube chamber A grader score cutoff values press down as to AR The effect of the predictive factor of the reaction of preparation for treating is in Figure 21 A and 21B on not receiving or receiving once (0-1 elder generation Preceding treatment) or two or more times (2+ prior treatment) be used for TNBC treat non-androgen receptor inhibitor medicine elder generation The treatment time that gets nowhere of the patient of preceding treatment further shows.It is accredited as meeting the substrate and pipe of the weighting more than -0.25 56 patients of the characteristic condition of chamber A grader scores show in Figure 21 B.Obtained by the grader less than or equal to -0.25 62 research patients of identification are divided to be accredited in Figure 21 A.Each bar in figure represents a patient.Receiving once or do not having It is that obvious (Figure 21 B) indicates triangle to have the golden hour without progression of disease in the reactor for receiving prior treatment Patient's bar is active (" active ") under study for action.The patient's bar for indicating asterisk represents to react (CR) or partial reaction completely (PR)。
Embodiment 14
Use>The substrate of -0.25 weighting and the new prognosis characterizations of tube chamber A grader score cutoff values press down as to AR The effect of the predictive factor of the reaction of preparation for treating (was schemed in Figure 22 A and 22B on patient's Progression free survival time of 64 weeks 22A) Overall survival (Figure 22 B) with 84 weeks is further shown.Figure 22 A result show be accredited as meet be more than- The substrate and tube chamber A graders score (" PR-AR DX+ of 0.25 weighting:>- 0.25 ", top curve) relative to being less than or wait In -0.25 grader score (" PR-AR DX-:<=-0.25 ", bottom curve) prognosis characterizations condition patient in prolong Long progression free survival phase.Figure 22 B result, which is shown, is being accredited as meeting the substrate and tube chamber A of the weighting more than -0.25 Grader score (" PR-AR DX+:>- 0.25 ", top curve) relative to grader the score (" PR- less than or equal to -0.25 AR DX-:<=-0.25 ", bottom curve) prognosis characterizations condition patient in extension progression free survival phase.It is unsatisfactory for pre- Afterwards the patient of characteristic condition be characterized in 8.1 weeks middle position progression free survival phase and the middle position Overall survival of 32.1 weeks.Compared to it Under, the patient for meeting prognosis characterizations condition is characterised by the middle position progression free survival phase of 16.1 weeks, and and not yet reach within 84 weeks To middle position Overall survival.
Embodiment 15
It has been reported that the II clinical trial phases of androgen receptor antagonists Bicalutamide.Ayca et al., " Phase II Trial of Bicalutamide in Patients with Androgen Receptor Positive,Hormone Receptor Negative Metastatic Breast Cancer”,Clin Cancer Res 19:5505-5512 (October 1,2013).It is negative and pregnant that the experiment is designed to the research Bicalutamide treatment AR positives, ERs (ER) The curative effect of the negative metastatic breast cancer of hormone receptor (PgR).
In brief, as described in Ayca et al., by immunohistochemistry (IHC) (>10% nuclear staining is considered as positive ) AR is intensively tested to the tumour from the negative advanced breast cancer patients of 452 ER feminine genders/PgR.Extra eligibility criteria ginseng See Ayca et al., page 5506.If primary or metastasis site is the positive, patient meets qualification with daily 150mg dosage Receive AR antagonist Bicalutamides.28 treatment patients under study for action.Orally administered according to continuous daily scheme than card Shandong Amine 150mg.Patient is treated until progression of disease or unacceptable adverse events.Allow most 2 dosage of >=3 grades of toxicity Reduce (100 and 50mg).Due to toxicity, treatment delay can at most allow 2 weeks.Two are removed from research and takes Bicalutamide Patient, leave 26 suffer from AR (+) ER/PgR (-) metastatic breast cancer research participants.5 patient experiences stable diseases>6 Month (the periodicity of completion:6,8,10+, 13,57+), this is its preferably reaction to treatment.In the presence of the complete or portion of no confirmation Divide reaction, the clinical benefit rate for causing target group is 19% (95%CI, 7%-39%) (n=26).In purpose Treatment analysis In, it was observed that 18% (95%CI, 6%-37%) CBR.Referring to Ayca et al., page 5507.
21 in the research patient of 26 Bicalutamide treatments are determined being also HER-2 negative, i.e., 21 patients have Triple negative breast cancer (Her-2 (-), ER (-) and progesterone receptor PgR (-)).Result of study shows, makes to receive Bicalutamide to control The patient tumor samples of the 21 TNBC patients treated have carried out the tube chamber A, tube chamber B, substrate using PAM50 parting models The intrinsic Subtypes of sample, HER2 enrichments and normal sample group.Each hypotype score of each sample is listed in Table 3 below.Also arranged in table 3 The substrate and tube chamber A grader scores of the weighting of each sample are gone out.Clinical test based on the miscellaneous Shandong amine of AR- receptor antagonist grace Embodiment 6 in the result that obtains, the substrate and tube chamber A graders score (" PR-AR DX+ of the weighting more than -0.25>- 0.25 ") show that such patient is more likely more right than the patient that substrate and tube chamber A the classification score of weighting are less than or equal to -0.25 Bicalutamide treatment reacts.8 patients meet the standard, and are appointed as in table 3 the amine treatment of contrast card Shandong and may have sun Property (" POS ") prognosis.The confidence level of each display 1 in 21 Patient Sample As, in addition to sample 16, its confidence level For 0.99.
Table 3
Embodiment 16
Research shows below, positive in the substrate of the weighting more than -0.25 and the prognostic marker of tube chamber A grader scores Cell in, the miscellaneous Shandong amine of grace adds the combination of taxol to have enhanced antitumor action.
Triple negative breast cancer cell line BT549, MDA-MB-436, MDA-MB-453 is selected to be studied.The letter of cell line RNA data sets are made to be downloaded from encyclopaedical (CCLE) database of cancerous cell line.Each cell is determined from the database of download The substrate and tube chamber A grader scores of the weighting of system.Using>The substrate and tube chamber A grader scores of -0.25 weighting are as right The reactive prognostic marker of AR inhibitor for treating, determines MDA-MB-453 but is not that BT549 and MDA-MB-436 meet should Standard.
Cell is maintained in 10%FBS supplement growth mediums.Vitality test is carried out in 10%FBS, and according to system The scheme (Promega) for making business uses CellTiter-Glo reagent measurings.It is individually or miscellaneous with the grace of Paclitaxel combinations in order to determine Shandong amine is to the molecular effect of androgen receptor signal transduction, by cell (BT549, MDA-MB-436 or MDA-MB-453) the 1st It is inoculated with 10%FBS.Cell is located with the miscellaneous Shandong amine of grace or taxol or the two combination (in 2% charcoal handles serum) Reason, and stimulated 4 hours with 10nM DHT.For kytoplasm and core fraction separation Cell Fractionation.Egg is determined using western blot method White matter expression.For each cell line, the IC of the miscellaneous Shandong amine of grace or taxol50As shown in table 4.Given for each cell line Average value (n=3).Compared with the negative BT549 and MDA-MB-463 cells of prognostic marker, the positive MDA- of prognostic marker MB-453 cells show higher sensitiveness to the miscellaneous Shandong amine of grace.
Table 4
Cell line The miscellaneous Shandong amine IC of grace50(μM) Taxol IC50(nM)
BT549 57.0 2.8
MDA-MB-436 73.0 6.7
MDA-MB-453 22.7 20.7
The miscellaneous Shandong amine (Enza) of grace in Figure 24 A-C and the vigor that cell is measured in the presence of the concentration of taxol (PTX). Average value (n=5) is presented for each cell line.In the positive MDA-MB-453 cell lines of prognostic marker, the miscellaneous Shandong amine of grace Plus the combination of taxol causes enhanced cytotoxicity.Referring to Figure 24 C.
Embodiment 17
In order to produce mice xenograft model, by the female NOD-SCID mouse and 6.0x10 of 5 to 6 week old6Individual MDA- MB-453 cell in-situs are expelled in mammary gland.By DHT (10.5mg in 60 days release pills) or control pill implantation animal body It is interior.When tumor size reaches~100mm3When, feed the miscellaneous Shandong amine of (PO) grace by (i) with 3mg/kg/ days (n=10) mouths (" Enza "), (ii) feeds taxol (" PTX "), or (iii) (i) and (ii) (n=10) with 6mg/kg QMWF (IP) (n=7) mouth Combined treatment mouse.With medium (0.5%Methocel solution) processing control group mice (n=8).Tumor size slide calliper rule Measurement.Tumor weight was determined at the 35th day.As a result Figure 25 A (gross tumor volume relative time) and Figure 25 B (tumor weight) are shown in.Figure Data point in 25A represents every group of mean tumour volume, and error bars reflect the SEM of data.Student T- is examined for calculating p Value:Figure 25 A:The miscellaneous Shandong amine of the relative grace of control, 0.007;The relative taxol of control, 0.0007;The miscellaneous Shandong amine of grace adds with respect to the miscellaneous Shandong amine of grace Taxol, 0.074;Taxol adds taxol, 0.013 with respect to the miscellaneous Shandong amine of grace.Figure 25 B:The miscellaneous Shandong amine of the relative grace of control, 0.001;It is right Photograph is to taxol, 0.0001;The miscellaneous Shandong amine of grace adds taxol, 0.08 with respect to the miscellaneous Shandong amine of grace;Taxol adds purple with respect to the miscellaneous Shandong amine of grace China fir alcohol, 0.017.As shown by data, compared with both medicines are used alone, it is enhanced that the miscellaneous Shandong amine of grace adds the combination of taxol to cause Antitumous effect.
The representative tumour from each treatment group is selected to carry out the immunohistochemistry for AR, Ki67 or p-AKT. Compared with the miscellaneous Shandong amine of grace or taxol single therapy group, the miscellaneous Shandong amine of grace adds the immune of Ki67 or AKT phosphorylations in taxol tumour Histochemical stain is significantly reduced (data are not shown).
The disclosure of herein cited each patent, patent application and publication is incorporated herein by reference in their entirety.This Art personnel will readily appreciate that, the present invention be perfectly suitable for realizing purpose and obtain mentioned objects and advantages with And wherein intrinsic objects and advantages.Although disclosing the present invention by reference to specific embodiment, but it is clear that this area skill Art personnel can be designed that other embodiments of the present invention and modification, without departing from the true spirit of the practice for the present invention And scope.Appended claims are intended to be interpreted as including all these embodiments and equivalent variations.
Sequence table
<110> MEDIVATION PROSTATE THERAPEUTICS, INC.
<120>The method predicted the method for the reaction to breast cancer treatment agent and treat breast cancer
<130> 212181-0001-00-WO
<150> US 62/091,195
<151> 2014-12-12
<150> US 62/142,504
<151> 2015-04-03
<150> US 62/167,110
<151> 2015-05-27
<160> 151
<170> PatentIn version 3.5
<210> 1
<211> 19
<212> DNA
<213>Artificial sequence
<220>
<223>The primer of chemical synthesis
<400> 1
aaagattcct gggacctga 19
<210> 2
<211> 21
<212> DNA
<213>Artificial sequence
<220>
<223>The primer of chemical synthesis
<400> 2
acagccactt tcagaagcaa g 21
<210> 3
<211> 22
<212> DNA
<213>Artificial sequence
<220>
<223>The primer of chemical synthesis
<400> 3
ctggaagagt tgaataaaga gc 22
<210> 4
<211> 18
<212> DNA
<213>Artificial sequence
<220>
<223>The primer of chemical synthesis
<400> 4
tacctgaacc ggcacctg 18
<210> 5
<211> 20
<212> DNA
<213>Artificial sequence
<220>
<223>The primer of chemical synthesis
<400> 5
gcacaaagcc attctaagtc 20
<210> 6
<211> 17
<212> DNA
<213>Artificial sequence
<220>
<223>The primer of chemical synthesis
<400> 6
gctggctgag cagaaag 17
<210> 7
<211> 19
<212> DNA
<213>Artificial sequence
<220>
<223>The primer of chemical synthesis
<400> 7
ctttcgcctg agcctattt 19
<210> 8
<211> 18
<212> DNA
<213>Artificial sequence
<220>
<223>The primer of chemical synthesis
<400> 8
ggccaaaatc gacaggac 18
<210> 9
<211> 19
<212> DNA
<213>Artificial sequence
<220>
<223>The primer of chemical synthesis
<400> 9
ctgtctgagt gccgtggat 19
<210> 10
<211> 20
<212> DNA
<213>Artificial sequence
<220>
<223>The primer of chemical synthesis
<400> 10
gtaaatcacc ttctgagcct 20
<210> 11
<211> 18
<212> DNA
<213>Artificial sequence
<220>
<223>The primer of chemical synthesis
<400> 11
ggaggcggaa gaaaccag 18
<210> 12
<211> 24
<212> DNA
<213>Artificial sequence
<220>
<223>The primer of chemical synthesis
<400> 12
gacaaggaga atcaaaagat cagc 24
<210> 13
<211> 17
<212> DNA
<213>Artificial sequence
<220>
<223>The primer of chemical synthesis
<400> 13
gtggcagcag atcacaa 17
<210> 14
<211> 20
<212> DNA
<213>Artificial sequence
<220>
<223>The primer of chemical synthesis
<400> 14
cctcacgaat tgctgaactt 20
<210> 15
<211> 23
<212> DNA
<213>Artificial sequence
<220>
<223>The primer of chemical synthesis
<400> 15
catgaaatag tgcatagttt gcc 23
<210> 16
<211> 25
<212> DNA
<213>Artificial sequence
<220>
<223>The primer of chemical synthesis
<400> 16
acacagaatc tatacccacc agagt 25
<210> 17
<211> 20
<212> DNA
<213>Artificial sequence
<220>
<223>The primer of chemical synthesis
<400> 17
gctggctctc acactgatag 20
<210> 18
<211> 18
<212> DNA
<213>Artificial sequence
<220>
<223>The primer of chemical synthesis
<400> 18
gcagggagag gagtttgt 18
<210> 19
<211> 23
<212> DNA
<213>Artificial sequence
<220>
<223>The primer of chemical synthesis
<400> 19
cccatccatg tgaggaagta taa 23
<210> 20
<211> 17
<212> DNA
<213>Artificial sequence
<220>
<223>The primer of chemical synthesis
<400> 20
cttcttggac cttggcg 17
<210> 21
<211> 17
<212> DNA
<213>Artificial sequence
<220>
<223>The primer of chemical synthesis
<400> 21
gctactacgc agacacg 17
<210> 22
<211> 19
<212> DNA
<213>Artificial sequence
<220>
<223>The primer of chemical synthesis
<400> 22
gatgttcgag tcacagagg 19
<210> 23
<211> 17
<212> DNA
<213>Artificial sequence
<220>
<223>The primer of chemical synthesis
<400> 23
ttcggctgga aggaacc 17
<210> 24
<211> 18
<212> DNA
<213>Artificial sequence
<220>
<223>The primer of chemical synthesis
<400> 24
cgtggcagat gtgaacga 18
<210> 25
<211> 20
<212> DNA
<213>Artificial sequence
<220>
<223>The primer of chemical synthesis
<400> 25
ggagatccgt caactccaaa 20
<210> 26
<211> 18
<212> DNA
<213>Artificial sequence
<220>
<223>The primer of chemical synthesis
<400> 26
tgggtcgtgt caggaaac 18
<210> 27
<211> 20
<212> DNA
<213>Artificial sequence
<220>
<223>The primer of chemical synthesis
<400> 27
cgcagtcatc cagagatgtg 20
<210> 28
<211> 21
<212> DNA
<213>Artificial sequence
<220>
<223>The primer of chemical synthesis
<400> 28
actcagtaca agaaagaacc g 21
<210> 29
<211> 22
<212> DNA
<213>Artificial sequence
<220>
<223>The primer of chemical synthesis
<400> 29
gttggaccag tcaacatctc tg 22
<210> 30
<211> 18
<212> DNA
<213>Artificial sequence
<220>
<223>The primer of chemical synthesis
<400> 30
tgtggctcat taggcaac 18
<210> 31
<211> 18
<212> DNA
<213>Artificial sequence
<220>
<223>The primer of chemical synthesis
<400> 31
gactccaagc gcgaaaac 18
<210> 32
<211> 24
<212> DNA
<213>Artificial sequence
<220>
<223>The primer of chemical synthesis
<400> 32
ccaacaaaat attcatggtt cttg 24
<210> 33
<211> 18
<212> DNA
<213>Artificial sequence
<220>
<223>The primer of chemical synthesis
<400> 33
ccagtagcat tgtccgag 18
<210> 34
<211> 19
<212> DNA
<213>Artificial sequence
<220>
<223>The primer of chemical synthesis
<400> 34
gtctctggta atgcacact 19
<210> 35
<211> 18
<212> DNA
<213>Artificial sequence
<220>
<223>The primer of chemical synthesis
<400> 35
gtggaatgcc tgctgacc 18
<210> 36
<211> 18
<212> DNA
<213>Artificial sequence
<220>
<223>The primer of chemical synthesis
<400> 36
aggggtgccc tctgagat 18
<210> 37
<211> 18
<212> DNA
<213>Artificial sequence
<220>
<223>The primer of chemical synthesis
<400> 37
cgagatcgcc aagatgtt 18
<210> 38
<211> 18
<212> DNA
<213>Artificial sequence
<220>
<223>The primer of chemical synthesis
<400> 38
aggcgaacac acaacgtc 18
<210> 39
<211> 19
<212> DNA
<213>Artificial sequence
<220>
<223>The primer of chemical synthesis
<400> 39
agcctcgaac aattgaaga 19
<210> 40
<211> 27
<212> DNA
<213>Artificial sequence
<220>
<223>The primer of chemical synthesis
<400> 40
atcgactgtg taaacaacta gagaaga 27
<210> 41
<211> 20
<212> DNA
<213>Artificial sequence
<220>
<223>The primer of chemical synthesis
<400> 41
tttaagaggg caatggaagg 20
<210> 42
<211> 18
<212> DNA
<213>Artificial sequence
<220>
<223>The primer of chemical synthesis
<400> 42
tgccgcagaa ctcacttg 18
<210> 43
<211> 20
<212> DNA
<213>Artificial sequence
<220>
<223>The primer of chemical synthesis
<400> 43
cctcagatga tgcctatcca 20
<210> 44
<211> 19
<212> DNA
<213>Artificial sequence
<220>
<223>The primer of chemical synthesis
<400> 44
cagcaagcga tggcatagt 19
<210> 45
<211> 17
<212> DNA
<213>Artificial sequence
<220>
<223>The primer of chemical synthesis
<400> 45
aatgccaccg aagcctc 17
<210> 46
<211> 23
<212> DNA
<213>Artificial sequence
<220>
<223>The primer of chemical synthesis
<400> 46
tcgaactgaa ggctatttac gag 23
<210> 47
<211> 18
<212> DNA
<213>Artificial sequence
<220>
<223>The primer of chemical synthesis
<400> 47
gtcgaagccg caattagg 18
<210> 48
<211> 20
<212> DNA
<213>Artificial sequence
<220>
<223>The primer of chemical synthesis
<400> 48
caaacgtgtg ttctggaagg 20
<210> 49
<211> 20
<212> DNA
<213>Artificial sequence
<220>
<223>The primer of chemical synthesis
<400> 49
tgccctgtat gatgtcagga 20
<210> 50
<211> 20
<212> DNA
<213>Artificial sequence
<220>
<223>The primer of chemical synthesis
<400> 50
gtgaggggtg tcagctcagt 20
<210> 51
<211> 22
<212> DNA
<213>Artificial sequence
<220>
<223>The primer of chemical synthesis
<400> 51
tggggcagtt ctgtattact tc 22
<210> 52
<211> 24
<212> DNA
<213>Artificial sequence
<220>
<223>The primer of chemical synthesis
<400> 52
cgatggtttt gtacaagatt tctc 24
<210> 53
<211> 17
<212> DNA
<213>Artificial sequence
<220>
<223>The primer of chemical synthesis
<400> 53
gcaaatcctt gggcaga 17
<210> 54
<211> 20
<212> DNA
<213>Artificial sequence
<220>
<223>The primer of chemical synthesis
<400> 54
gccgtacagt tccacaaagg 20
<210> 55
<211> 22
<212> DNA
<213>Artificial sequence
<220>
<223>The primer of chemical synthesis
<400> 55
gacgcttcct atcactctat tc 22
<210> 56
<211> 22
<212> DNA
<213>Artificial sequence
<220>
<223>The primer of chemical synthesis
<400> 56
ttcctccatc aagagttcaa ca 22
<210> 57
<211> 18
<212> DNA
<213>Artificial sequence
<220>
<223>The primer of chemical synthesis
<400> 57
gggcacatcc agatgttt 18
<210> 58
<211> 19
<212> DNA
<213>Artificial sequence
<220>
<223>The primer of chemical synthesis
<400> 58
gggtctgcac agactgcat 19
<210> 59
<211> 20
<212> DNA
<213>Artificial sequence
<220>
<223>The primer of chemical synthesis
<400> 59
tccttgtaat ggggagacca 20
<210> 60
<211> 23
<212> DNA
<213>Artificial sequence
<220>
<223>The primer of chemical synthesis
<400> 60
acttgggata tgtgaataag acc 23
<210> 61
<211> 20
<212> DNA
<213>Artificial sequence
<220>
<223>The primer of chemical synthesis
<400> 61
ggggaaagac aaagtttcca 20
<210> 62
<211> 20
<212> DNA
<213>Artificial sequence
<220>
<223>The primer of chemical synthesis
<400> 62
actgtctggg tccatggcta 20
<210> 63
<211> 18
<212> DNA
<213>Artificial sequence
<220>
<223>The primer of chemical synthesis
<400> 63
ggatttcgtg gtgggttc 18
<210> 64
<211> 20
<212> DNA
<213>Artificial sequence
<220>
<223>The primer of chemical synthesis
<400> 64
ccacagtctg tgataaacgg 20
<210> 65
<211> 24
<212> DNA
<213>Artificial sequence
<220>
<223>The primer of chemical synthesis
<400> 65
ccatcaacat tctctttatg aacg 24
<210> 66
<211> 20
<212> DNA
<213>Artificial sequence
<220>
<223>The primer of chemical synthesis
<400> 66
atcaactccc aaacggtcac 20
<210> 67
<211> 20
<212> DNA
<213>Artificial sequence
<220>
<223>The primer of chemical synthesis
<400> 67
gcccttacac atcggagaac 20
<210> 68
<211> 18
<212> DNA
<213>Artificial sequence
<220>
<223>The primer of chemical synthesis
<400> 68
gacttcaggg tgctggac 18
<210> 69
<211> 22
<212> DNA
<213>Artificial sequence
<220>
<223>The primer of chemical synthesis
<400> 69
tgtgaagcca gcaatatgta tc 22
<210> 70
<211> 21
<212> DNA
<213>Artificial sequence
<220>
<223>The primer of chemical synthesis
<400> 70
tattgggagg caggaggttt a 21
<210> 71
<211> 20
<212> DNA
<213>Artificial sequence
<220>
<223>The primer of chemical synthesis
<400> 71
ctgagttcat gttgctgacc 20
<210> 72
<211> 19
<212> DNA
<213>Artificial sequence
<220>
<223>The primer of chemical synthesis
<400> 72
gacagctact attcccgtt 19
<210> 73
<211> 21
<212> DNA
<213>Artificial sequence
<220>
<223>The primer of chemical synthesis
<400> 73
tatgtgagta agctcggaga c 21
<210> 74
<211> 17
<212> DNA
<213>Artificial sequence
<220>
<223>The primer of chemical synthesis
<400> 74
agtgggcatc ccgtaga 17
<210> 75
<211> 19
<212> DNA
<213>Artificial sequence
<220>
<223>The primer of chemical synthesis
<400> 75
agtggacatg cgagtggag 19
<210> 76
<211> 18
<212> DNA
<213>Artificial sequence
<220>
<223>The primer of chemical synthesis
<400> 76
caccgctgga aactgaac 18
<210> 77
<211> 19
<212> DNA
<213>Artificial sequence
<220>
<223>The primer of chemical synthesis
<400> 77
cgtgcacatc catgacctt 19
<210> 78
<211> 17
<212> DNA
<213>Artificial sequence
<220>
<223>The primer of chemical synthesis
<400> 78
gaggagatga ccttgcc 17
<210> 79
<211> 18
<212> DNA
<213>Artificial sequence
<220>
<223>The primer of chemical synthesis
<400> 79
gccatagcca ctgccact 18
<210> 80
<211> 17
<212> DNA
<213>Artificial sequence
<220>
<223>The primer of chemical synthesis
<400> 80
cttcgactgg actctgt 17
<210> 81
<211> 23
<212> DNA
<213>Artificial sequence
<220>
<223>The primer of chemical synthesis
<400> 81
cagacatgtt ggtattgcac att 23
<210> 82
<211> 20
<212> DNA
<213>Artificial sequence
<220>
<223>The primer of chemical synthesis
<400> 82
aggcgatcct gggaaattat 20
<210> 83
<211> 19
<212> DNA
<213>Artificial sequence
<220>
<223>The primer of chemical synthesis
<400> 83
cccatttgtc tgtcttcac 19
<210> 84
<211> 18
<212> DNA
<213>Artificial sequence
<220>
<223>The primer of chemical synthesis
<400> 84
ctgatggttg aggctgtt 18
<210> 85
<211> 19
<212> DNA
<213>Artificial sequence
<220>
<223>The primer of chemical synthesis
<400> 85
cgcactccag cacctagac 19
<210> 86
<211> 21
<212> DNA
<213>Artificial sequence
<220>
<223>The primer of chemical synthesis
<400> 86
tcacagggtc aaacttccag t 21
<210> 87
<211> 21
<212> DNA
<213>Artificial sequence
<220>
<223>The primer of chemical synthesis
<400> 87
gatggtagag ttccagtgat t 21
<210> 88
<211> 18
<212> DNA
<213>Artificial sequence
<220>
<223>The primer of chemical synthesis
<400> 88
tctggtcacg cagggcaa 18
<210> 89
<211> 20
<212> DNA
<213>Artificial sequence
<220>
<223>The primer of chemical synthesis
<400> 89
acacagatga tggagatgtc 20
<210> 90
<211> 25
<212> DNA
<213>Artificial sequence
<220>
<223>The primer of chemical synthesis
<400> 90
agtagctaca tctccaggtt ctctg 25
<210> 91
<211> 21
<212> DNA
<213>Artificial sequence
<220>
<223>The primer of chemical synthesis
<400> 91
cggattttat caacgatgca g 21
<210> 92
<211> 19
<212> DNA
<213>Artificial sequence
<220>
<223>The primer of chemical synthesis
<400> 92
catttgccgt ccttcatcg 19
<210> 93
<211> 20
<212> DNA
<213>Artificial sequence
<220>
<223>The primer of chemical synthesis
<400> 93
gcaggtcaaa actctcaaag 20
<210> 94
<211> 20
<212> DNA
<213>Artificial sequence
<220>
<223>The primer of chemical synthesis
<400> 94
agcgggcttc tgtaatctga 20
<210> 95
<211> 19
<212> DNA
<213>Artificial sequence
<220>
<223>The primer of chemical synthesis
<400> 95
gcctcagatt tcaactcgt 19
<210> 96
<211> 21
<212> DNA
<213>Artificial sequence
<220>
<223>The primer of chemical synthesis
<400> 96
ctgctgagaa tcaaagtggg a 21
<210> 97
<211> 19
<212> DNA
<213>Artificial sequence
<220>
<223>The primer of chemical synthesis
<400> 97
ggaacaaact gctctgcca 19
<210> 98
<211> 22
<212> DNA
<213>Artificial sequence
<220>
<223>The primer of chemical synthesis
<400> 98
acagctcttt agcatttgtg ga 22
<210> 99
<211> 23
<212> DNA
<213>Artificial sequence
<220>
<223>The primer of chemical synthesis
<400> 99
gggactatca atgttgggtt ctc 23
<210> 100
<211> 21
<212> DNA
<213>Artificial sequence
<220>
<223>The primer of chemical synthesis
<400> 100
cacacagttc actgctccac a 21
<210> 101
<211> 2199
<212> DNA
<213>Homo sapiens
<400> 101
cagcggcgct gcggcggctc gcgggagacg ctgcgcgcgg ggctagcggg cggcggagcg 60
gacggcgacg gggcgctctc gggctgccgg cggggccgag cgccgcgcgt cccgagcatg 120
gcaggctccc tgcctccctg cgtggtggac tgtggcaccg ggtataccaa gcttggctac 180
gcaggcaaca ctgagcccca gttcattatt ccttcatgta ttgccatcag agagtcagca 240
aaggtagttg accaagctca aaggagagtg ttgaggggag ttgatgacct tgactttttc 300
ataggagatg aagccatcga taaacctaca tatgctacaa agtggccgat acgacatgga 360
atcattgaag actgggatct tatggaaagg ttcatggagc aagtggtttt taaatatctt 420
cgagctgaac ctgaggacca ttatttttta atgacagaac ctccactcaa tacaccagaa 480
aacagagagt atcttgcaga aattatgttt gaatcattta acgtaccagg actctacatt 540
gcagttcagg cagtgctggc cttggcggca tcttggacat ctcgacaagt gggtgaacgt 600
acgttaacgg ggatagtcat tgacagcgga gatggagtca cccatgttat cccagtggca 660
gaaggttatg taattggaag ctgcatcaaa cacatcccga ttgcaggtag agatattacg 720
tatttcattc aacagctgct aagggagagg gaggtgggaa tccctcctga gcagtcactg 780
gagaccgcaa aagccattaa ggagaaatac tgttacattt gccccgatat agtcaaggaa 840
tttgccaagt atgatgtgga tccccggaag tggatcaaac agtacacggg tatcaatgcg 900
atcaaccaga agaagtttgt tatagacgtt ggttacgaaa gattcctggg acctgaaata 960
ttctttcacc cggagtttgc caacccagac tttatggagt ccatctcaga tgttgttgat 1020
gaagtaatac agaactgccc catcgatgtg cggcgcccgc tgtataagaa tgtcgtactc 1080
tcaggaggct ccaccatgtt cagggatttc ggacgccgac tgcagaggga tttgaagaga 1140
gtggtggatg ctaggctgag gctcagcgag gagctcagcg gcgggaggat caagccgaag 1200
cctgtggagg tccaggtggt cacgcatcac atgcagcgct acgccgtgtg gttcggaggc 1260
tccatgctgg cctcgactcc cgagttcttt caggtctgcc acaccaagaa ggactatgaa 1320
gagtacgggc ccagcatctg ccgccacaac cccgtctttg gagtcatgtc ctagtgtctg 1380
cctgaacgcg tcgttcgatg gtgtcacgtt ggggaacaag tgtccttcag aacccagaga 1440
aggccgccgt tctgtaaata gcgacgtcgg tgttgctgcc cagcagcgtg cttgcattgc 1500
cggtgcatga ggcgcggcgc gggcccttca gtaaaagcca tttatccgtg tgccgaccgc 1560
tgtctgccag cctcctcctt ctcccgccct cctcaccctc gctctccctc ctcctcctcc 1620
tccgagctgc tagctgacaa atacaattct gaaggaatcc aaatgtgact ttgaaaattg 1680
ttagagaaaa caacattaga aaatggcgca aaatcgttag gtcccaggag agaatgtggg 1740
ggcgcaaacc cttttcctcc cagcctattt ttgtaaataa aatgtttaaa cttgaaatac 1800
aaatcgatgt ttatatttcc tatcattttg tattttatgg tatttggtac aactggctga 1860
tactaagcac gaatagatat tgatgttatg gagtgctgta atccaaagtt tttaattgtg 1920
aggcatgttc tgatatgttt ataggcaaac aaataaaaca gcaaactttt ttgccacatg 1980
tttgctagaa aatgattata ctttattgga gtgacatgaa gtttgaacac taaacagtaa 2040
tgtatgagaa ttactacaga tacatgtatc ttttagtttt ttttgtttga actttctgga 2100
gctgttttat agaagatgat ggtttgttgt cggtgagtgt tggatgaaat acttccttgc 2160
accattgtaa taaaagctgt tagaatattt gtaaatatc 2199
<210> 102
<211> 1989
<212> DNA
<213>Homo sapiens
<400> 102
cagcggcgct gcggcggctc gcgggagacg ctgcgcgcgg ggctagcggg cggcggagcg 60
gacggcgacg gggcgctctc gggctgccgg cggggccgag cgccgcgcgt cccgagcatg 120
gcaggctccc tgcctccctg cgtggtggac tgtggcaccg ggtataccaa gcttggctac 180
gcaggcaaca ctgagcccca gttcattatt ccttcatgta ttgccatcag agagtcagca 240
aaggtagttg accaagctca aaggagagtg ttgaggggag ttgatgacct tgactttttc 300
ataggagatg aagccatcga taaacctaca tatgctacaa agtggccgat acgacatgga 360
atcattgaag actgggatct tatggaaagg ttcatggagc aagtggtttt taaatatctt 420
cgagctgaac ctgaggacca ttatttttta atgacagaac ctccactcaa tacaccagaa 480
aacagagagt atcttgcaga aattatgttt gaatcattta acgtaccagg actctacatt 540
gcagttcagg cagtgctggc cttggcggca tcttggacat ctcgacaagt gggtgaacgt 600
acgttaacgg ggatagtcat tgacagcgga gatggagtca cccatgttat cccagtggca 660
gaaggttatg taattggaag ctgcatcaaa cacatcccga ttgcaggtag agatattacg 720
tatttcattc aacagctgct aagggagagg gaggtgggaa tccctcctga gcagtcactg 780
gagaccgcaa aagccattaa ggagaaatac tgttacattt gccccgatat agtcaaggaa 840
tttgccaagt atgatgtgga tccccggaag tggatcaaac agtacacggg tatcaatgcg 900
atcaaccaga agaagtttgt tatagacgtt ggttacgaaa gattcctggg acctgaaata 960
ttctttcacc cggagtttgc caacccagac tttatggagt ccatctcaga tgttgttgat 1020
gaagtaatac agaactgccc catcgatgtg cggcgcccgc tgtataagcc cgagttcttt 1080
caggtctgcc acaccaagaa ggactatgaa gagtacgggc ccagcatctg ccgccacaac 1140
cccgtctttg gagtcatgtc ctagtgtctg cctgaacgcg tcgttcgatg gtgtcacgtt 1200
ggggaacaag tgtccttcag aacccagaga aggccgccgt tctgtaaata gcgacgtcgg 1260
tgttgctgcc cagcagcgtg cttgcattgc cggtgcatga ggcgcggcgc gggcccttca 1320
gtaaaagcca tttatccgtg tgccgaccgc tgtctgccag cctcctcctt ctcccgccct 1380
cctcaccctc gctctccctc ctcctcctcc tccgagctgc tagctgacaa atacaattct 1440
gaaggaatcc aaatgtgact ttgaaaattg ttagagaaaa caacattaga aaatggcgca 1500
aaatcgttag gtcccaggag agaatgtggg ggcgcaaacc cttttcctcc cagcctattt 1560
ttgtaaataa aatgtttaaa cttgaaatac aaatcgatgt ttatatttcc tatcattttg 1620
tattttatgg tatttggtac aactggctga tactaagcac gaatagatat tgatgttatg 1680
gagtgctgta atccaaagtt tttaattgtg aggcatgttc tgatatgttt ataggcaaac 1740
aaataaaaca gcaaactttt ttgccacatg tttgctagaa aatgattata ctttattgga 1800
gtgacatgaa gtttgaacac taaacagtaa tgtatgagaa ttactacaga tacatgtatc 1860
ttttagtttt ttttgtttga actttctgga gctgttttat agaagatgat ggtttgttgt 1920
cggtgagtgt tggatgaaat acttccttgc accattgtaa taaaagctgt tagaatattt 1980
gtaaatatc 1989
<210> 103
<211> 4786
<212> DNA
<213>Homo sapiens
<400> 103
ctcggcgctg aaattcaaat ttgaacggct gcagaggccg agtccgtcac tggaagccga 60
gaggagagga cagctggttg tgggagagtt cccccgcctc agactcctgg ttttttccag 120
gagacacact gagctgagac tcacttttct cttcctgaat ttgaaccacc gtttccatcg 180
tctcgtagtc cgacgcctgg ggcgatggat ccgtttacgg agaaactgct ggagcgaacc 240
cgtgccaggc gagagaatct tcagagaaaa atggctgaga ggcccacagc agctccaagg 300
tctatgactc atgctaagcg agctagacag ccactttcag aagcaagtaa ccagcagccc 360
ctctctggtg gtgaagagaa atcttgtaca aaaccatcgc catcaaaaaa acgctgttct 420
gacaacactg aagtagaagt ttctaacttg gaaaataaac aaccagttga gtcgacatct 480
gcaaaatctt gttctccaag tcctgtgtct cctcaggtgc agccacaagc agcagatacc 540
atcagtgatt ctgttgctgt cccggcatca ctgctgggca tgaggagagg gctgaactca 600
agattggaag caactgcagc ctcctcagtt aaaacacgta tgcaaaaact tgcagagcaa 660
cggcgccgtt gggataatga tgatatgaca gatgacattc ctgaaagctc actcttctca 720
ccaatgccat cagaggaaaa ggctgcttcc cctcccagac ctctgctttc aaatgcctcg 780
gcaactccag ttggcagaag gggccgtctg gccaatcttg ctgcaactat ttgctcctgg 840
gaagatgatg taaatcactc atttgcaaaa caaaacagtg tacaagaaca gcctggtacc 900
gcttgtttat ccaaattttc ctctgcaagt ggagcatctg ctaggatcaa tagcagcagt 960
gttaagcagg aagctacatt ctgttcccaa agggatggcg atgcctcttt gaataaagcc 1020
ctatcctcaa gtgctgatga tgcgtctttg gttaatgcct caatttccag ctctgtgaaa 1080
gctacttctc cagtgaaatc tactacatct atcactgatg ctaaaagttg tgagggacaa 1140
aatcctgagc tacttccaaa aactcctatt agtcctctga aaacgggggt atcgaaacca 1200
attgtgaagt caactttatc ccagacagtt ccatccaagg gagaattaag tagagaaatt 1260
tgtctgcaat ctcaatctaa agacaaatct acgacaccag gaggaacagg aattaagcct 1320
ttcctggaac gctttggaga gcgttgtcaa gaacatagca aagaaagtcc agctcgtagc 1380
acaccccaca gaacccccat tattactcca aatacaaagg ccatccaaga aagattattc 1440
aagcaagaca catcttcatc tactacccat ttagcacaac agctcaagca ggaacgtcaa 1500
aaagaactag catgtcttcg tggccgattt gacaagggca atatatggag tgcagaaaaa 1560
ggcggaaact caaaaagcaa acaactagaa accaaacagg aaactcactg tcagagcact 1620
cccctcaaaa aacaccaagg tgtttcaaaa actcagtcac ttccagtaac agaaaaggtg 1680
accgaaaacc agataccagc caaaaattct agtacagaac ctaaaggttt cactgaatgc 1740
gaaatgacga aatctagccc tttgaaaata acattgtttt tagaagagga caaatcctta 1800
aaagtaacat cagacccaaa ggttgagcag aaaattgaag tgatacgtga aattgagatg 1860
agtgtggatg atgatgatat caatagttcg aaagtaatta atgacctctt cagtgatgtc 1920
ctagaggaag gtgaactaga tatggagaag agccaagagg agatggatca agcattagca 1980
gaaagcagcg aagaacagga agatgcactg aatatctcct caatgtcttt acttgcacca 2040
ttggcacaaa cagttggtgt ggtaagtcca gagagtttag tgtccacacc tagactggaa 2100
ttgaaagaca ccagcagaag tgatgaaagt ccaaaaccag gaaaattcca aagaactcgt 2160
gtccctcgag ctgaatctgg tgatagcctt ggttctgaag atcgtgatct tctttacagc 2220
attgatgcat atagatctca aagattcaaa gaaacagaac gtccatcaat aaagcaggtg 2280
attgttcgga aggaagatgt tacttcaaaa ctggatgaaa aaaataatgc ctttccttgt 2340
caagttaata tcaaacagaa aatgcaggaa ctcaataacg aaataaatat gcaacagaca 2400
gtgatctatc aagctagcca ggctcttaac tgctgtgttg atgaagaaca tggaaaaggg 2460
tccctagaag aagctgaagc agaaagactt cttctaattg caactgggaa gagaacactt 2520
ttgattgatg aattgaataa attgaagaac gaaggacctc agaggaagaa taaggctagt 2580
ccccaaagtg aatttatgcc atccaaagga tcagttactt tgtcagaaat ccgcttgcct 2640
ctaaaagcag attttgtctg cagtacggtt cagaaaccag atgcagcaaa ttactattac 2700
ttaattatac taaaagcagg agctgaaaat atggtagcca caccattagc aagtacttca 2760
aactctctta acggtgatgc tctgacattc actactacat ttactctgca agatgtatcc 2820
aatgactttg aaataaatat tgaagtttac agcttggtgc aaaagaaaga tccctcaggc 2880
cttgataaga agaaaaaaac atccaagtcc aaggctatta ctccaaagcg actcctcaca 2940
tctataacca caaaaagcaa cattcattct tcagtcatgg ccagtccagg aggtcttagt 3000
gctgtgcgaa ccagcaactt cgcccttgtt ggatcttaca cattatcatt gtcttcagta 3060
ggaaatacta agtttgttct ggacaaggtc ccctttttat cttctttgga aggtcatatt 3120
tatttaaaaa taaaatgtca agtgaattcc agtgttgaag aaagaggttt tctaaccata 3180
tttgaagatg ttagtggttt tggtgcctgg catcgaagat ggtgtgttct ttctggaaac 3240
tgtatatctt attggactta tccagatgat gagaaacgca agaatcccat aggaaggata 3300
aatctggcta attgtaccag tcgtcagata gaaccagcca acagagaatt ttgtgcaaga 3360
cgcaacactt ttgaattaat tactgtccga ccacaaagag aagatgaccg agagactctt 3420
gtcagccaat gcagggacac actctgtgtt accaagaact ggctgtctgc agatactaaa 3480
gaagagcggg atctctggat gcaaaaactc aatcaagttc ttgttgatat tcgcctctgg 3540
caacctgatg cttgctacaa acctattgga aagccttaaa ccgggaaatt tccatgctat 3600
ctagaggttt ttgatgtcat cttaagaaac acacttaaga gcatcagatt tactgattgc 3660
attttatgct ttaagtacga aagggtttgt gccaatattc actacgtatt atgcagtatt 3720
tatatctttt gtatgtaaaa ctttaactga tttctgtcat tcatcaatga gtagaagtaa 3780
atacattata gttgattttg ctaaatctta atttaaaagc ctcattttcc tagaaatcta 3840
attattcagt tattcatgac aatatttttt taaaagtaag aaattctgag ttgtcttctt 3900
ggagctgtag gtcttgaagc agcaacgtct ttcaggggtt ggagacagaa acccattctc 3960
caatctcagt agttttttcg aaaggctgtg atcatttatt gatcgtgata tgacttgtta 4020
ctagggtact gaaaaaaatg tctaaggcct ttacagaaac atttttagta atgaggatga 4080
gaactttttc aaatagcaaa tatatattgg cttaaagcat gaggctgtct tcagaaaagt 4140
gatgtggaca taggaggcaa tgtgtgagac ttgggggttc aatattttat atagaagagt 4200
taataagcac atggtttaca tttactcagc tactatatat gcagtgtggt gcacattttc 4260
acagaattct ggcttcatta agatcattat ttttgctgcg tagcttacag acttagcata 4320
ttagtttttt ctactcctac aagtgtaaat tgaaaaatct ttatattaaa aaagtaaact 4380
gttatgaagc tgctatgtac taataatact ttgcttgcca aagtgtttgg gttttgttgt 4440
tgtttgtttg tttgtttgtt tttggttcat gaacaacagt gtctagaaac ccattttgaa 4500
agtggaaaat tattaagtca cctatcacct ttaaacgcct ttttttaaaa ttataaaata 4560
ttgtaaagca gggtctcaac ttttaaatac actttgaact tcttctctga attattaaag 4620
ttctttatga cctcatttat aaacactaaa ttctgtcacc tcctgtcatt ttatttttta 4680
ttcattcaaa tgtatttttt cttgtgcata ttataaaaat atattttatg agctcttact 4740
caaataaata cctgtaaatg tctaaaggaa aaaaaaaaaa aaaaaa 4786
<210> 104
<211> 3885
<212> DNA
<213>Homo sapiens
<400> 104
aggccggggc ggggctggga agtagtcggg cggggttgtg agacgccgcg ctcagcttcc 60
atcgctgggc ggtcaacaag tgcgggcctg gctcagcgcg ggggggcgcg gagaccgcga 120
ggcgaccggg agcggctggg ttcccggctg cgcgcccttc ggccaggccg ggagccgcgc 180
cagtcggagc ccccggccca gcgtggtccg cctccctctc ggcgtccacc tgcccggagt 240
actgccagcg ggcatgaccg acccaccagg ggcgccgccg ccggcgctcg caggccgcgg 300
atgaagaaga aaacccggcg ccgctcgacc cggagcgagg agttgacccg gagcgaggag 360
ttgaccctga gtgaggaagc gacctggagt gaagaggcga cccagagtga ggaggcgacc 420
cagggcgaag agatgaatcg gagccaggag gtgacccggg acgaggagtc gacccggagc 480
gaggaggtga ccagggagga aatggcggca gctgggctca ccgtgactgt cacccacagc 540
aatgagaagc acgaccttca tgttacctcc cagcagggca gcagtgaacc agttgtccaa 600
gacctggccc aggttgttga agaggtcata ggggttccac agtcttttca gaaactcata 660
tttaagggaa aatctctgaa ggaaatggaa acaccgttgt cagcacttgg aatacaagat 720
ggttgccggg tcatgttaat tgggaaaaag aacagtccac aggaagaggt tgaactaaag 780
aagttgaaac atttggagaa gtctgtggag aagatagctg accagctgga agagttgaat 840
aaagagctta ctggaatcca gcagggtttt ctgcccaagg atttgcaagc tgaagctctc 900
tgcaaacttg ataggagagt aaaagccaca atagagcagt ttatgaagat cttggaggag 960
attgacacac tgatcctgcc agaaaatttc aaagacagta gattgaaaag gaaaggcttg 1020
gtaaaaaagg ttcaggcatt cctagccgag tgtgacacag tggagcagaa catctgccag 1080
gagactgagc ggctgcagtc tacaaacttt gccctggccg agtgaggtgt agcagaaaaa 1140
ggctgtgctg ccctgaagaa tggcgccacc agctctgccg tctctggagc ggaatttacc 1200
tgatttcttc agggctgctg ggggcaactg gccatttgcc aattttccta ctctcacact 1260
ggttctcaat gaaaaatagt gtctttgtga ttttgagtaa agctcctatc tgttttctcc 1320
ttctgtctct gtggttgtac tgtccagcaa tccacctttt ctggagaggg ccacctctgc 1380
ccaaattttc ccagctgttt ggacctctgg gtgctttctt tgggctggtg agagctctaa 1440
tttgccttgg gccagtttca ggtttatagg ccccctcagt cttcagatac atgagggctt 1500
ctttgctctt gtgatcgtgt agtcccatag ctgtaaaacc agaatcacca ggaggttgca 1560
cctagtcagg aatattggga atggcctaga acaaggtgtt tggcacataa gtagaccact 1620
tatccctcat tgtgacctaa ttccagagca tctggctggg ttgttgggtt ctagactttg 1680
tcctcacctc ccagtgaccc tgactagcca caggccatga gataccaggg ggccgttcct 1740
tggatggagc ctgtggttga tgcaaggctt ccttgtcccc aagcaagtct tcagaaggtt 1800
agaacccagt gttgactgag tctgtgcttg aaaccaggcc agagccatgg attaggaagg 1860
gcaaagagaa ggcaccagaa tgagtaaagc aggcaggtgg tgaagccaac cataaacttc 1920
tcaggagtga catgtgcttc cttcaaaggc atttttgtta accatatcct tctgagttct 1980
atgtttcctt cacagctgtt ctatccattt tgtggactgt cccccacccc caccccatca 2040
ttgtttttaa aaaattaagg cctggcgcag cagctcatgc ctataatccc agcactttgg 2100
gaggctgagg cgggcggatc acttgaggcc aggagtttga gaccagccca ggcaacatag 2160
caaaacccca ttctgcttta aaaaaaaaaa aaaaaaaaat tagcttggcg tagtggcatg 2220
tgcctataat cccagctact ggggaggctg aggcacaaga atcatttgaa cctgggaggt 2280
agaggttgct gtgagccgag attacgcccc tgcactccag cctgggtcac agagtgagac 2340
tccatctcag aaaaaaaaaa aattgagtca ggtgcagtag ctccttcctg tagtcccagc 2400
tacttgggag gctgaggcta gaggatcact tgagcccagg agtttgagtc tagtctgggc 2460
aacatagcaa gaccccatct ctaaaattta agtaagtaaa agtagataaa taaaaagaaa 2520
aaaaaactgt ttatgtgctc atcataaagt agaagagtgg tttgcttttt tttttttttt 2580
tggattaatg aggaaatcat tctgtggctc tagtcataat ttatgcttaa taacattgat 2640
agtagccctt tgcgctataa ctctacctaa agactcacat catttggcag agagagagtc 2700
gttgaagtcc caggaattca ggactgggca ggttaagacc tcagacaagg tagtagaggt 2760
agacttgtgg acaaggctcg ggtcccagcc caccgcaccc caactttaat cagagtggtt 2820
cactattgat ctatttttgt gtgatagctg tgtggcgtgg gccacaacat ttaatgagaa 2880
gttactgtgc accaaactgc cgaacaccat tctaaactat tcatatatat tagtcattta 2940
attcttacat aacttgagag gtagacagat atccttattt tagagatgag gaaaccaaga 3000
gaacttaggt cattagcgca aggttgtaga gtaagcggca aagccaagac acaaagctgg 3060
gtggtttggt ttcagagcca gtgcttttcc cctctactgt actgcctctc aaccaacaca 3120
gggttgcaca ggcccattct ctgatttttt tcctcttgtc ctctgcctct ccctctagct 3180
cccacttcct ctctgctcta gttcattttc tttagagcag cccgagtgat catgaagtgc 3240
aaatcttgcc atgtcagtcc cctgcttaga accctccaat ggctcacttt ctctttaggc 3300
aaaagtcttt accccatgcc ttctcccatc tcatctcaac cccctcattt gttggctgtc 3360
tgctgtcagc cactcttctt tcaggtcctc agatgcactg caccctctcc tgcctggggg 3420
tctttgctcc tgctactacc tctgcttgaa cagctcctca ccttccttcc tccaacccta 3480
cccttgtata ggtgactttt gttcatcctt cagaattcaa ctcacatgtc tcttgcatgg 3540
agaaccctca cctactgtgt tgagaccctg tccagccccc aggtgggatc ctctctcgac 3600
ttcccataca tttctttcac agcatttaca tagtccatga tagtttactt gtgggattat 3660
ttggttaatc tttgccttta acaccagggt tccttgggtg aaggagcttc tttatcttgg 3720
taacagcatt atttcaagca taacttgtaa tatagttata ttacatatat aacatatata 3780
tatataacat aacatatata acatatataa caagcataac ttgttatata gtcttgtata 3840
tagtaagacc tcaataaata tttggagaac aaaaaaaaaa aaaaa 3885
<210> 105
<211> 6492
<212> DNA
<213>Homo sapiens
<400> 105
tttctgtgaa gcagaagtct gggaatcgat ctggaaatcc tcctaatttt tactccctct 60
ccccgcgact cctgattcat tgggaagttt caaatcagct ataactggag agtgctgaag 120
attgatggga tcgttgcctt atgcatttgt tttggtttta caaaaaggaa acttgacaga 180
ggatcatgct gtacttaaaa aatacaacat cacagaggaa gtagactgat attaacaata 240
cttactaata ataacgtgcc tcatgaaata aagatccgaa aggaattgga ataaaaattt 300
cctgcatctc atgccaaggg ggaaacacca gaatcaagtg ttccgcgtga ttgaagacac 360
cccctcgtcc aagaatgcaa agcacatcca ataaaatagc tggattataa ctcctcttct 420
ttctctgggg gccgtggggt gggagctggg gcgagaggtg ccgttggccc ccgttgcttt 480
tcctctggga aggatggcgc acgctgggag aacagggtac gataaccggg agatagtgat 540
gaagtacatc cattataagc tgtcgcagag gggctacgag tgggatgcgg gagatgtggg 600
cgccgcgccc ccgggggccg cccccgcacc gggcatcttc tcctcccagc ccgggcacac 660
gccccatcca gccgcatccc gggacccggt cgccaggacc tcgccgctgc agaccccggc 720
tgcccccggc gccgccgcgg ggcctgcgct cagcccggtg ccacctgtgg tccacctgac 780
cctccgccag gccggcgacg acttctcccg ccgctaccgc cgcgacttcg ccgagatgtc 840
cagccagctg cacctgacgc ccttcaccgc gcggggacgc tttgccacgg tggtggagga 900
gctcttcagg gacggggtga actgggggag gattgtggcc ttctttgagt tcggtggggt 960
catgtgtgtg gagagcgtca accgggagat gtcgcccctg gtggacaaca tcgccctgtg 1020
gatgactgag tacctgaacc ggcacctgca cacctggatc caggataacg gaggctggga 1080
tgcctttgtg gaactgtacg gccccagcat gcggcctctg tttgatttct cctggctgtc 1140
tctgaagact ctgctcagtt tggccctggt gggagcttgc atcaccctgg gtgcctatct 1200
gggccacaag tgaagtcaac atgcctgccc caaacaaata tgcaaaaggt tcactaaagc 1260
agtagaaata atatgcattg tcagtgatgt accatgaaac aaagctgcag gctgtttaag 1320
aaaaaataac acacatataa acatcacaca cacagacaga cacacacaca cacaacaatt 1380
aacagtcttc aggcaaaacg tcgaatcagc tatttactgc caaagggaaa tatcatttat 1440
tttttacatt attaagaaaa aaagatttat ttatttaaga cagtcccatc aaaactcctg 1500
tctttggaaa tccgaccact aattgccaag caccgcttcg tgtggctcca cctggatgtt 1560
ctgtgcctgt aaacatagat tcgctttcca tgttgttggc cggatcacca tctgaagagc 1620
agacggatgg aaaaaggacc tgatcattgg ggaagctggc tttctggctg ctggaggctg 1680
gggagaaggt gttcattcac ttgcatttct ttgccctggg ggctgtgata ttaacagagg 1740
gagggttcct gtggggggaa gtccatgcct ccctggcctg aagaagagac tctttgcata 1800
tgactcacat gatgcatacc tggtgggagg aaaagagttg ggaacttcag atggacctag 1860
tacccactga gatttccacg ccgaaggaca gcgatgggaa aaatgccctt aaatcatagg 1920
aaagtatttt tttaagctac caattgtgcc gagaaaagca ttttagcaat ttatacaata 1980
tcatccagta ccttaagccc tgattgtgta tattcatata ttttggatac gcacccccca 2040
actcccaata ctggctctgt ctgagtaaga aacagaatcc tctggaactt gaggaagtga 2100
acatttcggt gacttccgca tcaggaaggc tagagttacc cagagcatca ggccgccaca 2160
agtgcctgct tttaggagac cgaagtccgc agaacctgcc tgtgtcccag cttggaggcc 2220
tggtcctgga actgagccgg ggccctcact ggcctcctcc agggatgatc aacagggcag 2280
tgtggtctcc gaatgtctgg aagctgatgg agctcagaat tccactgtca agaaagagca 2340
gtagaggggt gtggctgggc ctgtcaccct ggggccctcc aggtaggccc gttttcacgt 2400
ggagcatggg agccacgacc cttcttaaga catgtatcac tgtagaggga aggaacagag 2460
gccctgggcc cttcctatca gaaggacatg gtgaaggctg ggaacgtgag gagaggcaat 2520
ggccacggcc cattttggct gtagcacatg gcacgttggc tgtgtggcct tggcccacct 2580
gtgagtttaa agcaaggctt taaatgactt tggagagggt cacaaatcct aaaagaagca 2640
ttgaagtgag gtgtcatgga ttaattgacc cctgtctatg gaattacatg taaaacatta 2700
tcttgtcact gtagtttggt tttatttgaa aacctgacaa aaaaaaagtt ccaggtgtgg 2760
aatatggggg ttatctgtac atcctggggc attaaaaaaa aaatcaatgg tggggaacta 2820
taaagaagta acaaaagaag tgacatcttc agcaaataaa ctaggaaatt tttttttctt 2880
ccagtttaga atcagccttg aaacattgat ggaataactc tgtggcatta ttgcattata 2940
taccatttat ctgtattaac tttggaatgt actctgttca atgtttaatg ctgtggttga 3000
tatttcgaaa gctgctttaa aaaaatacat gcatctcagc gtttttttgt ttttaattgt 3060
atttagttat ggcctataca ctatttgtga gcaaaggtga tcgttttctg tttgagattt 3120
ttatctcttg attcttcaaa agcattctga gaaggtgaga taagccctga gtctcagcta 3180
cctaagaaaa acctggatgt cactggccac tgaggagctt tgtttcaacc aagtcatgtg 3240
catttccacg tcaacagaat tgtttattgt gacagttata tctgttgtcc ctttgacctt 3300
gtttcttgaa ggtttcctcg tccctgggca attccgcatt taattcatgg tattcaggat 3360
tacatgcatg tttggttaaa cccatgagat tcattcagtt aaaaatccag atggcaaatg 3420
accagcagat tcaaatctat ggtggtttga cctttagaga gttgctttac gtggcctgtt 3480
tcaacacaga cccacccaga gccctcctgc cctccttccg cgggggcttt ctcatggctg 3540
tccttcaggg tcttcctgaa atgcagtggt gcttacgctc caccaagaaa gcaggaaacc 3600
tgtggtatga agccagacct ccccggcggg cctcagggaa cagaatgatc agacctttga 3660
atgattctaa tttttaagca aaatattatt ttatgaaagg tttacattgt caaagtgatg 3720
aatatggaat atccaatcct gtgctgctat cctgccaaaa tcattttaat ggagtcagtt 3780
tgcagtatgc tccacgtggt aagatcctcc aagctgcttt agaagtaaca atgaagaacg 3840
tggacgtttt taatataaag cctgttttgt cttttgttgt tgttcaaacg ggattcacag 3900
agtatttgaa aaatgtatat atattaagag gtcacggggg ctaattgctg gctggctgcc 3960
ttttgctgtg gggttttgtt acctggtttt aataacagta aatgtgccca gcctcttggc 4020
cccagaactg tacagtattg tggctgcact tgctctaaga gtagttgatg ttgcattttc 4080
cttattgtta aaaacatgtt agaagcaatg aatgtatata aaagcctcaa ctagtcattt 4140
ttttctcctc ttcttttttt tcattatatc taattatttt gcagttgggc aacagagaac 4200
catccctatt ttgtattgaa gagggattca catctgcatc ttaactgctc tttatgaatg 4260
aaaaaacagt cctctgtatg tactcctctt tacactggcc agggtcagag ttaaatagag 4320
tatatgcact ttccaaattg gggacaaggg ctctaaaaaa agccccaaaa ggagaagaac 4380
atctgagaac ctcctcggcc ctcccagtcc ctcgctgcac aaatactccg caagagaggc 4440
cagaatgaca gctgacaggg tctatggcca tcgggtcgtc tccgaagatt tggcaggggc 4500
agaaaactct ggcaggctta agatttggaa taaagtcaca gaattaagga agcacctcaa 4560
tttagttcaa acaagacgcc aacattctct ccacagctca cttacctctc tgtgttcaga 4620
tgtggccttc catttatatg tgatctttgt tttattagta aatgcttatc atctaaagat 4680
gtagctctgg cccagtggga aaaattagga agtgattata aatcgagagg agttataata 4740
atcaagatta aatgtaaata atcagggcaa tcccaacaca tgtctagctt tcacctccag 4800
gatctattga gtgaacagaa ttgcaaatag tctctatttg taattgaact tatcctaaaa 4860
caaatagttt ataaatgtga acttaaactc taattaattc caactgtact tttaaggcag 4920
tggctgtttt tagactttct tatcacttat agttagtaat gtacacctac tctatcagag 4980
aaaaacagga aaggctcgaa atacaagcca ttctaaggaa attagggagt cagttgaaat 5040
tctattctga tcttattctg tggtgtcttt tgcagcccag acaaatgtgg ttacacactt 5100
tttaagaaat acaattctac attgtcaagc ttatgaaggt tccaatcaga tctttattgt 5160
tattcaattt ggatctttca gggatttttt ttttaaatta ttatgggaca aaggacattt 5220
gttggagggg tgggagggag gaagaatttt taaatgtaaa acattcccaa gtttggatca 5280
gggagttgga agttttcaga ataaccagaa ctaagggtat gaaggacctg tattggggtc 5340
gatgtgatgc ctctgcgaag aaccttgtgt gacaaatgag aaacattttg aagtttgtgg 5400
tacgaccttt agattccaga gacatcagca tggctcaaag tgcagctccg tttggcagtg 5460
caatggtata aatttcaagc tggatatgtc taatgggtat ttaaacaata aatgtgcagt 5520
tttaactaac aggatattta atgacaacct tctggttggt agggacatct gtttctaaat 5580
gtttattatg tacaatacag aaaaaaattt tataaaatta agcaatgtga aactgaattg 5640
gagagtgata atacaagtcc tttagtctta cccagtgaat cattctgttc catgtctttg 5700
gacaaccatg accttggaca atcatgaaat atgcatctca ctggatgcaa agaaaatcag 5760
atggagcatg aatggtactg taccggttca tctggactgc cccagaaaaa taacttcaag 5820
caaacatcct atcaacaaca aggttgttct gcataccaag ctgagcacag aagatgggaa 5880
cactggtgga ggatggaaag gctcgctcaa tcaagaaaat tctgagacta ttaataaata 5940
agactgtagt gtagatactg agtaaatcca tgcacctaaa ccttttggaa aatctgccgt 6000
gggccctcca gatagctcat ttcattaagt ttttccctcc aaggtagaat ttgcaagagt 6060
gacagtggat tgcatttctt ttggggaagc tttcttttgg tggttttgtt tattatacct 6120
tcttaagttt tcaaccaagg tttgcttttg ttttgagtta ctggggttat ttttgtttta 6180
aataaaaata agtgtacaat aagtgttttt gtattgaaag cttttgttat caagattttc 6240
atacttttac cttccatggc tctttttaag attgatactt ttaagaggtg gctgatattc 6300
tgcaacactg tacacataaa aaatacggta aggatacttt acatggttaa ggtaaagtaa 6360
gtctccagtt ggccaccatt agctataatg gcactttgtt tgtgttgttg gaaaaagtca 6420
cattgccatt aaactttcct tgtctgtcta gttaatattg tgaagaaaaa taaagtacag 6480
tgtgagatac tg 6492
<210> 106
<211> 2724
<212> DNA
<213>Homo sapiens
<400> 106
cccagaaggc cgcggggggt ggaccgccta agagggcgtg cgctcccgac atgccccgcg 60
gcgcgccatt aaccgccaga tttgaatcgc gggacccgtt ggcagaggtg gcggcggcgg 120
catgggtgcc ccgacgttgc cccctgcctg gcagcccttt ctcaaggacc accgcatctc 180
tacattcaag aactggccct tcttggaggg ctgcgcctgc accccggagc ggatggccga 240
ggctggcttc atccactgcc ccactgagaa cgagccagac ttggcccagt gtttcttctg 300
cttcaaggag ctggaaggct gggagccaga tgacgacccc attgggccgg gcacggtggc 360
ttacgcctgt aataccagca ctttgggagg ccgaggcggg cggatcacga gagaggaaca 420
taaaaagcat tcgtccggtt gcgctttcct ttctgtcaag aagcagtttg aagaattaac 480
ccttggtgaa tttttgaaac tggacagaga aagagccaag aacaaaattg caaaggaaac 540
caacaataag aagaaagaat ttgaggaaac tgcggagaaa gtgcgccgtg ccatcgagca 600
gctggctgcc atggattgag gcctctggcc ggagctgcct ggtcccagag tggctgcacc 660
acttccaggg tttattccct ggtgccacca gccttcctgt gggcccctta gcaatgtctt 720
aggaaaggag atcaacattt tcaaattaga tgtttcaact gtgctcttgt tttgtcttga 780
aagtggcacc agaggtgctt ctgcctgtgc agcgggtgct gctggtaaca gtggctgctt 840
ctctctctct ctctcttttt tgggggctca tttttgctgt tttgattccc gggcttacca 900
ggtgagaagt gagggaggaa gaaggcagtg tcccttttgc tagagctgac agctttgttc 960
gcgtgggcag agccttccac agtgaatgtg tctggacctc atgttgttga ggctgtcaca 1020
gtcctgagtg tggacttggc aggtgcctgt tgaatctgag ctgcaggttc cttatctgtc 1080
acacctgtgc ctcctcagag gacagttttt ttgttgttgt gtttttttgt tttttttttt 1140
ttggtagatg catgacttgt gtgtgatgag agaatggaga cagagtccct ggctcctcta 1200
ctgtttaaca acatggcttt cttattttgt ttgaattgtt aattcacaga atagcacaaa 1260
ctacaattaa aactaagcac aaagccattc taagtcattg gggaaacggg gtgaacttca 1320
ggtggatgag gagacagaat agagtgatag gaagcgtctg gcagatactc cttttgccac 1380
tgctgtgtga ttagacaggc ccagtgagcc gcggggcaca tgctggccgc tcctccctca 1440
gaaaaaggca gtggcctaaa tcctttttaa atgacttggc tcgatgctgt gggggactgg 1500
ctgggctgct gcaggccgtg tgtctgtcag cccaaccttc acatctgtca cgttctccac 1560
acgggggaga gacgcagtcc gcccaggtcc ccgctttctt tggaggcagc agctcccgca 1620
gggctgaagt ctggcgtaag atgatggatt tgattcgccc tcctccctgt catagagctg 1680
cagggtggat tgttacagct tcgctggaaa cctctggagg tcatctcggc tgttcctgag 1740
aaataaaaag cctgtcattt caaacactgc tgtggaccct actgggtttt taaaatattg 1800
tcagtttttc atcgtcgtcc ctagcctgcc aacagccatc tgcccagaca gccgcagtga 1860
ggatgagcgt cctggcagag acgcagttgt ctctgggcgc ttgccagagc cacgaacccc 1920
agacctgttt gtatcatccg ggctccttcc gggcagaaac aactgaaaat gcacttcaga 1980
cccacttatt tctgccacat ctgagtcggc ctgagataga cttttccctc taaactggga 2040
gaatatcaca gtggtttttg ttagcagaaa atgcactcca gcctctgtac tcatctaagc 2100
tgcttatttt tgatatttgt gtcagtctgt aaatggatac ttcactttaa taactgttgc 2160
ttagtaattg gctttgtaga gaagctggaa aaaaatggtt ttgtcttcaa ctcctttgca 2220
tgccaggcgg tgatgtggat ctcggcttct gtgagcctgt gctgtgggca gggctgagct 2280
ggagccgccc ctctcagccc gcctgccacg gcctttcctt aaaggccatc cttaaaacca 2340
gaccctcatg gctaccagca cctgaaagct tcctcgacat ctgttaataa agccgtaggc 2400
ccttgtctaa gtgcaaccgc ctagactttc tttcagatac atgtccacat gtccattttt 2460
caggttctct aagttggagt ggagtctggg aagggttgtg aatgaggctt ctgggctatg 2520
ggtgaggttc caatggcagg ttagagcccc tcgggccaac tgccatcctg gaaagtagag 2580
acagcagtgc ccgctgccca gaagagacca gcaagccaaa ctggagcccc cattgcaggc 2640
tgtcgccatg tggaaagagt aactcacaat tgccaataaa gtctcatgtg gttttatcta 2700
aaaaaaaaaa aaaaaaaaaa aaaa 2724
<210> 107
<211> 4934
<212> DNA
<213>Homo sapiens
<400> 107
aatgagggta tttataaact acttaaatta taaaaagaat gagacatcag acttacagtt 60
ttggatacta atttttttca cttaacgttc attatgtgat aggagttttc catcctatta 120
taccgctgtg cgatctgatc ttgggcacgt taaccaacct cttgttgcct cgattttctc 180
acctgtaaaa gtgggggtaa tcataatgct tacttagtag gatagccctg aagaataagt 240
gacttagcga acataaatag cttacaatag ggttttcagc atgggaagga ttcagtaaat 300
gttagctgtc atcatcacca cctacaaagg aagcaatact gtgctgaaag tttttccatc 360
attaatgtaa tttctatagt acgattccca agaagatatt aaaattatgg aaataaaggt 420
attggtatat tcctaattat ttcctaaaag attgtattga taaatatgct catccttccc 480
ttaacgggat gcattccaga aaaacaagtc aaatgttaga caaagtatca gaagggaaat 540
tctgtagcca gagagctaaa aattacaata gggtctctaa ttatacttca acttttttag 600
gaataattct cagtgtgttt tcccacattt catatgtaat tttttttttt tttttttttt 660
gagacagagc ctcgccctgt caccaggctg gagtacagtg gcgcgatctc ggctcactgc 720
aacttccacc tgctgggttc aagcaattct tctgacctca ggtgatccac ccgcctcggc 780
ctcccaaagt gctgggatta taacaggcgt ggcatgagtc accgcgcccg gccgatcttt 840
acttttttat tctttgtacc ccctgcctat ccagttagca tgtgattaaa gtcaaagatt 900
tgccactttg ggccacatct attaattttc atctttgtta taattgtatt tagtttttga 960
tctacactgc ttattactcc cagtcatttt ttatagaact gaaaatctgg taaaatactc 1020
aaaattgcac tgacttctat gtagaggcga cactccatca gaaccgtggg ctgacaggga 1080
atcccactgt gcaggagctg cgcgcatttt catttctgat tctctttggc gtatccagga 1140
ctctgatgac atgatcatat atttatcagt agtaacaggt tgggccattt gttttttgtg 1200
gtaaatcata tatttaagat tttagaaata agttgatagc catgtatttt ggaatttgaa 1260
aaagacattg cattactcag cttcaaatta agctttaatc aaatagtgaa actttccatt 1320
aatggacagt gtataccttt ttgtgtattt aaaaaaaaaa acactgaata tagtgccttt 1380
gtgacagggg agcttggttc ctgacaatgt cctcttgagc cttttttttt tttttgagat 1440
ggagtctcac tgtgtcaccc aggctggagt gcagtggcgc catcttggct cactgcaacc 1500
tccgccccct gggttcaagt gattctcatt cctcagcttc ctaagtagct gggattacag 1560
gcacgcacca ccatgaccag ctaattttta tacttttagt agagacaggg ttttgccatg 1620
ttggctaggt tggtctcgaa ctcctgacct caagtaatcc acccaccatg gcctccccaa 1680
agtgctggga ttacaggcgt gagccatttc acccggcctc tcttccgtct ttgagctgtg 1740
aggaaatagc tacattacat gagctgctag atctgcctta tggtcagaaa tgaaggttga 1800
actctcagga acagtgacat atatacacac tgatatttcc aaagtacaat gccccaaatt 1860
gatccacaaa ggaattaagg tcatttgcaa caaaatcaca gaatagtaac aaataaatag 1920
aagataaata tggccaggga tgctgcaaac tgatatactg ccaagtttat cagttgggaa 1980
tcccaacagt gaaaagcata aaaatgaaag gaattttaag gagacttttt atagaagagt 2040
gggaaggatt ggaggagcca acaagtgatg gtgaggcaca cagggaagag cttcagtggg 2100
caccatcccc tctctggttt gaaggggtag ggaggggacc agagctggga ggagggggct 2160
ggaatactgc tggaggagcc actcccttcc agacctgctg tggccatcac agaatgcagc 2220
cactgccaga gcagcagccc gaggaaccag gcagggggag cacaagtacc ctagcctctc 2280
tctttctgtt tcttgcctgc cgatctcctc cactggctaa acccagctgg atgctaagag 2340
tacagtcagc ctgcctgctg aggagggacc accagggacc accatcagca agggatccaa 2400
tgtctttctg cctctgcaga atgaaggttg gggcgcgggg ggcgctctac ttcttaggga 2460
tattgtggga ataaaaggaa ataggcaaaa aatgtttttg aaaaacaaag cacatactgc 2520
gcacccgtgg gccactactg cttttgaccc ctggctctgt ttcatgaagt aatgtcgtgt 2580
cattctcttt ttaggtgcta caggatttct ttaggtttgt tttctgtcca ccatatttca 2640
actcatgtgt gctgtttgtt gtgctaaaac aaatatttgc tgatgcctga gtgaatagtt 2700
gaatatttta tataagtcaa atttatacgt aatgattttt cttgtaactt agccgtttct 2760
cttttacaaa ctcagaaaac ctcagacttt gaaaaggcct tgaagttcct cacctgaaat 2820
ctgagaactt ggagcgcctt aaaaaatcta aaggaaaaca aaacagtgaa agaacatgat 2880
atagtcagtg tagagaataa aattatttat gtaattaata ttgaggatgc agataacaca 2940
ttgtgaaatc ttgcttgtaa aaaatctcga tctgctgaag aaagatgttc tctctagaga 3000
tctttgaaag cataattatt gagcttttaa aatgttagaa acaaaagtta gacccacaca 3060
tattctggcg tgtggaagat ttgcattcct tcccctgccc gccccgcccc cacacttgtg 3120
agttgtgcct gtgtacgcag ttcctgtagc actcggctgg gcagaaatca tctttcagca 3180
ctaagggaac atagttatga tctggacctt ctgggagtgg tcagtgccca agaacaggta 3240
tgggactcca gaaagttctg ctctcaaccc tattttgaaa tagagttaca cattgttcta 3300
caattatttg agttaataag cagctctttt caaacgtgat tatgcccttc caagtttaaa 3360
tacactagac tttagtgaaa gtaattgacc tcatctcatt tctctcctgt tatattaaga 3420
tcactttcag taaaaggtag aagcttttga agtggtgagg aggaggtaga ggagggacat 3480
agagcagata ggggctggaa agtggggtga ggaagagagt ggcttctctt tggcagagta 3540
ccaaggaaaa gccctatctg tacagaacct ttgtgcctgg gaacttgatg gctgcaacct 3600
gagcctcaac ctagtttgct tgcggagcca gaagagaagc taaaaacctt cagttaacca 3660
agccagacac caagaaagtt aaaccgaaag agaacccccc accccccgca aaaaaaagaa 3720
gtaaagtggg ttaaagtgat atcatgttag cacagaaaga gaacataagg gtcatctaag 3780
ttcatctgcc ccctcttcta tttcaaggtg cagaaactaa ggcacaaggg accccgtgtc 3840
ctgctcttga tcacatagct agtgggtgcc aagccaggtc tagaactctg ttctctgggg 3900
tcacaggctg gctcttcatc cctctagaga gatagctcat ctgtgtgcac ctgagcccgt 3960
tgtgtttcgg agtcaaagca aataaaggct caaactccaa gactgttttg cagaccggct 4020
gcagtagata tggggggagg agaaacctgc tttaaattgc ttcaagcaag ttgtttctgc 4080
aaaggtgttg acttttttct ttcaactttc tagtgagtca ctgcagcctg agctgttatt 4140
tgtcattatg caataattca ggaactaact caagattctt ctttttaaat tatttgttta 4200
tttagagaca gagtcttgct ctgttgccca ggctggagtg cagtggtgtg atctcggctc 4260
actgcagcct ctgcctcctg ggttcaagca attctcatgt ctcagcctcc cgaatagctg 4320
gtattgcagg ctcgtgccac caccccctgc taatttttgt aattttagtg gagacacggt 4380
ttcgccatgt tggccgggct cgtcttgagc tcctggcctc aggtgatccg cccgcctcgg 4440
cctcccaaag tgctgggatt gcagccgtga gcctccacac ccggcctatt tatttatttt 4500
taaattggct gctcttagaa aggcatacca tgtttctgga tgggaaggct tattaattca 4560
ccctaattta atgtataaat ttgatgcaat catagtcaca gtcccagtgg aattttttaa 4620
cttggtaaga tgttctaaaa ttaatgagag aacttgaatt accaggtatt gaaacactgt 4680
aaagccacaa tcatgtaaac agtatgttat aaccatggga atagaggtct gtgatacagc 4740
agaaaaaagt gaaaaaaaga ataactgtat tcataaaaat ttaaatgtgg agtcactggg 4800
ggaaaggatt aaatattcga taatgtagaa acaactcaac tatttggaga aatgtaaatt 4860
tagagcctta tctcatgcca tataccaaaa tactatttag atttgattaa aaaataaaaa 4920
aaaaaaaaaa aaaa 4934
<210> 108
<211> 2177
<212> DNA
<213>Homo sapiens
<400> 108
cgaacgcctt cgcgcgatcg ccctggaaac gcattctctg cgaccggcag ccgccaatgg 60
gaagggagtg agtgccacga acaggccaat aaggagggag cagtgcgggg tttaaatctg 120
aggctaggct ggctcttctc ggcgtgctgc ggcggaacgg ctgttggttt ctgctgggtg 180
taggtccttg gctggtcggg cctccggtgt tctgcttctc cccgctgagc tgctgcctgg 240
tgaagaggaa gccatggcgc tccgagtcac caggaactcg aaaattaatg ctgaaaataa 300
ggcgaagatc aacatggcag gcgcaaagcg cgttcctacg gcccctgctg caacctccaa 360
gcccggactg aggccaagaa cagctcttgg ggacattggt aacaaagtca gtgaacaact 420
gcaggccaaa atgcctatga agaaggaagc aaaaccttca gctactggaa aagtcattga 480
taaaaaacta ccaaaacctc ttgaaaaggt acctatgctg gtgccagtgc cagtgtctga 540
gccagtgcca gagccagaac ctgagccaga acctgagcct gttaaagaag aaaaactttc 600
gcctgagcct attttggttg atactgcctc tccaagccca atggaaacat ctggatgtgc 660
ccctgcagaa gaagacctgt gtcaggcttt ctctgatgta attcttgcag taaatgatgt 720
ggatgcagaa gatggagctg atccaaacct ttgtagtgaa tatgtgaaag atatttatgc 780
ttatctgaga caacttgagg aagagcaagc agtcagacca aaatacctac tgggtcggga 840
agtcactgga aacatgagag ccatcctaat tgactggcta gtacaggttc aaatgaaatt 900
caggttgttg caggagacca tgtacatgac tgtctccatt attgatcggt tcatgcagaa 960
taattgtgtg cccaagaaga tgctgcagct ggttggtgtc actgccatgt ttattgcaag 1020
caaatatgaa gaaatgtacc ctccagaaat tggtgacttt gcttttgtga ctgacaacac 1080
ttatactaag caccaaatca gacagatgga aatgaagatt ctaagagctt taaactttgg 1140
tctgggtcgg cctctacctt tgcacttcct tcggagagca tctaagattg gagaggttga 1200
tgtcgagcaa catactttgg ccaaatacct gatggaacta actatgttgg actatgacat 1260
ggtgcacttt cctccttctc aaattgcagc aggagctttt tgcttagcac tgaaaattct 1320
ggataatggt gaatggacac caactctaca acattacctg tcatatactg aagaatctct 1380
tcttccagtt atgcagcacc tggctaagaa tgtagtcatg gtaaatcaag gacttacaaa 1440
gcacatgact gtcaagaaca agtatgccac atcgaagcat gctaagatca gcactctacc 1500
acagctgaat tctgcactag ttcaagattt agccaaggct gtggcaaagg tgtaacttgt 1560
aaacttgagt tggagtacta tatttacaaa taaaattggc accatgtgcc atctgtacat 1620
attactgttg catttacttt taataaagct tgtggcccct tttacttttt tatagcttaa 1680
ctaatttgaa tgtggttact tcctactgta gggtagcgga aaagttgtct taaaaggtat 1740
ggtggggata tttttaaaaa ctccttttgg tttacctggg gatccaattg atgtatatgt 1800
ttatatactg ggttcttgtt ttatatacct ggcttttact ttattaatat gagttactga 1860
aggtgatgga ggtatttgaa aattttactt ccataggaca tactgcatgt aagccaagtc 1920
atggagaatc tgctgcatag ctctatttta aagtaaaagt ctaccaccga atccctagtc 1980
cccctgtttt ctgtttcttc ttgtgattgc tgccataatt ctaagttatt tacttttacc 2040
actatttaag ttatcaactt tagctagtat cttcaaactt tcactttgaa aaatgagaat 2100
tttatattct aagccagttt tcattttggt tttgtgtttt ggttaataaa acaatactca 2160
aatacaaaaa aaaaaaa 2177
<210> 109
<211> 2011
<212> DNA
<213>Homo sapiens
<400> 109
gcggccgcca gcgcggtgta gggggcaggc gcggatcccg ccaccgccgc gcgctcggcc 60
cgccgactcc cggcgccgcc gccgccactg ccgtcgccgc cgccgcctgc cgggactgga 120
gcgcgccgtc cgccgcggac aagaccctgg cctcaggccg gagcagcccc atcatgccga 180
gggagcgcag ggagcgggat gcgaaggagc gggacaccat gaaggaggac ggcggcgcgg 240
agttctcggc tcgctccagg aagaggaagg caaacgtgac cgtttttttg caggatccag 300
atgaagaaat ggccaaaatc gacaggacgg cgagggacca gtgtgggagc cagccttggg 360
acaataatgc agtctgtgca gacccctgct ccctgatccc cacacctgac aaagaagatg 420
atgaccgggt ttacccaaac tcaacgtgca agcctcggat tattgcacca tccagaggct 480
ccccgctgcc tgtactgagc tgggcaaata gagaggaagt ctggaaaatc atgttaaaca 540
aggaaaagac atacttaagg gatcagcact ttcttgagca acaccctctt ctgcagccaa 600
aaatgcgagc aattcttctg gattggttaa tggaggtgtg tgaagtctat aaacttcaca 660
gggagacctt ttacttggca caagatttct ttgaccggta tatggcgaca caagaaaatg 720
ttgtaaaaac tcttttacag cttattggga tttcatcttt atttattgca gccaaacttg 780
aggaaatcta tcctccaaag ttgcaccagt ttgcgtatgt gacagatgga gcttgttcag 840
gagatgaaat tctcaccatg gaattaatga ttatgaaggc ccttaagtgg cgtttaagtc 900
ccctgactat tgtgtcctgg ctgaatgtat acatgcaggt tgcatatcta aatgacttac 960
atgaagtgct actgccgcag tatccccagc aaatctttat acagattgca gagctgttgg 1020
atctctgtgt cctggatgtt gactgccttg aatttcctta tggtatactt gctgcttcgg 1080
ccttgtatca tttctcgtca tctgaattga tgcaaaaggt ttcagggtat cagtggtgcg 1140
acatagagaa ctgtgtcaag tggatggttc catttgccat ggttataagg gagacgggga 1200
gctcaaaact gaagcacttc aggggcgtcg ctgatgaaga tgcacacaac atacagaccc 1260
acagagacag cttggatttg ctggacaaag cccgagcaaa gaaagccatg ttgtctgaac 1320
aaaatagggc ttctcctctc cccagtgggc tcctcacccc gccacagagc ggtaagaagc 1380
agagcagcgg gccggaaatg gcgtgaccac cccatccttc tccaccaaag acagttgcgc 1440
gcctgctcca cgttctcttc tgtctgttgc agcggaggcg tgcgtttgct tttacagata 1500
tctgaatgga agagtgtttc ttccacaaca gaagtatttc tgtggatggc atcaaacagg 1560
gcaaagtgtt ttttattgaa tgcttatagg ttttttttaa ataagtgggt caagtacacc 1620
agccacctcc agacaccagt gcgtgctccc gatgctgcta tggaaggtgc tacttgacct 1680
aagggactcc cacaacaaca aaagcttgaa gctgtggagg gccacggtgg cgtggctctc 1740
ctcgcaggtg ttctgggctc cgttgtacca agtggagcag gtggttgcgg gcaagcgttg 1800
tgcagagccc atagccagct gggcaggggg ctgccctctc cacattatca gttgacagtg 1860
tacaatgcct ttgatgaact gttttgtaag tgctgctata tctatccatt ttttaataaa 1920
gataatactg tttttgaaaa aaaaaaaaaa aaaaaaaaaa aaaaaaaaaa aaaaaaaaaa 1980
aaaaaaaaaa aaaaaaaaaa aaaaaaaaaa a 2011
<210> 110
<211> 1737
<212> DNA
<213>Homo sapiens
<400> 110
gagggcacgg gctccgtagg caccaactgc aaggacccct ccccctgcgg gcgctcccat 60
ggcacagttc gcgttcgaga gtgacctgca ctcgctgctt cagctggatg cacccatccc 120
caatgcaccc cctgcgcgct ggcagcgcaa agccaaggaa gccgcaggcc cggccccctc 180
acccatgcgg gccgccaacc gatcccacag cgccggcagg actccgggcc gaactcctgg 240
caaatccagt tccaaggttc agaccactcc tagcaaacct ggcggtgacc gctatatccc 300
ccatcgcagt gctgcccaga tggaggtggc cagcttcctc ctgagcaagg agaaccagcc 360
tgaaaacagc cagacgccca ccaagaagga acatcagaaa gcctgggctt tgaacctgaa 420
cggttttgat gtagaggaag ccaagatcct tcggctcagt ggaaaaacca caaaaatgcg 480
ccagagggtt atcacgaaca gactgaaagt actctacagc caaaaggcca ctcctggctc 540
cagccggaag acctgccgtt tacattcctt ccctgccaag accgtatcct ggatgcgcct 600
gaaatcgaat gactattaac tgaacctgtg ggactggcag tccggggaat gtccgggccg 660
ggccacggcc acgaggtgtt ccgtgtggag tgcaagctgg gacacaccgt gccgcttgtg 720
cacagggcca cgcggggaaa taatcccggg gcgcgcaaag cggcactggc gagagccgca 780
cgggccggtg ctgggggtgg tacaacaggc caaaacaaca cacaaggcca acaagacata 840
cgcgcgctga caccacggtg caaagcgctc agacgagtag taaccggcac tgtggttgct 900
gcctccccac ctctcccgct ctcagcgtaa gataaaagaa agaagagcaa aaagcaaaga 960
aagaagacga gacgagacac acaggaacga acagtaaagc aagctaaagc aaacgcaaga 1020
ccagacaaca gaaatagaaa gaaccaacag agaggagaca gaacaggacg ccagcaacat 1080
agcaacaaac gaacagaaga gagcactaaa caaaagcagc agcaagacga gacaggagag 1140
aaggaggaag gagggccgag cgagcaggga gcgcgagcag cgaggcgaag cagcagacaa 1200
gggcaggcga agggcaacga gaggaggcac cacacaaaaa ggagagggga caggagaagc 1260
agcgagagaa gcggaggagc aacaagagga agaaaaggag agggagagga gggagagagc 1320
ggaaggagga agaaacagca cgaggcgacg aaggggggag acgcgggggc aggaaaagac 1380
acaggaaggc agcgcggagg aggagaaggg gaagcaggaa ggagacggaa ggagaagagg 1440
gagaggacag cgcaagagag cgcgcgcggc gacagcgagg gacggagcga gagagaggaa 1500
acggaaagcg agagggaaga ggagaggcaa cgcagcgaac caaccgaaaa cagcagaaag 1560
agaggagaag gacgcgcaaa gaggcaagcg caagacgaca ggaaacgaag cgagagacga 1620
gaagccggtg acgagcagga gaaagggaag gcaggagaca ggacaggcgg aagagagaca 1680
cgcgagacgc aaagagtgag cagaacgaag cgaagagcaa cgcacgagag aaacgac 1737
<210> 111
<211> 3053
<212> DNA
<213>Homo sapiens
<400> 111
gagcgcggct ggagtttgct gctgccgctg tgcagtttgt tcaggggctt gtggtggtga 60
gtccgagagg ctgcgtgtga gagacgtgag aaggatcctg cactgaggag gtggaaagaa 120
gaggattgct cgaggaggcc tggggtctgt gaggcagcgg agctgggtga aggctgcggg 180
ttccggcgag gcctgagctg tgctgtcgtc atgcctcaaa cccgatccca ggcacaggct 240
acaatcagtt ttccaaaaag gaagctgtct cgggcattga acaaagctaa aaactccagt 300
gatgccaaac tagaaccaac aaatgtccaa accgtaacct gttctcctcg tgtaaaagcc 360
ctgcctctca gccccaggaa acgtctgggc gatgacaacc tatgcaacac tccccattta 420
cctccttgtt ctccaccaaa gcaaggcaag aaagagaatg gtccccctca ctcacataca 480
cttaagggac gaagattggt atttgacaat cagctgacaa ttaagtctcc tagcaaaaga 540
gaactagcca aagttcacca aaacaaaata ctttcttcag ttagaaaaag tcaagagatc 600
acaacaaatt ctgagcagag atgtccactg aagaaagaat ctgcatgtgt gagactattc 660
aagcaagaag gcacttgcta ccagcaagca aagctggtcc tgaacacagc tgtcccagat 720
cggctgcctg ccagggaaag ggagatggat gtcatcagga atttcttgag ggaacacatc 780
tgtgggaaaa aagctggaag cctttacctt tctggtgctc ctggaactgg aaaaactgcc 840
tgcttaagcc ggattctgca agacctcaag aaggaactga aaggctttaa aactatcatg 900
ctgaattgca tgtccttgag gactgcccag gctgtattcc cagctattgc tcaggagatt 960
tgtcaggaag aggtatccag gccagctggg aaggacatga tgaggaaatt ggaaaaacat 1020
atgactgcag agaagggccc catgattgtg ttggtattgg acgagatgga tcaactggac 1080
agcaaaggcc aggatgtatt gtacacgcta tttgaatggc catggctaag caattctcac 1140
ttggtgctga ttggtattgc taataccctg gatctcacag atagaattct acctaggctt 1200
caagctagag aaaaatgtaa gccacagctg ttgaacttcc caccttatac cagaaatcag 1260
atagtcacta ttttgcaaga tcgacttaat caggtatcta gagatcaggt tctggacaat 1320
gctgcagttc aattctgtgc ccgcaaagtc tctgctgttt caggagatgt tcgcaaagca 1380
ctggatgttt gcaggagagc tattgaaatt gtagagtcag atgtcaaaag ccagactatt 1440
ctcaaaccac tgtctgaatg taaatcacct tctgagcctc tgattcccaa gagggttggt 1500
cttattcaca tatcccaagt catctcagaa gttgatggta acaggatgac cttgagccaa 1560
gaaggagcac aagattcctt ccctcttcag cagaagatct tggtttgctc tttgatgctc 1620
ttgatcaggc agttgaaaat caaagaggtc actctgggga agttatatga agcctacagt 1680
aaagtctgtc gcaaacagca ggtggcggct gtggaccagt cagagtgttt gtcactttca 1740
gggctcttgg aagccagggg cattttagga ttaaagagaa acaaggaaac ccgtttgaca 1800
aaggtgtttt tcaagattga agagaaagaa atagaacatg ctctgaaaga taaagcttta 1860
attggaaata tcttagctac tggattgcct taaattcttc tcttacaccc cacccgaaag 1920
tattcagctg gcatttagag agctacagtc ttcattttag tgctttacac attcgggcct 1980
gaaaacaaat atgacctttt ttacttgaag ccaatgaatt ttaatctata gattctttaa 2040
tattagcaca gaataatatc tttgggtctt actattttta cccataaaag tgaccaggta 2100
gacccttttt aattacattc actacttcta ccacttgtgt atctctagcc aatgtgcttg 2160
caagtgtaca gatctgtgta gaggaatgtg tgtatattta cctcttcgtt tgctcaaaca 2220
tgagtgggta tttttttgtt tgtttttttt gttgttgttg tttttgaggc gcgtctcacc 2280
ctgttgccca ggctggagtg caatggcgcg ttctctgctc actacagcac ccgcttccca 2340
ggttgaagtg attctcttgc ctcagcctcc cgagtagctg ggattacagg tgcccaccac 2400
cgcgcccagc taatttttta atttttagta gagacagggt tttaccatgt tggccaggct 2460
ggtcttgaac tcctgaccct caagtgatct gcccaccttg gcctccctaa gtgctgggat 2520
tataggcgtg agccaccatg ctcagccatt aaggtatttt gttaagaact ttaagtttag 2580
ggtaagaaga atgaaaatga tccagaaaaa tgcaagcaag tccacatgga gatttggagg 2640
acactggtta aagaatttat ttctttgtat agtatactat gttcatggtg cagatactac 2700
aacattgtgg cattttagac tcgttgagtt tcttgggcac tcccaagggc gttggggtca 2760
taaggagact ataactctac agattgtgaa tatatttatt ttcaagttgc attctttgtc 2820
tttttaagca atcagatttc aagagagctc aagctttcag aagtcaatgt gaaaattcct 2880
tcctaggctg tcccacagtc tttgctgccc ttagatgaag ccacttgttt caagatgact 2940
actttggggt tgggttttca tctaaacaca tttttccagt cttattagat aaattagtcc 3000
atatggttgg ttaatcaaga gccttctggg tttggtttgg tggcattaaa tgg 3053
<210> 112
<211> 1843
<212> DNA
<213>Homo sapiens
<400> 112
gcggaatggg gcgggacttc cagtaggagg cggcaagttt gaaaagtgat gacggttgac 60
gtttgctgat ttttgacttt gcttgtagct gctccccgaa ctcgccgtct tcctgtcggc 120
ggccggcact gtagattaac aggaaacttc caagatggaa actttgtctt tccccagata 180
taatgtagct gagattgtga ttcatattcg caataagatc ttaacaggag ctgatggtaa 240
aaacctcacc aagaatgatc tttatccaaa tccaaagcct gaagtcttgc acatgatcta 300
catgagagcc ttacaaatag tatatggaat tcgactggaa catttttaca tgatgccagt 360
gaactctgaa gtcatgtatc cacatttaat ggaaggcttc ttaccattca gcaatttagt 420
tactcatctg gactcatttt tgcctatctg ccgggtgaat gactttgaga ctgctgatat 480
tctatgtcca aaagcaaaac ggacaagtcg gtttttaagt ggcattatca actttattca 540
cttcagagaa gcatgccgtg aaacgtatat ggaatttctt tggcaatata aatcctctgc 600
ggacaaaatg caacagttaa acgccgcaca ccaggaggca ttaatgaaac tggagagact 660
tgattctgtt ccagttgaag agcaagaaga gttcaagcag ctttcagatg gaattcagga 720
gctacaacaa tcactaaatc aggattttca tcaaaaaacg atagtgctgc aagagggaaa 780
ttcccaaaag aagtcaaata tttcagagaa aaccaagcgt ttgaatgaac taaaattgtc 840
ggtggtttct ttgaaagaaa tacaagagag tttgaaaaca aaaattgtgg attctccaga 900
gaagttaaag aattataaag aaaaaatgaa agatacggtc cagaagctta aaaatgccag 960
acaagaagtg gtggagaaat atgaaatcta tggagactca gttgactgcc tgccttcatg 1020
tcagttggaa gtgcagttat atcaaaagaa aatacaggac ctttcagata atagggaaaa 1080
attagccagt atcttaaagg agagcctgaa cttggaggac caaattgaga gtgatgagtc 1140
agaactgaag aaattgaaga ctgaagaaaa ttcgttcaaa agactgatga ttgtgaagaa 1200
ggaaaaactt gccacagcac aattcaaaat aaataagaag catgaagatg ttaagcaata 1260
caaacgcaca gtaattgagg attgcaataa agttcaagaa aaaagaggtg ctgtctatga 1320
acgagtaacc acaattaatc aagaaatcca aaaaattaaa cttggaattc aacaactaaa 1380
agatgctgct gaaagggaga aactgaagtc ccaggaaata tttctaaact tgaaaactgc 1440
tttggagaaa taccacgacg gtattgaaaa ggcagcagag gactcctatg ctaagataga 1500
tgagaagaca gctgaactga agaggaagat gttcaaaatg tcaacctgat taacaaaatt 1560
acatgtcttt ttgtaaatgg cttgccatct tttaattttc tatttagaaa gaaaagttga 1620
agcgaatgga agtatcagaa gtaccaaata atgttggctt catcagtttt tatacactct 1680
cataagtagt taataagatg aatttaatgt aggcttttat taatttataa ttaaaataac 1740
ttgtgcagct attcatgtct ctactctgcc ccttgttgta aatagtttga gtaaaacaaa 1800
actagttacc tttgaaatat atatattttt ttctgttact atc 1843
<210> 113
<211> 3686
<212> DNA
<213>Homo sapiens
<400> 113
ggctagcgcg ggaggtggag aaagaggctt gggcggcccc gctgtagccg cgtgtgggag 60
gacgcacggg cctgcttcaa agctttggga taacagcgcc tccgggggat aatgaatgcg 120
gagcctccgt tttcagtcga cttcagatgt gtctccactt ttttccgctg tagccgcaag 180
gcaaggaaac atttctcttc ccgtactgag gaggctgagg agtgcactgg gtgttctttt 240
ctcctctaac ccagaactgc gagacagagg ctgagtccct gtaaagaaca gctccagaaa 300
agccaggaga gcgcaggagg gcatccggga ggccaggagg ggttcgctgg ggcctcaacc 360
gcacccacat cggtcccacc tgcgaggggg cgggacctcg tggcgctgga ccaatcagca 420
cccacctgcg ctcacctggc ctcctcccgc tggctcccgg gggctgcggt gctcaaaggg 480
gcaagagctg agcggaacac cggcccgccg tcgcggcagc tgcttcaccc ctctctctgc 540
agccatgggg ctccctcgtg gacctctcgc gtctctcctc cttctccagg tttgctggct 600
gcagtgcgcg gcctccgagc cgtgccgggc ggtcttcagg gaggctgaag tgaccttgga 660
ggcgggaggc gcggagcagg agcccggcca ggcgctgggg aaagtattca tgggctgccc 720
tgggcaagag ccagctctgt ttagcactga taatgatgac ttcactgtgc ggaatggcga 780
gacagtccag gaaagaaggt cactgaagga aaggaatcca ttgaagatct tcccatccaa 840
acgtatctta cgaagacaca agagagattg ggtggttgct ccaatatctg tccctgaaaa 900
tggcaagggt cccttccccc agagactgaa tcagctcaag tctaataaag atagagacac 960
caagattttc tacagcatca cggggccggg ggcagacagc ccccctgagg gtgtcttcgc 1020
tgtagagaag gagacaggct ggttgttgtt gaataagcca ctggaccggg aggagattgc 1080
caagtatgag ctctttggcc acgctgtgtc agagaatggt gcctcagtgg aggaccccat 1140
gaacatctcc atcatagtga ccgaccagaa tgaccacaag cccaagttta cccaggacac 1200
cttccgaggg agtgtcttag agggagtcct accaggtact tctgtgatgc agatgacagc 1260
cacagatgag gatgatgcca tctacaccta caatggggtg gttgcttact ccatccatag 1320
ccaagaacca aaggacccac acgacctcat gttcacaatt caccggagca caggcaccat 1380
cagcgtcatc tccagtggcc tggaccggga aaaagtccct gagtacacac tgaccatcca 1440
ggccacagac atggatgggg acggctccac caccacggca gtggcagtag tggagatcct 1500
tgatgccaat gacaatgctc ccatgtttga cccccagaag tacgaggccc atgtgcctga 1560
gaatgcagtg ggccatgagg tgcagaggct gacggtcact gatctggacg cccccaactc 1620
accagcgtgg cgtgccacct accttatcat gggcggtgac gacggggacc attttaccat 1680
caccacccac cctgagagca accagggcat cctgacaacc aggaagggtt tggattttga 1740
ggccaaaaac cagcacaccc tgtacgttga agtgaccaac gaggcccctt ttgtgctgaa 1800
gctcccaacc tccacagcca ccatagtggt ccacgtggag gatgtgaatg aggcacctgt 1860
gtttgtccca ccctccaaag tcgttgaggt ccaggagggc atccccactg gggagcctgt 1920
gtgtgtctac actgcagaag accctgacaa ggagaatcaa aagatcagct accgcatcct 1980
gagagaccca gcagggtggc tagccatgga cccagacagt gggcaggtca cagctgtggg 2040
caccctcgac cgtgaggatg agcagtttgt gaggaacaac atctatgaag tcatggtctt 2100
ggccatggac aatggaagcc ctcccaccac tggcacggga acccttctgc taacactgat 2160
tgatgtcaac gaccatggcc cagtccctga gccccgtcag atcaccatct gcaaccaaag 2220
ccctgtgcgc caggtgctga acatcacgga caaggacctg tctccccaca cctccccttt 2280
ccaggcccag ctcacagatg actcagacat ctactggacg gcagaggtca acgaggaagg 2340
tgacacagtg gtcttgtccc tgaagaagtt cctgaagcag gatacatatg acgtgcacct 2400
ttctctgtct gaccatggca acaaagagca gctgacggtg atcagggcca ctgtgtgcga 2460
ctgccatggc catgtcgaaa cctgccctgg accctggaaa ggaggtttca tcctccctgt 2520
gctgggggct gtcctggctc tgctgttcct cctgctggtg ctgcttttgt tggtgagaaa 2580
gaagcggaag atcaaggagc ccctcctact cccagaagat gacacccgtg acaacgtctt 2640
ctactatggc gaagaggggg gtggcgaaga ggaccaggac tatgacatca cccagctcca 2700
ccgaggtctg gaggccaggc cggaggtggt tctccgcaat gacgtggcac caaccatcat 2760
cccgacaccc atgtaccgtc ctaggccagc caacccagat gaaatcggca actttataat 2820
tgagaacctg aaggcggcta acacagaccc cacagccccg ccctacgaca ccctcttggt 2880
gttcgactat gagggcagcg gctccgacgc cgcgtccctg agctccctca cctcctccgc 2940
ctccgaccaa gaccaagatt acgattatct gaacgagtgg ggcagccgct tcaagaagct 3000
ggcagacatg tacggtggcg gggaggacga ctaggcggcc tgcctgcagg gctggggacc 3060
aaacgtcagg ccacagagca tctccaaggg gtctcagttc ccccttcagc tgaggacttc 3120
ggagcttgtc aggaagtggc cgtagcaact tggcggagac aggctatgag tctgacgtta 3180
gagtggttgc ttccttagcc tttcaggatg gaggaatgtg ggcagtttga cttcagcact 3240
gaaaacctct ccacctgggc cagggttgcc tcagaggcca agtttccaga agcctcttac 3300
ctgccgtaaa atgctcaacc ctgtgtcctg ggcctgggcc tgctgtgact gacctacagt 3360
ggactttctc tctggaatgg aaccttctta ggcctcctgg tgcaacttaa tttttttttt 3420
taatgctatc ttcaaaacgt tagagaaagt tcttcaaaag tgcagcccag agctgctggg 3480
cccactggcc gtcctgcatt tctggtttcc agaccccaat gcctcccatt cggatggatc 3540
tctgcgtttt tatactgagt gtgcctaggt tgccccttat tttttatttt ccctgttgcg 3600
ttgctataga tgaagggtga ggacaatcgt gtatatgtac tagaactttt ttattaaaga 3660
aacttttccc aaaaaaaaaa aaaaaa 3686
<210> 114
<211> 10316
<212> DNA
<213>Homo sapiens
<400> 114
gagaccagaa gcgggcgaat tgggcaccgg tggcggctgc gggcagtttg aattagactc 60
tgggctccag cccgccgaag ccgcgccaga actgtactct ccgagaggtc gttttcccgt 120
ccccgagagc aagtttattt acaaatgttg gagtaataaa gaaggcagaa caaaatgagc 180
tgggctttgg aagaatggaa agaagggctg cctacaagag ctcttcagaa aattcaagag 240
cttgaaggac agcttgacaa actgaagaag gaaaagcagc aaaggcagtt tcagcttgac 300
agtctcgagg ctgcgctgca gaagcaaaaa cagaaggttg aaaatgaaaa aaccgagggt 360
acaaacctga aaagggagaa tcaaagattg atggaaatat gtgaaagtct ggagaaaact 420
aagcagaaga tttctcatga acttcaagtc aaggagtcac aagtgaattt ccaggaagga 480
caactgaatt caggcaaaaa acaaatagaa aaactggaac aggaacttaa aaggtgtaaa 540
tctgagcttg aaagaagcca acaagctgcg cagtctgcag atgtctctct gaatccatgc 600
aatacaccac aaaaaatttt tacaactcca ctaacaccaa gtcaatatta tagtggttcc 660
aagtatgaag atctaaaaga aaaatataat aaagaggttg aagaacgaaa aagattagag 720
gcagaggtta aagccttgca ggctaaaaaa gcaagccaga ctcttccaca agccaccatg 780
aatcaccgcg acattgcccg gcatcaggct tcatcatctg tgttctcatg gcagcaagag 840
aagaccccaa gtcatctttc atctaattct caaagaactc caattaggag agatttctct 900
gcatcttact tttctgggga acaagaggtg actccaagtc gatcaacttt gcaaataggg 960
aaaagagatg ctaatagcag tttctttgac aattctagca gtcctcatct tttggatcaa 1020
ttaaaagcgc agaatcaaga gctaagaaac aagattaatg agttggaact acgcctgcaa 1080
ggacatgaaa aagaaatgaa aggccaagtg aataagtttc aagaactcca actccaactg 1140
gagaaagcaa aagtggaatt aattgaaaaa gagaaagttt tgaacaaatg tagggatgaa 1200
ctagtgagaa caacagcaca atacgaccag gcgtcaacca agtatactgc attggaacaa 1260
aaactgaaaa aattgacgga agatttgagt tgtcagcgac aaaatgcaga aagtgccaga 1320
tgttctctgg aacagaaaat taaggaaaaa gaaaaggagt ttcaagagga gctctcccgt 1380
caacagcgtt ctttccaaac actggaccag gagtgcatcc agatgaaggc cagactcacc 1440
caggagttac agcaagccaa gaatatgcac aacgtcctgc aggctgaact ggataaactc 1500
acatcagtaa agcaacagct agaaaacaat ttggaagagt ttaagcaaaa gttgtgcaga 1560
gctgaacagg cgttccaggc gagtcagatc aaggagaatg agctgaggag aagcatggag 1620
gaaatgaaga aggaaaacaa cctccttaag agtcactctg agcaaaaggc cagagaagtc 1680
tgccacctgg aggcagaact caagaacatc aaacagtgtt taaatcagag ccagaatttt 1740
gcagaagaaa tgaaagcgaa gaatacctct caggaaacca tgttaagaga tcttcaagaa 1800
aaaataaatc agcaagaaaa ctccttgact ttagaaaaac tgaagcttgc tgtggctgat 1860
ctggaaaagc agcgagattg ttctcaagac cttttgaaga aaagagaaca tcacattgaa 1920
caacttaatg ataagttaag caagacagag aaagagtcca aagccttgct gagtgcttta 1980
gagttaaaaa agaaagaata tgaagaattg aaagaagaga aaactctgtt ttcttgttgg 2040
aaaagtgaaa acgaaaaact tttaactcag atggaatcag aaaaggaaaa cttgcagagt 2100
aaaattaatc acttggaaac ttgtctgaag acacagcaaa taaaaagtca tgaatacaac 2160
gagagagtaa gaacgctgga gatggacaga gaaaacctaa gtgtcgagat cagaaacctt 2220
cacaacgtgt tagacagtaa gtcagtggag gtagagaccc agaaactagc ttatatggag 2280
ctacagcaga aagctgagtt ctcagatcag aaacatcaga aggaaataga aaatatgtgt 2340
ttgaagactt ctcagcttac tgggcaagtt gaagatctag aacacaagct tcagttactg 2400
tcaaatgaaa taatggacaa agaccggtgt taccaagact tgcatgccga atatgagagc 2460
ctcagggatc tgctaaaatc caaagatgct tctctggtga caaatgaaga tcatcagaga 2520
agtcttttgg cttttgatca gcagcctgcc atgcatcatt cctttgcaaa tataattgga 2580
gaacaaggaa gcatgccttc agagaggagt gaatgtcgtt tagaagcaga ccaaagtccg 2640
aaaaattctg ccatcctaca aaatagagtt gattcacttg aattttcatt agagtctcaa 2700
aaacagatga actcagacct gcaaaagcag tgtgaagagt tggtgcaaat caaaggagaa 2760
atagaagaaa atctcatgaa agcagaacag atgcatcaaa gttttgtggc tgaaacaagt 2820
cagcgcatta gtaagttaca ggaagacact tctgctcacc agaatgttgt tgctgaaacc 2880
ttaagtgccc ttgagaacaa ggaaaaagag ctgcaacttt taaatgataa ggtagaaact 2940
gagcaggcag agattcaaga attaaaaaag agcaaccatc tacttgaaga ctctctaaag 3000
gagctacaac ttttatccga aaccctaagc ttggagaaga aagaaatgag ttccatcatt 3060
tctctaaata aaagggaaat tgaagagctg acccaagaga atgggactct taaggaaatt 3120
aatgcatcct taaatcaaga gaagatgaac ttaatccaga aaagtgagag ttttgcaaac 3180
tatatagatg aaagggagaa aagcatttca gagttatctg atcagtacaa gcaagaaaaa 3240
cttattttac tacaaagatg tgaagaaacc ggaaatgcat atgaggatct tagtcaaaaa 3300
tacaaagcag cacaggaaaa gaattctaaa ttagaatgct tgctaaatga atgcactagt 3360
ctttgtgaaa ataggaaaaa tgagttggaa cagctaaagg aagcatttgc aaaggaacac 3420
caagaattct taacaaaatt agcatttgct gaagaaagaa atcagaatct gatgctagag 3480
ttggagacag tgcagcaagc tctgagatct gagatgacag ataaccaaaa caattctaag 3540
agcgaggctg gtggtttaaa gcaagaaatc atgactttaa aggaagaaca aaacaaaatg 3600
caaaaggaag ttaatgactt attacaagag aatgaacagc tgatgaaggt aatgaagact 3660
aaacatgaat gtcaaaatct agaatcagaa ccaattagga actctgtgaa agaaagagag 3720
agtgagagaa atcaatgtaa ttttaaacct cagatggatc ttgaagttaa agaaatttct 3780
ctagatagtt ataatgcgca gttggtgcaa ttagaagcta tgctaagaaa taaggaatta 3840
aaacttcagg aaagtgagaa ggagaaggag tgcctgcagc atgaattaca gacaattaga 3900
ggagatcttg aaaccagcaa tttgcaagac atgcagtcac aagaaattag tggccttaaa 3960
gactgtgaaa tagatgcgga agaaaagtat atttcagggc ctcatgagtt gtcaacaagt 4020
caaaacgaca atgcacacct tcagtgctct ctgcaaacaa caatgaacaa gctgaatgag 4080
ctagagaaaa tatgtgaaat actgcaggct gaaaagtatg aactcgtaac tgagctgaat 4140
gattcaaggt cagaatgtat cacagcaact aggaaaatgg cagaagaggt agggaaacta 4200
ctaaatgaag ttaaaatatt aaatgatgac agtggtcttc tccatggtga gttagtggaa 4260
gacataccag gaggtgaatt tggtgaacaa ccaaatgaac agcaccctgt gtctttggct 4320
ccattggacg agagtaattc ctacgagcac ttgacattgt cagacaaaga agttcaaatg 4380
cactttgccg aattgcaaga gaaattctta tctttacaaa gtgaacacaa aattttacat 4440
gatcagcact gtcagatgag ctctaaaatg tcagagctgc agacctatgt tgactcatta 4500
aaggccgaaa atttggtctt gtcaacgaat ctgagaaact ttcaaggtga cttggtgaag 4560
gagatgcagc tgggcttgga ggaggggctc gttccatccc tgtcatcctc ttgtgtgcct 4620
gacagctcta gtcttagcag tttgggagac tcctcctttt acagagctct tttagaacag 4680
acaggagata tgtctctttt gagtaattta gaaggggctg tttcagcaaa ccagtgcagt 4740
gtagatgaag tattttgcag cagtctgcag gaggagaatc tgaccaggaa agaaacccct 4800
tcggccccag cgaagggtgt tgaagagctt gagtccctct gtgaggtgta ccggcagtcc 4860
ctcgagaagc tagaagagaa aatggaaagt caagggatta tgaaaaataa ggaaattcaa 4920
gagctcgagc agttattaag ttctgaaagg caagagcttg actgccttag gaagcagtat 4980
ttgtcagaaa atgaacagtg gcaacagaag ctgacaagcg tgactctgga gatggagtcc 5040
aagttggcgg cagaaaagaa acagacggaa caactgtcac ttgagctgga agtagcacga 5100
ctccagctac aaggtctgga cttaagttct cggtctttgc ttggcatcga cacagaagat 5160
gctattcaag gccgaaatga gagctgtgac atatcaaaag aacatacttc agaaactaca 5220
gaaagaacac caaagcatga tgttcatcag atttgtgata aagatgctca gcaggacctc 5280
aatctagaca ttgagaaaat aactgagact ggtgcagtga aacccacagg agagtgctct 5340
ggggaacagt ccccagatac caattatgag cctccagggg aagataaaac ccagggctct 5400
tcagaatgca tttctgaatt gtcattttct ggtcctaatg ctttggtacc tatggatttc 5460
ctggggaatc aggaagatat ccataatctt caactgcggg taaaagagac atcaaatgag 5520
aatttgagat tacttcatgt gatagaggac cgtgacagaa aagttgaaag tttgctaaat 5580
gaaatgaaag aattagactc aaaactccat ttacaggagg tacaactaat gaccaaaatt 5640
gaagcatgca tagaattgga aaaaatagtt ggggaactta agaaagaaaa ctcagattta 5700
agtgaaaaat tggaatattt ttcttgtgat caccaggagt tactccagag agtagaaact 5760
tctgaaggcc tcaattctga tttagaaatg catgcagata aatcatcacg tgaagatatt 5820
ggagataatg tggccaaggt gaatgacagc tggaaggaga gatttcttga tgtggaaaat 5880
gagctgagta ggatcagatc ggagaaagct agcattgagc atgaagccct ctacctggag 5940
gctgacttag aggtagttca aacagagaag ctatgtttag aaaaagacaa tgaaaataag 6000
cagaaggtta ttgtctgcct tgaagaagaa ctctcagtgg tcacaagtga gagaaaccag 6060
cttcgtggag aattagatac tatgtcaaaa aaaaccacgg cactggatca gttgtctgaa 6120
aaaatgaagg agaaaacaca agagcttgag tctcatcaaa gtgagtgtct ccattgcatt 6180
caggtggcag aggcagaggt gaaggaaaag acggaactcc ttcagacttt gtcctctgat 6240
gtgagtgagc tgttaaaaga caaaactcat ctccaggaaa agctgcagag tttggaaaag 6300
gactcacagg cactgtcttt gacaaaatgt gagctggaaa accaaattgc acaactgaat 6360
aaagagaaag aattgcttgt caaggaatct gaaagcctgc aggccagact gagtgaatca 6420
gattatgaaa agctgaatgt ctccaaggcc ttggaggccg cactggtgga gaaaggtgag 6480
ttcgcattga ggctgagctc aacacaggag gaagtgcatc agctgagaag aggcatcgag 6540
aaactgagag ttcgcattga ggccgatgaa aagaagcagc tgcacatcgc agagaaactg 6600
aaagaacgcg agcgggagaa tgattcactt aaggataaag ttgagaacct tgaaagggaa 6660
ttgcagatgt cagaagaaaa ccaggagcta gtgattcttg atgccgagaa ttccaaagca 6720
gaagtagaga ctctaaaaac acaaatagaa gagatggcca gaagcctgaa agtttttgaa 6780
ttagaccttg tcacgttaag gtctgaaaaa gaaaatctga caaaacaaat acaagaaaaa 6840
caaggtcagt tgtcagaact agacaagtta ctctcttcat ttaaaagtct gttagaagaa 6900
aaggagcaag cagagataca gatcaaagaa gaatctaaaa ctgcagtgga gatgcttcag 6960
aatcagttaa aggagctaaa tgaggcagta gcagccttgt gtggtgacca agaaattatg 7020
aaggccacag aacagagtct agacccacca atagaggaag agcatcagct gagaaatagc 7080
attgaaaagc tgagagcccg cctagaagct gatgaaaaga agcagctctg tgtcttacaa 7140
caactgaagg aaagtgagca tcatgcagat ttacttaagg gtagagtgga gaaccttgaa 7200
agagagctag agatagccag gacaaaccaa gagcatgcag ctcttgaggc agagaattcc 7260
aaaggagagg tagagaccct aaaagcaaaa atagaaggga tgacccaaag tctgagaggt 7320
ctggaattag atgttgttac tataaggtca gaaaaagaaa atctgacaaa tgaattacaa 7380
aaagagcaag agcgaatatc tgaattagaa ataataaatt catcatttga aaatattttg 7440
caagaaaaag agcaagagaa agtacagatg aaagaaaaat caagcactgc catggagatg 7500
cttcaaacac aattaaaaga gctcaatgag agagtggcag ccctgcataa tgaccaagaa 7560
gcctgtaagg ccaaagagca gaatcttagt agtcaagtag agtgtcttga acttgagaag 7620
gctcagttgc tacaaggcct tgatgaggcc aaaaataatt atattgtttt gcaatcttca 7680
gtgaatggcc tcattcaaga agtagaagat ggcaagcaga aactggagaa gaaggatgaa 7740
gaaatcagta gactgaaaaa tcaaattcaa gaccaagagc agcttgtctc taaactgtcc 7800
caggtggaag gagagcacca actttggaag gagcaaaact tagaactgag aaatctgaca 7860
gtggaattgg agcagaagat ccaagtgcta caatccaaaa atgcctcttt gcaggacaca 7920
ttagaagtgc tgcagagttc ttacaagaat ctagagaatg agcttgaatt gacaaaaatg 7980
gacaaaatgt cctttgttga aaaagtaaac aaaatgactg caaaggaaac tgagctgcag 8040
agggaaatgc atgagatggc acagaaaaca gcagagctgc aagaagaact cagtggagag 8100
aaaaataggc tagctggaga gttgcagtta ctgttggaag aaataaagag cagcaaagat 8160
caattgaagg agctcacact agaaaatagt gaattgaaga agagcctaga ttgcatgcac 8220
aaagaccagg tggaaaagga agggaaagtg agagaggaaa tagctgaata tcagctacgg 8280
cttcatgaag ctgaaaagaa acaccaggct ttgcttttgg acacaaacaa acagtatgaa 8340
gtagaaatcc agacataccg agagaaattg acttctaaag aagaatgtct cagttcacag 8400
aagctggaga tagacctttt aaagtctagt aaagaagagc tcaataattc attgaaagct 8460
actactcaga ttttggaaga attgaagaaa accaagatgg acaatctaaa atatgtaaat 8520
cagttgaaga aggaaaatga acgtgcccag gggaaaatga agttgttgat caaatcctgt 8580
aaacagctgg aagaggaaaa ggagatactg cagaaagaac tctctcaact tcaagctgca 8640
caggagaagc agaaaacagg tactgttatg gataccaagg tcgatgaatt aacaactgag 8700
atcaaagaac tgaaagaaac tcttgaagaa aaaaccaagg aggcagatga atacttggat 8760
aagtactgtt ccttgcttat aagccatgaa aagttagaga aagctaaaga gatgttagag 8820
acacaagtgg cccatctgtg ttcacagcaa tctaaacaag attcccgagg gtctcctttg 8880
ctaggtccag ttgttccagg accatctcca atcccttctg ttactgaaaa gaggttatca 8940
tctggccaaa ataaagcttc aggcaagagg caaagatcca gtggaatatg ggagaatggt 9000
agaggaccaa cacctgctac cccagagagc ttttctaaaa aaagcaagaa agcagtcatg 9060
agtggtattc accctgcaga agacacggaa ggtactgagt ttgagccaga gggacttcca 9120
gaagttgtaa agaaagggtt tgctgacatc ccgacaggaa agactagccc atatatcctg 9180
cgaagaacaa ccatggcaac tcggaccagc ccccgcctgg ctgcacagaa gttagcgcta 9240
tccccactga gtctcggcaa agaaaatctt gcagagtcct ccaaaccaac agctggtggc 9300
agcagatcac aaaaggtcaa agttgctcag cggagcccag tagattcagg caccatcctc 9360
cgagaaccca ccacgaaatc cgtcccagtc aataatcttc ctgagagaag tccgactgac 9420
agccccagag agggcctgag ggtcaagcga ggccgacttg tccccagccc caaagctgga 9480
ctggagtcca acggcagtga gaactgtaag gtccagtgaa ggcactttgt gtgtcagtac 9540
ccctgggagg tgccagtcat tgaatagata aggctgtgcc tacaggactt ctctttagtc 9600
agggcatgct ttattagtga ggagaaaaca attccttaga agtcttaaat atattgtact 9660
ctttagatct cccatgtgta ggtattgaaa aagtttggaa gcactgatca cctgttagca 9720
ttgccattcc tctactgcaa tgtaaatagt ataaagctat gtatataaag ctttttggta 9780
atatgttaca attaaaatga caagcactat atcacaatct ctgtttgtat gtgggtttta 9840
cactaaaaaa atgcaaaaca cattttattc ttctaattaa cagctcctag gaaaatgtag 9900
acttttgctt tatgatattc tatctgtagt atgaggcatg gaatagtttt gtatcgggaa 9960
tttctcagag ctgagtaaaa tgaaggaaaa gcatgttatg tgtttttaag gaaaatgtgc 10020
acacatatac atgtaggagt gtttatcttt ctcttacaat ctgttttaga catctttgct 10080
tatgaaacct gtacatatgt gtgtgtgggt atgtgtttat ttccagtgag ggctgcaggc 10140
ttcctagagg tgtgctatac catgcgtctg tcgttgtgct tttttctgtt tttagaccaa 10200
ttttttacag ttctttggta agcattgtcg tatctggtga tggattaaca tatagccttt 10260
gttttctaat aaaatagtcg ccttcgtttt ctgtaaaaaa aaaaaaaaaa aaaaaa 10316
<210> 115
<211> 2639
<212> DNA
<213>Homo sapiens
<400> 115
ggcacgaggg gccgacgcga gcgccgcgct tcgcttcagc tgctagctgg cccaagggag 60
gcgaccgcgg agggtggcga ggggcggcca ggacccgcag ccccggggcc gggccggtcc 120
ggaccgccag ggagggcagg tcagtgggca gatcgcgtcc gcgggattca atctctgccc 180
gctctgataa cagtcctttt ccctggcgct cacttcgtgc ctggcacccg gctgggcgcc 240
tcaagaccgt tgtctcttcg atcgcttctt tggacttggc gaccatttca gagatgtctt 300
ccagaagtac caaagattta attaaaagta agtggggatc gaagcctagt aactccaaat 360
ccgaaactac attagaaaaa ttaaagggag aaattgcaca cttaaagaca tcagtggatg 420
aaatcacaag tgggaaagga aagctgactg ataaagagag acacagactt ttggagaaaa 480
ttcgagtcct tgaggctgag aaggagaaga atgcttatca actcacagag aaggacaaag 540
aaatacagcg actgagagac caactgaagg ccagatatag tactaccgca ttgcttgaac 600
agctggaaga gacaacgaga gaaggagaaa ggagggagca ggtgttgaaa gccttatctg 660
aagagaaaga cgtattgaaa caacagttgt ctgctgcaac ctcacgaatt gctgaacttg 720
aaagcaaaac caatacactc cgtttatcac agactgtggc tccaaactgc ttcaactcat 780
caataaataa tattcatgaa atggaaatac agctgaaaga tgctctggag aaaaatcagc 840
agtggctcgt gtatgatcag cagcgggaag tctatgtaaa aggactttta gcaaagatct 900
ttgagttgga aaagaaaacg gaaacagctg ctcattcact cccacagcag acaaaaaagc 960
ctgaatcaga aggttatctt caagaagaga agcagaaatg ttacaacgat ctcttggcaa 1020
gtgcaaaaaa agatcttgag gttgaacgac aaaccataac tcagctgagt tttgaactga 1080
gtgaatttcg aagaaaatat gaagaaaccc aaaaagaagt tcacaattta aatcagctgt 1140
tgtattcaca aagaagggca gatgtgcaac atctggaaga tgataggcat aaaacagaga 1200
agatacaaaa actcagggaa gagaatgata ttgctagggg aaaacttgaa gaagagaaga 1260
agagatccga agagctctta tctcaggtcc agtttcttta cacatctctg ctaaagcagc 1320
aagaagaaca aacaagggta gctctgttgg aacaacagat gcaggcatgt actttagact 1380
ttgaaaatga aaaactcgac cgtcaacatg tgcagcatca attgcatgta attcttaagg 1440
agctccgaaa agcaagaaat caaataacac agttggaatc cttgaaacag cttcatgagt 1500
ttgccatcac agagccatta gtcactttcc aaggagagac tgaaaacaga gaaaaagttg 1560
ccgcctcacc aaaaagtccc actgctgcac tcaatgaaag cctggtggaa tgtcccaagt 1620
gcaatataca gtatccagcc actgagcatc gcgatctgct tgtccatgtg gaatactgtt 1680
caaagtagca aaataagtat ttgttttgat attaaaagat tcaatactgt attttctgtt 1740
agcttgtggg cattttgaat tatatatttc acattttgca taaaactgcc tatctacctt 1800
tgacactcca gcatgctagt gaatcatgta tcttttaggc tgctgtgcat ttctcttggc 1860
agtgatacct ccctgacatg gttcatcatc aggctgcaat gacagaatgt ggtgagcagc 1920
gtctactgag actactaaca ttttgcactg tcaaaatact tggtgaggaa aagatagctc 1980
aggttattgc taatgggtta atgcaccagc aagcaaaata ttttatgttt tgggggtttg 2040
aaaaatcaaa gataattaac caaggatctt aactgtgttc gcatttttta tccaagcact 2100
tagaaaacct acaatcctaa ttttgatgtc cattgttaag aggtggtgat agatactatt 2160
ttttttttca tattgtatag cggttattag aaaagttggg gattttcttg atctttattg 2220
ctgcttacca ttgaaactta acccagctgt gttccccaac tctgttctgc gcacgaaaca 2280
gtatctgttt gaggcataat cttaagtggc cacacacaat gttttctctt atgttatctg 2340
gcagtaactg taacttgaat tacattagca cattctgctt agctaaaatt gttaaaataa 2400
actttaataa acccatgtag ccctctcatt tgattgacag tattttagtt atttttggca 2460
ttcttaaagc tgggcaatgt aatgatcaga tctttgtttg tctgaacagg tatttttata 2520
catgcttttt gtaaaccaaa aacttttaaa tttcttcagg ttttctaaca tgcttaccac 2580
tgggctactg taaatgagaa aagaataaaa ttatttaatg ttttaaaaaa aaaaaaaaa 2639
<210> 116
<211> 2632
<212> DNA
<213>Homo sapiens
<400> 116
ggcggctgag cctgagcggg gatgtagagg cggcggcagc agaggcggca ctggcggcaa 60
gagcagacgc ccgagccgag cgagaagagc ggcagagcct tatcccctga agccgggccc 120
cgcgtcccag ccctgcccag cccgcgccca gccatgcgcg ccgcctgctg agtccgggcg 180
ccgcacgctg agccctccgc ccgcgagccg cgctcagctc gggggtgatt agttgctttt 240
tgttgttttt taatttgggc cgcggggagg gggaggaggg gcaggtgctg caggctcccc 300
cccctccccg cctcgggcca gccgcggcgg cgcgactcgg gctccggacc cgggcactgc 360
tggcggctgg agcggagcgc accgcggcgg tggtgcccag agcggagcgc agctccctgc 420
cccgcccctc cccctcggcc tcgcggcgac ggcggcggtg gcggcttgga cgactcggag 480
agccgagtga agacatttcc acctggacac ctgaccatgt gcctgccctg agcagcgagg 540
cccaccaggc atctctgttg tgggcagcag ggccaggtcc tggtctgtgg accctcggca 600
gttggcaggc tccctctgca gtggggtctg ggcctcggcc ccaccatgtc gagcctcggc 660
ggtggctccc aggatgccgg cggcagtagc agcagcagca ccaatggcag cggtggcagt 720
ggcagcagtg gcccaaaggc aggagcagca gacaagagtg cagtggtggc tgccgccgca 780
ccagcctcag tggcagatga cacaccaccc cccgagcgtc ggaacaagag cggtatcatc 840
agtgagcccc tcaacaagag cctgcgccgc tcccgcccgc tctcccacta ctcttctttt 900
ggcagcagtg gtggtagtgg cggtggcagc atgatgggcg gagagtctgc tgacaaggcc 960
actgcggctg cagccgctgc ctccctgttg gccaatgggc atgacctggc ggcggccatg 1020
gcggtggaca aaagcaaccc tacctcaaag cacaaaagtg gtgctgtggc cagcctgctg 1080
agcaaggcag agcgggccac ggagctggca gccgagggac agctgacgct gcagcagttt 1140
gcgcagtcca cagagatgct gaagcgcgtg gtgcaggagc atctcccgct gatgagcgag 1200
gcgggtgctg gcctgcctga catggaggct gtggcaggtg ccgaagccct caatggccag 1260
tccgacttcc cctacctggg cgctttcccc atcaacccag gcctcttcat tatgaccccg 1320
gcaggtgtgt tcctggccga gagcgcgctg cacatggcgg gcctggctga gtaccccatg 1380
cagggagagc tggcctctgc catcagctcc ggcaagaaga agcggaaacg ctgcggcatg 1440
tgcgcgccct gccggcggcg catcaactgc gagcagtgca gcagttgtag gaatcgaaag 1500
actggccatc agatttgcaa attcagaaaa tgtgaggaac tcaaaaagaa gccttccgct 1560
gctctggaga aggtgatgct tccgacggga gccgccttcc ggtggtttca gtgacggcgg 1620
cggaacccaa agctgccctc tccgtgcaat gtcactgctc gtgtggtctc cagcaaggga 1680
ttcgggcgaa gacaaacgga tgcacccgtc tttagaacca aaaatattct ctcacagatt 1740
tcattcctgt ttttatatat atattttttg ttgtcgtttt aacatctcca cgtccctagc 1800
ataaaaagaa aaagaaaaaa atttaaactg ctttttcgga agaacaacaa caaaaaagag 1860
gtaaagacga atctataaag taccgagact tcctgggcaa agaatggaca atcagtttcc 1920
ttcctgtgtc gatgtcgatg ttgtctgtgc aggagatgca gtttttgtgt agagaatgta 1980
aattttctgt aaccttttga aatctagtta ctaataagca ctactgtaat ttagcacagt 2040
ttaactccac cctcatttaa acttcctttg attctttccg accatgaaat agtgcatagt 2100
ttgcctggag aatccactca cgttcataaa gagaatgttg atggcgccgt gtagaagccg 2160
ctctgtatcc atccacgcgt gcagagctgc cagcagggag ctcacagaag gggagggagc 2220
accaggccag ctgagctgca cccacagtcc cgagactggg atcccccacc ccaacagtga 2280
ttttggaaaa aaaaatgaaa gttctgttcg tttatccatt gcgatctggg gagccccatc 2340
tcgatatttc caatcctggc tacttttctt agagaaaata agtccttttt ttctggcctt 2400
gctaatggca acagaagaaa gggcttcttt gcgtggtccc ctgctggtgg gggtgggtcc 2460
ccagggggcc ccctgcggcc tgggcccccc tgcccacggc cagcttcctg ctgatgaaca 2520
tgctgtttgt attgttttag gaaaccaggc tgttttgtga ataaaacgaa tgcatgtttg 2580
tgtcacgaaa aaaaaaaaaa aaaaaaaaaa aaaaaaaaaa aaaaaaaaaa aa 2632
<210> 117
<211> 5616
<212> DNA
<213>Homo sapiens
<400> 117
ccccggcgca gcgcggccgc agcagcctcc gccccccgca cggtgtgagc gcccgacgcg 60
gccgaggcgg ccggagtccc gagctagccc cggcggccgc cgccgcccag accggacgac 120
aggccacctc gtcggcgtcc gcccgagtcc ccgcctcgcc gccaacgcca caaccaccgc 180
gcacggcccc ctgactccgt ccagtattga tcgggagagc cggagcgagc tcttcgggga 240
gcagcgatgc gaccctccgg gacggccggg gcagcgctcc tggcgctgct ggctgcgctc 300
tgcccggcga gtcgggctct ggaggaaaag aaagtttgcc aaggcacgag taacaagctc 360
acgcagttgg gcacttttga agatcatttt ctcagcctcc agaggatgtt caataactgt 420
gaggtggtcc ttgggaattt ggaaattacc tatgtgcaga ggaattatga tctttccttc 480
ttaaagacca tccaggaggt ggctggttat gtcctcattg ccctcaacac agtggagcga 540
attcctttgg aaaacctgca gatcatcaga ggaaatatgt actacgaaaa ttcctatgcc 600
ttagcagtct tatctaacta tgatgcaaat aaaaccggac tgaaggagct gcccatgaga 660
aatttacagg aaatcctgca tggcgccgtg cggttcagca acaaccctgc cctgtgcaac 720
gtggagagca tccagtggcg ggacatagtc agcagtgact ttctcagcaa catgtcgatg 780
gacttccaga accacctggg cagctgccaa aagtgtgatc caagctgtcc caatgggagc 840
tgctggggtg caggagagga gaactgccag aaactgacca aaatcatctg tgcccagcag 900
tgctccgggc gctgccgtgg caagtccccc agtgactgct gccacaacca gtgtgctgca 960
ggctgcacag gcccccggga gagcgactgc ctggtctgcc gcaaattccg agacgaagcc 1020
acgtgcaagg acacctgccc cccactcatg ctctacaacc ccaccacgta ccagatggat 1080
gtgaaccccg agggcaaata cagctttggt gccacctgcg tgaagaagtg tccccgtaat 1140
tatgtggtga cagatcacgg ctcgtgcgtc cgagcctgtg gggccgacag ctatgagatg 1200
gaggaagacg gcgtccgcaa gtgtaagaag tgcgaagggc cttgccgcaa agtgtgtaac 1260
ggaataggta ttggtgaatt taaagactca ctctccataa atgctacgaa tattaaacac 1320
ttcaaaaact gcacctccat cagtggcgat ctccacatcc tgccggtggc atttaggggt 1380
gactccttca cacatactcc tcctctggat ccacaggaac tggatattct gaaaaccgta 1440
aaggaaatca cagggttttt gctgattcag gcttggcctg aaaacaggac ggacctccat 1500
gcctttgaga acctagaaat catacgcggc aggaccaagc aacatggtca gttttctctt 1560
gcagtcgtca gcctgaacat aacatccttg ggattacgct ccctcaagga gataagtgat 1620
ggagatgtga taatttcagg aaacaaaaat ttgtgctatg caaatacaat aaactggaaa 1680
aaactgtttg ggacctccgg tcagaaaacc aaaattataa gcaacagagg tgaaaacagc 1740
tgcaaggcca caggccaggt ctgccatgcc ttgtgctccc ccgagggctg ctggggcccg 1800
gagcccaggg actgcgtctc ttgccggaat gtcagccgag gcagggaatg cgtggacaag 1860
tgcaaccttc tggagggtga gccaagggag tttgtggaga actctgagtg catacagtgc 1920
cacccagagt gcctgcctca ggccatgaac atcacctgca caggacgggg accagacaac 1980
tgtatccagt gtgcccacta cattgacggc ccccactgcg tcaagacctg cccggcagga 2040
gtcatgggag aaaacaacac cctggtctgg aagtacgcag acgccggcca tgtgtgccac 2100
ctgtgccatc caaactgcac ctacggatgc actgggccag gtcttgaagg ctgtccaacg 2160
aatgggccta agatcccgtc catcgccact gggatggtgg gggccctcct cttgctgctg 2220
gtggtggccc tggggatcgg cctcttcatg cgaaggcgcc acatcgttcg gaagcgcacg 2280
ctgcggaggc tgctgcagga gagggagctt gtggagcctc ttacacccag tggagaagct 2340
cccaaccaag ctctcttgag gatcttgaag gaaactgaat tcaaaaagat caaagtgctg 2400
ggctccggtg cgttcggcac ggtgtataag ggactctgga tcccagaagg tgagaaagtt 2460
aaaattcccg tcgctatcaa ggaattaaga gaagcaacat ctccgaaagc caacaaggaa 2520
atcctcgatg aagcctacgt gatggccagc gtggacaacc cccacgtgtg ccgcctgctg 2580
ggcatctgcc tcacctccac cgtgcagctc atcacgcagc tcatgccctt cggctgcctc 2640
ctggactatg tccgggaaca caaagacaat attggctccc agtacctgct caactggtgt 2700
gtgcagatcg caaagggcat gaactacttg gaggaccgtc gcttggtgca ccgcgacctg 2760
gcagccagga acgtactggt gaaaacaccg cagcatgtca agatcacaga ttttgggctg 2820
gccaaactgc tgggtgcgga agagaaagaa taccatgcag aaggaggcaa agtgcctatc 2880
aagtggatgg cattggaatc aattttacac agaatctata cccaccagag tgatgtctgg 2940
agctacgggg tgaccgtttg ggagttgatg acctttggat ccaagccata tgacggaatc 3000
cctgccagcg agatctcctc catcctggag aaaggagaac gcctccctca gccacccata 3060
tgtaccatcg atgtctacat gatcatggtc aagtgctgga tgatagacgc agatagtcgc 3120
ccaaagttcc gtgagttgat catcgaattc tccaaaatgg cccgagaccc ccagcgctac 3180
cttgtcattc agggggatga aagaatgcat ttgccaagtc ctacagactc caacttctac 3240
cgtgccctga tggatgaaga agacatggac gacgtggtgg atgccgacga gtacctcatc 3300
ccacagcagg gcttcttcag cagcccctcc acgtcacgga ctcccctcct gagctctctg 3360
agtgcaacca gcaacaattc caccgtggct tgcattgata gaaatgggct gcaaagctgt 3420
cccatcaagg aagacagctt cttgcagcga tacagctcag accccacagg cgccttgact 3480
gaggacagca tagacgacac cttcctccca gtgcctgaat acataaacca gtccgttccc 3540
aaaaggcccg ctggctctgt gcagaatcct gtctatcaca atcagcctct gaaccccgcg 3600
cccagcagag acccacacta ccaggacccc cacagcactg cagtgggcaa ccccgagtat 3660
ctcaacactg tccagcccac ctgtgtcaac agcacattcg acagccctgc ccactgggcc 3720
cagaaaggca gccaccaaat tagcctggac aaccctgact accagcagga cttctttccc 3780
aaggaagcca agccaaatgg catctttaag ggctccacag ctgaaaatgc agaataccta 3840
agggtcgcgc cacaaagcag tgaatttatt ggagcatgac cacggaggat agtatgagcc 3900
ctaaaaatcc agactctttc gatacccagg accaagccac agcaggtcct ccatcccaac 3960
agccatgccc gcattagctc ttagacccac agactggttt tgcaacgttt acaccgacta 4020
gccaggaagt acttccacct cgggcacatt ttgggaagtt gcattccttt gtcttcaaac 4080
tgtgaagcat ttacagaaac gcatccagca agaatattgt ccctttgagc agaaatttat 4140
ctttcaaaga ggtatatttg aaaaaaaaaa aaagtatatg tgaggatttt tattgattgg 4200
ggatcttgga gtttttcatt gtcgctattg atttttactt caatgggctc ttccaacaag 4260
gaagaagctt gctggtagca cttgctaccc tgagttcatc caggcccaac tgtgagcaag 4320
gagcacaagc cacaagtctt ccagaggatg cttgattcca gtggttctgc ttcaaggctt 4380
ccactgcaaa acactaaaga tccaagaagg ccttcatggc cccagcaggc cggatcggta 4440
ctgtatcaag tcatggcagg tacagtagga taagccactc tgtcccttcc tgggcaaaga 4500
agaaacggag gggatggaat tcttccttag acttactttt gtaaaaatgt ccccacggta 4560
cttactcccc actgatggac cagtggtttc cagtcatgag cgttagactg acttgtttgt 4620
cttccattcc attgttttga aactcagtat gctgcccctg tcttgctgtc atgaaatcag 4680
caagagagga tgacacatca aataataact cggattccag cccacattgg attcatcagc 4740
atttggacca atagcccaca gctgagaatg tggaatacct aaggatagca ccgcttttgt 4800
tctcgcaaaa acgtatctcc taatttgagg ctcagatgaa atgcatcagg tcctttgggg 4860
catagatcag aagactacaa aaatgaagct gctctgaaat ctcctttagc catcacccca 4920
accccccaaa attagtttgt gttacttatg gaagatagtt ttctcctttt acttcacttc 4980
aaaagctttt tactcaaaga gtatatgttc cctccaggtc agctgccccc aaaccccctc 5040
cttacgcttt gtcacacaaa aagtgtctct gccttgagtc atctattcaa gcacttacag 5100
ctctggccac aacagggcat tttacaggtg cgaatgacag tagcattatg agtagtgtgg 5160
aattcaggta gtaaatatga aactagggtt tgaaattgat aatgctttca caacatttgc 5220
agatgtttta gaaggaaaaa agttccttcc taaaataatt tctctacaat tggaagattg 5280
gaagattcag ctagttagga gcccaccttt tttcctaatc tgtgtgtgcc ctgtaacctg 5340
actggttaac agcagtcctt tgtaaacagt gttttaaact ctcctagtca atatccaccc 5400
catccaattt atcaaggaag aaatggttca gaaaatattt tcagcctaca gttatgttca 5460
gtcacacaca catacaaaat gttccttttg cttttaaagt aatttttgac tcccagatca 5520
gtcagagccc ctacagcatt gttaagaaag tatttgattt ttgtctcaat gaaaataaaa 5580
ctatattcat ttccactcta aaaaaaaaaa aaaaaa 5616
<210> 118
<211> 4816
<212> DNA
<213>Homo sapiens
<400> 118
gttcccggat ttttgtgggc gcctgccccg cccctcgtcc ccctgctgtg tccatatatc 60
gaggcgatag ggttaaggga aggcggacgc ctgatgggtt aatgagcaaa ctgaagtgtt 120
ttccatgatc ttttttgagt cgcaattgaa gtaccacctc ccgagggtga ttgcttcccc 180
atgcggggta gaacctttgc tgtcctgttc accactctac ctccagcaca gaatttggct 240
tatgcctact caatgtgaag atgatgagga tgaaaacctt tgtgatgatc cacttccact 300
taatgaatgg tggcaaagca aagctatatt caagaccaca tgcaaagcta ctccctgagc 360
aaagagtcac agataaaacg ggggcaccag tagaatggcc aggacaaacg cagtgcagca 420
cagagactca gaccctggca gccatgcctg cgcaggcagt gatgagagtg acatgtactg 480
ttgtggacat gcacaaaagt gagtgtgcac cggcacagac atgaagctgc ggctccctgc 540
cagtcccgag acccacctgg acatgctccg ccacctctac cagggctgcc aggtggtgca 600
gggaaacctg gaactcacct acctgcccac caatgccagc ctgtccttcc tgcaggatat 660
ccaggaggtg cagggctacg tgctcatcgc tcacaaccaa gtgaggcagg tcccactgca 720
gaggctgcgg attgtgcgag gcacccagct ctttgaggac aactatgccc tggccgtgct 780
agacaatgga gacccgctga acaataccac ccctgtcaca ggggcctccc caggaggcct 840
gcgggagctg cagcttcgaa gcctcacaga gatcttgaaa ggaggggtct tgatccagcg 900
gaacccccag ctctgctacc aggacacgat tttgtggaag gacatcttcc acaagaacaa 960
ccagctggct ctcacactga tagacaccaa ccgctctcgg gcctgccacc cctgttctcc 1020
gatgtgtaag ggctcccgct gctggggaga gagttctgag gattgtcaga gcctgacgcg 1080
cactgtctgt gccggtggct gtgcccgctg caaggggcca ctgcccactg actgctgcca 1140
tgagcagtgt gctgccggct gcacgggccc caagcactct gactgcctgg cctgcctcca 1200
cttcaaccac agtggcatct gtgagctgca ctgcccagcc ctggtcacct acaacacaga 1260
cacgtttgag tccatgccca atcccgaggg ccggtataca ttcggcgcca gctgtgtgac 1320
tgcctgtccc tacaactacc tttctacgga cgtgggatcc tgcaccctcg tctgccccct 1380
gcacaaccaa gaggtgacag cagaggatgg aacacagcgg tgtgagaagt gcagcaagcc 1440
ctgtgcccga gtgtgctatg gtctgggcat ggagcacttg cgagaggtga gggcagttac 1500
cagtgccaat atccaggagt ttgctggctg caagaagatc tttgggagcc tggcatttct 1560
gccggagagc tttgatgggg acccagcctc caacactgcc ccgctccagc cagagcagct 1620
ccaagtgttt gagactctgg aagagatcac aggttaccta tacatctcag catggccgga 1680
cagcctgcct gacctcagcg tcttccagaa cctgcaagta atccggggac gaattctgca 1740
caatggcgcc tactcgctga ccctgcaagg gctgggcatc agctggctgg ggctgcgctc 1800
actgagggaa ctgggcagtg gactggccct catccaccat aacacccacc tctgcttcgt 1860
gcacacggtg ccctgggacc agctctttcg gaacccgcac caagctctgc tccacactgc 1920
caaccggcca gaggacgagt gtgtgggcga gggcctggcc tgccaccagc tgtgcgcccg 1980
agggcactgc tggggtccag ggcccaccca gtgtgtcaac tgcagccagt tccttcgggg 2040
ccaggagtgc gtggaggaat gccgagtact gcaggggctc cccagggagt atgtgaatgc 2100
caggcactgt ttgccgtgcc accctgagtg tcagccccag aatggctcag tgacctgttt 2160
tggaccggag gctgaccagt gtgtggcctg tgcccactat aaggaccctc ccttctgcgt 2220
ggcccgctgc cccagcggtg tgaaacctga cctctcctac atgcccatct ggaagtttcc 2280
agatgaggag ggcgcatgcc agccttgccc catcaactgc acccactcct gtgtggacct 2340
ggatgacaag ggctgccccg ccgagcagag agccagccct ctgacgtcca tcatctctgc 2400
ggtggttggc attctgctgg tcgtggtctt gggggtggtc tttgggatcc tcatcaagcg 2460
acggcagcag aagatccgga agtacacgat gcggagactg ctgcaggaaa cggagctggt 2520
ggagccgctg acacctagcg gagcgatgcc caaccaggcg cagatgcgga tcctgaaaga 2580
gacggagctg aggaaggtga aggtgcttgg atctggcgct tttggcacag tctacaaggg 2640
catctggatc cctgatgggg agaatgtgaa aattccagtg gccatcaaag tgttgaggga 2700
aaacacatcc cccaaagcca acaaagaaat cttagacgaa gcatacgtga tggctggtgt 2760
gggctcccca tatgtctccc gccttctggg catctgcctg acatccacgg tgcagctggt 2820
gacacagctt atgccctatg gctgcctctt agaccatgtc cgggaaaacc gcggacgcct 2880
gggctcccag gacctgctga actggtgtat gcagattgcc aaggggatga gctacctgga 2940
ggatgtgcgg ctcgtacaca gggacttggc cgctcggaac gtgctggtca agagtcccaa 3000
ccatgtcaaa attacagact tcgggctggc tcggctgctg gacattgacg agacagagta 3060
ccatgcagat gggggcaagg tgcccatcaa gtggatggcg ctggagtcca ttctccgccg 3120
gcggttcacc caccagagtg atgtgtggag ttatggtgtg actgtgtggg agctgatgac 3180
ttttggggcc aaaccttacg atgggatccc agcccgggag atccctgacc tgctggaaaa 3240
gggggagcgg ctgccccagc cccccatctg caccattgat gtctacatga tcatggtcaa 3300
atgttggatg attgactctg aatgtcggcc aagattccgg gagttggtgt ctgaattctc 3360
ccgcatggcc agggaccccc agcgctttgt ggtcatccag aatgaggact tgggcccagc 3420
cagtcccttg gacagcacct tctaccgctc actgctggag gacgatgaca tgggggacct 3480
ggtggatgct gaggagtatc tggtacccca gcagggcttc ttctgtccag accctgcccc 3540
gggcgctggg ggcatggtcc accacaggca ccgcagctca tctaccagga gtggcggtgg 3600
ggacctgaca ctagggctgg agccctctga agaggaggcc cccaggtctc cactggcacc 3660
ctccgaaggg gctggctccg atgtatttga tggtgacctg ggaatggggg cagccaaggg 3720
gctgcaaagc ctccccacac atgaccccag ccctctacag cggtacagtg aggaccccac 3780
agtacccctg ccctctgaga ctgatggcta cgttgccccc ctgacctgca gcccccagcc 3840
tgaatatgtg aaccagccag atgttcggcc ccagccccct tcgccccgag agggccctct 3900
gcctgctgcc cgacctgctg gtgccactct ggaaaggccc aagactctct ccccagggaa 3960
gaatggggtc gtcaaagacg tttttgcctt tgggggtgcc gtggagaacc ccgagtactt 4020
gacaccccag ggaggagctg cccctcagcc ccaccctcct cctgccttca gcccagcctt 4080
cgacaacctc tattactggg accaggaccc accagagcgg ggggctccac ccagcacctt 4140
caaagggaca cctacggcag agaacccaga gtacctgggt ctggacgtgc cagtgtgaac 4200
cagaaggcca agtccgcaga agccctgatg tgtcctcagg gagcagggaa ggcctgactt 4260
ctgctggcat caagaggtgg gagggccctc cgaccacttc caggggaacc tgccatgcca 4320
ggaacctgtc ctaaggaacc ttccttcctg cttgagttcc cagatggctg gaaggggtcc 4380
agcctcgttg gaagaggaac agcactgggg agtctttgtg gattctgagg ccctgcccaa 4440
tgagactcta gggtccagtg gatgccacag cccagcttgg ccctttcctt ccagatcctg 4500
ggtactgaaa gccttaggga agctggcctg agaggggaag cggccctaag ggagtgtcta 4560
agaacaaaag cgacccattc agagactgtc cctgaaacct agtactgccc cccatgagga 4620
aggaacagca atggtgtcag tatccaggct ttgtacagag tgcttttctg tttagttttt 4680
actttttttg ttttgttttt ttaaagatga aataaagacc cagggggaga atgggtgttg 4740
tatggggagg caagtgtggg gggtccttct ccacacccac tttgtccatt tgcaaatata 4800
ttttggaaaa cagcta 4816
<210> 119
<211> 6466
<212> DNA
<213>Homo sapiens
<400> 119
atggtcataa cagcctcctg tctaccgact cagaacggat tttaccaaaa ctgaaaatgc 60
aggctccatg ctcagaagct ctttaacagg ctcgaaaggt ccatgctcct ttctcctgcc 120
cattctatag cataagaaga cagtctctga gtgataatct tctcttcaag aagaagaaaa 180
ctaggaagga gtaagcacaa agatctcttc acattctccg ggactgcggt accaaatatc 240
agcacagcac ttcttgaaaa aggatgtaga ttttaatctg aactttgaac catcactgag 300
gtggcccgcc ggtttctgag ccttctgccc tgcggggaca cggtctgcac cctgcccgcg 360
gccacggacc atgaccatga ccctccacac caaagcatct gggatggccc tactgcatca 420
gatccaaggg aacgagctgg agcccctgaa ccgtccgcag ctcaagatcc ccctggagcg 480
gcccctgggc gaggtgtacc tggacagcag caagcccgcc gtgtacaact accccgaggg 540
cgccgcctac gagttcaacg ccgcggccgc cgccaacgcg caggtctacg gtcagaccgg 600
cctcccctac ggccccgggt ctgaggctgc ggcgttcggc tccaacggcc tggggggttt 660
ccccccactc aacagcgtgt ctccgagccc gctgatgcta ctgcacccgc cgccgcagct 720
gtcgcctttc ctgcagcccc acggccagca ggtgccctac tacctggaga acgagcccag 780
cggctacacg gtgcgcgagg ccggcccgcc ggcattctac aggccaaatt cagataatcg 840
acgccagggt ggcagagaaa gattggccag taccaatgac aagggaagta tggctatgga 900
atctgccaag gagactcgct actgtgcagt gtgcaatgac tatgcttcag gctaccatta 960
tggagtctgg tcctgtgagg gctgcaaggc cttcttcaag agaagtattc aaggacataa 1020
cgactatatg tgtccagcca ccaaccagtg caccattgat aaaaacagga ggaagagctg 1080
ccaggcctgc cggctccgca aatgctacga agtgggaatg atgaaaggtg ggatacgaaa 1140
agaccgaaga ggagggagaa tgttgaaaca caagcgccag agagatgatg gggagggcag 1200
gggtgaagtg gggtctgctg gagacatgag agctgccaac ctttggccaa gcccgctcat 1260
gatcaaacgc tctaagaaga acagcctggc cttgtccctg acggccgacc agatggtcag 1320
tgccttgttg gatgctgagc cccccatact ctattccgag tatgatccta ccagaccctt 1380
cagtgaagct tcgatgatgg gcttactgac caacctggca gacagggagc tggttcacat 1440
gatcaactgg gcgaagaggg tgccaggctt tgtggatttg accctccatg atcaggtcca 1500
ccttctagaa tgtgcctggc tagagatcct gatgattggt ctcgtctggc gctccatgga 1560
gcacccaggg aagctactgt ttgctcctaa cttgctcttg gacaggaacc agggaaaatg 1620
tgtagagggc atggtggaga tcttcgacat gctgctggct acatcatctc ggttccgcat 1680
gatgaatctg cagggagagg agtttgtgtg cctcaaatct attattttgc ttaattctgg 1740
agtgtacaca tttctgtcca gcaccctgaa gtctctggaa gagaaggacc atatccaccg 1800
agtcctggac aagatcacag acactttgat ccacctgatg gccaaggcag gcctgaccct 1860
gcagcagcag caccagcggc tggcccagct cctcctcatc ctctcccaca tcaggcacat 1920
gagtaacaaa ggcatggagc atctgtacag catgaagtgc aagaacgtgg tgcccctcta 1980
tgacctgctg ctggagatgc tggacgccca ccgcctacat gcgcccacta gccgtggagg 2040
ggcatccgtg gaggagacgg accaaagcca cttggccact gcgggctcta cttcatcgca 2100
ttccttgcaa aagtattaca tcacggggga ggcagagggt ttccctgcca cggtctgaga 2160
gctccctggc tcccacacgg ttcagataat ccctgctgca ttttaccctc atcatgcacc 2220
actttagcca aattctgtct cctgcataca ctccggcatg catccaacac caatggcttt 2280
ctagatgagt ggccattcat ttgcttgctc agttcttagt ggcacatctt ctgtcttctg 2340
ttgggaacag ccaaagggat tccaaggcta aatctttgta acagctctct ttcccccttg 2400
ctatgttact aagcgtgagg attcccgtag ctcttcacag ctgaactcag tctatgggtt 2460
ggggctcaga taactctgtg catttaagct acttgtagag acccaggcct ggagagtaga 2520
cattttgcct ctgataagca ctttttaaat ggctctaaga ataagccaca gcaaagaatt 2580
taaagtggct cctttaattg gtgacttgga gaaagctagg tcaagggttt attatagcac 2640
cctcttgtat tcctatggca atgcatcctt ttatgaaagt ggtacacctt aaagctttta 2700
tatgactgta gcagagtatc tggtgattgt caattcattc cccctatagg aatacaaggg 2760
gcacacaggg aaggcagatc ccctagttgg caagactatt ttaacttgat acactgcaga 2820
ttcagatgtg ctgaaagctc tgcctctggc tttccggtca tgggttccag ttaattcatg 2880
cctcccatgg acctatggag agcagcaagt tgatcttagt taagtctccc tatatgaggg 2940
ataagttcct gatttttgtt tttatttttg tgttacaaaa gaaagccctc cctccctgaa 3000
cttgcagtaa ggtcagcttc aggacctgtt ccagtgggca ctgtacttgg atcttcccgg 3060
cgtgtgtgtg ccttacacag gggtgaactg ttcactgtgg tgatgcatga tgagggtaaa 3120
tggtagttga aaggagcagg ggccctggtg ttgcatttag ccctggggca tggagctgaa 3180
cagtacttgt gcaggattgt tgtggctact agagaacaag agggaaagta gggcagaaac 3240
tggatacagt tctgaggcac agccagactt gctcagggtg gccctgccac aggctgcagc 3300
tacctaggaa cattccttgc agaccccgca ttgccctttg ggggtgccct gggatccctg 3360
gggtagtcca gctcttcttc atttcccagc gtggccctgg ttggaagaag cagctgtcac 3420
agctgctgta gacagctgtg ttcctacaat tggcccagca ccctggggca cgggagaagg 3480
gtggggaccg ttgctgtcac tactcaggct gactggggcc tggtcagatt acgtatgccc 3540
ttggtggttt agagataatc caaaatcagg gtttggtttg gggaagaaaa tcctccccct 3600
tcctcccccg ccccgttccc taccgcctcc actcctgcca gctcatttcc ttcaatttcc 3660
tttgacctat aggctaaaaa agaaaggctc attccagcca cagggcagcc ttccctgggc 3720
ctttgcttct ctagcacaat tatgggttac ttcctttttc ttaacaaaaa agaatgtttg 3780
atttcctctg ggtgacctta ttgtctgtaa ttgaaaccct attgagaggt gatgtctgtg 3840
ttagccaatg acccaggtga gctgctcggg cttctcttgg tatgtcttgt ttggaaaagt 3900
ggatttcatt catttctgat tgtccagtta agtgatcacc aaaggactga gaatctggga 3960
gggcaaaaaa aaaaaaaaag tttttatgtg cacttaaatt tggggacaat tttatgtatc 4020
tgtgttaagg atatgtttaa gaacataatt cttttgttgc tgtttgttta agaagcacct 4080
tagtttgttt aagaagcacc ttatatagta taatatatat ttttttgaaa ttacattgct 4140
tgtttatcag acaattgaat gtagtaattc tgttctggat ttaatttgac tgggttaaca 4200
tgcaaaaacc aaggaaaaat atttagtttt tttttttttt tttgtatact tttcaagcta 4260
ccttgtcatg tatacagtca tttatgccta aagcctggtg attattcatt taaatgaaga 4320
tcacatttca tatcaacttt tgtatccaca gtagacaaaa tagcactaat ccagatgcct 4380
attgttggat actgaatgac agacaatctt atgtagcaaa gattatgcct gaaaaggaaa 4440
attattcagg gcagctaatt ttgcttttac caaaatatca gtagtaatat ttttggacag 4500
tagctaatgg gtcagtgggt tctttttaat gtttatactt agattttctt ttaaaaaaat 4560
taaaataaaa caaaaaaaaa tttctaggac tagacgatgt aataccagct aaagccaaac 4620
aattatacag tggaaggttt tacattattc atccaatgtg tttctattca tgttaagata 4680
ctactacatt tgaagtgggc agagaacatc agatgattga aatgttcgcc caggggtctc 4740
cagcaacttt ggaaatctct ttgtattttt acttgaagtg ccactaatgg acagcagata 4800
ttttctggct gatgttggta ttgggtgtag gaacatgatt taaaaaaaaa ctcttgcctc 4860
tgctttcccc cactctgagg caagttaaaa tgtaaaagat gtgatttatc tggggggctc 4920
aggtatggtg gggaagtgga ttcaggaatc tggggaatgg caaatatatt aagaagagta 4980
ttgaaagtat ttggaggaaa atggttaatt ctgggtgtgc accagggttc agtagagtcc 5040
acttctgccc tggagaccac aaatcaacta gctccattta cagccatttc taaaatggca 5100
gcttcagttc tagagaagaa agaacaacat cagcagtaaa gtccatggaa tagctagtgg 5160
tctgtgtttc ttttcgccat tgcctagctt gccgtaatga ttctataatg ccatcatgca 5220
gcaattatga gaggctaggt catccaaaga gaagacccta tcaatgtagg ttgcaaaatc 5280
taacccctaa ggaagtgcag tctttgattt gatttcccta gtaaccttgc agatatgttt 5340
aaccaagcca tagcccatgc cttttgaggg ctgaacaaat aagggactta ctgataattt 5400
acttttgatc acattaaggt gttctcacct tgaaatctta tacactgaaa tggccattga 5460
tttaggccac tggcttagag tactccttcc cctgcatgac actgattaca aatactttcc 5520
tattcatact ttccaattat gagatggact gtgggtactg ggagtgatca ctaacaccat 5580
agtaatgtct aatattcaca ggcagatctg cttggggaag ctagttatgt gaaaggcaaa 5640
tagagtcata cagtagctca aaaggcaacc ataattctct ttggtgcagg tcttgggagc 5700
gtgatctaga ttacactgca ccattcccaa gttaatcccc tgaaaactta ctctcaactg 5760
gagcaaatga actttggtcc caaatatcca tcttttcagt agcgttaatt atgctctgtt 5820
tccaactgca tttcctttcc aattgaatta aagtgtggcc tcgtttttag tcatttaaaa 5880
ttgttttcta agtaattgct gcctctatta tggcacttca attttgcact gtcttttgag 5940
attcaagaaa aatttctatt cttttttttg catccaattg tgcctgaact tttaaaatat 6000
gtaaatgctg ccatgttcca aacccatcgt cagtgtgtgt gtttagagct gtgcacccta 6060
gaaacaacat attgtcccat gagcaggtgc ctgagacaca gacccctttg cattcacaga 6120
gaggtcattg gttatagaga cttgaattaa taagtgacat tatgccagtt tctgttctct 6180
cacaggtgat aaacaatgct ttttgtgcac tacatactct tcagtgtaga gctcttgttt 6240
tatgggaaaa ggctcaaatg ccaaattgtg tttgatggat taatatgccc ttttgccgat 6300
gcatactatt actgatgtga ctcggttttg tcgcagcttt gctttgttta atgaaacaca 6360
cttgtaaacc tcttttgcac tttgaaaaag aatccagcgg gatgctcgag cacctgtaaa 6420
caattttctc aacctatttg atgttcaaat aaagaattaa actaaa 6466
<210> 120
<211> 3478
<212> DNA
<213>Homo sapiens
<400> 120
aaattgaaag gtcagccttt cgcgcgctgt gtaggcaagt tacccgtgtt ctgcgttgcc 60
ggccgtgggt gctctggcca cagtgagtta ggggcgtcgg agcgggtttc tccaaccgca 120
atcggctccg ctcaagggga ggaggagagt cccttctcgg aaggcctaag gaaacgtgtc 180
gtctggaatg ggcttggggg ccacgcctgc acatctccgc gagacagagg gataaagtga 240
agatggtgct gttattgtta cctcgagtgc cacatgcgac ctctgagata tgtacacagt 300
cattcttact atcgcactca gccattctta ctacgctaaa gaagaaataa ttattcgagg 360
atatttgcct ggcccagaag aaacttatgt aaatttcatg aactattata tccgttttcc 420
tcggagtgag agaaaactct ttttagatat catctgagag aactagtgaa tcccagtcac 480
tgagtggagt tgagagtcta agaacctctg aaatttgaga actgctggac cagagccttt 540
agagctctga taaggtgtca acagggtagt taatttggca ccatggggat acagggattg 600
ctacaattta tcaaagaagc ttcagaaccc atccatgtga ggaagtataa agggcaggta 660
gtagctgtgg atacatattg ctggcttcac aaaggagcta ttgcttgtgc tgaaaaacta 720
gccaaaggtg aacctactga taggtatgta ggattttgta tgaaatttgt aaatatgtta 780
ctatctcatg ggatcaagcc tattctcgta tttgatggat gtactttacc ttctaaaaag 840
gaagtagaga gatctagaag agaaagacga caagccaatc ttcttaaggg aaagcaactt 900
cttcgtgagg ggaaagtctc ggaagctcga gagtgtttca cccggtctat caatatcaca 960
catgccatgg cccacaaagt aattaaagct gcccggtctc agggggtaga ttgcctcgtg 1020
gctccctatg aagctgatgc gcagttggcc tatcttaaca aagcgggaat tgtgcaagcc 1080
ataattacag aggactcgga tctcctagct tttggctgta aaaaggtaat tttaaagatg 1140
gaccagtttg gaaatggact tgaaattgat caagctcggc taggaatgtg cagacagctt 1200
ggggatgtat tcacggaaga gaagtttcgt tacatgtgta ttctttcagg ttgtgactac 1260
ctgtcatcac tgcgtgggat tggattagca aaggcatgca aagtcctaag actagccaat 1320
aatccagata tagtaaaggt tatcaagaaa attggacatt atctcaagat gaatatcacg 1380
gtaccagagg attacatcaa cgggtttatt cgggccaaca ataccttcct ctatcagcta 1440
gtttttgatc ccatcaaaag gaaacttatt cctctgaacg cctatgaaga tgatgttgat 1500
cctgaaacac taagctacgc tgggcaatat gttgatgatt ccatagctct tcaaatagca 1560
cttggaaata aagatataaa tacttttgaa cagatcgatg actacaatcc agacactgct 1620
atgcctgccc attcaagaag tcatagttgg gatgacaaaa catgtcaaaa gtcagctaat 1680
gttagcagca tttggcatag gaattactct cccagaccag agtcgggtac tgtttcagat 1740
gccccacaat tgaaggaaaa tccaagtact gtgggagtgg aacgagtgat tagtactaaa 1800
gggttaaatc tcccaaggaa atcatccatt gtgaaaagac caagaagtgc agagctgtca 1860
gaagatgacc tgttgagtca gtattctctt tcatttacga agaagaccaa gaaaaatagc 1920
tctgaaggca ataaatcatt gagcttttct gaagtgtttg tgcctgacct ggtaaatgga 1980
cctactaaca aaaagagtgt aagcactcca cctaggacga gaaataaatt tgcaacattt 2040
ttacaaagga aaaatgaaga aagtggtgca gttgtggttc cagggaccag aagcaggttt 2100
ttttgcagtt cagattctac tgactgtgta tcaaacaaag tgagcatcca gcctctggat 2160
gaaactgctg tcacagataa agagaacaat ctgcatgaat cagagtatgg agaccaagaa 2220
ggcaagagac tggttgacac agatgtagca cgtaattcaa gtgatgacat tccgaataat 2280
catattccag gtgatcatat tccagacaag gcaacagtgt ttacagatga agagtcctac 2340
tcttttgaga gcagcaaatt tacaaggacc atttcaccac ccactttggg aacactaaga 2400
agttgtttta gttggtctgg aggtcttgga gatttttcaa gaacgccgag cccctctcca 2460
agcacagcat tgcagcagtt ccgaagaaag agcgattccc ccacctcttt gcctgagaat 2520
aatatgtctg atgtgtcgca gttaaagagc gaggagtcca gtgacgatga gtctcatccc 2580
ttacgagaag aggcatgttc ttcacagtcc caggaaagtg gagaattctc actgcagagt 2640
tcaaatgcat caaagctttc tcagtgctct agtaaggact ctgattcaga ggaatctgat 2700
tgcaatatta agttacttga cagtcaaagt gaccagacct ccaagctacg tttatctcat 2760
ttctcaaaaa aagacacacc tctaaggaac aaggttcctg ggctatataa gtccagttct 2820
gcagactctc tttctacaac caagatcaaa cctctaggac ctgccagagc cagtgggctg 2880
agcaagaagc cggcaagcat ccagaagaga aagcatcata atgccgagaa caagccgggg 2940
ttacagatca aactcaatga gctctggaaa aactttggat ttaaaaaaga ttctgaaaag 3000
cttcctcctt gtaagaaacc cctgtcccca gtcagagata acatccaact aactccagaa 3060
gcggaagagg atatatttaa caaacctgaa tgtggccgtg ttcaaagagc aatattccag 3120
taaatgcaga ctgctgcaaa gcttttgcct gcaagagaat ctgatcaatt tgaagtccct 3180
gtttgggaat gaggcactta tcagcatgaa gaattttttc tcattctgtg ccattttaaa 3240
aatagaatac attttgtata ttaactttat aattgggttg tggttttttt gctcagcttt 3300
ttatattttt ataagaagct aaatagaaga ataattgtat ctctgacagg tttttggagg 3360
ttttagtgtt aattgggaaa atcctctgga gtttataaaa gtctactcta aatatttctg 3420
taatgttgtc aagtagaaag atagtaaatg gagaaactac aaaaaaaaaa aaaaaaaa 3478
<210> 121
<211> 5192
<212> DNA
<213>Homo sapiens
<400> 121
ccatgacctg ccttgagaag gggcagggga agccagatgg actggaagtg gagtggcagt 60
gaccaaggag gaggaggtgt gataggcttc ccacgcaggg tagatccaga gacaccagtg 120
ccacccatag gcccctagga ctgcagtggt cacccgattc ctttgtccca gctgagactc 180
agttctgagt gttctatttt ggggaacaga ggcgtccttg gtagcatttg gaagaggata 240
gccagctggg gtgtgtgtac atcacagcct gacagtaaca gcatccgaac cagaggtgac 300
tggctaaggg cagacccagg gcaacaggtt aaccgttcta gggccgggca cagggaggag 360
aacattccaa cactctgtgt gcccagtgcc gacgcacgtt ctctctttta tcctcaaaac 420
agtcctatga ggatataagc cagagagaga cagagacaag gaattacaag ttggtgagag 480
tcaggatttg aacttggctc tggcagatgg aaaattaggg tctgtattct ttacaaaacc 540
gtgtgtgcct cagatggagt tggtgcataa caagcagagg tatccagggt cgcggtcctg 600
cttgccacgg aaggggccgc cttgtcagtt gtgaccaccc agccctggaa atgtcagtaa 660
tgctgtaagg agtggggatc ggatcagatg ccatccagat gctgaagttt gaccttgtgt 720
catttttcac tttctttttt ggctcttctg caatcaattc atttatttag caaaaaagaa 780
attatgtgtg ccgagagcat gcagaagata tgtctccgtt ctctgcttcc ctccaaaaaa 840
gaatcccaaa actgctttct gtgaacgtgt gccagggtcc cagcaggact cagggagagc 900
aggaagccca gcccagaccc cttgcacaac ctaccgtggg gaggccttag gctctggcta 960
ctacagagct ggttccagtc tgcactgcca cagcctggcc agggacttgg acacatctgc 1020
tggccacttc ctgtctcagt ttccttatct gcaaaataag ggaaaagccc ccacaaaggt 1080
gcacgtgtag caggagctct tttccctccc tattttagga aggcagttgg tgggaagtcc 1140
agcttgggtc cctgagagct gtgagaagga gatgcggctg ctgctggccc tgttgggggt 1200
cctgctgagt gtgcctgggc ctccagtctt gtccctggag gcctctgagg aagtggagct 1260
tggtatggct tctgaggtgg gagagggtgg caggggtggg aagagtgggc accaggaggg 1320
ggctgctggg ctgagcaaag ctggaaagga tccttgccca ggccctgaga aggtggcggc 1380
agggcagggc tcaaccactg agactcagtc agtgcctggc ttccagcaag cattcatcta 1440
tcactgtgtc tgcgagagag gactggcctt gcagggcgca gggccctaag ctgggctgca 1500
gagctggtgg tgagctcctt gcctgggtgt gtgtgcgtgt gtgtgtgtgt tctgtgcact 1560
gggtgtgtga cctaggaggt ccaggcagca tgtgtggtat aagcattatg agggtgatat 1620
gccccggtgc agcatgaccc tgtatgtggc accaacagca tgtgccttgt gtgtgtgtgt 1680
gtccgtatgt gtgtgtgtgt atgcgtgtgt gtgtgtgtgt gtgtgtgtct tggccactgt 1740
catgtgcact aaatgctgtg tgtgtgacat gccccaagag tgtggcattt gccctgggtg 1800
tggcatccgc agcatgtggc tgtgtgggtg tcaaggagtg gtggctcctt cagcatgcgt 1860
tgcgaagtgc ttgtgccctg catgtgcggt gtgttctctg tacacaggag gctgcctcag 1920
atggggctgc ggggtctgct gacctctgcc ctctgcccac agagccctgc ctggctccca 1980
gcctggagca gcaagagcag gagctgacag tagcccttgg gcagcctgtg cggctgtgct 2040
gtgggcgggc tgagcgtggt ggccactggt acaaggaggg cagtcgcctg gcacctgctg 2100
gccgtgtacg gggctggagg ggccgcctag agattgccag cttcctacct gaggatgctg 2160
gccgctacct ctgcctggca cgaggctcca tgatcgtcct gcagaatctc accttgatta 2220
caggtgactc cttgacctcc agcaacgatg atgaggaccc caagtcccat agggacctct 2280
cgaataggca cagttacccc cagcaaggtc agtaggtctc caaggacttg tgtccccgct 2340
gctgctcatc tgatcactga gaagaggagg cctgtgtggg aacacacggt cattctaggg 2400
gccttcccct gccctccagc accctactgg acacaccccc agcgcatgga gaagaaactg 2460
catgcagtac ctgcggggaa caccgtcaag ttccgctgtc cagctgcagg caaccccacg 2520
cccaccatcc gctggcttaa ggatggacag gcctttcatg gggagaaccg cattggaggc 2580
attcggctgc gccatcagca ctggagtctc gtgatggaga gcgtggtgcc ctcggaccgc 2640
ggcacataca cctgcctggt agagaacgct gtgggcagca tccgttataa ctacctgcta 2700
gatgtgctgg agcggtcccc gcaccggccc atcctgcagg ccgggctccc ggccaacacc 2760
acagccgtgg tgggcagcga cgtggagctg ctgtgcaagg tgtacagcga tgcccagccc 2820
cacatccagt ggctgaagca catcgtcatc aacggcagca gcttcggagc cgacggtttc 2880
ccctatgtgc aagtcctaaa gactgcagac atcaatagct cagaggtgga ggtcctgtac 2940
ctgcggaacg tgtcagccga ggacgcaggc gagtacacct gcctcgcagg caattccatc 3000
ggcctctcct accagtctgc ctggctcacg gtgctgccag gtgagcacct gaagggccag 3060
gagatgctgc gagatgcccc tctgggccag cagtgggggc tgtggcctgt tgggtggtca 3120
gtctctgttg gcctgtgggg tctggcctgg ggggcagtgt gtggatttgt gggtttgagc 3180
tgtatgacag cccctctgtg cctctccaca cgtggccgtc catgtgaccg tctgctgagg 3240
tgtgggtgcc tgggactggg cataactaca gcttcctccg tgtgtgtccc cacatatgtt 3300
gggagctggg agggactgag ttagggtgca cggggcggcc agtctcacca ctgaccagtt 3360
tgtctgtctg tgtgtgtcca tgtgcgaggg cagaggagga ccccacatgg accgcagcag 3420
cgcccgaggc caggtatacg gacatcatcc tgtacgcgtc gggctccctg gccttggctg 3480
tgctcctgct gctggccagg ctgtatcgag ggcaggcgct ccacggccgg cacccccgcc 3540
cgcccgccac tgtgcagaag ctctcccgct tccctctggc ccgacagttc tccctggagt 3600
caggctcttc cggcaagtca agctcatccc tggtacgagg cgtgcgtctc tcctccagcg 3660
gccccgcctt gctcgccggc ctcgtgagtc tagatctacc tctcgaccca ctatgggagt 3720
tcccccggga caggctggtg cttgggaagc ccctaggcga gggctgcttt ggccaggtag 3780
tacgtgcaga ggcctttggc atggaccctg cccggcctga ccaagccagc actgtggccg 3840
tcaagatgct caaagacaac gcctctgaca aggacctggc cgacctggtc tcggagatgg 3900
aggtgatgaa gctgatcggc cgacacaaga acatcatcaa cctgcttggt gtctgcaccc 3960
aggaagggcc cctgtacgtg atcgtggagt gcgccgccaa gggaaacctg cgggagttcc 4020
tgcgggcccg gcgcccccca ggccccgacc tcagccccga cggtcctcgg agcagtgagg 4080
ggccgctctc cttcccagtc ctggtctcct gcgcctacca ggtggcccga ggcatgcagt 4140
atctggagtc ccggaagtgt atccaccggg acctggctgc ccgcaatgtg ctggtgactg 4200
aggacaatgt gatgaagatt gctgactttg ggctggcccg cggcgtccac cacattgact 4260
actataagaa aaccagcaac ggccgcctgc ctgtgaagtg gatggcgccc gaggccttgt 4320
ttgaccgggt gtacacacac cagagtgacg tgtggtcttt tgggatcctg ctatgggaga 4380
tcttcaccct cgggggctcc ccgtatcctg gcatcccggt ggaggagctg ttctcgctgc 4440
tgcgggaggg acatcggatg gaccgacccc cacactgccc cccagagctg tacgggctga 4500
tgcgtgagtg ctggcacgca gcgccctccc agaggcctac cttcaagcag ctggtggagg 4560
cgctggacaa ggtcctgctg gccgtctctg aggagtacct cgacctccgc ctgaccttcg 4620
gaccctattc cccctctggt ggggacgcca gcagcacctg ctcctccagc gattctgtct 4680
tcagccacga ccccctgcca ttgggatcca gctccttccc cttcgggtct ggggtgcaga 4740
catgagcaag gctcaaggct gtgcaggcac ataggctggt ggccttgggc cttggggctc 4800
agccacagcc tgacacagtg ctcgaccttg atagcatggg gcccctggcc cagagttgct 4860
gtgccgtgtc caagggccgt gcccttgccc ttggagctgc cgtgcctgtg tcctgatggc 4920
ccaaatgtca gggttctgct cggcttcttg gaccttggcg cttagtcccc atcccgggtt 4980
tggctgagcc tggctggaga gctgctatgc taaacctcct gcctcccaat accagcagga 5040
ggttctgggc ctctgaaccc cctttcccca cacctccccc tgctgctgct gccccagcgt 5100
cttgacggga gcattggccc ctgagcccag agaagctgga agcctgccga aaacaggagc 5160
aaatggcgtt ttataaatta tttttttgaa at 5192
<210> 122
<211> 3124
<212> DNA
<213>Homo sapiens
<400> 122
taagatccac atcagctcaa ctgcacttgc ctcgcagagg cagcccgctc acttcccgcg 60
gaggcgctcc ccggcgccgc gctccgcggc agccgcctgc ccccggcgct gcccccgccc 120
gccgcgccgc cgccgccgcc gcgcacgccg cgccccgcag ctctgggctt cctcttcgcc 180
cgggtggcgt tgggcccgcg cgggcgctcg ggtgactgca gctgctcagc tcccctcccc 240
cgccccgcgc cgcgcggccg cccgtcgctt cgcacagggc tggatggttg tattgggcag 300
ggtggctcca ggatgttagg aactgtgaag atggaagggc atgaaaccag cgactggaac 360
agctactacg cagacacgca ggaggcctac tcctccgtcc cggtcagcaa catgaactca 420
ggcctgggct ccatgaactc catgaacacc tacatgacca tgaacaccat gactacgagc 480
ggcaacatga ccccggcgtc cttcaacatg tcctatgcca acccgggcct aggggccggc 540
ctgagtcccg gcgcagtagc cggcatgccg gggggctcgg cgggcgccat gaacagcatg 600
actgcggccg gcgtgacggc catgggtacg gcgctgagcc cgagcggcat gggcgccatg 660
ggtgcgcagc aggcggcctc catgaatggc ctgggcccct acgcggccgc catgaacccg 720
tgcatgagcc ccatggcgta cgcgccgtcc aacctgggcc gcagccgcgc gggcggcggc 780
ggcgacgcca agacgttcaa gcgcagctac ccgcacgcca agccgcccta ctcgtacatc 840
tcgctcatca ccatggccat ccagcaggcg cccagcaaga tgctcacgct gagcgagatc 900
taccagtgga tcatggacct cttcccctat taccggcaga accagcagcg ctggcagaac 960
tccatccgcc actcgctgtc cttcaatgac tgcttcgtca aggtggcacg ctccccggac 1020
aagccgggca agggctccta ctggacgctg cacccggact ccggcaacat gttcgagaac 1080
ggctgctact tgcgccgcca gaagcgcttc aagtgcgaga agcagccggg ggccggcggc 1140
gggggcggga gcggaagcgg gggcagcggc gccaagggcg gccctgagag ccgcaaggac 1200
ccctctggcg cctctaaccc cagcgccgac tcgcccctcc atcggggtgt gcacgggaag 1260
accggccagc tagagggcgc gccggccccc gggcccgccg ccagccccca gactctggac 1320
cacagtgggg cgacggcgac agggggcgcc tcggagttga agactccagc ctcctcaact 1380
gcgcccccca taagctccgg gcccggggcg ctggcctctg tgcccgcctc tcacccggca 1440
cacggcttgg caccccacga gtcccagctg cacctgaaag gggaccccca ctactccttc 1500
aaccacccgt tctccatcaa caacctcatg tcctcctcgg agcagcagca taagctggac 1560
ttcaaggcat acgaacaggc actgcaatac tcgccttacg gctctacgtt gcccgccagc 1620
ctgcctctag gcagcgcctc ggtgaccacc aggagcccca tcgagccctc agccctggag 1680
ccggcgtact accaaggtgt gtattccaga cccgtcctaa acacttccta gctcccggga 1740
ctggggggtt tgtctggcat agccatgctg gtagcaagag agaaaaaatc aacagcaaac 1800
aaaaccacac aaaccaaacc gtcaacagca taataaaatc ccaacaacta tttttatttc 1860
atttttcatg cacaaccttt cccccagtgc aaaagactgt tactttatta ttgtattcaa 1920
aattcattgt gtatattact acaaagacaa ccccaaacca atttttttcc tgcgaagttt 1980
aatgatccac aagtgtatat atgaaattct cctccttcct tgcccccctc tctttcttcc 2040
ctctttcccc tccagacatt ctagtttgtg gagggttatt taaaaaaaca aaaaaggaag 2100
atggtcaagt ttgtaaaata tttgtttgtg ctttttcccc ctccttacct gaccccctac 2160
gagtttacag gtctgtggca atactcttaa ccataagaat tgaaatggtg aagaaacaag 2220
tatacactag aggctcttaa aagtattgaa agacaatact gctgttatat agcaagacat 2280
aaacagatta taaacatcag agccatttgc ttctcagttt acatttctga tacatgcaga 2340
tagcagatgt ctttaaatga aatacatgta tattgtgtat ggacttaatt atgcacatgc 2400
tcagatgtgt agacatcctc cgtatattta cataacatat agaggtaata gataggtgat 2460
atacatgata cattctcaag agttgcttga ccgaaagtta caaggacccc aacccctttg 2520
tcctctctac ccacagatgg ccctgggaat caattcctca ggaattgccc tcaagaactc 2580
tgcttcttgc tttgcagagt gccatggtca tgtcattctg aggtcacata acacataaaa 2640
ttagtttcta tgagtgtata ccatttaaag aatttttttt tcagtaaaag ggaatattac 2700
aatgttggag gagagataag ttatagggag ctggatttca aaacgtggtc caagattcaa 2760
aaatcctatt gatagtggcc attttaatca ttgccatcgt gtgcttgttt catccagtgt 2820
tatgcacttt ccacagttgg acatggtgtt agtatagcca gacgggtttc attattattt 2880
ctctttgctt tctcaatgtt aatttattgc atggtttatt ctttttcttt acagctgaaa 2940
ttgctttaaa tgatggttaa aattacaaat taaattgtta atttttatca atgtgattgt 3000
aattaaaaat attttgattt aaataacaaa aataatacca gattttaagc cgtggaaaat 3060
gttcttgatc atttgcagtt aaggacttta aataaatcaa atgttaacaa aaaaaaaaaa 3120
aaaa 3124
<210> 123
<211> 3452
<212> DNA
<213>Homo sapiens
<400> 123
atgcaggcgc gctactccgt gtccagcccc aactccctgg gagtggtgcc ctacctcggc 60
ggcgagcaga gctactaccg cgcggcggcc gcggcggccg ggggcggcta caccgccatg 120
ccggccccca tgagcgtgta ctcgcaccct gcgcacgccg agcagtaccc gggcggcatg 180
gcccgcgcct acgggcccta cacgccgcag ccgcagccca aggacatggt gaagccgccc 240
tatagctaca tcgcgctcat caccatggcc atccagaacg ccccggacaa gaagatcacc 300
ctgaacggca tctaccagtt catcatggac cgcttcccct tctaccggga caacaagcag 360
ggctggcaga acagcatccg ccacaacctc tcgctcaacg agtgcttcgt caaggtgccg 420
cgcgacgaca agaagccggg caagggcagc tactggacgc tggacccgga ctcctacaac 480
atgttcgaga acggcagctt cctgcggcgg cggcggcgct tcaagaagaa ggacgcggtg 540
aaggacaagg aggagaagga caggctgcac ctcaaggagc cgcccccgcc cggccgccag 600
cccccgcccg cgccgccgga gcaggccgac ggcaacgcgc ccggtccgca gccgccgccc 660
gtgcgcatcc aggacatcaa gaccgagaac ggtacgtgcc cctcgccgcc ccagcccctg 720
tccccggccg ccgccctggg cagcggcagc gccgccgcgg tgcccaagat cgagagcccc 780
gacagcagca gcagcagcct gtccagcggg agcagccccc cgggcagcct gccgtcggcg 840
cggccgctca gcctggacgg tgcggattcc gcgccgccgc cgcccgcgcc ctccgccccg 900
ccgccgcacc atagccaggg cttcagcgtg gacaacatca tgacgtcgct gcgggggtcg 960
ccgcagagcg cggccgcgga gctcagctcc ggccttctgg cctcggcggc cgcgtcctcg 1020
cgcgcgggga tcgcaccccc gctggcgctc ggcgcctact cgcccggcca gagctccctc 1080
tacagctccc cctgcagcca gacctccagc gcgggcagct cgggcggcgg cggcggcggc 1140
gcgggggccg cggggggcgc gggcggcgcc gggacctacc actgcaacct gcaagccatg 1200
agcctgtacg cggccggcga gcgcgggggc cacttgcagg gcgcgcccgg gggcgcgggc 1260
ggctcggccg tggacgaccc cctgcccgac tactctctgc ctccggtcac cagcagcagc 1320
tcgtcgtccc tgagtcacgg cggcggcggc ggcggcggcg ggggaggcca ggaggccggc 1380
caccaccctg cggcccacca aggccgcctc acctcgtggt acctgaacca ggcgggcgga 1440
gacctgggcc acttggcgag cgcggcggcg gcggcggcgg ccgcaggcta cccgggccag 1500
cagcagaact tccactcggt gcgggagatg ttcgagtcac agaggatcgg cttgaacaac 1560
tctccagtga acgggaatag tagctgtcaa atggccttcc cttccagcca gtctctgtac 1620
cgcacgtccg gagctttcgt ctacgactgt agcaagtttt gacacaccct caaagccgaa 1680
ctaaatcgaa ccccaaagca ggaaaagcta aaggaaccca tcaaggcaaa atcgaaacta 1740
aaaaaaaaaa atccaattaa aaaaaacccc tgagaatatt caccacacca gcgaacagaa 1800
tatccctcca aaaattcagc tcaccagcac cagcacgaag aaaactctat tttcttaacc 1860
gattaattca gagccacctc cactttgcct tgtctaaata aacaaacccg taaactgttt 1920
tatacagaga cagcaaaatc ttggtttatt aaaggacagt gttactccag ataacacgta 1980
agtttcttct tgcttttcag agacctgctt tcccctcctc ccgtctcccc tctcttgcct 2040
tcttccttgc ctctcacctg taagatatta ttttatccta tgttgaaggg agggggaaag 2100
tccccgttta tgaaagtcgc tttcttttta ttcatggact tgttttaaaa tgtaaattgc 2160
aacatagtaa tttattttta atttgtagtt ggatgtcgtg gaccaaacgc cagaaagtgt 2220
tcccaaaacc tgacgttaaa ttgcctgaaa ctttaaattg tgcttttttt ctcattataa 2280
aaagggaaac tgtattaatc ttattctatc ctcttttctt tctttttgtt gaacatattc 2340
attgtttgtt tattaataaa ttaccattca gtttgaatga gacctatatg tctggatact 2400
ttaatagagc tttaattatt acgaaaaaag atttcagaga taaaacacta gaagttacct 2460
attctccacc taaatctctg aaaaatggag aaaccctctg actagtccat gtcaaatttt 2520
actaaaagtc tttttgttta gatttatttt cctgcagcat cttctgcaaa atgtactata 2580
tagtcagctt gctttgaggc tagtaaaaag atatttttct aaacagattg gagttggcat 2640
ataaacaaat acgttttctc actaatgaca gtccatgatt cggaaatttt aagcccatga 2700
atcagccgcg gtcttaccac ggtgatgcct gtgtgccgag agatgggact gtgcggccag 2760
atatgcacag ataaatattt ggcttgtgta ttccatataa aattgcagtg catattatac 2820
atccctgtga gccagatgct gaatagatat tttcctatta tttcagtcct ttataaaagg 2880
aaaaataaac cagtttttaa atgtatgtat ataattctcc cccatttaca atccttcatg 2940
tattacatag aaggattgct tttttaaaaa tatactgcgg gttggaaagg gatatttaat 3000
ctttgagaaa ctattttaga aaatatgttt gtagaacaat tatttttgaa aaagatttaa 3060
agcaataaca agaaggaagg cgagaggagc agaacatttt ggtctagggt ggtttctttt 3120
taaaccattt tttcttgtta atttacagtt aaacctaggg gacaatccgg attggccctc 3180
ccccttttgt aaataaccca ggaaatgtaa taaattcatt atcttagggt gatctgccct 3240
gccaatcaga ctttggggag atggcgattt gattacagac gttcgggggg gtggggggct 3300
tgcagtttgt tttggagata atacagtttc ctgctatctg ccgctcctat ctagaggcaa 3360
cacttaagca gtaattgctg ttgcttgttg tcaaaatttg atcattgtta aaggattgct 3420
gcaaataaat acactttaat ttcagtcaaa aa 3452
<210> 124
<211> 1749
<212> DNA
<213>Homo sapiens
<400> 124
gtggcctcga ggtggtggca gggccgcccc ctgcagtccg gagacgaacg cacggaccgg 60
gcctccggag gcaggttcgg ctggaaggaa ccgctctcgc ttcgtcctac acttgcgcaa 120
atgtctccga gcttactcac atagcatatt ggtatatcaa aatgaaatgc aaggaaccaa 180
aaataacata attgaaggca gtaaaagtga aattaaatag gaagatcatc agtcaaggaa 240
gacccactgg agaggacaga aaatgaagca gtgttttatc atgtgtattt cagcaggtct 300
tcttgaaatt taactaaaaa tatgactgct ctctcttcag agaactgctc ttttcagtac 360
cagttacgtc aaacaaacca gcccctagac gttaactatc tgctattctt gatcatactt 420
gggaaaatat tattaaatat ccttacacta ggaatgagaa gaaaaaacac ctgtcaaaat 480
tttatggaat atttttgcat ttcactagca ttcgttgatc ttttactttt ggtaaacatt 540
tccattatat tgtatttcag ggattttgta cttttaagca ttaggttcac taaataccac 600
atctgcctat ttactcaaat tatttccttt acttatggct ttttgcatta tccagttttc 660
ctgacagctt gtatagatta ttgcctgaat ttctctaaaa caaccaagct ttcatttaag 720
tgtcaaaaat tattttattt ctttacagta attttaattt ggatttcagt ccttgcttat 780
gttttgggag acccagccat ctaccaaagc ctgaaggcac agaatgctta ttctcgtcac 840
tgtcctttct atgtcagcat tcagagttac tggctgtcat ttttcatggt gatgatttta 900
tttgtagctt tcataacctg ttgggaagaa gttactactt tggtacaggc tatcaggata 960
acttcctata tgaatgaaac tatcttatat tttccttttt catcccactc cagttatact 1020
gtgagatcta aaaaaatatt cttatccaag ctcattgtct gttttctcag tacctggtta 1080
ccatttgtac tacttcaggt aatcattgtt ttacttaaag ttcagattcc agcatatatt 1140
gagatgaata ttccctggtt atactttgtc aatagttttc tcattgctac agtgtattgg 1200
tttaattgtc acaagcttaa tttaaaagac attggattac ctttggatcc atttgtcaac 1260
tggaagtgct gcttcattcc acttacaatt cctaatcttg agcaaattga aaagcctata 1320
tcaataatga tttgttaata ttattaatta aaagttacag ctgtcataag atcataattt 1380
tatgaacaga aagaactcag gacatattaa aaaataaact gaactaaaac aacttttgcc 1440
ccctgactga tagcatttca gaatgtgtct tttgaagggc tataccagtt attaaatagt 1500
gttttatttt aaaaacaaaa taattccaag aagtttttat agttattcag ggacactata 1560
ttacaaatat tactttgtta ttaacacaaa aagtgataag agttaacatt tggctatact 1620
gatgtttgtg ttactcaaaa aaactactgg atgcaaactg ttatgtaaat ctgagatttc 1680
actgacaact ttaagatatc aacctaaaca tttttattaa atgttcaaat gtaagcaaga 1740
aaaaaaaaa 1749
<210> 125
<211> 2285
<212> DNA
<213>Homo sapiens
<400> 125
acccgccccc atctgcccaa gataatttta gtttccttgg gcctggaatc tggacacaca 60
gggctccccc ccgcctctga cttctctgtc cgaagtcggg acaccctcct accacctgta 120
gagaagcggg agtggatctg aaataaaatc caggaatctg ggggttccta gacggagcca 180
gacttcggaa cgggtgtcct gctactcctg ctggggctcc tccaggacaa gggcacacaa 240
ctggttccgt taagcccctc tctcgctcag acgccatgga gctggatctg tctccacctc 300
atcttagcag ctctccggaa gacctttgcc cagcccctgg gacccctcct gggactcccc 360
ggccccctga tacccctctg cctgaggagg taaagaggtc ccagcctctc ctcatcccaa 420
ccaccggcag gaaacttcga gaggaggaga ggcgtgccac ctccctcccc tctatcccca 480
accccttccc tgagctctgc agtcctccct cacagagccc aattctcggg ggcccctcca 540
gtgcaagggg gctgctcccc cgcgatgcca gccgccccca tgtagtaaag gtgtacagtg 600
aggatggggc ctgcaggtct gtggaggtgg cagcaggtgc cacagctcgc cacgtgtgtg 660
aaatgctggt gcagcgagct cacgccttga gcgacgagac ctgggggctg gtggagtgcc 720
acccccacct agcactggag cggggtttgg aggaccacga gtccgtggtg gaagtgcagg 780
ctgcctggcc cgtgggcgga gatagccgct tcgtcttccg gaaaaacttc gccaagtacg 840
aactgttcaa gagctcccca cactccctgt tcccagaaaa aatggtctcc agctgtctcg 900
atgcacacac tggtatatcc catgaagacc tcatccagaa cttcctgaat gctggcagct 960
ttcctgagat ccagggcttt ctgcagctgc ggggttcagg acggaagctt tggaaacgct 1020
ttttctgctt cttgcgccga tctggcctct attactccac caagggcacc tctaaggatc 1080
cgaggcacct gcagtacgtg gcagatgtga acgagtccaa cgtgtacgtg gtgacgcagg 1140
gccgcaagct ctacgggatg cccactgact tcggtttctg tgtcaagccc aacaagcttc 1200
gaaatggcca caaggggctt cggatcttct gcagtgaaga tgagcagagc cgcacctgct 1260
ggctggctgc cttccgcctc ttcaagtacg gggtgcagct gtacaagaat taccagcagg 1320
cacagtctcg ccatctgcat ccatcttgtt tgggctcccc acccttgaga agtgcctcag 1380
ataataccct ggtggccatg gacttctctg gccatgctgg gcgtgtcatt gagaaccccc 1440
gggaggctct gagtgtggcc ctggaggagg cccaggcctg gaggaagaag acaaaccacc 1500
gcctcagcct gcccatgcca gcctccggca cgagcctcag tgcagccatc caccgcaccc 1560
aactctggtt ccacgggcgc atttcccgtg aggagagcca gcggcttatt ggacagcagg 1620
gcttggtaga cggcctgttc ctggtccggg agagtcagcg gaacccccag ggctttgtcc 1680
tctctttgtg ccacctgcag aaagtgaagc attatctcat cctgccgagc gaggaggagg 1740
gccgcctgta cttcagcatg gatgatggcc agacccgctt cactgacctg ctgcagctcg 1800
tggagttcca ccagctgaac cgcggcatcc tgccgtgctt gctgcgccat tgctgcacgc 1860
gggtggccct ctgaccaggc cgtggactgg ctcatgcctc agcccgcctt caggctgccc 1920
gccgcccctc cacccatcca gtggactctg gggcgcggcc acaggggacg ggatgaggag 1980
cgggagggtt ccgccactcc agttttctcc tctgcttctt tgcctccctc agatagaaaa 2040
cagcccccac tccagtccac tcctgacccc tctcctcaag ggaaggcctt gggtggcccc 2100
ctctccttct cctagctctg gaggtgctgc tctagggcag ggaattatgg gagaagtggg 2160
ggcagcccag gcggtttcac gccccacact ttgtacagac cgagaggcca gttgatctgc 2220
tctgttttat actagtgaca ataaagatta ttttttgata caaaaaaaaa aaaaaaaaaa 2280
aaaaa 2285
<210> 126
<211> 935
<212> DNA
<213>Homo sapiens
<400> 126
agtcagaggt cgcgcaggcg ctggtacccc gttggtccgc gcgttgctgc gttgtgaggg 60
gtgtcagctc agtgcatccc aggcagctct tagtgtggag cagtgaactg tgtgtggttc 120
cttctacttg gggatcatgc agagagcttc acgtctgaag agagagctgc acatgttagc 180
cacagagcca cccccaggca tcacatgttg gcaagataaa gaccaaatgg atgacctgcg 240
agctcaaata ttaggtggag ccaacacacc ttatgagaaa ggtgttttta agctagaagt 300
tatcattcct gagaggtacc catttgaacc tcctcagatc cgatttctca ctccaattta 360
tcatccaaac attgattctg ctggaaggat ttgtctggat gttctcaaat tgccaccaaa 420
aggtgcttgg agaccatccc tcaacatcgc aactgtgttg acctctattc agctgctcat 480
gtcagaaccc aaccctgatg acccgctcat ggctgacata tcctcagaat ttaaatataa 540
taagccagcc ttcctcaaga atgccagaca gtggacagag aagcatgcaa gacagaaaca 600
aaaggctgat gaggaagaga tgcttgataa tctaccagag gctggtgact ccagagtaca 660
caactcaaca cagaaaagga aggccagtca gctagtaggc atagaaaaga aatttcatcc 720
tgatgtttag gggacttgtc ctggttcatc ttagttaatg tgttctttgc caaggtgatc 780
taagttgcct accttgaatt tttttttaaa tatatttgat gacataattt ttgtgtagtt 840
tatttatctt gtacatatgt attttgaaat cttttaaacc tgaaaaataa atagtcattt 900
aatgttgaaa aaaaaaaaaa aaaaaaaaaa aaaaa 935
<210> 127
<211> 2896
<212> DNA
<213>Homo sapiens
<400> 127
acgcttgcgc gcgggattta aactgcggcg gtttacgcgg cgttaagact tcgtagggtt 60
agcgaaattg aggtttcttg gtattgcgcg tttctcttcc ttgctgactc tccgaatggc 120
catggactcg tcgcttcagg cccgcctgtt tcccggtctc gctatcaaga tccaacgcag 180
taatggttta attcacagtg ccaatgtaag gactgtgaac ttggagaaat cctgtgtttc 240
agtggaatgg gcagaaggag gtgccacaaa gggcaaagag attgattttg atgatgtggc 300
tgcaataaac ccagaactct tacagcttct tcccttacat ccgaaggaca atctgccctt 360
gcaggaaaat gtaacaatcc agaaacaaaa acggagatcc gtcaactcca aaattcctgc 420
tccaaaagaa agtcttcgaa gccgctccac tcgcatgtcc actgtctcag agcttcgcat 480
cacggctcag gagaatgaca tggaggtgga gctgcctgca gctgcaaact cccgcaagca 540
gttttcagtt cctcctgccc ccactaggcc ttcctgccct gcagtggctg aaataccatt 600
gaggatggtc agcgaggaga tggaagagca agtccattcc atccgaggca gctcttctgc 660
aaaccctgtg aactcagttc ggaggaaatc atgtcttgtg aaggaagtgg aaaaaatgaa 720
gaacaagcga gaagagaaga aggcccagaa ctctgaaatg agaatgaaga gagctcagga 780
gtatgacagt agttttccaa actgggaatt tgcccgaatg attaaagaat ttcgggctac 840
tttggaatgt catccactta ctatgactga tcctatcgaa gagcacagaa tatgtgtctg 900
tgttaggaaa cgcccactga ataagcaaga attggccaag aaagaaattg atgtgatttc 960
cattcctagc aagtgtctcc tcttggtaca tgaacccaag ttgaaagtgg acttaacaaa 1020
gtatctggag aaccaagcat tctgctttga ctttgcattt gatgaaacag cttcgaatga 1080
agttgtctac aggttcacag caaggccact ggtacagaca atctttgaag gtggaaaagc 1140
aacttgtttt gcatatggcc agacaggaag tggcaagaca catactatgg gcggagacct 1200
ctctgggaaa gcccagaatg catccaaagg gatctatgcc atggcctccc gggacgtctt 1260
cctcctgaag aatcaaccct gctaccggaa gttgggcctg gaagtctatg tgacattctt 1320
cgagatctac aatgggaagc tgtttgacct gctcaacaag aaggccaagc tgcgcgtgct 1380
ggaggacggc aagcaacagg tgcaagtggt ggggctgcag gagcatctgg ttaactctgc 1440
tgatgatgtc atcaagatga tcgacatggg cagcgcctgc agaacctctg ggcagacatt 1500
tgccaactcc aattcctccc gctcccacgc gtgcttccaa attattcttc gagctaaagg 1560
gagaatgcat ggcaagttct ctttggtaga tctggcaggg aatgagcgag gcgcggacac 1620
ttccagtgct gaccggcaga cccgcatgga gggcgcagaa atcaacaaga gtctcttagc 1680
cctgaaggag tgcatcaggg ccctgggaca gaacaaggct cacaccccgt tccgtgagag 1740
caagctgaca caggtgctga gggactcctt cattggggag aactctagga cttgcatgat 1800
tgccacgatc tcaccaggca taagctcctg tgaatatact ttaaacaccc tgagatatgc 1860
agacagggtc aaggagctga gcccccacag tgggcccagt ggagagcagt tgattcaaat 1920
ggaaacagaa gagatggaag cctgctctaa cggggcgctg attccaggca atttatccaa 1980
ggaagaggag gaactgtctt cccagatgtc cagctttaac gaagccatga ctcagatcag 2040
ggagctggag gagaaggcta tggaagagct caaggagatc atacagcaag gaccagactg 2100
gcttgagctc tctgagatga ccgagcagcc agactatgac ctggagacct ttgtgaacaa 2160
agcggaatct gctctggccc agcaagccaa gcatttctca gccctgcgag atgtcatcaa 2220
ggccttgcgc ctggccatgc agctggaaga gcaggctagc agacaaataa gcagcaagaa 2280
acggccccag tgacgactgc aaataaaaat ctgtttggtt tgacacccag cctcttccct 2340
ggccctcccc agagaacttt gggtacctgg tgggtctagg cagggtctga gctgggacag 2400
gttctggtaa atgccaagta tgggggcatc tgggcccagg gcagctgggg agggggtcag 2460
agtgacatgg gacactcctt ttctgttcct cagttgtcgc cctcacgaga ggaaggagct 2520
cttagttacc cttttgtgtt gcccttcttt ccatcaaggg gaatgttctc agcatagagc 2580
tttctccgca gcatcctgcc tgcgtggact ggctgctaat ggagagctcc ctggggttgt 2640
cctggctctg gggagagaga cggagccttt agtacagcta tctgctggct ctaaaccttc 2700
tacgcctttg ggccgagcac tgaatgtctt gtactttaaa aaaatgtttc tgagacctct 2760
ttctacttta ctgtctccct agagatccta gaggatccct actgttttct gttttatgtg 2820
tttatacatt gtatgtaaca ataaagagaa aaaataaatc agctgtttaa gtgtgtggaa 2880
aaaaaaaaaa aaaaaa 2896
<210> 128
<211> 2209
<212> DNA
<213>Homo sapiens
<400> 128
actgcgcgcg tcgtgcgtaa tgacgtcagc gccggcggag aatttcaaat tcgaacggct 60
ttggcgggcc gaggaaggac ctggtgtttt gatgaccgct gtcctgtcta gcagatactt 120
gcacggttta cagaaattcg gtccctgggt cgtgtcagga aactggaaaa aaggtcataa 180
gcatgaagcg cagttcagtt tccagcggtg gtgctggccg cctctccatg caggagttaa 240
gatcccagga tgtaaataaa caaggcctct atacccctca aaccaaagag aaaccaacct 300
ttggaaagtt gagtataaac aaaccgacat ctgaaagaaa agtctcgcta tttggcaaaa 360
gaactagtgg acatggatcc cggaatagtc aacttggtat attttccagt tctgagaaaa 420
tcaaggaccc gagaccactt aatgacaaag cattcattca gcagtgtatt cgacaactct 480
gtgagtttct tacagaaaat ggttatgcac ataatgtgtc catgaaatct ctacaagctc 540
cctctgttaa agacttcctg aagatcttca catttcttta tggcttcctg tgcccctcat 600
acgaacttcc tgacacaaag tttgaagaag aggttccaag aatctttaaa gaccttgggt 660
atccttttgc actatccaaa agctccatgt acacagtggg ggctcctcat acatggcctc 720
acattgtggc agccttagtt tggctaatag actgcatcaa gatacatact gccatgaaag 780
aaagctcacc tttatttgat gatgggcagc cttggggaga agaaactgaa gatggaatta 840
tgcataataa gttgtttttg gactacacca taaaatgcta tgagagtttt atgagtggtg 900
ccgacagctt tgatgagatg aatgcagagc tgcagtcaaa actgaaggat ttatttaatg 960
tggatgcttt taagctggaa tcattagaag caaaaaacag agcattgaat gaacagattg 1020
caagattgga acaagaaaga gaaaaagaac cgaatcgtct agagtcgttg agaaaactga 1080
aggcttcctt acaaggagat gttcaaaagt atcaggcata catgagcaat ttggagtctc 1140
attcagccat tcttgaccag aaattaaatg gtctcaatga ggaaattgct agagtagaac 1200
tagaatgtga aacaataaaa caggagaaca ctcgactaca gaatatcatt gacaaccaga 1260
agtactcagt tgcagacatt gagcgaataa atcatgaaag aaatgaattg cagcagacta 1320
ttaataaatt aaccaaggac ctggaagctg aacaacagaa gttgtggaat gaggagttaa 1380
aatatgccag aggcaaagaa gcgattgaaa cacaattagc agagtatcac aaattggcta 1440
gaaaattaaa acttattcct aaaggtgctg agaattccaa aggttatgac tttgaaatta 1500
agtttaatcc cgaggctggt gccaactgcc ttgtcaaata cagggctcaa gtttatgtac 1560
ctcttaagga actcctgaat gaaactgaag aagaaattaa taaagcccta aataaaaaaa 1620
tgggtttgga ggatacttta gaacaattga atgcaatgat aacagaaagc aagagaagtg 1680
tgagaactct gaaagaagaa gttcaaaagc tggatgatct ttaccaacaa aaaattaagg 1740
aagcagagga agaggatgaa aaatgtgcca gtgagcttga gtccttggag aaacacaagc 1800
acctgctaga aagtactgtt aaccaggggc tcagtgaagc tatgaatgaa ttagatgctg 1860
ttcagcggga ataccaacta gttgtgcaaa ccacgactga agaaagacga aaagtgggaa 1920
ataacttgca acgtctgtta gagatggttg ctacacatgt tgggtctgta gagaaacatc 1980
ttgaggagca gattgctaaa gttgatagag aatatgaaga atgcatgtca gaagatctct 2040
cggaaaatat taaagagatt agagataagt atgagaagaa agctactcta attaagtctt 2100
ctgaagaatg aagataaaat gttgatcatg tatatatatc catagtgaat aaaattgtct 2160
cagtaaagtg taaaaaaaaa aaaaaaaaaa aaaaaaaaaa aaaaaaaaa 2209
<210> 129
<211> 1740
<212> DNA
<213>Homo sapiens
<400> 129
ctccctcctc tgcaccatga ctacctgcag ccgccagttc acctcctcca gctccatgaa 60
gggctcctgc ggcatcgggg gcggcatcgg gggcggctcc agccgcatct cctccgtcct 120
ggccggaggg tcctgccgcg cccccagcac ctacgggggc ggcctgtctg tctcatcctc 180
ccgcttctcc tctgggggag cctatgggtt ggggggcggc tatggcggtg gcttcagcag 240
cagcagcagc agctttggta gtggctttgg gggaggatat ggtggtggcc ttggtgctgg 300
cttgggtggt ggctttggtg gtggctttgc tggtggtgat gggcttctgg tgggcagtga 360
gaaggtgacc atgcagaacc tcaacgaccg cctggcctcc tacctggaca aggtgcgtgc 420
tctggaggag gccaacgccg acctggaagt gaagatccgt gactggtacc agaggcagcg 480
gcctgctgag atcaaagact acagtcccta cttcaagacc attgaggacc tgaggaacaa 540
gattctcaca gccacagtgg acaatgccaa tgtccttctg cagattgaca atgcccgtct 600
ggccgcggat gacttccgca ccaagtatga gacagagttg aacctgcgca tgagtgtgga 660
agccgacatc aatggcctgc gcagggtgct ggacgaactg accctggcca gagctgacct 720
ggagatgcag attgagagcc tgaaggagga gctggcctac ctgaagaaga accacgagga 780
ggagatgaat gccctgagag gccaggtggg tggagatgtc aatgtggaga tggacgctgc 840
acctggcgtg gacctgagcc gcattctgaa cgagatgcgt gaccagtatg agaagatggc 900
agagaagaac cgcaaggatg ccgaggaatg gttcttcacc aagacagagg agctgaaccg 960
cgaggtggcc accaacagcg agctggtgca gagcggcaag agcgagatct cggagctccg 1020
gcgcaccatg cagaacctgg agattgagct gcagtcccag ctcagcatga aagcatccct 1080
ggagaacagc ctggaggaga ccaaaggtcg ctactgcatg cagctggccc agatccagga 1140
gatgattggc agcgtggagg agcagctggc ccagctccgc tgcgagatgg agcagcagaa 1200
ccaggagtac aagatcctgc tggacgtgaa gacgcggctg gagcaggaga tcgccaccta 1260
ccgccgcctg ctggagggcg aggacgccca cctctcctcc tcccagttct cctctggatc 1320
gcagtcatcc agagatgtga cctcctccag ccgccaaatc cgcaccaagg tcatggatgt 1380
gcacgatggc aaggtggtgt ccacccacga gcaggtcctt cgcaccaaga actgaggctg 1440
cccagccccg ctcaggccta ggaggccccc cgtgtggaca cagatcccac tggaagatcc 1500
cctctcctgc ccaagcactt cacagctgga ccctgcttca ccctcacccc ctcctggcaa 1560
tcaatacagc ttcattatct gagttgcata aaaaaaaaaa aaaaaaaaaa aaaaaaaaaa 1620
aaaaaaaaaa aaaaaaaaaa aaaaaaaaaa aaaaaaaaaa aaaaaaaaaa aaaaaaaaaa 1680
aaaaaaaaaa aaaaaaaaaa aaaaaaaaaa aaaaaaaaaa aaaaaaaaaa aaaaaaaaaa 1740
<210> 130
<211> 2895
<212> DNA
<213>Homo sapiens
<400> 130
ctcttttgca ggggccgttc ctcggggcat gacgctggct cctgcacaga tcctgctcct 60
ctgtggcctt cctgggctgc cctcccctcc tccgggactg ctctggactg acactgctca 120
ggttcggatt ccctcaaaga ctttgggaga caagacttgg tccccctttt acaaacaagg 180
gaacggaggc tctagaactg acttcctgaa aggcttggat ccaaagctcc ctcagttcag 240
cggccacgtc tatttccctc agacacaggg atccttgaac ctgtgggctg tatctccccg 300
cggacttgga agaatcccaa gagagtgggg ctcccacagg ctggagtgca atggtgtgat 360
ctcggctcac tgcaacctcc acctcccagg ttcaagctat tctcctgcct cagcctcctg 420
agtagctggg attacagatc ctggtggctg tggtcggtaa ttccagcttc gtgctggcta 480
caggtggatg atgcccacct ggctgccgat gacctctgca ccaagtgagg ctgggtctct 540
ggagctgccc caggggctgg acaagctgac cctggccggg gccaacctgg agatgcagat 600
tgagaacctc aaggaggacc tggtctacct gaagaagaac cacaagcagg aaatgaacgt 660
cctttgaggt caggtggatg aggatgtcag tgtgaagatg gacactgtgc ctggagtgaa 720
cctgagctgc atcctgaatg agatgcgtga ccaggacaag acattggtgg agaagagctg 780
caaggatgcc gagggctggt tcttcagcat ggtgggtggc cgtgcgtaag caggtgtgta 840
cacgtgtggg cacatgtgct gcatgctggt gcagctggag cactggcaga tccacaggct 900
gtcccagttg gaaggacttt tggaaaccag ttggaccagc ccctcatgtt ttagatgtaa 960
aacgtgaggc tcagagagga ctcaagctca cacagccctt cactgtggcc tgcaaaatag 1020
atccaggtct ctacaagtct ggtcttgggt ttccaccaca gctgtttaca ggatgtgcgt 1080
atttgaatac atatgtatac ccttggcaag cacaggctga gtatctccgg tatcctaggg 1140
acagcaacag gcgcaaaaga ataacaccca gtgcctgtct ttgaggtgct gcagttcagt 1200
aggaaaaaga aatgcaaatg accgcagagc aggctgaatt cctccaagtt ccaatgtggg 1260
tgcagaggct ctctgtgtgc agaaagaggg gctgaactgc gaggtggcca ccaacacaga 1320
ggccctgcag agtggctgga tagagatatg gagctctacg tctctgtgca gaacctgagc 1380
cgtcccagct cagcaagaaa gcatcgctgg agggcagcct ggtggagatg gaggtgtgtt 1440
acaggaccct gccggcccag ctgcaggggc ttaacagaag catggagcag cagctgtgcg 1500
agctctgctg cgacacggag caccaggacc acaagcacag gtccttctgg acgtgaagac 1560
gtggctggag caggagatcg ccacctaccg ccgcttgctg gaggttgagg acgcccagag 1620
gtgatactga cgatgcaggc tggagtctgg ctgaggagcc ttgaatgcca agttaaagcg 1680
tctggactag atcacgtagg caatggggag ccatggaggg atttggagca ggagagtgaa 1740
atgaacatca agagatttta gaacattcac tctggctgca gagggagaaa tggatcagag 1800
gggtcagggc ggggccagag agatgtgtca gggggctgga gcagggagtc tggccagaga 1860
agtcccgtgc ggtggtgggt agtggggcag gggaaggaag gtggtgcacg cagaagagag 1920
gttatagctc aaaacagcgg gactggatgc ctggatctcg gggtaagcat ggctcacagt 1980
caggactcag taagtgtcgg gagaacacat gaaggagcag gcattgatgg ccctgggttt 2040
ctggttctga tgactgtgtg agtggtgaag agcaaggtgg gtggtggttg ggtttgcagt 2100
tgggaagggt gatcaggcct tcagctgaga gtgtcccgga gtctccatgc ttagtcacac 2160
gttgcagctt tttgctcccc ggaaatggtg aagtccatct atagtctaac aacagtctct 2220
cctgctttaa ttgggtctat ttgttgggcc ctctgggtta tggaaaaacc acttgctcag 2280
cttctccttg taaattcctg gtgagtagcc acagagtgcc gccagaccta ctgctgtgct 2340
gtttcttttt cttcttcctg ctgtgctgaa cccctgccct ttcattcttg ggcctgcgct 2400
aatttctgtg cattcccaac tgtgattttt caccaattta ggggaacctc ctctgccagg 2460
gcctacttct ccccagcagt gcttgcaggt gcctgggctg gctggcatcc ctgggctgat 2520
gggtgcttct ctccctgcag gctggccact cagtactcct tgtccctggc ctcgcagccc 2580
acccgggaag ccacagtgac cagccaccag gtgtgccatc gtggaggaag tccaggttgg 2640
agaggtggtc ttcttctgtg agcaggtcca cttctccacc cactgagacc cctttctgtc 2700
tgcgacagcc ccacctcgag ggccacggca cagccatcag ctccagctcc cagcatgcta 2760
ctgccacgcc ccgagtgtcc gtctgggccc cggtgcatgg cctgttgtct ttctgtatct 2820
actttctgca gcccctcact gaggaggcct cctgggtttg tccagtgcct actattaaag 2880
ctttgctcca agttc 2895
<210> 131
<211> 2529
<212> DNA
<213>Homo sapiens
<400> 131
gcatcctttt tgggctgctc acagccccca gcctctatgg tgaagacata cttgctagca 60
gcgtcaccaa cttgctgcca agagatcagt gctgcaaggc aaggttattt ctaactgagc 120
agagcctgcc aggaagaaag cgtttgcacc ccacaccact gtgcaggtgt gaccggtgag 180
ctcacagctg ccccccaggc atgcccagcc cacttaatca ttcacagctc gacagctctc 240
tcgcccagcc cagttctgga agggataaaa agggggcatc accgttcctg ggtaacagag 300
ccaccttctg cgtcctgctg agctctgttc tctccagcac ctcccaaccc actagtgcct 360
ggttctcttg ctccaccagg aacaagccac catgtctcgc cagtcaagtg tgtccttccg 420
gagcgggggc agtcgtagct tcagcaccgc ctctgccatc accccgtctg tctcccgcac 480
cagcttcacc tccgtgtccc ggtccggggg tggcggtggt ggtggcttcg gcagggtcag 540
ccttgcgggt gcttgtggag tgggtggcta tggcagccgg agcctctaca acctgggggg 600
ctccaagagg atatccatca gcactagagg aggcagcttc aggaaccggt ttggtgctgg 660
tgctggaggc ggctatggct ttggaggtgg tgccggtagt ggatttggtt tcggcggtgg 720
agctggtggt ggctttgggc tcggtggcgg agctggcttt ggaggtggct tcggtggccc 780
tggctttcct gtctgccctc ctggaggtat ccaagaggtc actgtcaacc agagtctcct 840
gactcccctc aacctgcaaa tcgaccccag catccagagg gtgaggaccg aggagcgcga 900
gcagatcaag accctcaaca ataagtttgc ctccttcatc gacaaggtgc ggttcctgga 960
gcagcagaac aaggttctgg acaccaagtg gaccctgctg caggagcagg gcaccaagac 1020
tgtgaggcag aacctggagc cgttgttcga gcagtacatc aacaacctca ggaggcagct 1080
ggacagcatc gtgggggaac ggggccgcct ggactcagag ctgagaaaca tgcaggacct 1140
ggtggaagac ttcaagaaca agtatgagga tgaaatcaac aagcgtacca ctgctgagaa 1200
tgagtttgtg atgctgaaga aggatgtaga tgctgcctac atgaacaagg tggagctgga 1260
ggccaaggtt gatgcactga tggatgagat taacttcatg aagatgttct ttgatgcgga 1320
gctgtcccag atgcagacgc atgtctctga cacctcagtg gtcctctcca tggacaacaa 1380
ccgcaacctg gacctggata gcatcatcgc tgaggtcaag gcccagtatg aggagattgc 1440
caaccgcagc cggacagaag ccgagtcctg gtatcagacc aagtatgagg agctgcagca 1500
gacagctggc cggcatggcg atgacctccg caacaccaag catgagatca cagagatgaa 1560
ccggatgatc cagaggctga gagccgagat tgacaatgtc aagaaacagt gcgccaatct 1620
gcagaacgcc attgcggatg ccgagcagcg tggggagctg gccctcaagg atgccaggaa 1680
caagctggcc gagctggagg aggccctgca gaaggccaag caggacatgg cccggctgct 1740
gcgtgagtac caggagctca tgaacaccaa gctggccctg gacgtggaga tcgccactta 1800
ccgcaagctg ctggagggcg aggaatgcag actcagtgga gaaggagttg gaccagtcaa 1860
catctctgtt gtcacaagca gtgtttcctc tggatatggc agtggcagtg gctatggcgg 1920
tggcctcggt ggaggtcttg gcggcggcct cggtggaggt cttgccggag gtagcagtgg 1980
aagctactac tccagcagca gtgggggtgt cggcctaggt ggtgggctca gtgtgggggg 2040
ctctggcttc agtgcaagca gtggccgagg gctgggggtg ggctttggca gtggcggggg 2100
tagcagctcc agcgtcaaat ttgtctccac cacctcctcc tcccggaaga gcttcaagag 2160
ctaagaacct gctgcaagtc actgccttcc aagtgcagca acccagccca tggagattgc 2220
ctcttctagg cagttgctca agccatgttt tatccttttc tggagagtag tctagaccaa 2280
gccaattgca gaaccacatt ctttggttcc caggagagcc ccattcccag cccctggtct 2340
cccgtgccgc agttctatat tctgcttcaa atcagccttc aggtttccca cagcatggcc 2400
cctgctgaca cgagaaccca aagttttccc aaatctaaat catcaaaaca gaatccccac 2460
cccaatccca aattttgttt tggttctaac tacctccaga atgtgttcaa taaaatgctt 2520
ttataatat 2529
<210> 132
<211> 6816
<212> DNA
<213>Homo sapiens
<400> 132
ggacggccga gcggcagggc gctcgcgcgc gcccactagt ggccggagga gaaggctccc 60
gcggaggccg cgctgcccgc cccctcccct ggggaggctc gcgttcccgc tgctcgcgcc 120
tgcgccgccc gccggcctca ggaacgcgcc ctcttcgccg gcgcgcgccc tcgcagtcac 180
cgccacccac cagctccggc accaacagca gcgccgctgc caccgcccac cttctgccgc 240
cgccaccaca gccaccttct cctcctccgc tgtcctctcc cgtcctcgcc tctgtcgact 300
atcaggtgaa ctttgaacca ggatggctga gccccgccag gagttcgaag tgatggaaga 360
tcacgctggg acgtacgggt tgggggacag gaaagatcag gggggctaca ccatgcacca 420
agaccaagag ggtgacacgg acgctggcct gaaagaatct cccctgcaga cccccactga 480
ggacggatct gaggaaccgg gctctgaaac ctctgatgct aagagcactc caacagcgga 540
agatgtgaca gcacccttag tggatgaggg agctcccggc aagcaggctg ccgcgcagcc 600
ccacacggag atcccagaag gaaccacagc tgaagaagca ggcattggag acacccccag 660
cctggaagac gaagctgctg gtcacgtgac ccaagagcct gaaagtggta aggtggtcca 720
ggaaggcttc ctccgagagc caggcccccc aggtctgagc caccagctca tgtccggcat 780
gcctggggct cccctcctgc ctgagggccc cagagaggcc acacgccaac cttcggggac 840
aggacctgag gacacagagg gcggccgcca cgcccctgag ctgctcaagc accagcttct 900
aggagacctg caccaggagg ggccgccgct gaagggggca gggggcaaag agaggccggg 960
gagcaaggag gaggtggatg aagaccgcga cgtcgatgag tcctcccccc aagactcccc 1020
tccctccaag gcctccccag cccaagatgg gcggcctccc cagacagccg ccagagaagc 1080
caccagcatc ccaggcttcc cagcggaggg tgccatcccc ctccctgtgg atttcctctc 1140
caaagtttcc acagagatcc cagcctcaga gcccgacggg cccagtgtag ggcgggccaa 1200
agggcaggat gcccccctgg agttcacgtt tcacgtggaa atcacaccca acgtgcagaa 1260
ggagcaggcg cactcggagg agcatttggg aagggctgca tttccagggg cccctggaga 1320
ggggccagag gcccggggcc cctctttggg agaggacaca aaagaggctg accttccaga 1380
gccctctgaa aagcagcctg ctgctgctcc gcgggggaag cccgtcagcc gggtccctca 1440
actcaaagct cgcatggtca gtaaaagcaa agacgggact ggaagcgatg acaaaaaagc 1500
caagacatcc acacgttcct ctgctaaaac cttgaaaaat aggccttgcc ttagccccaa 1560
acaccccact cctggtagct cagaccctct gatccaaccc tccagccctg ctgtgtgccc 1620
agagccacct tcctctccta aatacgtctc ttctgtcact tcccgaactg gcagttctgg 1680
agcaaaggag atgaaactca agggggctga tggtaaaacg aagatcgcca caccgcgggg 1740
agcagcccct ccaggccaga agggccaggc caacgccacc aggattccag caaaaacccc 1800
gcccgctcca aagacaccac ccagctctgc gactaagcaa gtccagagaa gaccaccccc 1860
tgcagggccc agatctgaga gaggtgaacc tccaaaatca ggggatcgca gcggctacag 1920
cagccccggc tccccaggca ctcccggcag ccgctcccgc accccgtccc ttccaacccc 1980
acccacccgg gagcccaaga aggtggcagt ggtccgtact ccacccaagt cgccgtcttc 2040
cgccaagagc cgcctgcaga cagcccccgt gcccatgcca gacctgaaga atgtcaagtc 2100
caagatcggc tccactgaga acctgaagca ccagccggga ggcgggaagg tgcagataat 2160
taataagaag ctggatctta gcaacgtcca gtccaagtgt ggctcaaagg ataatatcaa 2220
acacgtcccg ggaggcggca gtgtgcaaat agtctacaaa ccagttgacc tgagcaaggt 2280
gacctccaag tgtggctcat taggcaacat ccatcataaa ccaggaggtg gccaggtgga 2340
agtaaaatct gagaagcttg acttcaagga cagagtccag tcgaagattg ggtccctgga 2400
caatatcacc cacgtccctg gcggaggaaa taaaaagatt gaaacccaca agctgacctt 2460
ccgcgagaac gccaaagcca agacagacca cggggcggag atcgtgtaca agtcgccagt 2520
ggtgtctggg gacacgtctc cacggcatct cagcaatgtc tcctccaccg gcagcatcga 2580
catggtagac tcgccccagc tcgccacgct agctgacgag gtgtctgcct ccctggccaa 2640
gcagggtttg tgatcaggcc cctggggcgg tcaataattg tggagaggag agaatgagag 2700
agtgtggaaa aaaaaagaat aatgacccgg cccccgccct ctgcccccag ctgctcctcg 2760
cagttcggtt aattggttaa tcacttaacc tgcttttgtc actcggcttt ggctcgggac 2820
ttcaaaatca gtgatgggag taagagcaaa tttcatcttt ccaaattgat gggtgggcta 2880
gtaataaaat atttaaaaaa aaacattcaa aaacatggcc acatccaaca tttcctcagg 2940
caattccttt tgattctttt ttcttccccc tccatgtaga agagggagaa ggagaggctc 3000
tgaaagctgc ttctggggga tttcaaggga ctgggggtgc caaccacctc tggccctgtt 3060
gtgggggtgt cacagaggca gtggcagcaa caaaggattt gaaacttggt gtgttcgtgg 3120
agccacaggc agacgatgtc aaccttgtgt gagtgtgacg ggggttgggg tggggcggga 3180
ggccacgggg gaggccgagg caggggctgg gcagagggga gaggaagcac aagaagtggg 3240
agtgggagag gaagccacgt gctggagagt agacatcccc ctccttgccg ctgggagagc 3300
caaggcctat gccacctgca gcgtctgagc ggccgcctgt ccttggtggc cgggggtggg 3360
ggcctgctgt gggtcagtgt gccaccctct gcagggcagc ctgtgggaga agggacagcg 3420
ggtaaaaaga gaaggcaagc tggcaggagg gtggcacttc gtggatgacc tccttagaaa 3480
agactgacct tgatgtcttg agagcgctgg cctcttcctc cctccctgca gggtaggggg 3540
cctgagttga ggggcttccc tctgctccac agaaaccctg ttttattgag ttctgaaggt 3600
tggaactgct gccatgattt tggccacttt gcagacctgg gactttaggg ctaaccagtt 3660
ctctttgtaa ggacttgtgc ctcttgggag acgtccaccc gtttccaagc ctgggccact 3720
ggcatctctg gagtgtgtgg gggtctggga ggcaggtccc gagccccctg tccttcccac 3780
ggccactgca gtcaccccgt ctgcgccgct gtgctgttgt ctgccgtgag agcccaatca 3840
ctgcctatac ccctcatcac acgtcacaat gtcccgaatt cccagcctca ccaccccttc 3900
tcagtaatga ccctggttgg ttgcaggagg tacctactcc atactgaggg tgaaattaag 3960
ggaaggcaaa gtccaggcac aagagtggga ccccagcctc tcactctcag ttccactcat 4020
ccaactggga ccctcaccac gaatctcatg atctgattcg gttccctgtc tcctcctccc 4080
gtcacagatg tgagccaggg cactgctcag ctgtgaccct aggtgtttct gccttgttga 4140
catggagaga gccctttccc ctgagaaggc ctggcccctt cctgtgctga gcccacagca 4200
gcaggctggg tgtcttggtt gtcagtggtg gcaccaggat ggaagggcaa ggcacccagg 4260
gcaggcccac agtcccgctg tcccccactt gcaccctagc ttgtagctgc caacctccca 4320
gacagcccag cccgctgctc agctccacat gcatagtatc agccctccac acccgacaaa 4380
ggggaacaca cccccttgga aatggttctt ttcccccagt cccagctgga agccatgctg 4440
tctgttctgc tggagcagct gaacatatac atagatgttg ccctgccctc cccatctgca 4500
ccctgttgag ttgtagttgg atttgtctgt ttatgcttgg attcaccaga gtgactatga 4560
tagtgaaaag aaaaaaaaaa aaaaaaaagg acgcatgtat cttgaaatgc ttgtaaagag 4620
gtttctaacc caccctcacg aggtgtctct cacccccaca ctgggactcg tgtggcctgt 4680
gtggtgccac cctgctgggg cctcccaagt tttgaaaggc tttcctcagc acctgggacc 4740
caacagagac cagcttctag cagctaagga ggccgttcag ctgtgacgaa ggcctgaagc 4800
acaggattag gactgaagcg atgatgtccc cttccctact tccccttggg gctccctgtg 4860
tcagggcaca gactaggtct tgtggctggt ctggcttgcg gcgcgaggat ggttctctct 4920
ggtcatagcc cgaagtctca tggcagtccc aaaggaggct tacaactcct gcatcacaag 4980
aaaaaggaag ccactgccag ctggggggat ctgcagctcc cagaagctcc gtgagcctca 5040
gccacccctc agactgggtt cctctccaag ctcgccctct ggaggggcag cgcagcctcc 5100
caccaagggc cctgcgacca cagcagggat tgggatgaat tgcctgtcct ggatctgctc 5160
tagaggccca agctgcctgc ctgaggaagg atgacttgac aagtcaggag acactgttcc 5220
caaagccttg accagagcac ctcagcccgc tgaccttgca caaactccat ctgctgccat 5280
gagaaaaggg aagccgcctt tgcaaaacat tgctgcctaa agaaactcag cagcctcagg 5340
cccaattctg ccacttctgg tttgggtaca gttaaaggca accctgaggg acttggcagt 5400
agaaatccag ggcctcccct ggggctggca gcttcgtgtg cagctagagc tttacctgaa 5460
aggaagtctc tgggcccaga actctccacc aagagcctcc ctgccgttcg ctgagtccca 5520
gcaattctcc taagttgaag ggatctgaga aggagaagga aatgtggggt agatttggtg 5580
gtggttagag atatgccccc ctcattactg ccaacagttt cggctgcatt tcttcacgca 5640
cctcggttcc tcttcctgaa gttcttgtgc cctgctcttc agcaccatgg gccttcttat 5700
acggaaggct ctgggatctc ccccttgtgg ggcaggctct tggggccagc ctaagatcat 5760
ggtttagggt gatcagtgct ggcagataaa ttgaaaaggc acgctggctt gtgatcttaa 5820
atgaggacaa tccccccagg gctgggcact cctcccctcc cctcacttct cccacctgca 5880
gagccagtgt ccttgggtgg gctagatagg atatactgta tgccggctcc ttcaagctgc 5940
tgactcactt tatcaatagt tccatttaaa ttgacttcag tggtgagact gtatcctgtt 6000
tgctattgct tgttgtgcta tggggggagg ggggaggaat gtgtaagata gttaacatgg 6060
gcaaagggag atcttggggt gcagcactta aactgcctcg taaccctttt catgatttca 6120
accacatttg ctagagggag ggagcagcca cggagttaga ggcccttggg gtttctcttt 6180
tccactgaca ggctttccca ggcagctggc tagttcattc cctccccagc caggtgcagg 6240
cgtaggaata tggacatctg gttgctttgg cctgctgccc tctttcaggg gtcctaagcc 6300
cacaatcatg cctccctaag accttggcat ccttccctct aagccgttgg cacctctgtg 6360
ccacctctca cactggctcc agacacacag cctgtgcttt tggagctgag atcactcgct 6420
tcaccctcct catctttgtt ctccaagtaa agccacgagg tcggggcgag ggcagaggtg 6480
atcacctgcg tgtcccatct acagacctgc agcttcataa aacttctgat ttctcttcag 6540
ctttgaaaag ggttaccctg ggcactggcc tagagcctca cctcctaata gacttagccc 6600
catgagtttg ccatgttgag caggactatt tctggcactt gcaagtccca tgatttcttc 6660
ggtaattctg agggtggggg gagggacatg aaatcatctt agcttagctt tctgtctgtg 6720
aatgtctata tagtgtattg tgtgttttaa caaatgattt acactgactg ttgctgtaaa 6780
agtgaatttg gaaataaagt tattactctg attaaa 6816
<210> 133
<211> 2372
<212> DNA
<213>Homo sapiens
<400> 133
gcaccgcgcg agcttggctg cttctggggc ctgtgtggcc ctgtgtgtcg gaaagatgga 60
gcaagaagcc gagcccgagg ggcggccgcg acccctctga ccgagatcct gctgctttcg 120
cagccaggag caccgtccct ccccggatta gtgcgtacga gcgcccagtg ccctggcccg 180
gagagtggaa tgatccccga ggcccagggc gtcgtgcttc cgcagtagtc agtccccgtg 240
aaggaaactg gggagtcttg agggaccccc gactccaagc gcgaaaaccc cggatggtga 300
ggagcaggca aatgtgcaat accaacatgt ctgtacctac tgatggtgct gtaaccacct 360
cacagattcc agcttcggaa caagagaccc tggttagacc aaagccattg cttttgaagt 420
tattaaagtc tgttggtgca caaaaagaca cttatactat gaaagaggtt cttttttatc 480
ttggccagta tattatgact aaacgattat atgatgagaa gcaacaacat attgtatatt 540
gttcaaatga tcttctagga gatttgtttg gcgtgccaag cttctctgtg aaagagcaca 600
ggaaaatata taccatgatc tacaggaact tggtagtagt caatcagcag gaatcatcgg 660
actcaggtac atctgtgagt gagaacaggt gtcaccttga aggtgggagt gatcaaaagg 720
accttgtaca agagcttcag gaagagaaac cttcatcttc acatttggtt tctagaccat 780
ctacctcatc tagaaggaga gcaattagtg agacagaaga aaattcagat gaattatctg 840
gtgaacgaca aagaaaacgc cacaaatctg atagtatttc cctttccttt gatgaaagcc 900
tggctctgtg tgtaataagg gagatatgtt gtgaaagaag cagtagcagt gaatctacag 960
ggacgccatc gaatccggat cttgatgctg gtgtaagtga acattcaggt gattggttgg 1020
atcaggattc agtttcagat cagtttagtg tagaatttga agttgaatct ctcgactcag 1080
aagattatag ccttagtgaa gaaggacaag aactctcaga tgaagatgat gaggtatatc 1140
aagttactgt gtatcaggca ggggagagtg atacagattc atttgaagaa gatcctgaaa 1200
tttccttagc tgactattgg aaatgcactt catgcaatga aatgaatccc ccccttccat 1260
cacattgcaa cagatgttgg gcccttcgtg agaattggct tcctgaagat aaagggaaag 1320
ataaagggga aatctctgag aaagccaaac tggaaaactc aacacaagct gaagagggct 1380
ttgatgttcc tgattgtaaa aaaactatag tgaatgattc cagagagtca tgtgttgagg 1440
aaaatgatga taaaattaca caagcttcac aatcacaaga aagtgaagac tattctcagc 1500
catcaacttc tagtagcatt atttatagca gccaagaaga tgtgaaagag tttgaaaggg 1560
aagaaaccca agacaaagaa gagagtgtgg aatctagttt gccccttaat gccattgaac 1620
cttgtgtgat ttgtcaaggt cgacctaaaa atggttgcat tgtccatggc aaaacaggac 1680
atcttatggc ctgctttaca tgtgcaaaga agctaaagaa aaggaataag ccctgcccag 1740
tatgtagaca accaattcaa atgattgtgc taacttattt cccctagttg acctgtctat 1800
aagagaatta tatatttcta actatataac cctaggaatt tagacaacct gaaatttatt 1860
cacatatatc aaagtgagaa aatgcctcaa ttcacataga tttcttctct ttagtataat 1920
tgacctactt tggtagtgga atagtgaata cttactataa tttgacttga atatgtagct 1980
catcctttac accaactcct aattttaaat aatttctact ctgtcttaaa tgagaagtac 2040
ttggtttttt ttttcttaaa tatgtatatg acatttaaat gtaacttatt attttttttg 2100
agaccgagtc ttgctctgtt acccaggctg gagtgcagtg ggtgatcttg gctcactgca 2160
agctctgccc tccccgggtt cgcaccattc tcctgcctca gcctcccaat tagcttggcc 2220
tacagtcatc tgccaccaca cctggctaat tttttgtact tttagtagag acagggtttc 2280
accgtgttag ccaggatggt ctcgatctcc tgacctcgtg atccgcccac ctcggcctcc 2340
caaagtgctg ggattacagg catgagccac cg 2372
<210> 134
<211> 2486
<212> DNA
<213>Homo sapiens
<400> 134
gagatttgat tcccttggcg ggcggaagcg gccacaaccc ggcgatcgaa aagattctta 60
ggaacgccgt accagccgcg tctctcagga cagcaggccc ctgtccttct gtcgggcgcc 120
gctcagccgt gccctccgcc cctcaggttc tttttctaat tccaaataaa cttgcaagag 180
gactatgaaa gattatgatg aacttctcaa atattatgaa ttacatgaaa ctattgggac 240
aggtggcttt gcaaaggtca aacttgcctg ccatatcctt actggagaga tggtagctat 300
aaaaatcatg gataaaaaca cactagggag tgatttgccc cggatcaaaa cggagattga 360
ggccttgaag aacctgagac atcagcatat atgtcaactc taccatgtgc tagagacagc 420
caacaaaata ttcatggttc ttgagtactg ccctggagga gagctgtttg actatataat 480
ttcccaggat cgcctgtcag aagaggagac ccgggttgtc ttccgtcaga tagtatctgc 540
tgttgcttat gtgcacagcc agggctatgc tcacagggac ctcaagccag aaaatttgct 600
gtttgatgaa tatcataaat taaagctgat tgactttggt ctctgtgcaa aacccaaggg 660
taacaaggat taccatctac agacatgctg tgggagtctg gcttatgcag cacctgagtt 720
aatacaaggc aaatcatatc ttggatcaga ggcagatgtt tggagcatgg gcatactgtt 780
atatgttctt atgtgtggat ttctaccatt tgatgatgat aatgtaatgg ctttatacaa 840
gaagattatg agaggaaaat atgatgttcc caagtggctc tctcccagta gcattctgct 900
tcttcaacaa atgctgcagg tggacccaaa gaaacggatt tctatgaaaa atctattgaa 960
ccatccctgg atcatgcaag attacaacta tcctgttgag tggcaaagca agaatccttt 1020
tattcacctc gatgatgatt gcgtaacaga actttctgta catcacagaa acaacaggca 1080
aacaatggag gatttaattt cactgtggca gtatgatcac ctcacggcta cctatcttct 1140
gcttctagcc aagaaggctc ggggaaaacc agttcgttta aggctttctt ctttctcctg 1200
tggacaagcc agtgctaccc cattcacaga catcaagtca aataattgga gtctggaaga 1260
tgtgaccgca agtgataaaa attatgtggc gggattaata gactatgatt ggtgtgaaga 1320
tgatttatca acaggtgctg ctactccccg aacatcacag tttaccaagt actggacaga 1380
atcaaatggg gtggaatcta aatcattaac tccagcctta tgcagaacac ctgcaaataa 1440
attaaagaac aaagaaaatg tatatactcc taagtctgct gtaaagaatg aagagtactt 1500
tatgtttcct gagccaaaga ctccagttaa taagaaccag cataagagag aaatactcac 1560
tacgccaaat cgttacacta caccctcaaa agctagaaac cagtgcctga aagaaactcc 1620
aattaaaata ccagtaaatt caacaggaac agacaagtta atgacaggtg tcattagccc 1680
tgagaggcgg tgccgctcag tggaattgga tctcaaccaa gcacatatgg aggagactcc 1740
aaaaagaaag ggagccaaag tgtttgggag ccttgaaagg gggttggata aggttatcac 1800
tgtgctcacc aggagcaaaa ggaagggttc tgccagagac gggcccagaa gactaaagct 1860
tcactataac gtgactacaa ctagattagt gaatccagat caactgttga atgaaataat 1920
gtctattctt ccaaagaagc atgttgactt tgtacaaaag ggttatacac tgaagtgtca 1980
aacacagtca gattttggga aagtgacaat gcaatttgaa ttagaagtgt gccagcttca 2040
aaaacccgat gtggtgggta tcaggaggca gcggcttaag ggcgatgcct gggtttacaa 2100
aagattagtg gaagacatcc tatctagctg caaggtataa ttgatggatt cttccatcct 2160
gccggatgag tgtgggtgtg atacagccta cataaagact gttatgatcg ctttgatttt 2220
aaagttcatt ggaactacca acttgtttct aaagagctat cttaagacca atatctcttt 2280
gtttttaaac aaaagatatt attttgtgta tgaatctaaa tcaagcccat ctgtcattat 2340
gttactgtct tttttaatca tgtggttttg tatattaata attgttgact ttcttagatt 2400
cacttccata tgtgaatgta agctcttaac tatgtctctt tgtaatgtgt aatttctttc 2460
tgaaataaaa ccatttgtga atatag 2486
<210> 135
<211> 1140
<212> DNA
<213>Homo sapiens
<220>
<221>Miscellaneous feature
<222> (1140)..(1140)
<223>N is a, c, g or t
<400> 135
gcagcggagg agcccagtcc acgatggccc ggtccctggt gtgccttggt gtcatcatct 60
tgctgtctgc cttctccgga cctggtgtca ggggtggtcc tatgcccaag ctggctgacc 120
ggaagctgtg tgcggaccag gagtgcagcc accctatctc catggctgtg gcccttcagg 180
actacatggc ccccgactgc cgattcctga ccattcaccg gggccaagtg gtgtatgtct 240
tctccaagct gaagggccgt gggcggctct tctggggagg cagcgttcag ggagattact 300
atggagatct ggctgctcgc ctgggctatt tccccagtag cattgtccga gaggaccaga 360
ccctgaaacc tggcaaagtc gatgtgaaga cagacaaatg ggatttctac tgccagtgag 420
ctcagcctac cgctggccct gccgtttccc ctccttgggt ttatgcaaat acaatcagcc 480
cagtgcaaaa aaaaaaaaaa aaaaaaaaaa cttcggagaa gagatagcaa caaaaggccg 540
cttgtgtgaa ggcgccaaaa gttttcgccc aagagacctt cggcctcccc cagggcgcgc 600
gcaaaggcgc cttgttttga caacctcttg gacaaccgga ggggctaccg cccggagacc 660
cctgtggtgg accccccggg caacccggtg tgacagggta ctcaccccca cggctttgtc 720
gggggtccca ccaaaggccc caaagaggct ctttcaaggc actattcctt gttgtagacc 780
ttgtgtgtgc cacaggcgcc aaagaaacct cggggggcta acaaacgcac gtgcttggca 840
gctccgagaa ggctctctcc cacccgaggg gtggacgcaa cagggggaat gggccatcat 900
attgttgccc ccggtgggca ccaactcttt ttcccccata gagaggcctt agcacactat 960
gtggggcacg ttattgccgc ctagagaaac cgagcgccag aaaatttcga aggggggggc 1020
gcttctcatc attttgcgca aaaccccctt gtgggagtat gccccgaact cctctggaac 1080
acacaagcga cacttgcgcg gggtctgcaa aaaacctcct gttgggaagc cggcttcacn 1140
<210> 136
<211> 12507
<212> DNA
<213>Homo sapiens
<400> 136
taccgggcgg aggtgagcgc ggcgccggct cctcctgcgg cggactttgg gtgcgacttg 60
acgagcggtg gttcgacaag tggccttgcg ggccggatcg tcccagtgga agagttgtaa 120
atttgcttct ggccttcccc tacggattat acctggcctt cccctacgga ttatactcaa 180
cttactgttt agaaaatgtg gcccacgaga cgcctggtta ctatcaaaag gagcggggtc 240
gacggtcccc actttcccct gagcctcagc acctgcttgt ttggaagggg tattgaatgt 300
gacatccgta tccagcttcc tgttgtgtca aaacaacatt gcaaaattga aatccatgag 360
caggaggcaa tattacataa tttcagttcc acaaatccaa cacaagtaaa tgggtctgtt 420
attgatgagc ctgtacggct aaaacatgga gatgtaataa ctattattga tcgttccttc 480
aggtatgaaa atgaaagtct tcagaatgga aggaagtcaa ctgaatttcc aagaaaaata 540
cgtgaacagg agccagcacg tcgtgtctca agatctagct tctcttctga ccctgatgag 600
aaagctcaag attccaaggc ctattcaaaa atcactgaag gaaaagtttc aggaaatcct 660
caggtacata tcaagaatgt caaagaagac agtaccgcag atgactcaaa agacagtgtt 720
gctcagggaa caactaatgt tcattcctca gaacatgctg gacgtaatgg cagaaatgca 780
gctgatccca tttctgggga ttttaaagaa atttccagcg ttaaattagt gagccgttat 840
ggagaattga agtctgttcc cactacacaa tgtcttgaca atagcaaaaa aaatgaatct 900
cccttttgga agctttatga gtcagtgaag aaagagttgg atgtaaaatc acaaaaagaa 960
aatgtcctac agtattgtag aaaatctgga ttacaaactg attacgcaac agagaaagaa 1020
agtgctgatg gtttacaggg ggagacccaa ctgttggtct cgcgtaagtc aagaccaaaa 1080
tctggtggga gcggccacgc tgtggcagag cctgcttcac ctgaacaaga gcttgaccag 1140
aacaagggga agggaagaga cgtggagtct gttcagactc ccagcaaggc tgtgggcgcc 1200
agctttcctc tctatgagcc ggctaaaatg aagacccctg tacaatattc acagcaacaa 1260
aattctccac aaaaacataa gaacaaagac ctgtatacta ctggtagaag agaatctgtg 1320
aatctgggta aaagtgaagg cttcaaggct ggtgataaaa ctcttactcc caggaagctt 1380
tcaactagaa atcgaacacc agctaaagtt gaagatgcag ctgactctgc cactaagcca 1440
gaaaatctct cttccaaaac cagaggaagt attcctacag atgtggaagt tctgcctacg 1500
gaaactgaaa ttcacaatga gccattttta actctgtggc tcactcaagt tgagaggaag 1560
atccaaaagg attccctcag caagcctgag aaattgggca ctacagctgg acagatgtgc 1620
tctgggttac ctggtcttag ttcagttgat atcaacaact ttggtgattc cattaatgag 1680
agtgagggaa tacctttgaa aagaaggcgt gtgtcctttg gtgggcacct aagacctgaa 1740
ctatttgatg aaaacttgcc tcctaatacg cctctcaaaa ggggagaagc cccaaccaaa 1800
agaaagtctc tggtaatgca cactccacct gtcctgaaga aaatcatcaa ggaacagcct 1860
caaccatcag gaaaacaaga gtcaggttca gaaatccatg tggaagtgaa ggcacaaagc 1920
ttggttataa gccctccagc tcctagtcct aggaaaactc cagttgccag tgatcaacgc 1980
cgtaggtcct gcaaaacagc ccctgcttcc agcagcaaat ctcagacaga ggttcctaag 2040
agaggaggga gaaagagtgg caacctgcct tcaaagagag tgtctatcag ccgaagtcaa 2100
catgatattt tacagatgat atgttccaaa agaagaagtg gtgcttcgga agcaaatctg 2160
attgttgcaa aatcatgggc agatgtagta aaacttggtg caaaacaaac acaaactaaa 2220
gtcataaaac atggtcctca aaggtcaatg aacaaaaggc aaagaagacc tgctactcca 2280
aagaagcctg tgggcgaagt tcacagtcaa tttagtacag gccacgcaaa ctctccttgt 2340
accataataa tagggaaagc tcatactgaa aaagtacatg tgcctgctcg accctacaga 2400
gtgctcaaca acttcatttc caaccaaaaa atggacttta aggaagatct ttcaggaata 2460
gctgaaatgt tcaagacccc agtgaaggag caaccgcagt tgacaagcac atgtcacatc 2520
gctatttcaa attcagagaa tttgcttgga aaacagtttc aaggaactga ttcaggagaa 2580
gaacctctgc tccccacctc agagagtttt ggaggaaatg tgttcttcag tgcacagaat 2640
gcagcaaaac agccatctga taaatgctct gcaagccctc ccttaagacg gcagtgtatt 2700
agagaaaatg gaaacgtagc aaaaacgccc aggaacacct acaaaatgac ttctctggag 2760
acaaaaactt cagatactga gacagagcct tcaaaaacag tatccactgc aaacaggtca 2820
ggaaggtcta cagagttcag gaatatacag aagctacctg tggaaagtaa gagtgaagaa 2880
acaaatacag aaattgttga gtgcatccta aaaagaggtc agaaggcaac actactacaa 2940
caaaggagag aaggagagat gaaggaaata gaaagacctt ttgagacata taaggaaaat 3000
attgaattaa aagaaaacga tgaaaagatg aaagcaatga agagatcaag aacttggggg 3060
cagaaatgtg caccaatgtc tgacctgaca gacctcaaga gcttgcctga tacagaactc 3120
atgaaagaca cggcacgtgg ccagaatctc ctccaaaccc aagatcatgc caaggcacca 3180
aagagtgaga aaggcaaaat cactaaaatg ccctgccagt cattacaacc agaaccaata 3240
aacaccccaa cacacacaaa acaacagttg aaggcatccc tggggaaagt aggtgtgaaa 3300
gaagagctcc tagcagtcgg caagttcaca cggacgtcag gggagaccac gcacacgcac 3360
agagagccag caggagatgg caagagcatc agaacgttta aggagtctcc aaagcagatc 3420
ctggacccag cagcccgtgt aactggaatg aagaagtggc caagaacgcc taaggaagag 3480
gcccagtcac tagaagacct ggctggcttc aaagagctct tccagacacc aggtccctct 3540
gaggaatcaa tgactgatga gaaaactacc aaaatagcct gcaaatctcc accaccagaa 3600
tcagtggaca ctccaacaag cacaaagcaa tggcctaaga gaagtctcag gaaagcagat 3660
gtagaggaag aattcttagc actcaggaaa ctaacaccat cagcagggaa agccatgctt 3720
acgcccaaac cagcaggagg tgatgagaaa gacattaaag catttatggg aactccagtg 3780
cagaaactgg acctggcagg aactttacct ggcagcaaaa gacagctaca gactcctaag 3840
gaaaaggccc aggctctaga agacctggct ggctttaaag agctcttcca gactcctggt 3900
cacaccgagg aattagtggc tgctggtaaa accactaaaa taccctgcga ctctccacag 3960
tcagacccag tggacacccc aacaagcaca aagcaacgac ccaagagaag tatcaggaaa 4020
gcagatgtag agggagaact cttagcgtgc aggaatctaa tgccatcagc aggcaaagcc 4080
atgcacacgc ctaaaccatc agtaggtgaa gagaaagaca tcatcatatt tgtgggaact 4140
ccagtgcaga aactggacct gacagagaac ttaaccggca gcaagagacg gccacaaact 4200
cctaaggaag aggcccaggc tctggaagac ctgactggct ttaaagagct cttccagacc 4260
cctggtcata ctgaagaagc agtggctgct ggcaaaacta ctaaaatgcc ctgcgaatct 4320
tctccaccag aatcagcaga caccccaaca agcacaagaa ggcagcccaa gacacctttg 4380
gagaaaaggg acgtacagaa ggagctctca gccctgaaga agctcacaca gacatcaggg 4440
gaaaccacac acacagataa agtaccagga ggtgaggata aaagcatcaa cgcgtttagg 4500
gaaactgcaa aacagaaact ggacccagca gcaagtgtaa ctggtagcaa gaggcaccca 4560
aaaactaagg aaaaggccca acccctagaa gacctggctg gcttgaaaga gctcttccag 4620
acaccagtat gcactgacaa gcccacgact cacgagaaaa ctaccaaaat agcctgcaga 4680
tcacaaccag acccagtgga cacaccaaca agctccaagc cacagtccaa gagaagtctc 4740
aggaaagtgg acgtagaaga agaattcttc gcactcagga aacgaacacc atcagcaggc 4800
aaagccatgc acacacccaa accagcagta agtggtgaga aaaacatcta cgcatttatg 4860
ggaactccag tgcagaaact ggacctgaca gagaacttaa ctggcagcaa gagacggcta 4920
caaactccta aggaaaaggc ccaggctcta gaagacctgg ctggctttaa agagctcttc 4980
cagacacgag gtcacactga ggaatcaatg actaacgata aaactgccaa agtagcctgc 5040
aaatcttcac aaccagaccc agacaaaaac ccagcaagct ccaagcgacg gctcaagaca 5100
tccctgggga aagtgggcgt gaaagaagag ctcctagcag ttggcaagct cacacagaca 5160
tcaggagaga ctacacacac acacacagag ccaacaggag atggtaagag catgaaagca 5220
tttatggagt ctccaaagca gatcttagac tcagcagcaa gtctaactgg cagcaagagg 5280
cagctgagaa ctcctaaggg aaagtctgaa gtccctgaag acctggccgg cttcatcgag 5340
ctcttccaga caccaagtca cactaaggaa tcaatgacta acgaaaaaac taccaaagta 5400
tcctacagag cttcacagcc agacctagtg gacaccccaa caagctccaa gccacagccc 5460
aagagaagtc tcaggaaagc agacactgaa gaagaatttt tagcatttag gaaacaaacg 5520
ccatcagcag gcaaagccat gcacacaccc aaaccagcag taggtgaaga gaaagacatc 5580
aacacgtttt tgggaactcc agtgcagaaa ctggaccagc caggaaattt acctggcagc 5640
aatagacggc tacaaactcg taaggaaaag gcccaggctc tagaagaact gactggcttc 5700
agagagcttt tccagacacc atgcactgat aaccccacga ctgatgagaa aactaccaaa 5760
aaaatactct gcaaatctcc gcaatcagac ccagcggaca ccccaacaaa cacaaagcaa 5820
cggcccaaga gaagcctcaa gaaagcagac gtagaggaag aatttttagc attcaggaaa 5880
ctaacaccat cagcaggcaa agccatgcac acgcctaaag cagcagtagg tgaagagaaa 5940
gacatcaaca catttgtggg gactccagtg gagaaactgg acctgctagg aaatttacct 6000
ggcagcaaga gacggccaca aactcctaaa gaaaaggcca aggctctaga agatctggct 6060
ggcttcaaag agctcttcca gacaccaggt cacactgagg aatcaatgac cgatgacaaa 6120
atcacagaag tatcctgcaa atctccacaa ccagacccag tcaaaacccc aacaagctcc 6180
aagcaacgac tcaagatatc cttggggaaa gtaggtgtga aagaagaggt cctaccagtc 6240
ggcaagctca cacagacgtc agggaagacc acacagacac acagagagac agcaggagat 6300
ggaaagagca tcaaagcgtt taaggaatct gcaaagcaga tgctggaccc agcaaactat 6360
ggaactggga tggagaggtg gccaagaaca cctaaggaag aggcccaatc actagaagac 6420
ctggccggct tcaaagagct cttccagaca ccagaccaca ctgaggaatc aacaactgat 6480
gacaaaacta ccaaaatagc ctgcaaatct ccaccaccag aatcaatgga cactccaaca 6540
agcacaagga ggcggcccaa aacacctttg gggaaaaggg atatagtgga agagctctca 6600
gccctgaagc agctcacaca gaccacacac acagacaaag taccaggaga tgaggataaa 6660
ggcatcaacg tgttcaggga aactgcaaaa cagaaactgg acccagcagc aagtgtaact 6720
ggtagcaaga ggcagccaag aactcctaag ggaaaagccc aacccctaga agacttggct 6780
ggcttgaaag agctcttcca gacaccaata tgcactgaca agcccacgac tcatgagaaa 6840
actaccaaaa tagcctgcag atctccacaa ccagacccag tgggtacccc aacaatcttc 6900
aagccacagt ccaagagaag tctcaggaaa gcagacgtag aggaagaatc cttagcactc 6960
aggaaacgaa caccatcagt agggaaagct atggacacac ccaaaccagc aggaggtgat 7020
gagaaagaca tgaaagcatt tatgggaact ccagtgcaga aattggacct gccaggaaat 7080
ttacctggca gcaaaagatg gccacaaact cctaaggaaa aggcccaggc tctagaagac 7140
ctggctggct tcaaagagct cttccagaca ccaggcactg acaagcccac gactgatgag 7200
aaaactacca aaatagcctg caaatctcca caaccagacc cagtggacac cccagcaagc 7260
acaaagcaac ggcccaagag aaacctcagg aaagcagacg tagaggaaga atttttagca 7320
ctcaggaaac gaacaccatc agcaggcaaa gccatggaca caccaaaacc agcagtaagt 7380
gatgagaaaa atatcaacac atttgtggaa actccagtgc agaaactgga cctgctagga 7440
aatttacctg gcagcaagag acagccacag actcctaagg aaaaggctga ggctctagag 7500
gacctggttg gcttcaaaga actcttccag acaccaggtc acactgagga atcaatgact 7560
gatgacaaaa tcacagaagt atcctgtaaa tctccacagc cagagtcatt caaaacctca 7620
agaagctcca agcaaaggct caagataccc ctggtgaaag tggacatgaa agaagagccc 7680
ctagcagtca gcaagctcac acggacatca ggggagacta cgcaaacaca cacagagcca 7740
acaggagata gtaagagcat caaagcgttt aaggagtctc caaagcagat cctggaccca 7800
gcagcaagtg taactggtag caggaggcag ctgagaactc gtaaggaaaa ggcccgtgct 7860
ctagaagacc tggttgactt caaagagctc ttctcagcac caggtcacac tgaagagtca 7920
atgactattg acaaaaacac aaaaattccc tgcaaatctc ccccaccaga actaacagac 7980
actgccacga gcacaaagag atgccccaag acacgtccca ggaaagaagt aaaagaggag 8040
ctctcagcag ttgagaggct cacgcaaaca tcagggcaaa gcacacacac acacaaagaa 8100
ccagcaagcg gtgatgaggg catcaaagta ttgaagcaac gtgcaaagaa gaaaccaaac 8160
ccagtagaag aggaacccag caggagaagg ccaagagcac ctaaggaaaa ggcccaaccc 8220
ctggaagacc tggccggctt cacagagctc tctgaaacat caggtcacac tcaggaatca 8280
ctgactgctg gcaaagccac taaaataccc tgcgaatctc ccccactaga agtggtagac 8340
accacagcaa gcacaaagag gcatctcagg acacgtgtgc agaaggtaca agtaaaagaa 8400
gagccttcag cagtcaagtt cacacaaaca tcaggggaaa ccacggatgc agacaaagaa 8460
ccagcaggtg aagataaagg catcaaagca ttgaaggaat ctgcaaaaca gacaccggct 8520
ccagcagcaa gtgtaactgg cagcaggaga cggccaagag cacccaggga aagtgcccaa 8580
gccatagaag acctagctgg cttcaaagac ccagcagcag gtcacactga agaatcaatg 8640
actgatgaca aaaccactaa aataccctgc aaatcatcac cagaactaga agacaccgca 8700
acaagctcaa agagacggcc caggacacgt gcccagaaag tagaagtgaa ggaggagctg 8760
ttagcagttg gcaagctcac acaaacctca ggggagacca cgcacaccga caaagagccg 8820
gtaggtgagg gcaaaggcac gaaagcattt aagcaacctg caaagcggaa gctggacgca 8880
gaagatgtaa ttggcagcag gagacagcca agagcaccta aggaaaaggc ccaacccctg 8940
gaagatctgg ccagcttcca agagctctct caaacaccag gccacactga ggaactggca 9000
aatggtgctg ctgatagctt tacaagcgct ccaaagcaaa cacctgacag tggaaaacct 9060
ctaaaaatat ccagaagagt tcttcgggcc cctaaagtag aacccgtggg agacgtggta 9120
agcaccagag accctgtaaa atcacaaagc aaaagcaaca cttccctgcc cccactgccc 9180
ttcaagaggg gaggtggcaa agatggaagc gtcacgggaa ccaagaggct gcgctgcatg 9240
ccagcaccag aggaaattgt ggaggagctg ccagccagca agaagcagag ggttgctccc 9300
agggcaagag gcaaatcatc cgaacccgtg gtcatcatga agagaagttt gaggacttct 9360
gcaaaaagaa ttgaacctgc ggaagagctg aacagcaacg acatgaaaac caacaaagag 9420
gaacacaaat tacaagactc ggtccctgaa aataagggaa tatccctgcg ctccagacgc 9480
caaaataaga ctgaggcaga acagcaaata actgaggtct ttgtattagc agaaagaata 9540
gaaataaaca gaaatgaaaa gaagcccatg aagacctccc cagagatgga cattcagaat 9600
ccagatgatg gagcccggaa acccatacct agagacaaag tcactgagaa caaaaggtgc 9660
ttgaggtctg ctagacagaa tgagagctcc cagcctaagg tggcagagga gagcggaggg 9720
cagaagagtg cgaaggttct catgcagaat cagaaaggga aaggagaagc aggaaattca 9780
gactccatgt gcctgagatc aagaaagaca aaaagccagc ctgcagcaag cactttggag 9840
agcaaatctg tgcagagagt aacgcggagt gtcaagaggt gtgcagaaaa tccaaagaag 9900
gctgaggaca atgtgtgtgt caagaaaata agaaccagaa gtcataggga cagtgaagat 9960
atttgacaga aaaatcgaac tgggaaaaat ataataaagt tagttttgtg ataagttcta 10020
gtgcagtttt tgtcataaat tacaagtgaa ttctgtaagt aaggctgtca gtctgcttaa 10080
gggaagaaaa ctttggattt gctgggtctg aatcggcttc ataaactcca ctgggagcac 10140
tgctgggctc ctggactgag aatagttgaa caccgggggc tttgtgaagg agtctgggcc 10200
aaggtttgcc ctcagctttg cagaatgaag ccttgaggtc tgtcaccacc cacagccacc 10260
ctacagcagc cttaactgtg acacttgcca cactgtgtcg tcgtttgttt gcctatgtcc 10320
tccagggcac ggtggcagga acaactatcc tcgtctgtcc caacactgag caggcactcg 10380
gtaaacacga atgaatggat gagcgcacgg atgaatggag cttacaagat ctgtctttcc 10440
aatggccggg ggcatttggt ccccaaatta aggctattgg acatctgcac aggacagtcc 10500
tatttttgat gtcctttcct ttctgaaaat aaagttttgt gctttggaga atgactcgtg 10560
agcacatctt tagggaccaa gagtgacttt ctgtaaggag tgactcgtgg cttgccttgg 10620
tctcttggga atacttttct aactagggtt gctctcacct gagacattct ccacccgcgg 10680
aatctcaggg tcccaggctg tgggccatca cgacctcaaa ctggctccta atctccagct 10740
ttcctgtcat tgaaagcttc ggaagtttac tggctctgct cccgcctgtt ttctttctga 10800
ctctatctgg cagcccgatg ccacccagta caggaagtga caccagtact ctgtaaagca 10860
tcatcatcct tggagagact gagcactcag caccttcagc cacgatttca ggatcgcttc 10920
cttgtgagcc gctgcctccg aaatctcctt tgaagcccag acatctttct ccagcttcag 10980
acttgtagat ataactcgtt catcttcatt tactttccac tttgccccct gtcctctctg 11040
tgttccccaa atcagagaat agcccgccat cccccaggtc acctgtctgg attcctcccc 11100
attcacccac cttgccaggt gcaggtgagg atggtgcacc agacagggta gctgtccccc 11160
aaaatgtgcc ctgtgcgggc agtgccctgt ctccacgttt gtttccccag tgtctggcgg 11220
ggagccaggt gacatcataa atacttgctg aatgaatgca gaaatcagcg gtactgactt 11280
gtactatatt ggctgccatg atagggttct cacagcgtca tccatgatcg taagggagaa 11340
tgacattctg cttgagggag ggaatagaaa ggggcaggga ggggacatct gagggcttca 11400
cagggctgca aagggtacag ggattgcacc agggcagaac aggggagggt gttcaaggaa 11460
gagtggctct tagcagaggc actttggaag gtgtgaggca taaatgcttc cttctacgta 11520
ggccaacctc aaaactttca gtaggaatgt tgctatgatc aagttgttct aacactttag 11580
acttagtagt aattatgaac ctcacataga aaaatttcat ccagccatat gcctgtggag 11640
tggaatattc tgtttagtag aaaaatcctt tagagttcag ctctaaccag aaatcttgct 11700
gaagtatgtc agcacctttt ctcaccctgg taagtacagt atttcaagag cacgctaagg 11760
gtggttttca ttttacaggg ctgttgatga tgggttaaaa atgttcattt aagggctacc 11820
cccgtgttta atagatgaac accacttcta cacaaccctc cttggtactg ggggagggag 11880
agatctgaca aatactgccc attcccctag gctgactgga tttgagaaca aatacccacc 11940
catttccacc atggtatggt aacttctctg agcttcagtt tccaagtgaa tttccatgta 12000
ataggacatt cccattaaat acaagctgtt tttacttttt cgcctcccag ggcctgtggg 12060
atctggtccc ccagcctctc ttgggctttc ttacactaac tctgtaccta ccatctcctg 12120
cctcccttag gcaggcacct ccaaccacca cacactccct gctgttttcc ctgcctggaa 12180
ctttccctcc tgccccacca agatcatttc atccagtcct gagctcagct taagggaggc 12240
ttcttgcctg tgggttccct cacccccatg cctgtcctcc aggctggggc aggttcttag 12300
tttgcctgga attgttctgt acctctttgt agcacgtagt gttgtggaaa ctaagccact 12360
aattgagttt ctggctcccc tcctggggtt gtaagttttg ttcattcatg agggccgact 12420
gcatttcctg gttactctat cccagtgacc agccacagga gatgtccaat aaagtatgtg 12480
atgaaatggt cttaaaaaaa aaaaaaa 12507
<210> 137
<211> 3771
<212> DNA
<213>Homo sapiens
<400> 137
gcgccgggac gtggccagtt gcccgcctgc cccggagagc caggcgctaa ccagccgctc 60
tgcgccccgc gccctgcttg cccccattat ccagccttgc cccggcgccc tgacctgacg 120
ccctggcctg acgccctgct tcgtcgcctc ctttctctcc caggtgctgg accagggact 180
gagcgtcccc cggagagggt ccggtgtgac cccgacaaga agcagaaatg gggaagaaac 240
tggatctttc caagctcact gatgaagagg cccagcatgt cttggaagtt gttcaacgag 300
attttgacct ccgaaggaaa gaagaggaac ggctagaggc gttgaagggc aagattaaga 360
aggaaagctc caagagggag ctgctttccg acactgccca tctgaacgag acccactgcg 420
cccgctgcct gcagccctac cagctgcttg tgaatagcaa aaggcagtgc ctggaatgtg 480
gcctcttcac ctgcaaaagc tgtggccgcg tccacccgga ggagcagggc tggatctgtg 540
acccctgcca tctggccaga gtcgtgaaga tcggctcact ggagtggtac tatgagcatg 600
tgaaagcccg cttcaagagg ttcggaagtg ccaaggtcat ccggtccctc cacgggcggc 660
tgcagggtgg agctgggcct gaactgatat ctgaagagag aagtggagac agcgaccaga 720
cagatgagga tggagaacct ggctcagagg cccaggccca ggcccagccc tttggcagca 780
aaaaaaagcg cctcctctcc gtccacgact tcgacttcga gggagactca gatgactcca 840
ctcagcctca aggtcactcc ctgcacctgt cctcagtccc tgaggccagg gacagcccac 900
agtccctcac agatgagtcc tgctcagaga aggcagcccc tcacaaggct gagggcctgg 960
aggaggctga tactggggcc tctgggtgcc actcccatcc ggaagagcag ccgaccagca 1020
tctcaccttc cagacacggc gccctggctg agctctgccc gcctggaggc tcccacagga 1080
tggccctggg gactgctgct gcactcgggt cgaatgtcat caggaatgag cagctgcccc 1140
tgcagtactt ggccgatgtg gacacctctg atgaggaaag catccgggct cacgtgatgg 1200
cctcccacca ttccaagcgg agaggccggg cgtcttctga gagtcagatc tttgagctga 1260
ataagcatat ttcagctgtg gaatgcctgc tgacctacct ggagaacaca gttgtgcctc 1320
ccttggccaa gggtctaggt gctggagtgc gcacggaggc cgatgtagag gaggaggccc 1380
tgaggaggaa gctggaggag ctgaccagca acgtcagtga ccaggagacc tcgtccgagg 1440
aggaggaagc caaggacgaa aaggcagagc ccaacaggga caaatcagtt gggcctctcc 1500
cccaggcgga cccggaggtg ggcacggctg cccatcaaac caacagacag gaaaaaagcc 1560
cccaggaccc tggggacccc gtccagtaca acaggaccac agatgaggag ctgtcagagc 1620
tggaggacag agtggcagtg acggcctcag aagtccagca ggcagagagc gaggtttcag 1680
acattgaatc caggattgca gccctgaggg ccgcagggct cacggtgaag ccctcgggaa 1740
agccccggag gaagtcaaac ctcccgatat ttctccctcg agtggctggg aaacttggca 1800
agagaccaga ggacccaaat gcagaccctt caagtgaggc caaggcaatg gctgtgccct 1860
atcttctgag aagaaagttc agtaattccc tgaaaagtca aggtaaagat gatgattctt 1920
ttgatcggaa atcagtgtac cgaggctcgc tgacacagag aaaccccaac gcgaggaaag 1980
gaatggccag ccacaccttc gcgaaacctg tggtggccca ccagtcctaa cgggacagga 2040
cagagagaca gagcagccct gcactgtttt ccctccacca cagccatcct gtccctcatt 2100
ggctctgtgc tttccactat acacagtcac cgtcccaatg agaaacaaga aggagcaccc 2160
tccacatgga ctcccacctg caagtggaca gcgacattca gtcctgcact gctcacctgg 2220
gtttactgat gactcctggc tgccccacca tcctctctga tctgtgagaa acagctaagc 2280
tgctgtgact tccctttagg acaatgttgt gtaaatcttt gaaggacaca ccgaagacct 2340
ttatactgtg atcttttacc cctttcactc ttggctttct tatgttgctt tcatgaatgg 2400
aatggaaaaa agatgactca gttaaggcac cagccatatg tgtattcttg atggtctata 2460
tcggggtgtg agcagatgtt tgcgtatttc ttgtgggtgt gactggatat tagacatccg 2520
gacaagtgac tgaactaatg atctgctgaa taatgaagga ggaatagaca ccccagtccc 2580
caccctacgt gcacccgctc tgcaagttcc catgtgatct gtagaccagg ggaaattaca 2640
ctgcggtcaa gggcagagcc tgcacatgac agcaagtgag catttgatag atgctcagat 2700
gctagtgcag agagcctgct gggagacgaa gagacagcag gcagagctcc agatgggcaa 2760
ggaagaggct tggttctagc ctggctctgc ccctcactgc agtggatcca gtggggcaga 2820
ggacagaggg tcacaaccaa tgagggatgt ctgccaagga tgggggtgca gaggccacag 2880
gagtcagctt gccactcgcc cattggttac atagatgatc tctcagacag gctgggactc 2940
agagttattt cctagtatcg gtgtgcccca tccagtttta agtggagccc tccaagactc 3000
tccagagctg cctttgaaca tcctaacagt aatcacatct caccctccct gaggttcact 3060
ttagacagga cccaatggct gcactgcctt tgtcagaggg ggtgctgaga ggagtggctt 3120
cttttagaat caaacagtag agacaagagt caagccttgt gtcttcaagc attgaccaag 3180
ttaagtgttt ccttccctct ctcaataaga cacttccagg agctttccaa tctctcactt 3240
aaaactaagg tttgaatctc aaagtgttgc tgggaggctg atactcctgc aacttcagga 3300
gacctgtgag cacacattag cagctgtttc tctgactcct tgtggcatca gataaaaacg 3360
tgggagtttt tccatataat tcccagcctt acttataaat tctattcttt gaaaaaatta 3420
ttcaggctag gtaaggtggc tcatacctat aatcccagcc ctttgagagg ccaaggtggg 3480
agaattgctt gaggccagga gtttgagacc tcctgggcaa catagtgaga tcccatctct 3540
acaaaaaaca aaacaaaaaa attacccaag catgatggta tatgcctgta gtcgtaccta 3600
cttacttagg aggctgaggc aggaggatca cttgagccct ggaggttggg gctgcagtga 3660
gccatgatcg catcactata ctcgagcctg ggcaacagag tgagaccttg tctcttaaaa 3720
aaattaataa taaataaatg aaaataattc ttcagaaaaa aaaaaaaaaa a 3771
<210> 138
<211> 2240
<212> DNA
<213>Homo sapiens
<400> 138
aagcccagca gccccggggc ggatggctcc ggccgcctgg ctccgcagcg cggccgcgcg 60
cgccctcctg cccccgatgc tgctgctgct gctccagccg ccgccgctgc tggcccgggc 120
tctgccgccg gacgcccacc acctccatgc cgagaggagg gggccacagc cctggcatgc 180
agccctgccc agtagcccgg cacctgcccc tgccacgcag gaagcccccc ggcctgccag 240
cagcctcagg cctccccgct gtggcgtgcc cgacccatct gatgggctga gtgcccgcaa 300
ccgacagaag aggttcgtgc tttctggcgg gcgctgggag aagacggacc tcacctacag 360
gatccttcgg ttcccatggc agttggtgca ggagcaggtg cggcagacga tggcagaggc 420
cctaaaggta tggagcgatg tgacgccact cacctttact gaggtgcacg agggccgtgc 480
tgacatcatg atcgacttcg ccaggtactg gcatggggac gacctgccgt ttgatgggcc 540
tgggggcatc ctggcccatg ccttcttccc caagactcac cgagaagggg atgtccactt 600
cgactatgat gagacctgga ctatcgggga tgaccagggc acagacctgc tgcaggtggc 660
agcccatgaa tttggccacg tgctggggct gcagcacaca acagcagcca aggccctgat 720
gtccgccttc tacacctttc gctacccact gagtctcagc ccagatgact gcaggggcgt 780
tcaacaccta tatggccagc cctggcccac tgtcacctcc aggaccccag ccctgggccc 840
ccaggctggg atagacacca atgagattgc accgctggag ccagacgccc cgccagatgc 900
ctgtgaggcc tcctttgacg cggtctccac catccgaggc gagctctttt tcttcaaagc 960
gggctttgtg tggcgcctcc gtgggggcca gctgcagccc ggctacccag cattggcctc 1020
tcgccactgg cagggactgc ccagccctgt ggacgctgcc ttcgaggatg cccagggcca 1080
catttggttc ttccaaggtg ctcagtactg ggtgtacgac ggtgaaaagc cagtcctggg 1140
ccccgcaccc ctcaccgagc tgggcctggt gaggttcccg gtccatgctg ccttggtctg 1200
gggtcccgag aagaacaaga tctacttctt ccgaggcagg gactactggc gtttccaccc 1260
cagcacccgg cgtgtagaca gtcccgtgcc ccgcagggcc actgactgga gaggggtgcc 1320
ctctgagatc gacgctgcct tccaggatgc tgatggctat gcctacttcc tgcgcggccg 1380
cctctactgg aagtttgacc ctgtgaaggt gaaggctctg gaaggcttcc cccgtctcgt 1440
gggtcctgac ttctttggct gtgccgagcc tgccaacact ttcctctgac catggcttgg 1500
atgccctcag gggtgctgac ccctgccagg ccacgaatat caggctagag acccatggcc 1560
atctttgtgg ctgtgggcac caggcatggg actgagccca tgtctcctca gggggatggg 1620
gtggggtaca accaccatga caactgccgg gagggccacg caggtcgtgg tcacctgcca 1680
gcgactgtct cagactgggc agggaggctt tggcatgact taagaggaag ggcagtcttg 1740
ggcccgctat gcaggtcctg gcaaacctgg ctgccctgtc tccatccctg tccctcaggg 1800
tagcaccatg gcaggactgg gggaactgga gtgtccttgc tgtatccctg ttgtgaggtt 1860
ccttccaggg gctggcactg aagcaagggt gctggggccc catggccttc agccctggct 1920
gagcaactgg gctgtagggc agggccactt cctgaggtca ggtcttggta ggtgcctgca 1980
tctgtctgcc ttctggctga caatcctgga aatctgttct ccagaatcca ggccaaaaag 2040
ttcacagtca aatggggagg ggtattcttc atgcaggaga ccccaggccc tggaggctgc 2100
aacatacctc aatcctgtcc caggccggat cctcctgaag cccttttcgc agcactgcta 2160
tcctccaaag ccattgtaaa tgtgtgtaca gtgtgtataa accttcttct tctttttttt 2220
tttttaaact gaggattgtc 2240
<210> 139
<211> 3167
<212> DNA
<213>Homo sapiens
<400> 139
tagcagcaca caagggttcg tgtttgtgga accaggtagc ttccttcaga gctgacattt 60
gcccacagcc agcctggccc agccccatac caccagccct ggcgctctgg ggcgtgaggt 120
gccttttctg cccccctgct ctagggcagg tggaaatcac ccatggtggg tctacatctg 180
atagaagcat cttatagttc tgcttctgga ccagaccatc ctgggttttt ctctgttctg 240
ctgaagggtt ccctccacgt gtccatcacc tcggtgaact cttgggagac ctgggaagat 300
gctggcctca cctctcgcct ctcctttccc tcattgtgct gccaccatcc ttctcacaca 360
ggctctccag ggagagctgg gcaggatggg atcttcctgg gttcccacct tgctccgtgc 420
cccctctcac tgttcctgaa gtgtggccac ggactgcctt gttttctgga aagtcccaag 480
tctggaccat gactgagcag cattctcggc tatctgccac ctgtctgggg ctcctggccc 540
ctcttagact cccctctccc ttctgtttcc cccgagcccc tgacttggac ctgcagggtg 600
gggagaggga tgggacgaga acctgtgctg gggccaaagg tcgcactggg ggaaggtgga 660
gccagggcag cagagtgcct ggcgtcggcc cctatcctgt cactagttcc cccgttctgg 720
cccctggcag gtttgtaacc ccagatcaga agtactccat ggacaacact ccccacacgc 780
caaccccgtt caagaacgcc ctggagaagt acggacccct gaagcccctg gtacgtggtg 840
tggtcactgc cgtggatctc tgcacagtgg gatcccttcg gttcatccaa ccatgttcag 900
tccacaggac ccttccctct gaggtctcat ttgattcttt ctcctgagaa gatgcagaga 960
tcctgataat ataaatgggg aagctgaggc tgctctttgt cacttcctcc gactgctcct 1020
gagcacctga gtttgcaagc acgcgccggc tggtgctaga gacatggtgg tatcccgtga 1080
cactcagcct caggatgggg gagactgatg tgaaatacaa ataacttaaa cactttcagg 1140
caaagataag cactgggcct agttcagaga agtggcaaat tgctactctg gcctgtctct 1200
gaccaactcc cagttctcta cagagcacgg gaaagcccct cggggacgtc tttcctgcag 1260
tgtgcaggct gcccttctcc cctgctcttc ccagttgatg ggatggttgt gttttctcta 1320
tgaaaaaagg agttggcacc ttgggctttc tgaaacacac aggtgtttta gaaatcagtg 1380
gagggtgaga gaaaggcatg gttgtggagg cactggactg tgaacaaggt ctgcagcggg 1440
tccccctgct gtctctctct actgcatgga gcctcctatg aagcccaagg tggctggggg 1500
ctgaggctcc cttgggcctg ccatggaact gattctgagt caagcagact ttccacggac 1560
catgctacat gagccgaggt gaggcactag ttagtgctcc tttcctgttg cagtggagat 1620
ttggctcctc tgtactaaaa tatctgcatg ctctccaaac aggtgtgagg gcaaatcaca 1680
tgaccttggc agctgtaatt aaagtttgtg ggggcttttc ggatgactta tgaggagtgg 1740
ctgtgattcg cacctttcac tcttagtagc actcgccctc ccctgttctc tgttgcctga 1800
agctggagag gtccttggaa ccccgaggcc tgagaaaggg aaatgggttt gagagccccc 1860
attagtgtgg aacaaagggt tgagtgagcc tgggctttga gctgtcgggg tcctaattca 1920
gcagctgtgt gactgtgtgc caggctgttg atctctgagc ttctgtttct acctgcttaa 1980
aatgacggtt actgcacagg gctgtgtgag ggttacagtg cgtctctggg ctgctcccag 2040
ccatggcagg cccctgggaa tcaaggtcat cagctgcttg tccaaggcag cagttagtgg 2100
ttgtgaatgg tgcgtgtgag atctgcatcc tggcgtcagg cctccttcct gccttaccca 2160
ggacagccca gttgcagctg ggttggtccc acagtcccac acacacacag cccgagtgtg 2220
gtgcctcacg tgggctgccc cgtgcctacc cacagccaca gaccccgcac ctggaggagg 2280
acttgaagga ggtgctgcgt tctgaggctg gcatcgaact catcatcgag gacgacatca 2340
ggcccgagaa gcagaagagg aagcctgggc tgcggcggag ccccatcaag aaagtccgga 2400
agtctctggc tcttgacatt gtggatgagg atgtgaagct gatgatgtcc acactgccca 2460
agtctctatc cttgccgaca actgcccctt caaactcttc cagcctcacc ctgtcaggta 2520
tcaaagaaga caacagcttg ctcaaccagg gcttcttgca ggccaagccc gagaaggcag 2580
cagtggccca gaagccccga agccacttca cgacacctgc ccctatgtcc agtgcctgga 2640
agacggtggc ctgcgggggg accagggacc agcttttcat gcaggagaaa gcccggcagc 2700
tcctgggccg cctgaagccc agccacacat ctcggaccct catcttgtcc tgaggtgttg 2760
agggtgtcac gagcccattc acatgtttac aggggttgtg ggggcagagg gggtctgtga 2820
atctgagagt cattcaggtg acctcctgca gggagccttc tgccaccagc ccctccccag 2880
actctcaggt ggaggcaaca gggccatgtg ctgccctgtt gccgagccca gctgtgggcg 2940
gctcctggtg ctaacaacaa agttccactt ccaggtctgc ctggttcccc ccccaaggcc 3000
acagggagct ccgtcagctt ctcccaagcc cacgtcaggc ctggcctcat ctcagaccct 3060
gcttaggatg ggggatgtgg ccaggggtgc tcctgtgctc accctctctt ggtgcatttt 3120
tttggaagaa taaaattgcc tctctctttg aaaaaaaaaa aaaaaaa 3167
<210> 140
<211> 2379
<212> DNA
<213>Homo sapiens
<400> 140
gacccccgag ctgtgctgct cgcggccgcc accgccgggc cccggccgtc cctggctccc 60
ctcctgcctc gagaagggca gggcttctca gaggcttggc gggaaaaaga acggagggag 120
ggatcgcgct gagtataaaa gccggttttc ggggctttat ctaactcgct gtagtaattc 180
cagcgagagg cagagggagc gagcgggcgg ccggctaggg tggaagagcc gggcgagcag 240
agctgcgctg cgggcgtcct gggaagggag atccggagcg aatagggggc ttcgcctctg 300
gcccagccct cccgctgatc ccccagccag cggtccgcaa cccttgccgc atccacgaaa 360
ctttgcccat agcagcgggc gggcactttg cactggaact tacaacaccc gagcaaggac 420
gcgactctcc cgacgcgggg aggctattct gcccatttgg ggacacttcc ccgccgctgc 480
caggacccgc ttctctgaaa ggctctcctt gcagctgctt agacgctgga tttttttcgg 540
gtagtggaaa accagcagcc tcccgcgacg atgcccctca acgttagctt caccaacagg 600
aactatgacc tcgactacga ctcggtgcag ccgtatttct actgcgacga ggaggagaac 660
ttctaccagc agcagcagca gagcgagctg cagcccccgg cgcccagcga ggatatctgg 720
aagaaattcg agctgctgcc caccccgccc ctgtccccta gccgccgctc cgggctctgc 780
tcgccctcct acgttgcggt cacacccttc tcccttcggg gagacaacga cggcggtggc 840
gggagcttct ccacggccga ccagctggag atggtgaccg agctgctggg aggagacatg 900
gtgaaccaga gtttcatctg cgacccggac gacgagacct tcatcaaaaa catcatcatc 960
caggactgta tgtggagcgg cttctcggcc gccgccaagc tcgtctcaga gaagctggcc 1020
tcctaccagg ctgcgcgcaa agacagcggc agcccgaacc ccgcccgcgg ccacagcgtc 1080
tgctccacct ccagcttgta cctgcaggat ctgagcgccg ccgcctcaga gtgcatcgac 1140
ccctcggtgg tcttccccta ccctctcaac gacagcagct cgcccaagtc ctgcgcctcg 1200
caagactcca gcgccttctc tccgtcctcg gattctctgc tctcctcgac ggagtcctcc 1260
ccgcagggca gccccgagcc cctggtgctc catgaggaga caccgcccac caccagcagc 1320
gactctgagg aggaacaaga agatgaggaa gaaatcgatg ttgtttctgt ggaaaagagg 1380
caggctcctg gcaaaaggtc agagtctgga tcaccttctg ctggaggcca cagcaaacct 1440
cctcacagcc cactggtcct caagaggtgc cacgtctcca cacatcagca caactacgca 1500
gcgcctccct ccactcggaa ggactatcct gctgccaaga gggtcaagtt ggacagtgtc 1560
agagtcctga gacagatcag caacaaccga aaatgcacca gccccaggtc ctcggacacc 1620
gaggagaatg tcaagaggcg aacacacaac gtcttggagc gccagaggag gaacgagcta 1680
aaacggagct tttttgccct gcgtgaccag atcccggagt tggaaaacaa tgaaaaggcc 1740
cccaaggtag ttatccttaa aaaagccaca gcatacatcc tgtccgtcca agcagaggag 1800
caaaagctca tttctgaaga ggacttgttg cggaaacgac gagaacagtt gaaacacaaa 1860
cttgaacagc tacggaactc ttgtgcgtaa ggaaaagtaa ggaaaacgat tccttctaac 1920
agaaatgtcc tgagcaatca cctatgaact tgtttcaaat gcatgatcaa atgcaacctc 1980
acaaccttgg ctgagtcttg agactgaaag atttagccat aatgtaaact gcctcaaatt 2040
ggactttggg cataaaagaa cttttttatg cttaccatct tttttttttc tttaacagat 2100
ttgtatttaa gaattgtttt taaaaaattt taagatttac acaatgtttc tctgtaaata 2160
ttgccattaa atgtaaataa ctttaataaa acgtttatag cagttacaca gaatttcaat 2220
cctagtatat agtacctagt attataggta ctataaaccc taattttttt tatttaagta 2280
cattttgctt tttaaagttg atttttttct attgttttta gaaaaaataa aataactggc 2340
aaatatatca ttgagccaaa tcttaaaaaa aaaaaaaaa 2379
<210> 141
<211> 1799
<212> DNA
<213>Homo sapiens
<400> 141
gtgggaggat tgcattcagt ctagttcctg gttgccggct gaaataacct gctctccaaa 60
atgtccacaa aagtgactta agtcaggttc ccccaaacca gacaccaaga caagaatcca 120
tgtgtgtgtg actgaaggaa gtgctgggag agccccagct gcagcctgga tgtgaactgc 180
aactccaaag tgtgtccaga ctcaaggcaa gggcactagg ctttccagac ctcctactaa 240
gtcattgatc cagcactgcc ctgccaggac ataaatccct ggcacctctt gctctctgca 300
aaggagggca aagcagcttc aggagccctt gggagtcctc caaagagagt ctagggtaca 360
ggtccgaaag tagaagaaca cagaaggcag gccaggggca ctgtgagatg gtaaaagaga 420
tctgaaggga tccagaattc aagccaggaa gaagcagcaa tctgtcttct ggattaaaac 480
tgaagatcaa cctactttca acttactaag aaaggggatc atggacattg aagcatatct 540
tgaaagaatt ggctataaga agtctaggaa caaattggac ttggaaacat taactgatat 600
tcttcaacac cagatccgag ctgttccctt tgagaacctt aacatccatt gtggggatgc 660
catggactta ggcttagagg ccatttttga tcaagttgtg agaagaaatc ggggtggatg 720
gtgtctccag gtcaatcatc ttctgtactg ggctctgacc actattggtt ttgagaccac 780
gatgttggga gggtatgttt acagcactcc agccaaaaaa tacagcactg gcatgattca 840
ccttctcctg caggtgacca ttgatggcag gaactacatt gtcgatgctg ggtttggacg 900
ctcataccag atgtggcagc ctctggagtt aatttctggg aaggatcagc ctcaggtgcc 960
ttgtgtcttc cgtttgacgg aagagaatgg attctggtat ctagaccaaa tcagaaggga 1020
acagtacatt ccaaatgaag aatttcttca ttctgatctc ctagaagaca gcaaataccg 1080
aaaaatctac tcctttactc ttaagcctcg aacaattgaa gattttgagt ctatgaatac 1140
atacctgcag acatctccat catctgtgtt tactagtaaa tcattttgtt ccttgcagac 1200
cccagatggg gttcactgtt tggtgggctt caccctcacc cataggagat tcaattataa 1260
ggacaataca gatctaatag agttcaagac tctgagtgag gaagaaatag aaaaagtgct 1320
gaaaaatata tttaatattt ccttgcagag aaagcttgtg cccaaacatg gtgatagatt 1380
ttttactatt tagaataagg agtaaaacaa tcttgtctat ttgtcatcca gctcaccagt 1440
tatcaactga cgacctatca tgtatcttct gtacccttac cttattttga agaaaatcct 1500
agacatcaaa tcatttcacc tataaaaatg tcatcatata taattaaaca gctttttaaa 1560
gaaacataac cacaaacctt ttcaaataat aataataata ataataataa atgtctttta 1620
aagatggcct gtggttatct tggaaattgg tgatttatgc tagaaagctt ttaatgttgg 1680
tttattgttg aattcctaga aaagttttat gggtagatga gtaaataaaa tattgtaaaa 1740
aaacttattg tctataaagt atattaaaac attgttggct aatataaaaa aaaaaaaaa 1799
<210> 142
<211> 1644
<212> DNA
<213>Homo sapiens
<400> 142
gcgcgcgggt ttcgttgacc cgcggcgttc acgggaattg ttcgctttag tgccggcgcc 60
atggggtcgg agctgatcgg gcgcctagcc ccgcgcctgg gcctcgccga gcccgacatg 120
ctgaggaaag cagaggagta cttgcgcctg tcccgggtga agtgtgtcgg cctctccgca 180
cgcaccacgg agaccagcag tgcagtcatg tgcctggacc ttgcagcttc ctggatgaag 240
tgccccttgg acagggctta tttaattaaa ctttctggtt tgaacaagga gacatatcag 300
agctgtctta aatcttttga gtgtttactg ggcctgaatt caaatattgg aataagagac 360
ctagctgtac agtttagctg tatagaagca gtgaacatgg cttcaaagat actaaaaagc 420
tatgagtcca gtcttcccca gacacagcaa gtggatcttg acttatccag gccacttttc 480
acttctgctg cactgctttc agcatgcaag attctaaagc tgaaagtgga taaaaacaaa 540
atggtagcca catccggtgt aaaaaaagct atatttgatc gactgtgtaa acaactagag 600
aagattggac agcaggtcga cagagaacct ggagatgtag ctactccacc acggaagaga 660
aagaagatag tggttgaagc cccagcaaag gaaatggaga aggtagagga gatgccacat 720
aaaccacaga aagatgaaga tctgacacag gattatgaag aatggaaaag aaaaattttg 780
gaaaatgctg ccagtgctca aaaggctaca gcagagtgat ttcagcttcc aaactggtat 840
acattccaaa ctgatagtac attgccatct ccaggaagac ttgacggctt tgggattttg 900
tttaaacttt tataataagg atcctaagac tgttgccttt aaatagcaaa gcagcctacc 960
tggaggctaa gtctgggcag tgggctggcc cctggtgtga gcattagacc agccacagtg 1020
cctgattggt atagccttat gtgctttcct acaaaatgga attggaggcc gggcgcagtg 1080
gctcacgcct gtaatcccag cactttggga ggccaaggtg ggtggatcac ctgaggtcag 1140
gagctcgaga ccagcctggc caacatggtg aaaccccatc tctactaaaa atacaaaaat 1200
tagccaggtg tgatggtgca tgcctgtaat cccagctcct cagtaggctg agacaggagc 1260
atcacttgaa cgtgggaggc agaggttgca gtgagccgag attgcaccac cgcactccag 1320
cctgggtgac agagcgagac ttatctcata aataaataga tagatactcc agcctgggtg 1380
acagagcgag acttatagat agatagatag atagatggat agatagatag atagatagat 1440
agatagataa acggaattgg agccattttg ctttaagtga atggcagtcc cttgtcttat 1500
tcagaatata aaattcagtc tgaatggcat cttacagatt ttacttcaat ttttgtgtac 1560
ggtatttttt atttgactaa atcaatatat tgtacagcct aagttaataa atgttattta 1620
tatatgcaaa aaaaaaaaaa aaaa 1644
<210> 143
<211> 13037
<212> DNA
<213>Homo sapiens
<400> 143
agtccacagc tgtcactaat cggggtaagc cttgttgtat ttgtgcgtgt gggtggcatt 60
ctcaatgaga actagcttca cttgtcattt gagtgaaatc tacaacccga ggcggctagt 120
gctcccgcac tactgggatc tgagatcttc ggagatgact gtcgcccgca gtacggagcc 180
agcagaagtc cgacccttcc tgggaatggg ctgtaccgag aggtccgact agccccaggg 240
ttttagtgag ggggcagtgg aactcagcga gggactgaga gcttcacagc atgcacgagt 300
ttgatgccag agaaaaagtc gggagataaa ggagccgcgt gtcactaaat tgccgtcgca 360
gccgcagcca ctcaagtgcc ggacttgtga gtactctgcg tctccagtcc tcggacagaa 420
gttggagaac tctcttggag aactccccga gttaggagac gagatctcct aacaattact 480
actttttctt gcgctcccca cttgccgctc gctgggacaa acgacagcca cagttcccct 540
gacgacagga tggaggccaa gggcaggagc tgaccagcgc cgccctcccc cgcccccgac 600
ccaggaggtg gagatccctc cggtccagcc acattcaaca cccactttct cctccctctg 660
cccctatatt cccgaaaccc cctcctcctt cccttttccc tcctcctgga gacgggggag 720
gagaaaaggg gagtccagtc gtcatgactg agctgaaggc aaagggtccc cgggctcccc 780
acgtggcggg cggcccgccc tcccccgagg tcggatcccc actgctgtgt cgcccagccg 840
caggtccgtt cccggggagc cagacctcgg acaccttgcc tgaagtttcg gccataccta 900
tctccctgga cgggctactc ttccctcggc cctgccaggg acaggacccc tccgacgaaa 960
agacgcagga ccagcagtcg ctgtcggacg tggagggcgc atattccaga gctgaagcta 1020
caaggggtgc tggaggcagc agttctagtc ccccagaaaa ggacagcgga ctgctggaca 1080
gtgtcttgga cactctgttg gcgccctcag gtcccgggca gagccaaccc agccctcccg 1140
cctgcgaggt caccagctct tggtgcctgt ttggccccga acttcccgaa gatccaccgg 1200
ctgcccccgc cacccagcgg gtgttgtccc cgctcatgag ccggtccggg tgcaaggttg 1260
gagacagctc cgggacggca gctgcccata aagtgctgcc ccggggcctg tcaccagccc 1320
ggcagctgct gctcccggcc tctgagagcc ctcactggtc cggggcccca gtgaagccgt 1380
ctccgcaggc cgctgcggtg gaggttgagg aggaggatgg ctctgagtcc gaggagtctg 1440
cgggtccgct tctgaagggc aaacctcggg ctctgggtgg cgcggcggct ggaggaggag 1500
ccgcggctgt cccgccgggg gcggcagcag gaggcgtcgc cctggtcccc aaggaagatt 1560
cccgcttctc agcgcccagg gtcgccctgg tggagcagga cgcgccgatg gcgcccgggc 1620
gctccccgct ggccaccacg gtgatggatt tcatccacgt gcctatcctg cctctcaatc 1680
acgccttatt ggcagcccgc actcggcagc tgctggaaga cgaaagttac gacggcgggg 1740
ccggggctgc cagcgccttt gccccgccgc ggagttcacc ctgtgcctcg tccaccccgg 1800
tcgctgtagg cgacttcccc gactgcgcgt acccgcccga cgccgagccc aaggacgacg 1860
cgtaccctct ctatagcgac ttccagccgc ccgctctaaa gataaaggag gaggaggaag 1920
gcgcggaggc ctccgcgcgc tccccgcgtt cctaccttgt ggccggtgcc aaccccgcag 1980
ccttcccgga tttcccgttg gggccaccgc ccccgctgcc gccgcgagcg accccatcca 2040
gacccgggga agcggcggtg acggccgcac ccgccagtgc ctcagtctcg tctgcgtcct 2100
cctcggggtc gaccctggag tgcatcctgt acaaagcgga gggcgcgccg ccccagcagg 2160
gcccgttcgc gccgccgccc tgcaaggcgc cgggcgcgag cggctgcctg ctcccgcggg 2220
acggcctgcc ctccacctcc gcctctgccg ccgccgccgg ggcggccccc gcgctctacc 2280
ctgcactcgg cctcaacggg ctcccgcagc tcggctacca ggccgccgtg ctcaaggagg 2340
gcctgccgca ggtctacccg ccctatctca actacctgag gccggattca gaagccagcc 2400
agagcccaca atacagcttc gagtcattac ctcagaagat ttgtttaatc tgtggggatg 2460
aagcatcagg ctgtcattat ggtgtcctta cctgtgggag ctgtaaggtc ttctttaaga 2520
gggcaatgga agggcagcac aactacttat gtgctggaag aaatgactgc atcgttgata 2580
aaatccgcag aaaaaactgc ccagcatgtc gccttagaaa gtgctgtcag gctggcatgg 2640
tccttggagg tcgaaaattt aaaaagttca ataaagtcag agttgtgaga gcactggatg 2700
ctgttgctct cccacagcca gtgggcgttc caaatgaaag ccaagcccta agccagagat 2760
tcactttttc accaggtcaa gacatacagt tgattccacc actgatcaac ctgttaatga 2820
gcattgaacc agatgtgatc tatgcaggac atgacaacac aaaacctgac acctccagtt 2880
ctttgctgac aagtcttaat caactaggcg agaggcaact tctttcagta gtcaagtggt 2940
ctaaatcatt gccaggtttt cgaaacttac atattgatga ccagataact ctcattcagt 3000
attcttggat gagcttaatg gtgtttggtc taggatggag atcctacaaa cacgtcagtg 3060
ggcagatgct gtattttgca cctgatctaa tactaaatga acagcggatg aaagaatcat 3120
cattctattc attatgcctt accatgtggc agatcccaca ggagtttgtc aagcttcaag 3180
ttagccaaga agagttcctc tgtatgaaag tattgttact tcttaataca attcctttgg 3240
aagggctacg aagtcaaacc cagtttgagg agatgaggtc aagctacatt agagagctca 3300
tcaaggcaat tggtttgagg caaaaaggag ttgtgtcgag ctcacagcgt ttctatcaac 3360
ttacaaaact tcttgataac ttgcatgatc ttgtcaaaca acttcatctg tactgcttga 3420
atacatttat ccagtcccgg gcactgagtg ttgaatttcc agaaatgatg tctgaagtta 3480
ttgctgcaca attacccaag atattggcag ggatggtgaa accccttctc tttcataaaa 3540
agtgaatgtc atctttttct tttaaagaat taaattttgt ggtatgtctt tttgttttgg 3600
tcaggattat gaggtcttga gtttttataa tgttcttctg aaagccttac atttataaca 3660
tcatagtgtg taaatttaaa agaaaaattg tgaggttcta attattttct tttataaagt 3720
ataattagaa tgtttaactg ttttgtttac ccatattttc ttgaagaatt tacaagattg 3780
aaaaagtact aaaattgtta aagtaaacta tcttatccat attatttcat accatgtagg 3840
tgaggatttt taacttttgc atctaacaaa tcatcgactt aagagaaaaa atcttacatg 3900
taataacaca aagctattat atgttatttc taggtaactc cctttgtgtc aattatattt 3960
ccaaaaatga acctttaaaa tggtatgcaa aattttgtct atatatattt gtgtgaggag 4020
gaaattcata actttcctca gattttcaaa agtattttta atgcaaaaaa tgtagaaaga 4080
gtttaaaacc actaaaatag attgatgttc ttcaaactag gcaaaacaac tcatatgtta 4140
agaccatttt ccagattgga aacacaaatc tcttaggaag ttaataagta gattcatatc 4200
attatgcaaa tagtattgtg ggttttgtag gtttttaaaa taaccttttt tggggagaga 4260
attgtcctct aatgaggtat tgcgagtgga cataagaaat cagaagatta tggcctaact 4320
gtactcctta ccaactgtgg catgctgaaa gttagtcact cttactgatt ctcaattctc 4380
tcacctttga aagtagtaaa atatctttcc tgccaattgc tcctttgggt cagagcttat 4440
taacatcttt tcaaatcaaa ggaaagaaga aagggagagg aggaggaggg aggtatcaat 4500
tcacatacct ttctcctctt tatcctccac tatcatgaat tcatattatg tttcagccat 4560
gcaaatcttt ttaccatgaa atttcttcca gaattttccc cctttgacac aaattccatg 4620
catgtttcaa ccttcgagac tcagccaaat gtcatttctg taaaatcttc cctgagtctt 4680
ccaagcagta atttgccttc tcctagagtt tacctgccat tttgtgcaca tttgagttac 4740
agtagcatgt tattttacaa ttgtgactct cctgggagtc tgggagccat ataaagtggt 4800
caatagtgtt tgctgactga gagttgaatg acattttctc tctgtcttgg tattactgta 4860
gatttcgatc attctttggt tacatttctg catatttctg tacccatgac tttatcactt 4920
tcttctccca tgctttatct ccatcaatta tcttcattac ttttaaattt tccacctttg 4980
cttcctactt tgtgagatct ctccctttac tgactataac atagaagaat agaagtgtat 5040
tttatgtgtc ttaaggacaa tactttagat tccttgttct aagtttttaa actgaatgaa 5100
tggaatatta tttctctccc taagcaaaat tccacaaaac aattatttct tatgtttatg 5160
tagccttaaa ttgttttgta ctgtaaacct cagcataaaa actttcttca tttctaattt 5220
cattcaacaa atattgattg aatacctggt attagcacaa gaaaaatgtg ctaataagcc 5280
ttatgagaat ttggagctga agaaagacat ataactcagg aaagttacag tccagtagta 5340
ggtataaatt acagtgcctg ataaataggc attttaatat ttgtacactc aacgtatact 5400
aggtaggtgc aaaacattta catataattt tactgatacc catgcagcac aaaggtacta 5460
actttaaata ttaaataaca cctttatgtg tcagtaattc atttgcatta aatcttattg 5520
aaaaggcttt caatatattt tccccacaaa tgtcatccca agaaaaaagt atttttaaca 5580
tctcccaaat ataatagtta caggaaatct acctctgtga gagtgacacc tctcagaatg 5640
aactgtgtga cacaagaaaa tgaatgtagg tctatccaaa aaaaacccca agaaacaaaa 5700
acaatattat tagcccttta tgcttaagtg atggactcag ggaacagttg atgttgtgat 5760
cattttatta tctgattctt gttactttga attaaaccaa tattttgatg atataaatca 5820
tttccaccag catatattta atttccataa taactttaaa attttctaat ttcactcaac 5880
tatgagggaa tagaatgtgg tggccacagg tttggctttt gttaaaatgt ttgatatctt 5940
cgatgttgat ctctgtctgc aatgtagatg tctaaacact aggatttaat atttaaggct 6000
aagctttaaa aataaagtac ctttttaaaa agaatatggc ttcaccaaat ggaaaatacc 6060
taatttctaa atctttttct ctacaaagtc ctatctacta atgtctccat tactatttag 6120
tcatcataac cattatcttc attttacatg tcgtgttctt tctggtagct ctaaaatgac 6180
actaaatcat aagaagacag gttacatatc aggaaatact tgaaggttac tgaaatagat 6240
tcttgagtta atgaaaatat tttctgtaaa aaggtttgaa aagccatttg agtctaaagc 6300
attatacctc cattatcagt agttatgtga caattgtgtg tgtgtttaat gtttaaagat 6360
gtggcacttt ttaataaggc aatgctatgc tattttttcc catttaacat taagataatt 6420
tattgctata cagatgatat ggaaatatga tgaacaatat tttttttgcc aaaactatgc 6480
cttgtaagta gccatggaat gtcaacctgt aacttaaatt atccacagat agtcatgtgt 6540
ttgatgatgg gcactgtgga gataactgac ataggactgt gccccccttc tctgccactt 6600
actagctgga tgagattaag caagtcattt aactgctctg attaaacctg cctttcccaa 6660
gtgctttgta atgaatagaa atggaaacca aaaaaaacgt atacaggcct tcagaaatag 6720
taattgctac tattttgttt tcattaagcc atagttctgg ctataatttt atcaaactca 6780
ccagctatat tctacagtga aagcaggatt ctagaaagtc tcactgtttt atttatgtca 6840
ccatgtgcta tgatatattt ggttgaattc atttgaaatt agggctggaa gtattcaagt 6900
aatttcttct gctgaaaaaa tacagtgttt tgagtttagg gcctgtttta tcaaagttct 6960
aaagagccta tcactcttcc attgtagaca ttttaaaata atgacactga ttttaacatt 7020
tttaagtgtc tttttagaac agagagcctg actagaacac agcccctcca aaaacccatg 7080
ctcaaattat ttttactatg gcagcaattc cacaaaaggg aacaatgggt ttagaaatta 7140
caatgaagtc atcaacccaa aaaacatccc tatccctaag aaggttatga tataaaatgc 7200
ccacaagaaa tctatgtctg ctttaatctg tcttttattg ctttggaagg atggctatta 7260
catttttagt ttttgctgtg aatacctgag cagtttctct catccatact tatccttcac 7320
acatcagaag tcaggataga atatgaatca ttttaaaaac ttttacaact ccagagccat 7380
gtgcataaga agcattcaaa acttgccaaa acatacattt tttttcaaat ttaaagatac 7440
tctatttttg tattcaatag ctcaacaact gtggtcccca ctgataaagt gaagtggaca 7500
aggagacaag taatggcata agtttgtttt tcccaaagta tgcctgttca atagccattg 7560
gatgtgggaa atttctacat ctcttaaaat tttacagaaa atacatagcc agatagtcta 7620
gcaaaagttc accaagtcct aaattgctta tccttacttc actaagtcat gaaatcattt 7680
taatgaaaag aacatcacct aggttttgtg gtttcttttt ttcttattca tggctgagtg 7740
aaaacaacaa tctctgtttc tccctagcat ctgtggacta tttaatgtac cattattcca 7800
cactctatgg tccttactaa atacaaaatt gaacaaaaag cagtaaaaca actgactctt 7860
cacccatatt ataaaatata atccaagcca gattagtcaa catccataag atgaatccaa 7920
gctgaactgg gcctagatta ttgagttcag gttggatcac atccctattt attaataaac 7980
ttaggaaaga aggccttaca gaccatcagt tagctggagc taatagaacc tacacttcta 8040
aagttcggcc tagaatcaat gtggccttaa aagctgaaaa gaagcaggaa agaacagttt 8100
tcttcaataa tttgtccacc ctgtcactgg agaaaattta agaatttggg ggtgttggta 8160
gtaagttaaa cacagcagct gttcatggca gaaattattc aatacatacc ttctctgaat 8220
atcctataac caaagcaaag aaaaacacca aggggtttgt tctcctcctt ggagttgacc 8280
tcattccaag gcagagctca ggtcacaggc acaggggctg cgcccaagct tgtccgcagc 8340
cttatgcagc tgtggagtct ggaagactgt tgcaggactg ctggcctagt cccagaatgt 8400
cagcctcatt ttcgatttac tggctcttgt tgctgtatgt catgctgacc ttattgttaa 8460
acacaggttt gtttgctttt tttccactca tggagacatg ggagaggcat tatttttaag 8520
ctggttgaaa gctttaaccg ataaagcatt tttagagaaa tgtgaatcag gcagctaaga 8580
aagcatactc tgtccattac ggtaaagaaa atgcacagat tattaactct gcagtgtggc 8640
attagtgtcc tggtcaatat tcggatagat atgaataaaa tatttaaatg gtattgtaaa 8700
tagttttcag gacatatgct atagcttatt tttattatct tttgaaattg ctcttaatac 8760
atcaaatcct gatgtattca atttatcaga tataaattat tctaaatgaa gcccagttaa 8820
atgtttttgt cttgtcagtt atatgttaag tttctgatct ctttgtctat gacgtttact 8880
aatctgcatt tttactgtta tgaattattt tagacagcag tggtttcaag ctttttgcca 8940
ctaaaaatac cttttatttt ctcctccccc agaaaagtct ataccttgaa gtatctatcc 9000
accaaactgt acttctatta agaaatagtt attgtgtttt cttaatgttt tgttattcaa 9060
agacatatca atgaaagctg ctgagcagca tgaataacaa ttatatccac acagatttga 9120
tatattttgt gcagccttaa cttgatagta taaaatgtca ttgcttttta aataatagtt 9180
agtcaatgga cttctatcat agctttccta aactaggtta agatccagag ctttggggtc 9240
ataatatatt acatacaatt aagttatctt tttctaaggg ctttaaaatt catgagaata 9300
accaaaaaag gtatgtggag agttaataca aacataccat attcttgttg aaacagagat 9360
gtggctctgc ttgttctcca taaggtagaa atactttcca gaatttgcct aaactagtaa 9420
gccctgaatt tgctatgatt agggatagga agagattttc acatggcaga ctttagaatt 9480
cttcacttta gccagtaaag tatctccttt tgatcttagt attctgtgta ttttaacttt 9540
tctgagttgt gcatgtttat aagaaaaatc agcacaaagg gtttaagtta aagccttttt 9600
actgaaattt gaaagaaaca gaagaaaata tcaaagttct ttgtattttg agaggattaa 9660
atatgattta caaaagttac atggagggct ctctaaaaca ttaaattaat tattttttgt 9720
tgaaaagtct tactttaggc atcattttat tcctcagcaa ctagctgtga agcctttact 9780
gtgctgtatg ccagtcactc tgctagattg tggagattac cagtgttccc gtcttctccg 9840
agcttagagt tggatgggga ataaagacag gtaaacagat agctacaata ttgtactgtg 9900
aatgcttatg ctggaggaag tacagggaac tattggagca cctaagagga gcacctacct 9960
tgaatttagg ggttagcaga ggcatcctga aaaaagtcaa agctaagcca caatctataa 10020
gcagtttagg aattagcaga acgtgcgtgg tgaggagatg ccaaaggcaa gaagagaaga 10080
gtattccaaa caggagggat tccaaagaga gaagagtatc ccaaacaaca tttgcacaaa 10140
cctgatgggg agagagaatg tggggtgggg atggatgatg agactgaaga agaaagccag 10200
gtctagataa tcagtggcct tgtacaccat gttaaagagt gtagacttga ttctgttgta 10260
aacaggaaag cagcacaatt catatgaata ttttagaaga ctcccactgg aatatggaga 10320
ataaagttgg agatgactaa tcctggaagc agggagaaca tttttgagga agttgcacta 10380
ttttggtgaa aatgatgatc ataaacatga agaattgtag gtgatcatga cctcctctct 10440
aattttccag aagggttttg gaagatataa cataggaaca ttgacaggac tgacgaaagg 10500
agatgaaata caccatataa attgtcaaac acaaggccag atgtctaatt attttgctta 10560
tgtgttgaaa ttacaaattt ttcatcagga aaccaaaaac tacaaaactt agttttccca 10620
agtcccagaa ttctatctgt ccaaacaatc tgtaccactc cacctatatc cctacctttg 10680
catgtctgtc caacctcaaa gtccaggtct atacacacgg gtaagactag agcagttcaa 10740
gtttcagaaa atgagaaaga ggaactgagt tgtgctgaac ccatacaaaa taaacacatt 10800
ctttgtatag attcttggaa cctcgagagg aattcaccta actcataggt atttgatggt 10860
atgaatccat ggctgggctc ggcttttaaa aagccttatc tgggattcct tctatggaac 10920
caagttccat caaagcccat ttaaaagcct acattaaaaa caaaattctt gctgcattgt 10980
atacaaataa tgatgtcatg atcaaataat cagatgccat tatcaagtgg aattacaaaa 11040
tggtataccc actccaaaaa aaaaaaaaaa gctaaattct cagtagaaca ttgtgacttc 11100
atgagccctc cacagccttg gagctgagga gggagcactg gtgagcagta ggttgaagag 11160
aaaacttggc gcttaataat ctatccatgt tttttcatct aaaagagcct tctttttgga 11220
ttaccttatt caatttccat caaggaaatt gttagttcca ctaaccagac agcagctggg 11280
aaggcagaag cttactgtat gtacatggta gctgtgggaa ggaggtttct ttctccaggt 11340
cctcactggc catacaccag tcccttgtta gttatgcctg gtcatagacc cccgttgcta 11400
tcatctcata tttaagtctt tggcttgtga atttatctat tctttcagct tcagcactgc 11460
agagtgctgg gactttgcta acttccattt cttgctggct tagcacattc ctcataggcc 11520
cagctctttt ctcatctggc cctgctgtgg agtcaccttg ccccttcagg agagccatgg 11580
cttaccactg cctgctaagc ctccactcag ctgccaccac actaaatcca agcttctcta 11640
agatgttgca gactttacag gcaagcataa aaggcttgat cttcctggac ttccctttac 11700
ttgtctgaat ctcacctcct tcaactttca gtctcagaat gtaggcattt gtcctctttg 11760
ccctacatct tccttcttct gaatcatgaa agcctctcac ttcctcttgc tatgtgctgg 11820
aggcttctgt caggttttag aatgagttct catctagtcc tagtagcttt tgatgcttaa 11880
gtccaccttt taaggatacc tttgagattt agaccatgtt tttcgcttga gaaagcccta 11940
atctccagac ttgcctttct gtggatttca aagaccaact gaggaagtca aaagctgaat 12000
gttgactttc tttgaacatt tccgctataa caattccaat tctcctcaga gcaatatgcc 12060
tgcctccaac tgaccaggag aaaggtccag tgccaaagag aaaaacacaa agattaatta 12120
tttcagttga gcacatactt tcaaagtggt ttgggtattc atatgaggtt ttctgtcaag 12180
agggtgagac tcttcatcta tccatgtgtg cctgacagtt ctcctggcac tggctggtaa 12240
cagatgcaaa actgtaaaaa ttaagtgatc atgtatttta acgatatcat cacatactta 12300
ttttctatgt aatgttttaa atttccccta acatactttg actgttttgc acatggtaga 12360
tattcacatt tttttgtgtt gaagttgatg caatcttcaa agttatctac cccgttgctt 12420
attagtaaaa ctagtgttaa tacttggcaa gagatgcagg gaatctttct catgactcac 12480
gccctattta gttattaatg ctactaccct attttgagta agtagtaggt ccctaagtac 12540
attgtccaga gttatacttt taaagatatt tagccccata tacttcttga atctaaagtc 12600
atacaccttg ctcctcattt ctgagtggga aagacatttg agagtatgtt gacaattgtt 12660
ctgaaggttt ttgccaagaa ggtgaaactg tcctttcatc tgtgtatgcc tggggctggg 12720
tccctggcag tgatggggtg acaatgcaaa gctgtaaaaa ctaggtgcta gtgggcacct 12780
aatatcatca tcatatactt attttcaagc taatatgcaa aatcccatct ctgtttttaa 12840
actaagtgta gatttcagag aaaatatttt gtggttcaca taagaaaaca gtctactcag 12900
cttgacaagt gttttatgtt aaattggctg gtggtttgaa atgaatcatc ttcacataat 12960
gttttcttta aaaatattgt gaatttaact ctaattcttg ttattctgtg tgataataaa 13020
gaataaacta atttcta 13037
<210> 144
<211> 3180
<212> DNA
<213>Homo sapiens
<400> 144
attctatgct gcagcctaag catcattcct cttctcttct tagtggagat aaaattaccc 60
actgctctcc ttacatttac tttgtccata tttgctccta tgctctaggc tcgtgcacaa 120
caaacacagt gtgggccctt accctagaag ccaacttctc atgacctttc tctatctcca 180
gaatccatgc agtgggaatg aaggtaaaag aaggttttca tgggatccag ctgagagctc 240
tacggggaaa atggatctga ggagccatgt gctccatctc ttttatttta caggtagaga 300
ctaggggtat agagtgaggt gaattaccgc agtgacccac acattgttgg cagacctagg 360
attagaactc tgtcttcctg gttcccagct tggtgctttt gaaagcatac ttgctgcttt 420
cttaccggcc tggtgtctgc cactttggga cagagtgtgg acttgctcac ctgccccatt 480
tcttagggat tctcattctg tgtttgagca agaatattct tattctggaa agaaccacat 540
accacaggat tctgggtgag cataaggaag attgtcttgg ggatctgact tagctcacgt 600
atagtggcta tgatgaattc agtgtcttat tttttgcata tgtatatttt tagtctaata 660
ttgcctgggt gtctgagcaa gtctagatga atttaattgc tctcattttt cccctgcccc 720
tcttcctttg gtctctcttt taggaaatgt ttttctttca acattcgttt cattcattat 780
ttactcattc ggccaaccaa catttattga gtgccttccc tgtatcaggg acaggggctt 840
acaaagtaga atttgatccc acctctgccc tcagtagctc agtgtctaat ggaggtagtg 900
atgttcatta agcgtcgcca gatactgtgc taggtgctgt gcctgttctc tctcgcttgt 960
tcctcacaca cttgagaagg ccgaagctga ttcatagctt ggaaggcagg ggccttggat 1020
ttgaacccag gcctgaccaa tggcagaacc tatcagatgt gtggacagat gacattgcct 1080
ttctttcttt ggatatatca aaatcagcca gcaggcagga actcccattt tgagcaagca 1140
atgtgcagga atgatagggt atacagagag gaacaggaga tggcccctga cttccagcat 1200
gtgtctgatg gacatccagg ctgcaggcat catggtgctg tctagagaga tgagccaggt 1260
gcccagagcc catgggccaa tgctgccctt tcttgagcat gccaaacaaa gcggttggtg 1320
tgttagaggc acagtctcct ccactctaag taaaaatcag catgagtcct agcccacatt 1380
tccctagtga gtacaccaaa gatatctatg aactggcagt catcagtgac ttcctaaggt 1440
tccggaaatg catctcttac tcaggagtaa gcaatgatgt gcctgcggct ttacgagttc 1500
tcacagaatg actttctgga cccaaatgtt ttttctgctt caggactgtg aaggccttat 1560
tgttcgctct gccaccaagg tgaccgctga tgtcatcaac gcagctgaga aactccaggt 1620
ggtgggcagg gctggcacag gtgtggacaa tgtggatctg gaggccgcaa caaggaaggg 1680
catcttggtt atgaacaccc ccaatgggaa cagcctcagt gccgcagaac tcacttgtgg 1740
aatgatcatg tgcctggcca ggcagattcc ccaggcgacg gcttcgatga aggacggcaa 1800
atgggagcgg aagaagttca tgggaacaga gctgaatgga aagaccctgg gaattcttgg 1860
cctgggcagg attgggagag aggtagctac ccggatgcag tcctttggga tgaagactat 1920
agggtatgac cccatcattt ccccagaggt ctcggcctcc tttggtgttc agcagctgcc 1980
cctggaggag atctggcctc tctgtgattt catcactgtg cacactcctc tcctgccctc 2040
cacgacaggc ttgctgaatg acaacacctt tgcccagtgc aagaaggggg tgcgtgtggt 2100
gaactgtgcc cgtggaggga tcgtggacga aggcgccctg ctccgggccc tgcagtctgg 2160
ccagtgtgcc ggggctgcac tggacgtgtt tacggaagag ccgccacggg accgggcctt 2220
ggtggaccat gagaatgtca tcagctgtcc ccacctgggt gccagcacca aggaggctca 2280
gagccgctgt ggggaggaaa ttgctgttca gttcgtggac atggtgaagg ggaaatctct 2340
cacgggggtt gtgaatgccc aggcccttac cagtgccttc tctccacaca ccaagccttg 2400
gattggtctg gcagaagctc tggggacact gatgcgagcc tgggctgggt cccccaaagg 2460
gaccatccag gtgataacac agggaacatc cctgaagaat gctgggaact gcctaagccc 2520
cgcagtcatt gtcggcctcc tgaaagaggc ttccaagcag gcggatgtga acttggtgaa 2580
cgctaagctg ctggtgaaag aggctggcct caatgtcacc acctcccaca gccctgctgc 2640
accagggggg caaggcttcg gggaatgcct cctggccgtg gccctggcag gcgcccctta 2700
ccaggctgtg ggcttggtcc aaggcactac acctgtactg caggggctca atggagctgt 2760
cttcaggcca gaagtgcctc tccgcaggga cctgcccctg ctcctattcc ggactcagac 2820
ctctgaccct gcaatgctgc ctaccatgat tggcctcctg gcagaggcag gcgtgcggct 2880
gctgtcctac cagacttcac tggtgtcaga tggggagacc tggcacgtca tgggcatctc 2940
ctccttgctg cccagcctgg aagcgtggaa gcagcatgtg actgaagcct tccagttcca 3000
cttctaacct tggagctcac tggtccctgc ctctggggct tttctgaaga aacccaccca 3060
ctgtgatcaa tagggagaga aaatccacat tcttgggctg aacgcgagcc tctgacactg 3120
cttacactgc actctgaccc tgtagtacag caataaccgt ctaataaaga gcctaccccc 3180
<210> 145
<211> 1301
<212> DNA
<213>Homo sapiens
<220>
<221>Miscellaneous feature
<222> (1301)..(1301)
<223>N is a, c, g or t
<400> 145
caaacaaaaa cagccaagct tttctgccaa aaagatgact gagaagactg ttaaagcaaa 60
aagctctgtt cctgcctcag atgatgccta tccagaaata gaaaaattct ttcccttcaa 120
tcctctagac tttgagagtt ttgacctgcc tgaagagcac cagattgcgc acctcccctt 180
gagtggagtg cctctcatga tccttgacga ggagagagag cttgaaaagc tgtttcagct 240
gggcccccct tcacctgtga agatgccctc tccaccatgg gaatccaatc tgttgcagtc 300
tccttcaagc attctgtcga ccctggatgt tgaattgcca cctgtttgct gtgacataga 360
tatttaaatt tcttagtgct tcagagtctg tgtgtatttg tattaataaa gcattcttta 420
acagaaaaaa aaaaaaaaaa aaaaaaaaaa aaaaaaaaaa aaaaaaaaaa agggggggga 480
gacacaaaaa gaattcccca agagggggcc acaagataat cagaggatat cacacaagat 540
ctctcggcgc accaacgacg ggggccccaa ataagggaga gacccagaat cacaacagcc 600
aagacacggt ggacacgacg gaaacaaaca cacagcccag acacgggggc aaacacgcgc 660
gcacaccgcg gacaccatgg gacaaagcag acaccaccca caaaacaaca ccgcggaggg 720
ggaagaacaa caaaacaagt gcgcaaacag aacacaacca cagaaagaga aaaattaaaa 780
cggcccccaa gacggcgaca acacaacaaa acaaccacta cagagcgctc aacagccgag 840
taaaaacaca acaacggaca actaacacac aaaggaatga aacaaagcgg ggccacacac 900
cgacaccgga aatccggcga acaactcaca ccgagcgagg gtcccagaca acaaatacac 960
agacaacgaa accgagaaac aagaccagca agacgagcag gcaaaagaca aacaagacag 1020
aggagacgac gacgaacgca aaggacaaga ggacacaacg acgcgaggag cgagagcgag 1080
aggaagagac aacaaaaaga cacaaaagaa caacaagcaa gcagcgaaga acgacacaca 1140
accacacgag acagcaggag cagaggcgga gaaaacacaa cgagcaagcc aagaccaaga 1200
gaggagaaca aaataaaaaa atacgagagc aggcggacga gagcacgaga cgaacagaca 1260
aacgggaatc agaagcataa cgatccgcga cgcgaacaac n 1301
<210> 146
<211> 3203
<212> DNA
<213>Homo sapiens
<400> 146
gtgcaccctg tcccagccgt cctgtcctgg ctgctcgctc tgcttcgctg cgcctccact 60
atgctctccc tccgtgtccc gctcgcgccc atcacggacc cgcagcagct gcagctctcg 120
ccgctgaagg ggctcagctt ggtcgacaag gagaacacgc cgccggccct gagcgggacc 180
cgcgtcctgg ccagcaagac cgcgaggagg atcttccagg agaaaacccc cgccgctttg 240
tcatcttccc catcgagtac catgatatct ggcagatgta taagaaggca gaggcttcct 300
tttggaccgc cgaggaggtg gacctctcca aggacattca gcactgggaa tccctgaaac 360
ccgaggagag atattttata tcccatgttc tggctttctt tgcagcaagc gatggcatag 420
taaatgaaaa cttggtggag cgatttagcc aagaagttca gattacagaa gcccgctgtt 480
tctatggctt ccaaattgcc atggaaaaca tacattctga aatgtatagt cttcttattg 540
acacttacat aaaagatccc aaagaaaggg aatttctctt caatgccatt gaaacgatgc 600
cttgtgtcaa gaagaaggca gactgggcct tgcgctggat tggggacaaa gaggctacct 660
atggtgaacg tgttgtagcc tttgctgcag tggaaggcat tttcttttcc ggttcttttg 720
cgtcgatatt ctggctcaag aaacgaggac tgatgcctgg cctcacattt tctaatgaac 780
ttattagcag agatgagggt ttacactgtg attttgcttg cctgatgttc aaacacctgg 840
tacacaaacc atcggaggag agagtaagag aaataattat caatgctgtt cggatagaac 900
aggagttcct cactgaggcc ttgcctgtga agctcattgg gatgaattgc actctaatga 960
agcaatacat tgagtttgtg gcagacagac ttatgctgga actgggtttt agcaaggttt 1020
tcagagtaga gaacccattt gactttatgg agaatatttc actggaagga aagactaact 1080
tctttgagaa gagagtaggc gagtatcaga ggatgggagt gatgtcaagt ccaacagaga 1140
attcttttac cttggatgct gacttctaaa tgaactgaag atgtgccctt acttggctga 1200
tttttttttt tccatctcat aagaaaaatc agctgaagtg ttaccaacta gccacaccat 1260
gaattgtccg taatgttcat taacagcatc tttaaaactg tgtagctacc tcacaaccag 1320
tcctgtctgt ttatagtgct ggtagtatca ccttttgcca gaaggcctgg ctggctgtga 1380
cttaccatag cagtgacaat ggcagtcttg gctttaaagt gaggggtgac cctttagtga 1440
gcttagcaca gcgggattaa acagtccttt aaccagcaca gccagttaaa agatgcagcc 1500
tcactgcttc aacgcagatt ttaatgttta cttaaatata aacctggcac tttacaaaca 1560
aataaacatt gtttgtactc acaaggcgat aatagcttga tttatttggt ttctacacca 1620
aatacattct cctgaccact aatgggagcc aattcacaat tcactaagtg actaaagtaa 1680
gttaaacttg tgtagactaa gcatgtaatt tttaagtttt attttaatga attaaaatat 1740
ttgttaacca actttaaagt cagtcctgtg tatacctaga tattagtcag ttggtgccag 1800
atagaagaca ggttgtgttt ttatcctgtg gcttgtgtag tgtcctggga ttctctgccc 1860
cctctgagta gagtgttgtg ggataaagga atctctcagg gcaaggagct tcttaagtta 1920
aatcactaga aatttagggg tgatctgggc cttcatatgt gtgagaagcc gtttcatttt 1980
atttctcact gtattttcct caacgtctgg ttgatgagaa aaaattcttg aagagttttc 2040
atatgtggga gctaaggtag tattgtaaaa tttcaagtca tccttaaaca aaatgatcca 2100
cctaagatct tgcccctgtt aagtggtgaa atcaactaga ggtggttcct acaagttgtt 2160
cattctagtt ttgtttggtg taagtaggtt gtgtgagtta attcatttat atttactatg 2220
tctgttaaat cagaaatttt ttattatcta tgttcttcta gattttacct gtagttcata 2280
cttcagtcac ccagtgtctt attctggcat tgtctaaatc tgagcattgt ctagggggat 2340
cttaaacttt agtaggaaac catgagctgt taatacagtt tccattcaaa tattaatttc 2400
agaatgaaac ataatttttt tttttttttt ttgagatgga gtctcgctct gttgcccagg 2460
ctggagtgca gtggcgcgat tttggctcac tgtaacctcc atctcctggg ttcaagcaat 2520
tctcctgtct cagcctccct agtagctggg actgcaggta tgtgctacca cacctggcta 2580
atttttgtat ttttagtaga gatggagttt caccatattg gtcaggctgg tcttgaactc 2640
ctgacctcag gtgatccacc cacctcggcc tcccaaagtg ctgggattgc aggcgtgata 2700
aacaaatatt cttaataggg ctactttgaa ttaatctgcc tttatgtttg ggagaagaaa 2760
gctgagacat tgcatgaaag atgatgagag ataaatgttg atcttttggc cccatttgtt 2820
aattgtattc agtatttgaa cgtcgtcctg tttattgtta gttttcttca tcatttattg 2880
tatagacaat ttttaaatct ctgtaatatg atacattttc ctatctttta agttattgtt 2940
acctaaagtt aatccagatt atatggtcct tatatgtgta caacattaaa atgaaaggct 3000
ttgtcttgca ttgtgaggta caggcggaag ttggaatcag gttttaggat tctgtctctc 3060
attagctgaa taatgtgagg attaacttct gccagctcag accatttcct aatcagttga 3120
aagggaaaca agtatttcag tctcaaaatt gaataatgca caagtcttaa gtgattaaaa 3180
taaaactgtt cttatgtcag ttt 3203
<210> 147
<211> 4482
<212> DNA
<213>Homo sapiens
<400> 147
agcgggggca ctccagccct gcagcctccg gagtcagtgc cgcgcgcccg ccgccccgcg 60
ccttcctgct cgccgcacct ccgggagccg gggcgcaccc agcccgcagc gccgcctccc 120
cgcccgcgcc gcctccgacc gcaggccgag ggccgccact ggccgggggg accgggcagc 180
agcttgcggc cgcggagccg ggcaacgctg gggactgcgc cttttgtccc cggaggtccc 240
tggaagtttg cggcaggacg cgcgcgggga ggcggcggag gcagccccga cgtcgcggag 300
aacagggcgc agagccggca tgggcatcgg gcgcagcgag gggggccgcc gcggggcagc 360
cctgggcgtg ctgctggcgc tgggcgcggc gcttctggcc gtgggctcgg ccagcgagta 420
cgactacgtg agcttccagt cggacatcgg cccgtaccag agcgggcgct tctacaccaa 480
gccacctcag tgcgtggaca tccccgcgga cctgcggctg tgccacaacg tgggctacaa 540
gaagatggtg ctgcccaacc tgctggagca cgagaccatg gcggaggtga agcagcaggc 600
cagcagctgg gtgcccctgc tcaacaagaa ctgccacgcc ggcacccagg tcttcctctg 660
ctcgctcttc gcgcccgtct gcctggaccg gcccatctac ccgtgtcgct ggctctgcga 720
ggccgtgcgc gactcgtgcg agccggtcat gcagttcttc ggcttctact ggcccgagat 780
gcttaagtgt gacaagttcc ccgaggggga cgtctgcatc gccatgacgc cgcccaatgc 840
caccgaagcc tccaagcccc aaggcacaac ggtgtgtcct ccctgtgaca acgagttgaa 900
atctgaggcc atcattgaac atctctgtgc cagcgagttt gcactgagga tgaaaataaa 960
agaagtgaaa aaagaaaatg gcgacaagaa gattgtcccc aagaagaaga agcccctgaa 1020
gttggggccc atcaagaaga aggacctgaa gaagcttgtg ctgtacctga agaatggggc 1080
tgactgtccc tgccaccagc tggacaacct cagccaccac ttcctcatca tgggccgcaa 1140
ggtgaagagc cagtacttgc tgacggccat ccacaagtgg gacaagaaaa acaaggagtt 1200
caaaaacttc atgaagaaaa tgaaaaacca tgagtgcccc acctttcagt ccgtgtttaa 1260
gtgattctcc cgggggcagg gtggggaggg agcctcgggt ggggtgggag cgggggggac 1320
agtgccccgg gaacccggtg ggtcacacac acgcactgcg cctgtcagta gtggacattt 1380
aatccagtcg gcttgttctt gcagcattcc cgctcccttc cctccatagc cacgctccaa 1440
accccagggt agccatggcc gggtaaagca agggccattt agattaggaa ggtttttaag 1500
atccgcaatg tggagcagca gccactgcac aggaggaggt gacaaaccat ttccaacagc 1560
aacacagcca ctaaaacaca aaaaggggga ttgggcggaa agtgagagcc agcagcaaaa 1620
actacatttt gcaacttgtt ggtgtggatc tattggctga tctatgcctt tcaactagaa 1680
aattctaatg attggcaagt cacgttgttt tcaggtccag agtagtttct ttctgtctgc 1740
tttaaatgga aacagactca taccacactt acaattaagg tcaagcccag aaagtgataa 1800
gtgcagggag gaaaagtgca agtccattat gtaatagtga cagcaaaggg accaggggag 1860
aggcattgcc ttctctgccc acagtctttc cgtgtgattg tctttgaatc tgaatcagcc 1920
agtctcagat gccccaaagt ttcggttcct atgagcccgg ggcatgatct gatccccaag 1980
acatgtggag gggcagcctg tgcctgcctt tgtgtcagaa aaaggaaacc acagtgagcc 2040
tgagagagac ggcgattttc gggctgagaa ggcagtagtt ttcaaaacac atagttaaaa 2100
aagaaacaaa tgaaaaaaat tttagaacag tccagcaaat tgctagtcag ggtgaattgt 2160
gaaattgggt gaagagctta cgattctaat ctcatgtttt ttccttttca catttttaaa 2220
agaacaatga caaacaccca cttatttttc aaggttttaa aacagtctac attgagcatt 2280
tgaaaggtgt gctagaacaa ggtctcctga tccgtccgag gctgcttccc agaggagcag 2340
ctctccccag gcatttgcca agggaggcgg atttccctgg tagtgtagct gtgtggcttt 2400
ccttcctgaa gagtccgtgg ttgccctaga acctaacacc ccctagcaaa actcacagag 2460
ctttccgttt ttttctttcc tgtaaagaaa catttccttt gaacttgatt gcctatggat 2520
caaagaaatt cagaacagcc tgcctgtccc cccgcacttt ttacatatat ttgtttcatt 2580
tctgcagatg gaaagttgac atgggtgggg tgtccccatc cagcgagaga gtttaaaaag 2640
caaaacatct ctgcagtttt tcccaagtgc cctgagatac ttcccaaagc ccttatgttt 2700
aatcagcgat gtatataagc cagttcactt agacaacttt acccttcttg tccaatgtac 2760
aggaagtagt tctaaaaaaa atgcatatta atttcttccc ccaaagccgg attcttaatt 2820
ctctgcaaca ctttgaggac atttatgatt gtccctctgg gccaatgctt atacccagtg 2880
aggatgctgc agtgaggctg taaagtggcc ccctgcggcc ctagcctgac ccggaggaaa 2940
ggatggtaga ttctgttaac tcttgaagac tccagtatga aaatcagcat gcccgcctag 3000
ttacctaccg gagagttatc ctgataaatt aacctctcac agttagtgat cctgtccttt 3060
taacaccttt tttgtggggt tctctctgac ctttcatcgt aaagtgctgg ggaccttaag 3120
tgatttgcct gtaattttgg atgattaaaa aatgtgtata tatattagct aattagaaat 3180
attctacttc tctgttgtca aactgaaatt cagagcaagt tcctgagtgc gtggatctgg 3240
gtcttagttc tggttgattc actcaagagt tcagtgctca tacgtatctg ctcattttga 3300
caaagtgcct catgcaaccg ggccctctct ctgcggcaga gtccttagtg gaggggttta 3360
cctggaacat tagtagttac cacagaatac ggaagagcag gtgactgtgc tgtgcagctc 3420
tctaaatggg aattctcagg taggaagcaa cagcttcaga aagagctcaa aataaattgg 3480
aaatgtgaat cgcagctgtg ggttttacca ccgtctgtct cagagtccca ggaccttgag 3540
tgtcattagt tactttattg aaggttttag acccatagca gctttgtctc tgtcacatca 3600
gcaatttcag aaccaaaagg gaggctctct gtaggcacag agctgcacta tcacgagcct 3660
ttgtttttct ccacaaagta tctaacaaaa ccaatgtgca gactgattgg cctggtcatt 3720
ggtctccgag agaggaggtt tgcctgtgat ttcctaatta tcgctagggc caaggtggga 3780
tttgtaaagc tttacaataa tcattctgga tagagtcctg ggaggtcctt ggcagaactc 3840
agttaaatct ttgaagaata tttgtagtta tcttagaaga tagcatggga ggtgaggatt 3900
ccaaaaacat tttattttta aaatatcctg tgtaacactt ggctcttggt acctgtgggt 3960
tagcatcaag ttctccccag ggtagaattc aatcagagct ccagtttgca tttggatgtg 4020
taaattacag taatcccatt tcccaaacct aaaatctgtt tttctcatca gactctgagt 4080
aactggttgc tgtgtcataa cttcatagat gcaggaggct caggtgatct gtttgagcag 4140
agcaccctag gcagcctgca gggaataaca tactggccgt tctgacctgt tgccagcaga 4200
tacacaggac atggatgaaa ttcccgtttc ctctagtttc ttcctgtagt actcctcttt 4260
tagatcctaa gtctcttaca aaagctttga atactgtgaa aatgttttac attccatttc 4320
atttgtgttg tttttttaac tgcattttac cagatgtttt gatgttatcg cttatgttaa 4380
tagtaattcc cgtacgtgtt cattttattt tcatgctttt tcagccatgt atcaatattc 4440
acttgactaa aatcactcaa ttaatcaaaa aaaaaaaaaa aa 4482
<210> 148
<211> 3637
<212> DNA
<213>Homo sapiens
<400> 148
agtcctgggc gaagggggcg gtggttcccc gcggcgctgc gcgcggcggt aattagtgat 60
tgtcttccag cttcgcgaag gctaggggcg cggctgccgg gtggctgcgc ggcgctgccc 120
ccggaccgag gggcagccaa cccaatgaaa ccaccgcgtg ttcgcgcctg gtagagattt 180
ctcgaagaca ccagtgggcc cgttccgagc cctctggacc gcccgtgtgg aaccaaacct 240
gcgcgcgtgg ccgggccgtg ggacaacgag gccgcggaga cgaaggcgca atggcgagga 300
agttatctgt aatcttgatc ctgacctttg ccctctctgt cacaaatccc cttcatgaac 360
taaaagcagc tgctttcccc cagaccactg agaaaattag tccgaattgg gaatctggca 420
ttaatgttga cttggcaatt tccacacggc aatatcatct acaacagctt ttctaccgct 480
atggagaaaa taattctttg tcagttgaag ggttcagaaa attacttcaa aatataggca 540
tagataagat taaaagaatc catatacacc atgaccacga ccatcactca gaccacgagc 600
atcactcaga ccatgagcgt cactcagacc atgagcatca ctcagaccac gagcatcact 660
ctgaccatga tcatcactct caccataatc atgctgcttc tggtaaaaat aagcgaaaag 720
ctctttgccc agaccatgac tcagatagtt caggtaaaga tcctagaaac agccagggga 780
aaggagctca ccgaccagaa catgccagtg gtagaaggaa tgtcaaggac agtgttagtg 840
ctagtgaagt gacctcaact gtgtacaaca ctgtctctga aggaactcac tttctagaga 900
caatagagac tccaagacct ggaaaactct tccccaaaga tgtaagcagc tccactccac 960
ccagtgtcac atcaaagagc cgggtgagcc ggctggctgg taggaaaaca aatgaatctg 1020
tgagtgagcc ccgaaaaggc tttatgtatt ccagaaacac aaatgaaaat cctcaggagt 1080
gtttcaatgc atcaaagcta ctgacatctc atggcatggg catccaggtt ccgctgaatg 1140
caacagagtt caactatctc tgtccagcca tcatcaacca aattgatgct agatcttgtc 1200
tgattcatac aagtgaaaag aaggctgaaa tccctccaaa gacctattca ttacaaatag 1260
cctgggttgg tggttttata gccatttcca tcatcagttt cctgtctctg ctgggggtta 1320
tcttagtgcc tctcatgaat cgggtgtttt tcaaatttct cctgagtttc cttgtggcac 1380
tggccgttgg gactttgagt ggtgatgctt ttttacacct tcttccacat tctcatgcaa 1440
gtcaccacca tagtcatagc catgaagaac cagcaatgga aatgaaaaga ggaccacttt 1500
tcagtcatct gtcttctcaa aacatagaag aaagtgccta ttttgattcc acgtggaagg 1560
gtctaacagc tctaggaggc ctgtatttca tgtttcttgt tgaacatgtc ctcacattga 1620
tcaaacaatt taaagataag aagaaaaaga atcagaagaa acctgaaaat gatgatgatg 1680
tggagattaa gaagcagttg tccaagtatg aatctcaact ttcaacaaat gaggagaaag 1740
tagatacaga tgatcgaact gaaggctatt tacgagcaga ctcacaagag ccctcccact 1800
ttgattctca gcagcctgca gtcttggaag aagaagaggt catgatagct catgctcatc 1860
cacaggaagt ctacaatgaa tatgtaccca gagggtgcaa gaataaatgc cattcacatt 1920
tccacgatac actcggccag tcagacgatc tcattcacca ccatcatgac taccatcata 1980
ttctccatca tcaccaccac caaaaccacc atcctcacag tcacagccag cgctactctc 2040
gggaggagct gaaagatgcc ggcgtcgcca ctctggcctg gatggtgata atgggtgatg 2100
gcctgcacaa tttcagcgat ggcctagcaa ttggtgctgc ttttactgaa ggcttatcaa 2160
gtggtttaag tacttctgtt gctgtgttct gtcatgagtt gcctcatgaa ttaggtgact 2220
ttgctgttct actaaaggct ggcatgaccg ttaagcaggc tgtcctttat aatgcattgt 2280
cagccatgct ggcgtatctt ggaatggcaa caggaatttt cattggtcat tatgctgaaa 2340
atgtttctat gtggatattt gcacttactg ctggcttatt catgtatgtt gctctggttg 2400
atatggtacc tgaaatgctg cacaatgatg ctagtgacca tggatgtagc cgctgggggt 2460
atttcttttt acagaatgct gggatgcttt tgggttttgg aattatgtta cttatttcca 2520
tatttgaaca taaaatcgtg tttcgtataa atttctagtt aaggtttaaa tgctagagta 2580
gcttaaaaag ttgtcatagt ttcagtaggt catagggaga tgagtttgta tgctgtacta 2640
tgcagcgttt aaagttagtg ggttttgtga tttttgtatt gaatattgct gtctgttaca 2700
aagtcagtta aaggtacgtt ttaatattta agttattcta tcttggagat aaaatctgta 2760
tgtgcaattc accggtatta ccagtttatt atgtaaacaa gagatttggc atgacatgtt 2820
ctgtatgttt cagggaaaaa tgtctttaat gctttttcaa gaactaacac agttattcct 2880
atactggatt ttaggtctct gaagaactgc tggtgtttag gaataagaat gtgcatgaag 2940
cctaaaatac caagaaagct tatactgaat ttaagcaaag aaataaagga gaaaagagaa 3000
gaatctgaga attggggagg catagattct tataaaaatc acaaaatttg ttgtaaatta 3060
gaggggagaa atttagaatt aagtataaaa aggcagaatt agtatagagt acattcatta 3120
aacatttttg tcaggattat ttcccgtaaa aacgtagtga gcacttttca tatactaatt 3180
tagttgtaca tttaactttg tataatacag aaatctaaat atatttaatg aattcaagca 3240
atatatcact tgaccaagaa attggaattt caaaatgttc gtgcgggtat ataccagatg 3300
agtacagtga gtagttttat gtatcaccag actgggttat tgccaagtta tatatcacca 3360
aaagctgtat gactggatgt tctggttacc tggtttacaa aattatcaga gtagtaaaac 3420
tttgatatat atgaggatat taaaactaca ctaagtatca tttgattcga ttcagaaagt 3480
actttgatat ctctcagtgc ttcagtgcta tcattgtgag caattgtctt ttatatacgg 3540
tactgtagcc atactaggcc tgtctgtggc attctctaga tgtttctttt ttacacaata 3600
aattccttat atcagcttga aaaaaaaaaa aaaaaaa 3637
<210> 149
<211> 2208
<212> DNA
<213>Homo sapiens
<400> 149
aacgcacttg gcgcgcggcg cgggctgcag acggctgcga ggcgctgggc acaggtgtcc 60
tgatggcaaa tttcaagggc cacgcgcttc cagggagttt cttcctgatc attgggctgt 120
gttggtcagt gaagtacccg ctgaagtact ttagccacac gcggaagaac agcccactac 180
attactatca gcgtctcgag atcgtcgaag ccgcaattag gactttgttt tccgtcactg 240
ggatcctggc agagcagttt gttccggatg ggccccacct gcacctctac catgagaacc 300
actggataaa gttaatgaat tggcagcaca gcaccatgta cctattcttt gcagtctcag 360
gaattgttga catgctcacc tatctggtca gccacgttcc cttgggggtg gacagactgg 420
ttatggctgt ggcagtattc atggaaggtt tcctcttcta ctaccacgtc cacaaccggc 480
ctccgctgga ccagcacatc cactcactcc tgctgtatgc tctgttcgga gggtgtgtta 540
gtatctccct agaggtgatc ttccgggacc acattgtgct ggaacttttc cgaaccagtc 600
tcatcattct tcagggaacc tggttctggc agattgggtt tgtgctgttc ccaccttttg 660
gaacacccga atgggaccag aaggatgatg ccaacctcat gttcatcacc atgtgcttct 720
gctggcacta cctggctgcc ctcagcattg tggccgtcaa ctattctctt gtttactgcc 780
ttttgactcg gatgaagaga cacggaaggg gagaaatcat tggaattcag aagctgaatt 840
cagatgacac ttaccagacc gccctcttga gtggctcaga tgaggaatga gccgagatgc 900
ggagggcgca gatgtcccac tgcacagctg gaatgaatgg agttcatccc ctccacctga 960
atgcctgctg tggtctgatc ttaagggtct atatatttgc acctcctcat tcaacacagg 1020
gctggaggtt ctacaacagg aaatcaggcc tacagcatcc tgtgtatctt gcagttggga 1080
tttttaaaca tactataaag tctgtgttgg tatagtaccc ttcataagga aaaatgaagt 1140
aatgcctata agtagcaggc ctttgtgcct cagtgtcaag agaaatcaag agatgctaaa 1200
agctttacaa tggaagtggc ctcatggatg aatccggggt atgagcccag gagaacgtgc 1260
tgcttttggt aacttatccc tttttctctt aagaaagcag gtactttctt attagaaata 1320
tgttagaatg tgtaagcaaa cgacagtgcc tttagaatta caattctaac ttacatattt 1380
tttgaaagta aaataattca caagctttgg tattttaaaa ttattgttaa acatatcata 1440
actaatcata ccagggtact gcaataccac tgtttataag tgacaaaatt aggccaaagg 1500
tgattttttt ttaaatcagg aagctggtta ctggctctac tgagagttgg agccctgatg 1560
ttctgattct tcaaagtcac cctaaaagaa gatctgacag gaaagctgta taatgagata 1620
gaaaaacgtc aggtatggaa ggctttcagt tttaatatgg ctgaaagcaa aggataacga 1680
attcagaatt agtaatgtaa aatcttgata ccctaatctt gcttctggat ctgttctttt 1740
tttaaaaaaa cttccttcac cgcgcctata atcctagcac tttgggaggc cgaggcaggc 1800
agatcacggg gtcaggagat caagaccatc ctggctaaca tggtgaaacc ccgtctctac 1860
tgaaaataca aaaaattagc cgggtgtggt ggcgggcgcc tgtagttcca gctactcggg 1920
aggctgaggc aagagaatgg catgaacccg gtaggggagc ttgcagtgag cccagatcat 1980
gccactgtac tccagcctag gtgacagagc aagactctgt ctcaaaaaca agcaaacaga 2040
cttccttcaa caaatattta ttaaatatcc actttgcaac agcactgaaa tggctgtaag 2100
gactcctgag atatgtgtcc agcaaggagt ttacagtcaa acaggagaga catgcctgta 2160
gttacatcca gtgtgatggg tgctgagagg caagtacaaa ccacgatg 2208
<210> 150
<211> 1678
<212> DNA
<213>Homo sapiens
<220>
<221>Miscellaneous feature
<222> (523)..(523)
<223>N is a, c, g or t
<220>
<221>Miscellaneous feature
<222> (569)..(569)
<223>N is a, c, g or t
<220>
<221>Miscellaneous feature
<222> (961)..(961)
<223>N is a, c, g or t
<220>
<221>Miscellaneous feature
<222> (1021)..(1021)
<223>N is a, c, g or t
<220>
<221>Miscellaneous feature
<222> (1066)..(1066)
<223>N is a, c, g or t
<220>
<221>Miscellaneous feature
<222> (1069)..(1069)
<223>N is a, c, g or t
<220>
<221>Miscellaneous feature
<222> (1194)..(1194)
<223>N is a, c, g or t
<220>
<221>Miscellaneous feature
<222> (1202)..(1202)
<223>N is a, c, g or t
<220>
<221>Miscellaneous feature
<222> (1287)..(1287)
<223>N is a, c, g or t
<220>
<221>Miscellaneous feature
<222> (1472)..(1472)
<223>N is a, c, g or t
<400> 150
tcccgccgcg ccacttcgcc tgcctccgtc ccccgcccgc cgcgccatgc ctgtggccgg 60
ctcggagctg ccgcgccggc ccttgccccc cgccgcacag gagcgggacg ccgagccgcg 120
tccgccgcac ggggagctgc agtacctggg gcagatccaa cacatcctcc gctgcggcgt 180
caggaaggac gcccgcccgg gcaccggtac cctgccggta ttcggcatgc aggcgcgcta 240
cagcctgaga gatgaattcc ctctgctgac aaccaaacgt gtgttctgga acggtgcttc 300
ggaggagctg ctgtggctta tcaagggatc cacaaacgct atagacctgt cttccccggc 360
agcgaaaatc tcgggatgcc actggatccc gacactctct ggacaccctg ggattctcca 420
ccagagaaga acgcgacttg ggcccagttt gtggctctca gcggaggcct cctgtggcag 480
aatacataca tttccaatca gatcacttcc cggacacgga ccntgaccag cctgccaaaa 540
agtggatttc cccccacccc agaacccanc ccctgacgca cagaaaccaa cccattcgtt 600
gttgccgcct tgcgaacccc aaccagaatc tctcccccct ggccggcgcg cctgccgctg 660
ccaatgcccc tatggcggcc tcttggcccg caccttccaa ttggtcgccc tgcgcaacca 720
gcgagaaaac actggcccgc ccgtctcccc cccgctccgc ctaccccact taatgcgcct 780
ccgtggcatg acgcacgcgt ttggtgtccg ccgccgtctc atgtccgcgc ggtgtggacc 840
cccttttctc tcgcggcaca tcccccctat tcccttgccc tttggggggc accccctcta 900
gacccgcgct tctcttctcg tccggtgggg gacattggtt tgcctgccgc ggcgggggcg 960
ntaaaaataa aaacagcctg ttagcccggc ccagtacccc cccccggccg gggccgcctt 1020
ncgtttgcat ttatacccca acccataaag ccgcgcccct ttagcnccnt aacttttgtg 1080
gtgtggcctc cccccttttt cccggggagc agcaacggac atctgtacac taatgctggc 1140
cccgaccttt cccaaaaacc ccccgcccgt gtcccgtata aatttggtgc caancctgac 1200
gngttctccc ccgccctcgc cccgttggcc gcccgtttaa agcccccccg gtggttgcgc 1260
cgcccaacga gtccacctat agttaantcc accaacaccc ccaccttttc ctccccgccg 1320
catcttcccc acgtaccccc ttttgtcgcg agatggccac tccccccccc ctgtttgttt 1380
aaaacaacga gaatggtgct gccaacgctg gtcttttccc cccccggacc gcgaccgcca 1440
gggggaatac gtaccataag cccccgcgcc cncctttttt cccccctccc cgccaatcaa 1500
gatccgccgt ccattagacg tattattttt cccgcgatac acgaaaaaac agggccgccc 1560
atttataact aaattcccgt cgccgccgcg cggatatgtt tcccaaaata ccaccccccc 1620
ccccccattt tctttgcccc caactcctgc gcaccggtgt tcaccagcct cgcgccgc 1678
<210> 151
<211> 1611
<212> DNA
<213>Homo sapiens
<400> 151
ggacgcgtgg gtcgacccac gcgtccggac ccacgcgtcc ggtcgtgttc tccgagttcc 60
tgtctctctg ccaacgccgc ccggatggct tcccaaaacc gcgacccagc cgccactagc 120
gtcgccgccg cccgtaaagg agctgagccg agcgggggcg ccgcccgggg tccggtgggc 180
aaaaggctac agcaggagct gatgaccctc atggtgagtg attaagtgcc cagaacccca 240
gccttccatc caattttcag tagcctcctt ttttccgtca gcttttttgc tagacatagg 300
ggtaatgtaa tttgctccct cctgggaaag aagttcatac accccaccta caccatttct 360
tccagcagtc cctcctccca attccatccc cccacacgaa gttatctcga acacttccct 420
gaagtcatac aagaccctcc ctatccagtg tgtccctact tcctagcccc aaccaagctt 480
tacccacacc caactccccg cccttcttgg tatttctagc ctatgaattt ggttgcttta 540
ttttggatca gagtgatgag attaagggga ggctgggcgc ggtagctcac accttataat 600
cccaaagtgc tgggattaca ggcgtgagcc accgcgcccg gccagcaact aatattctaa 660
ttgaactaaa gcacaggatg ccaatttaca atccttagac caaagagtca ctgatgtctc 720
caccagataa gaggaaagca tcaggctagg catagtggct cacacctgta atctcagcac 780
tttgggaggc tgaggcaggc agatcacatg agcccaggag tttgagactg gcctgggcaa 840
catggtgaaa ccctgtctct aaaataaaaa ctaaactaaa aaaacttttt aaaaaggcag 900
tggggagcat cagaaccagc tcaacagttt gtctactgtc cggtcccaga gaaactcaag 960
attctagcaa gccccttgtg tggggcttgg gttgggacat gaggctgctg ctggagctta 1020
ctctgcaact gtttctccaa atgccaggta tatgaagacc tgaggtataa gctctcgcta 1080
gagttcccca gtggctaccc ttacaatgcg cccacagtga agttcctcac gccctgctat 1140
caccccaacg tggacaccca gggtaacata tgcctggaca tcctgaagga aaagtggtct 1200
gccctgtatg atgtcaggac cattctgctc tccatccaga gccttctagg agaacccaac 1260
attgatagtc ccttgaacac acatgctgcc gagctctgga aaaaccccac agcttttaag 1320
aagtacctgc aagaaaccta ctcaaagcag gtcaccagcc aggagccctg acccaggctg 1380
cccagcctgt ccttgtgtcg tctttttaat ttttccttag atggtctgtc ctttttgtga 1440
tttctgtata ggactcttta tcttgagctg tggtattttt gttttgtttt tgtcttttaa 1500
attaagcctc ggttgagccc ttgtatatta aataaatgca tttttgtcct tttttaaaaa 1560
aaaaataaaa aaaaaaaaaa aaaaaaaaaa aaaaaaaaaa aaaaaaaaaa a 1611

Claims (80)

1. screening the method for the treatment for triple negative breast cancer, the treatment is described comprising androgen receptor inhibitor is used Method includes determining the biological sample obtained from subject, to determine whether the biological sample obtained from subject is classified as base Original pattern hypotype or another hypotype.
2. according to the method described in claim 1, wherein determining the biological sample to determine whether the biological sample is divided Class is that substrate sample hypotype or another hypotype are carried out by detecting the expression of the intrinsic gene set shown in table 1.
3. method according to claim 2, including:
(a) the substrate barycenter grader score of sample is determined from the expression of the intrinsic gene set shown in table 1;
(b) the tube chamber A barycenter grader scores of sample are determined from the expression of the intrinsic gene set shown in table 1;With
(c) substrate of weighting is calculated from substrate barycenter grader score and tube chamber A barycenter graders score according to following equation With tube chamber A grader scores:
(tube chamber A barycenter is classified for the substrate of weighting and tube chamber A graders score=- 0.25 (substrate barycenter grader score)+0.27 Device score)
If the substrate and tube chamber A graders score of wherein weighting are more than -0.3, obtained with the substrate and tube chamber A graders of weighting Divide and compared less than or equal to -0.3, the breast cancer treatment comprising androgen receptor inhibitor is more likely effective in subject 's.
4. method according to claim 3, if wherein the substrate and tube chamber A graders score of weighting are more than -0.2, Compared with the substrate and tube chamber A graders score of weighting are less than or equal to -0.2, include the breast cancer of androgen receptor inhibitor Treatment is more likely effective in subject.
5. method according to claim 4, if wherein the substrate and tube chamber A graders score of weighting are more than -0.25, Compared with the substrate and tube chamber A graders score of weighting are less than or equal to -0.25, the breast cancer comprising androgen receptor inhibitor Treatment is more likely effective in subject.
6. method according to claim 2, includes the substrate matter of the expression determination sample from the intrinsic gene set shown in table 1 Heart grader score, if wherein substrate barycenter grader score be less than or equal to 0.9, it is big with substrate barycenter grader score Compared in 0.9, the breast cancer treatment comprising androgen receptor inhibitor is more likely effective when treating subject.
7. method according to claim 6, if wherein the substrate barycenter grader score is less than or equal to 0.6, Breast cancer treatment comprising androgen receptor inhibitor is probably effective when treating subject.
8. method according to claim 6, if wherein scope of the substrate barycenter grader score 0.2 to 0.8 Interior, then the breast cancer treatment comprising androgen receptor inhibitor is probably effective when treating subject.
9. method according to claim 8, if wherein scope of the substrate barycenter grader score 0.4 to 0.7 Interior, then the breast cancer treatment comprising androgen receptor inhibitor is probably effective when treating subject.
10. method according to any one of claim 1 to 9, wherein the breast cancer of the subject is characterised by male The presence of hormone receptor positive tumors cell.
11. method according to any one of claim 1 to 10, wherein the biological sample is selected from cell, tissue and body Liquid.
12. method according to claim 11, wherein the biological sample includes breast tissue or cell.
13. method according to claim 11, wherein the tissue is obtained from biopsy.
14. method according to claim 11, wherein the body fluid is selected from blood, lymph, urine, saliva, from conduit The liquid of irrigating solution, and nipple aspirate.
15. androgen receptor inhibitor, it is used to treat the triple negative breast cancer in subject, wherein it has been determined that from institute The biological sample of subject is stated to determine whether sample is classified as substrate sample hypotype or another hypotype.
16. the purposes of inhibitor according to claim 15, wherein determining the biological sample to determine the biological sample Whether product are classified as substrate sample hypotype or another hypotype by the expression of the intrinsic gene shown in detection table 1 to carry out.
17. the purposes of inhibitor according to claim 16, including the expression of the intrinsic gene set shown in table 1 are determined The substrate barycenter grader score and tube chamber A barycenter grader scores of sample, and classified according to following equation from substrate barycenter Device score and tube chamber A barycenter graders score calculate the substrate and tube chamber A grader scores of weighting:
(tube chamber A barycenter is classified for the substrate of weighting and tube chamber A graders score=- 0.25 (substrate barycenter grader score)+0.27 Device score)
If the substrate and tube chamber A graders score of wherein weighting are more than -0.3, breast cancer treatment is applied to subject.
18. the purposes of inhibitor according to claim 17, if wherein the substrate and tube chamber A grader scores of weighting are big In -0.2, then using breast cancer treatment.
19. the purposes of inhibitor according to claim 18, if wherein the substrate and tube chamber A grader scores of weighting are big In -0.25, then using breast cancer treatment.
20. the purposes of inhibitor according to claim 16, including determine sample from the expression of the intrinsic gene set shown in table 1 The substrate barycenter grader score of product, if wherein substrate barycenter grader score is less than or equal to 0.9, administration breast cancer is controlled Treat.
21. the purposes of inhibitor according to claim 20, if wherein substrate barycenter grader score is less than or equal to 0.6, then using breast cancer treatment.
22. the purposes of inhibitor according to claim 20, wherein, if substrate barycenter grader score is 0.2 to 0.8 In the range of, then using breast cancer treatment.
23. the purposes of inhibitor according to claim 22, if wherein substrate barycenter grader score is 0.4 to 0.7 In the range of, then using breast cancer treatment.
24. the purposes of the inhibitor according to any one of claim 15 to 23, wherein the breast cancer of the subject It is characterised by the presence of androgen receptor positive tumor cell.
25. the purposes of the inhibitor according to any one of claim 15 to 24, wherein the androgen receptor inhibitor It is selected from:The miscellaneous Shandong amine of grace, Bicalutamide, Flutamide, Nilutamide, ARN509, ketoconazole, abiraterone acetate, VN/124-1 (TOK-001), orteronel (TAK-700), Finasteride, galeterone, CPA, andarine, Yi Jiqi Combination.
26. the purposes of inhibitor according to claim 25, wherein the androgen receptor inhibitor is the miscellaneous Shandong amine of grace.
27. the purposes of inhibitor according to claim 26, wherein the miscellaneous Shandong amine of the grace is oral daily once, dosage is 160mg。
28. the purposes of inhibitor according to claim 27, wherein the miscellaneous Shandong amine of the grace is as including the miscellaneous Shandong amine of 160mg grace Single capsule apply.
29. the purposes of inhibitor according to claim 27, wherein the miscellaneous Shandong amine of the grace is applied in the form of four capsules, Each capsule includes the miscellaneous Shandong amine of 40mg grace.
30. the purposes of the inhibitor according to any one of claim 15 to 29, wherein including androgen receptor inhibitor Breast cancer treatment also comprising one or more be not androgen receptor inhibitor other anticancers.
31. the purposes of inhibitor according to claim 30, suppresses wherein the one or more are not androgen receptors Other anticancers of agent are selected from endoxan, fluorouracil, 5 FU 5 fluorouracil, methotrexate (MTX), thiotepa, carboplatin, cis-platinum, Japanese yew Alkane, taxol, the taxol that protein is combined, docetaxel, vinorelbine, TAM, Raloxifene, Toremifene, fluorine Dimension department group, gemcitabine, Irinotecan, Ipsapirone, Temozolomide, TPT, vincristine, vinblastine, Ai Bu Woods, mutamycin, capecitabine, capecitabine, Anastrozole, Exemestane, Letrozole, Leuprorelin, abarelix, Bath Woods, Goserelin, megestrol acetate, Risedronate, Pamidronate, ibandronate, Alendronate, ground promise list Resist, zoledronate, Herceptin, Lapatinib or Avastin, with and combinations thereof.
32. purposes according to claim 31, wherein described is not that other anticancers of androgen receptor inhibitor are purple China fir alcohol.
33. the purposes of the inhibitor according to any one of claim 15 to 32, wherein the biological sample be selected from cell, Tissue and body fluid.
34. the purposes of inhibitor according to claim 33, wherein the biological sample includes breast tissue or cell.
35. the purposes of inhibitor according to claim 33, wherein the tissue is obtained from biopsy.
36. the purposes of inhibitor according to claim 33, wherein the body fluid be selected from blood, lymph, urine, saliva, Liquid from ductal lavage fluid, and nipple aspirate.
37. treating the method for the triple negative breast cancer in subject, the subject has comprising having been classified as not being base The breast cancer of the breast cancer cell of original pattern hypotype, methods described includes applying the breast comprising androgen receptor inhibitor to subject Gland cancer is treated, so as to treat the triple negative breast cancer in subject.
38. the method according to claim 37, wherein the breast cancer cell of the subject is characterised by according to following formula Weighting substrate and tube chamber A graders score be more than -0.3:
(tube chamber A barycenter is classified for the substrate of weighting and tube chamber A graders score=- 0.25 (substrate barycenter grader score)+0.27 Device score)
Wherein described substrate barycenter grader score and the tube chamber A barycenter grader score be for subject breast cancer it is thin Expression of intrinsic gene set of the born of the same parents shown in table 1 in the cell is determined.
39. the method according to claim 38, wherein the breast cancer cell of the subject is characterised by the base of weighting Bottom and tube chamber A graders score are more than -0.2.
40. the method according to claim 39, wherein the breast cancer cell of the subject is characterised by the base of weighting Bottom and tube chamber A graders score are more than -0.25.
41. the method according to claim 37, wherein the breast cancer cell of the subject is characterised by the institute from table 1 The substrate barycenter grader score that expression of the intrinsic gene set shown in the cell is determined is less than or equal to 0.9.
42. method according to claim 41, wherein the breast cancer cell of the subject is characterised by substrate barycenter Grader score is less than or equal to 0.6.
43. method according to claim 41, wherein the breast cancer cell of the subject is characterised by substrate barycenter Grader score is in the range of 0.2 to 0.8.
44. method according to claim 43, wherein the breast cancer cell of the subject is characterised by substrate barycenter Grader score is in the range of 0.4 to 0.7.
45. the method according to any one of claim 37 to 44, wherein the breast cancer of the subject is characterised by The presence of androgen receptor positive tumor cell.
46. the method according to any one of claim 37 to 45, wherein the androgen receptor inhibitor is selected from:Grace is miscellaneous Shandong amine, Bicalutamide, Flutamide, Nilutamide, ARN509, ketoconazole, abiraterone acetate, VN/124-1 (TOK-001), Orteronel (TAK-700), Finasteride, galeterone, CPA, andarine, with and combinations thereof.
47. according to the method for claim 46, wherein androgen receptor inhibitor is the miscellaneous Shandong amine of grace.
48. method according to claim 47, wherein the miscellaneous Shandong amine of the grace is oral daily once, dosage is 160mg.
49. method according to claim 48, wherein the miscellaneous Shandong amine of the grace is used as the single glue for including the miscellaneous Shandong amine of 160mg grace Capsule is applied.
50. method according to claim 48, wherein the miscellaneous Shandong amine of the grace is applied in the form of four capsules, each capsule Include the miscellaneous Shandong amine of 40mg grace.
51. the method according to any one of claim 37 to 50, wherein the breast cancer comprising androgen receptor inhibitor Treatment is not also other anticancers of androgen receptor inhibitor comprising one or more.
52. method according to claim 51, wherein not being that other anticancers of androgen receptor inhibitor are selected from ring phosphorus Acid amides, fluorouracil, 5 FU 5 fluorouracil, methotrexate (MTX), thiotepa, carboplatin, cis-platinum, taxane, taxol, what protein was combined Taxol, docetaxel, vinorelbine, TAM, Raloxifene, Toremifene, fulvestrant, gemcitabine, Yi Li is replaced Health, Ipsapirone, Temozolomide, TPT, vincristine, vinblastine, eribulin, mutamycin, capecitabine, card Train his shore, Anastrozole, Exemestane, Letrozole, Leuprorelin, abarelix, Bath woods, Goserelin, tumer it is pregnant Ketone, Risedronate, Pamidronate, ibandronate, Alendronate, ground promise monoclonal antibody, zoledronate, toltrazuril list It is anti-, Lapatinib or Avastin, with and combinations thereof.
53. method according to claim 52, wherein described is not that other anticancers of androgen receptor inhibitor are purple China fir alcohol.
54. the method according to claim 37, in addition to test the subject to determine whether the subject has The step of including not being the breast cancer of breast cancer cell of substrate sample hypotype.
55. the method according to any one of claim 38 to 40, in addition to test the subject with determine it is described by The step of substrate and tube chamber A grader scores of the weighting of the breast cancer cell of examination person.
56. the method according to any one of claim 41 to 44, in addition to test the subject with determine it is described by The step of substrate barycenter grader score of the breast cancer cell of examination person.
57. method according to claim 40, wherein the subject does not receive or received except androgen receptor One wheel prior treatment of anticancer outside inhibitor is to treat triple negative breast cancer.
58. the method for triple negative breast cancer is treated in the subject for needing to treat, including:
(a) biological sample from subject is provided;
(b) biological sample is determined to determine whether biological sample is classified as substrate sample hypotype or another hypotype;With
If (c) biological sample is classified as not be substrate sample hypotype, subject is applied and includes androgen receptor inhibitor Breast cancer treatment, so as to treat the breast cancer of subject.
59. method according to claim 58, wherein determining biological sample to determine whether biological sample is classified as base Original pattern hypotype or another hypotype are carried out by detecting the expression of the intrinsic gene shown in table 1.
60. method according to claim 59, including:
(a) substrate barycenter grader score and the classification of tube chamber A barycenter of sample are determined from the expression of the intrinsic gene set shown in table 1 Device score;With
(b) substrate of weighting is calculated from substrate barycenter grader score and tube chamber A barycenter graders score according to following equation With tube chamber A grader scores:
(tube chamber A barycenter is classified for the substrate of weighting and tube chamber A graders score=- 0.25 (substrate barycenter grader score)+0.27 Device score)
With
If the substrate and tube chamber A graders score of wherein described weighting are more than -0.3, breast cancer is applied to the subject Treatment.
61. method according to claim 60, if wherein the substrate and tube chamber A graders score of weighting are more than -0.2, Then apply breast cancer treatment.
62. method according to claim 61, if wherein the substrate and tube chamber A graders score of the weighting be more than- 0.25, then using breast cancer treatment.
63. method according to claim 59, includes the base for expressing determination sample of the intrinsic gene set shown in table 1 Substrate heart grader score, if wherein substrate barycenter grader score is less than or equal to 0.9, using breast cancer treatment.
64. method according to claim 63, if wherein substrate barycenter grader score is applied less than or equal to 0.6 Use breast cancer treatment.
65. method according to claim 63, if wherein substrate barycenter grader score is in the range of 0.2 to 0.8, Breast cancer treatment then is applied to subject.
66. method according to claim 65, if wherein substrate barycenter grader score is in the range of 0.4 to 0.7, Breast cancer treatment then is applied to subject.
67. the method according to any one of claim 58 to 66, wherein the breast cancer of the subject is characterised by The presence of androgen receptor positive tumor cell.
68. the method according to any one of claim 58 to 67, wherein the androgen receptor inhibitor is miscellaneous selected from grace Shandong amine, Bicalutamide, Flutamide, Nilutamide, ARN509, ketoconazole, abiraterone acetate, VN/124-1 (TOK-001), Orteronel (TAK-700), Finasteride, galeterone, CPA, andarine, with and combinations thereof.
69. method according to claim 68, wherein the androgen receptor inhibitor is the miscellaneous Shandong amine of grace.
70. method according to claim 69, wherein the miscellaneous Shandong amine of the grace is oral daily once, dosage is 160mg.
71. method according to claim 70, wherein the miscellaneous Shandong amine of the grace is used as the single glue for including the miscellaneous Shandong amine of 160mg grace Capsule is applied.
72. method according to claim 70, wherein the miscellaneous Shandong amine of the grace is applied in the form of four capsules, each capsule Include the miscellaneous Shandong amine of 40mg grace.
73. the method according to any one of claim 58 to 72, wherein the breast cancer comprising androgen receptor inhibitor Treatment is not also other anticancers of androgen receptor inhibitor comprising one or more.
74. the method according to claim 73, wherein described is not that other anticancers of androgen receptor inhibitor are selected from Endoxan, fluorouracil, 5 FU 5 fluorouracil, methotrexate (MTX), thiotepa, carboplatin, cis-platinum, taxane, taxol, protein knot The taxol of conjunction, docetaxel, vinorelbine, TAM, Raloxifene, Toremifene, fulvestrant, gemcitabine, she It is vertical to replace health, Ipsapirone, Temozolomide, TPT, vincristine, vinblastine, eribulin, mutamycin, Ka Peita Shore, capecitabine, Anastrozole, Exemestane, Letrozole, Leuprorelin, abarelix, Bath woods, Goserelin, tumer Ground progesterone, Risedronate, Pamidronate, ibandronate, Alendronate, ground promise monoclonal antibody, zoledronate, toltrazuril Monoclonal antibody, Lapatinib or Avastin, with and combinations thereof.
75. according to the method for claim 74, wherein described is not that other anticancers of androgen receptor inhibitor are taxols.
76. the method according to any one of claim 58 to 75, wherein the biological sample is selected from cell, tissue and body Liquid.
77. the method according to claim 76, wherein the biological sample includes breast tissue or cell.
78. the method described in claim 77, wherein the tissue is obtained from biopsy.
79. the method according to claim 77, wherein the body fluid is selected from blood, lymph, urine, saliva, from conduit The liquid and nipple aspirate of irrigating solution.
80. method according to claim 62, wherein the subject does not receive or received except androgen receptor One wheel prior treatment of anticancer outside inhibitor is to treat triple negative breast cancer.
CN201580068041.7A 2014-12-12 2015-12-08 The method predicted the method for the reaction to breast cancer treatment agent and treat breast cancer Pending CN107109488A (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201462091195P 2014-12-12 2014-12-12
US62/091,195 2014-12-12
US201562142504P 2015-04-03 2015-04-03
US62/142,504 2015-04-03
US201562167110P 2015-05-27 2015-05-27
US62/167,110 2015-05-27
PCT/US2015/064500 WO2016094408A1 (en) 2014-12-12 2015-12-08 Method for predicting response to breast cancer therapeutic agents and method of treatment of breast cancer

Publications (1)

Publication Number Publication Date
CN107109488A true CN107109488A (en) 2017-08-29

Family

ID=55273509

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201580068041.7A Pending CN107109488A (en) 2014-12-12 2015-12-08 The method predicted the method for the reaction to breast cancer treatment agent and treat breast cancer

Country Status (15)

Country Link
US (3) US10196693B2 (en)
EP (2) EP3604556A1 (en)
JP (1) JP6735277B2 (en)
KR (1) KR20170095306A (en)
CN (1) CN107109488A (en)
AU (1) AU2015360767A1 (en)
BR (1) BR112017012142A2 (en)
CA (1) CA2970469A1 (en)
ES (1) ES2748005T3 (en)
IL (1) IL252587A0 (en)
MX (1) MX2017007707A (en)
RU (1) RU2017120330A (en)
SG (1) SG11201704425TA (en)
WO (1) WO2016094408A1 (en)
ZA (1) ZA201703904B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109735625A (en) * 2019-03-18 2019-05-10 马榕 Application of the nipple discharge in detection tumor-related gene
WO2020001473A1 (en) * 2018-06-28 2020-01-02 复旦大学 Use of small nucleolar ribonucleic acid snord33 as biomarker for preparation of detection kit

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6158180B2 (en) 2011-07-29 2017-07-05 メディベイション プロステイト セラピューティクス, インコーポレイテッド Breast cancer treatment
US20140243211A1 (en) 2013-02-28 2014-08-28 Indiana University Research & Technology Corporation Blood biomarkers for suicidality
US10196693B2 (en) 2014-12-12 2019-02-05 Medivation Prostate Therapeutics Llc Method for predicting response to breast cancer therapeutic agents and method of treatment of breast cancer
AU2016274988A1 (en) 2015-06-12 2017-12-21 Indiana University Research & Technology Corporation Predicting suicidality using a combined genomic and clinical risk assessment
KR101966493B1 (en) * 2016-06-27 2019-04-05 국립암센터 Biomarkers for Predicting Triple Negative Breast Cancer Prognostication
KR101896558B1 (en) * 2016-11-21 2018-09-07 주식회사 젠큐릭스 Methods for predicting risk of recurrence of breast cancer patients
JPWO2018198927A1 (en) * 2017-04-26 2019-11-07 日本電信電話株式会社 N × N optical switch
CA3105451A1 (en) 2017-05-12 2018-11-15 Indiana University Research And Technology Corporation Precision medicine for treating and preventing suicidality
RU2648523C1 (en) * 2017-05-22 2018-03-26 Федеральное государственное бюджетное научное учреждение "Томский национальный исследовательский медицинский центр" Российской академии наук ("Томский НИМЦ") Method for predicting the outcome of a disease in patients with luminal and thrice negative breast cancer in patients who did not receive chemotherapy or hormone therapy in the neoadjuvant regimen
WO2024035653A1 (en) * 2022-08-06 2024-02-15 H. Lee Moffitt Cancer Center And Research Institute, Inc. Predictive biomarker in avastin in colon cancer

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101917982A (en) * 2007-11-12 2010-12-15 彼帕科学公司 Treatment of breast cancer with a PARP inhibitor alone or in combination with anti-tumor agents
CN103997894A (en) * 2011-07-29 2014-08-20 麦迪韦逊前列腺治疗股份有限公司 Treatment of breast cancer

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US5800992A (en) 1989-06-07 1998-09-01 Fodor; Stephen P.A. Method of detecting nucleic acids
US6040138A (en) 1995-09-15 2000-03-21 Affymetrix, Inc. Expression monitoring by hybridization to high density oligonucleotide arrays
EP0880598A4 (en) 1996-01-23 2005-02-23 Affymetrix Inc Nucleic acid analysis techniques
US6033860A (en) 1997-10-31 2000-03-07 Affymetrix, Inc. Expression profiles in adult and fetal organs
US6020135A (en) 1998-03-27 2000-02-01 Affymetrix, Inc. P53-regulated genes
US6937713B1 (en) 1999-12-30 2005-08-30 At&T Corp. IP call forward profile
US7504222B2 (en) 2001-10-31 2009-03-17 Millennium Pharmaceuticals, Inc. Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
US20070192880A1 (en) 2003-10-03 2007-08-16 University Of Rochester Horming response element binding transregulators
US20070059720A9 (en) 2004-12-06 2007-03-15 Suzanne Fuqua RNA expression profile predicting response to tamoxifen in breast cancer patients
DK2444085T3 (en) 2005-05-13 2015-04-27 Univ California Diarylhydantoinforbindelser as androgenreceptorantagonister for treating cancer
US7709517B2 (en) 2005-05-13 2010-05-04 The Regents Of The University Of California Diarylhydantoin compounds
CA2630974A1 (en) 2005-11-23 2007-05-31 University Of Utah Research Foundation Methods and compositions involving intrinsic genes
DK2368550T3 (en) 2006-03-27 2013-09-30 Univ California Androgen receptor modulator for the treatment of prostate cancer and androgen receptor-associated diseases
RU2449993C2 (en) 2006-03-29 2012-05-10 Те Риджентс Оф Те Юниверсити Оф Калифорния Diarylthiohydatoic compounds
EP2397469B1 (en) 2007-10-26 2014-12-31 The Regents of The University of California Diarylhydantoin compounds
US8450290B2 (en) 2007-11-26 2013-05-28 Enzon Pharmaceuticals, Inc. Methods for treating androgen receptor dependent disorders including cancers
US20110130296A1 (en) 2008-03-14 2011-06-02 The Regents Of The University Of California Multi-gene classifiers and prognostic indicators for cancers
WO2009158143A1 (en) 2008-05-30 2009-12-30 The University Of North Carolina At Chapel Hill Gene expression profiles to predict breast cancer outcomes
ES2535466T3 (en) 2009-02-24 2015-05-11 Medivation Prostate Therapeutics, Inc. Specific compounds of diarylthiohydantoin
EP2416657A4 (en) 2009-04-09 2012-09-05 Medivation Prostate Therapeutics Inc Substituted di-arylhydantoin and di-arylthiohydantoin compounds and methods for use thereof
WO2010125117A2 (en) 2009-04-29 2010-11-04 Ralph Wirtz A method to assess prognosis and to predict therapeutic success in cancer by determining hormone receptor expression levels
US8507195B2 (en) 2009-08-20 2013-08-13 The Regents Of The University Of Colorado MiRNAs dysregulated in triple-negative breast cancer
JP2013504064A (en) 2009-09-03 2013-02-04 ザ スクリプス リサーチ インスティチュート How to classify circulating tumor cells
EP2485804A4 (en) 2009-10-07 2015-07-29 Medivation Technologies Inc Substituted phenylcarbamoyl alkylamino arene compounds and n,n'-bis-arylurea compounds
CA2830240A1 (en) 2011-03-15 2012-09-20 The University Of North Carolina At Chapell Hill Methods of treating breast cancer with anthracycline therapy
US8781912B2 (en) 2011-03-15 2014-07-15 Opera Solutions, Llc Computer-based method and computer program product for setting floor prices for items sold at auction
US9181588B2 (en) 2011-11-30 2015-11-10 The University Of Utah Research Foundation Methods of treating breast cancer with taxane therapy
ES2696202T3 (en) 2012-08-23 2019-01-14 Univ Colorado Regents Method to determine the treatment of breast cancer
US9175291B2 (en) * 2012-10-11 2015-11-03 Isis Pharmaceuticals Inc. Modulation of androgen receptor expression
US20140154681A1 (en) 2012-11-12 2014-06-05 Nanostring Technologies, Inc. Methods to Predict Breast Cancer Outcome
US10679730B2 (en) * 2013-05-28 2020-06-09 The University Of Chicago Prognostic and predictive breast cancer signature
US10196693B2 (en) 2014-12-12 2019-02-05 Medivation Prostate Therapeutics Llc Method for predicting response to breast cancer therapeutic agents and method of treatment of breast cancer

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101917982A (en) * 2007-11-12 2010-12-15 彼帕科学公司 Treatment of breast cancer with a PARP inhibitor alone or in combination with anti-tumor agents
CN103997894A (en) * 2011-07-29 2014-08-20 麦迪韦逊前列腺治疗股份有限公司 Treatment of breast cancer

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
FUTOSHI AKIYAMA等: "Triple Negative Breast Cancer: Clinicopathological Characteristics and Treatment Strategies", 《BREAST CANCER》 *
林能明等: "《新编抗肿瘤药物学》", 31 May 2014, 军事医学科学出版社 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020001473A1 (en) * 2018-06-28 2020-01-02 复旦大学 Use of small nucleolar ribonucleic acid snord33 as biomarker for preparation of detection kit
CN109735625A (en) * 2019-03-18 2019-05-10 马榕 Application of the nipple discharge in detection tumor-related gene

Also Published As

Publication number Publication date
EP3230471B1 (en) 2019-08-28
IL252587A0 (en) 2017-07-31
US11186876B2 (en) 2021-11-30
RU2017120330A (en) 2019-01-14
US20220056541A1 (en) 2022-02-24
US11952634B2 (en) 2024-04-09
RU2017120330A3 (en) 2019-07-24
BR112017012142A2 (en) 2018-01-02
KR20170095306A (en) 2017-08-22
JP2018504892A (en) 2018-02-22
WO2016094408A1 (en) 2016-06-16
EP3230471A1 (en) 2017-10-18
US10196693B2 (en) 2019-02-05
AU2015360767A1 (en) 2017-06-08
US20190169697A1 (en) 2019-06-06
MX2017007707A (en) 2018-03-06
JP6735277B2 (en) 2020-08-05
ES2748005T3 (en) 2020-03-12
US20160168646A1 (en) 2016-06-16
SG11201704425TA (en) 2017-06-29
EP3604556A1 (en) 2020-02-05
ZA201703904B (en) 2019-12-18
CA2970469A1 (en) 2016-06-16

Similar Documents

Publication Publication Date Title
AU2012345789B2 (en) Methods of treating breast cancer with taxane therapy
CN107109488A (en) The method predicted the method for the reaction to breast cancer treatment agent and treat breast cancer
KR102023584B1 (en) PREDICTING GASTROENTEROPANCREATIC NEUROENDOCRINE NEOPLASMS (GEP-NENs)
RU2721130C2 (en) Assessment of activity of cell signaling pathways using a linear combination(s) of target gene expression
RU2719194C2 (en) Assessing activity of cell signaling pathways using probabilistic modeling of expression of target genes
CN106119405B (en) A kind of prognostic markers object of lung cancer, the method and application for using label prediction lung cancer for prognosis
CN110382521A (en) The active method of tumor-inhibitory FOXO is distinguished from oxidative stress
AU2013337264B2 (en) Novel fusion molecules and uses thereof
US20030087266A1 (en) IGs as modifiers of the p53 pathway and methods of use
CN112795650A (en) Evaluation of PI3K cell signaling pathway activity using mathematical modeling of target gene expression
KR20230005422A (en) Methods and compositions for reducing immunosupression by tumor cells
EP1463928A2 (en) Methods of diagnosis of lung cancer, compositions and methods of screening for modulators of lung cancer
KR20080007659A (en) Composition and method for diagnosing esophageal cancer and metastasis of esophageal cancer
CN101573453A (en) Methods of predicting distant metastasis of lymph node-negative primary breast cancer using biological pathway gene expression analysis
CN101687050A (en) Be used to differentiate the method and the material of the origin of the cancer that former initiation source is not clear
CN111448325A (en) Assessment of JAK-STAT3 cell signaling pathway activity using mathematical modeling of target gene expression
KR20140140069A (en) Compositions and methods for diagnosis and treatment of pervasive developmental disorder
CN113383085A (en) Method and system for analyzing nucleic acid molecules
KR101695866B1 (en) Phosphodiesterase 9a as prostate cancer marker
US20230022417A1 (en) Chemical compositions and methods of use
CN107002124B (en) Method for determining the prognosis of survival of a patient suffering from pancreatic cancer
CN101778954A (en) Predictive markers for egfr inhibitor treatment
KR101783994B1 (en) A method for diagnosing a gastric cancer and a diagnostic kit using the method
KR20190126812A (en) Biomarkers for Disease Diagnosis
US20220265798A1 (en) Cancer vaccine compositions and methods for using same to prevent and/or treat cancer

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
CB02 Change of applicant information
CB02 Change of applicant information

Address after: American California

Applicant after: Maddie Wilson prostate Medical Co., Ltd.

Address before: American California

Applicant before: Mai Diweixun prostate treatment limited company

REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1240626

Country of ref document: HK

WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20170829